data_1l5c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l5c _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -93.82 -170.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.82 162.9 28.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.658 0.742 . . . . 0.0 112.971 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.412 ' OD2' HD12 ' A' ' 5' ' ' LEU . 37.9 t70 -83.18 -76.57 0.27 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.404 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.74 HD13 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -146.35 -136.56 0.09 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.81 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.637 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.9 -40.57 68.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.74 ' CG2' HD13 ' A' ' 5' ' ' LEU . 19.4 m -94.58 101.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.586 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 87.0 mtt180 -67.65 -164.76 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.904 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER 46.75 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.213 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.041 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.496 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 19.6 Cg_exo . . . . . 0 N--CA 1.459 -0.54 0 CA-C-O 121.322 0.468 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.6 t -158.06 -176.54 5.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.268 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 59.79 -136.06 50.42 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.36 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.424 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 12.7 Cg_endo -89.79 108.53 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 112.847 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.17 -67.39 2.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.068 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.27 32.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.439 0.466 . . . . 0.0 112.686 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.69 -36.88 73.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.063 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -103.01 -174.56 26.55 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.786 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.23 179.5 7.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -84.03 146.99 27.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 13.0 m-85 -120.96 -101.98 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.938 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.68 -98.56 0.35 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.669 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 26' ' ' ILE . 26.3 Cg_endo -99.7 -119.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.617 2.878 . . . . 0.0 111.627 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.98 51.38 0.4 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.596 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -128.07 157.12 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 122.251 1.024 . . . . 0.0 113.35 -176.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -154.97 134.16 12.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.607 178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 32.2 m -152.1 119.38 5.94 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.783 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.83 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.96 122.55 7.35 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.369 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 44.1 t0 -58.08 -56.32 23.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.73 1.265 . . . . 0.0 107.824 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.02 24.82 0.74 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.83 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.84 33.17 0.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . 51.08 172.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.661 ' SG ' ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -104.17 129.77 51.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.804 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.53 116.66 17.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.55 177.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.4 t -97.95 106.89 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.065 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.39 26.41 56.56 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.895 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.804 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.6 m -95.95 173.46 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.611 0.364 . . . . 0.0 110.62 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.72 -56.57 4.33 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.327 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.4 mp0 -73.07 6.16 2.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -113.27 -21.62 10.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.785 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.87 -19.15 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.6 -23.67 6.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.886 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.401 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.582 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.658 0.266 . . . . 0.0 110.486 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.724 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.5 Cg_exo -40.01 159.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.237 3.291 . . . . 0.0 116.982 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.19 152.64 10.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.767 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.94 3.25 6.97 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.955 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -90.27 57.29 3.67 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 117.33 0.565 . . . . 0.0 111.135 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.8 34.31 36.83 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.85 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.74 -156.57 28.6 Favored Glycine 0 CA--C 1.502 -0.739 0 C-N-CA 120.449 -0.882 . . . . 0.0 115.128 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.724 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.7 mmt-85 -116.32 152.94 32.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.189 0.519 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -63.61 160.54 16.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.579 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -159.97 -96.1 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.782 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.661 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -75.9 -169.81 1.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.876 0.87 . . . . 0.0 112.558 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.734 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -38.16 97.46 0.01 OUTLIER 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.508 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.884 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 50.81 30.47 21.75 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.099 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 5.1 mm -90.34 155.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 122.097 0.951 . . . . 0.0 111.628 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.739 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 19.0 t -141.81 106.52 4.88 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -91.61 160.56 15.33 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.485 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -127.11 -179.83 1.04 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 113.996 -1.457 . . . . 0.0 110.052 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.2 Cg_exo -72.67 -10.83 25.58 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.453 2.102 . . . . 0.0 112.352 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.91 -29.5 9.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.87 31.27 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.437 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.581 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.2 m -97.81 167.94 10.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.097 0.475 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.708 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -151.87 144.61 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.391 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -61.92 94.29 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.739 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.1 m-20 -91.85 126.78 52.43 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.84 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 34.0 Cg_exo -59.83 -3.25 2.01 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 123.658 2.905 . . . . 0.0 109.716 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.39 -25.76 59.68 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.309 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.884 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.3 m -127.46 -20.14 4.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.8 t70 171.18 -26.15 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.068 1 N-CA-C 121.909 4.04 . . . . 0.0 121.909 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.786 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.1 Cg_endo -103.1 -70.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.656 0 C-N-CA 122.335 2.024 . . . . 0.0 112.135 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -72.52 -6.97 47.56 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.051 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.84 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.67 -157.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 112.436 -2.166 . . . . 0.0 112.546 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.79 -178.32 1.49 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.122 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -74.37 62.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.257 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.573 ' CG2' ' H ' ' A' ' 3' ' ' LEU . 3.6 p -144.69 -162.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.383 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.581 ' HG ' ' HE ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.47 157.3 38.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.84 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.33 -122.69 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.185 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -94.97 -139.44 0.24 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.535 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.97 -36.15 49.36 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.722 ' H ' HD23 ' A' ' 5' ' ' LEU . 28.0 m -100.98 85.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.33 0.586 . . . . 0.0 111.495 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.581 ' HE ' ' HG ' ' A' ' 3' ' ' LEU . 9.2 mtt180 -73.09 123.97 24.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.048 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -173.35 74.38 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.667 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 6.6 Cg_exo . . . . . 0 N--CA 1.458 -0.613 0 N-CA-C 114.121 0.777 . . . . 0.0 114.121 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 19' ' ' GLY . 8.2 t -153.75 -171.21 3.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.747 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.05 -136.93 49.97 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.555 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.8 Cg_endo -89.06 98.71 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.641 3.561 . . . . 0.0 112.965 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.07 -67.18 3.71 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.9 34.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-O 121.744 0.636 . . . . 0.0 112.282 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.773 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.83 -34.41 69.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.371 -0.915 . . . . 0.0 110.264 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.74 -168.34 15.32 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.821 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.733 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.52 -179.54 7.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.726 0.263 . . . . 0.0 110.612 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.443 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 1.7 m -78.59 158.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.733 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 37.6 m-85 -138.99 -69.52 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.749 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -132.5 -105.05 0.95 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.177 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -100.28 105.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.444 2.763 . . . . 0.0 113.037 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 52.5 21.98 1.98 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.756 0.313 . . . . 0.0 110.264 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.749 HG22 ' H ' ' A' ' 23' ' ' GLY . 4.8 tt -110.84 160.93 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.22 1.009 . . . . 0.0 112.763 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 145.62 27.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.736 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -146.43 103.84 3.72 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.897 -177.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.897 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.86 118.84 5.71 Favored Glycine 0 N--CA 1.409 -3.133 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.804 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 26.0 t0 -58.25 -57.72 11.65 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -83.09 21.78 1.04 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.897 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.24 35.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 39.23 -169.97 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.289 0.476 . . . . 0.0 114.289 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.3 t -125.17 138.24 54.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.792 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.03 119.32 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.493 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.535 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.4 t -95.2 105.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.804 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.25 22.15 55.17 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.855 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -89.09 178.64 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.553 0.341 . . . . 0.0 110.163 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -50.21 -56.42 11.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.827 0.346 . . . . 0.0 111.171 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.85 5.12 3.44 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.05 -23.91 12.15 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.98 -17.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.86 -23.18 1.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 111.482 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.71 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.964 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.851 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 31.5 Cg_exo -37.23 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.979 3.12 . . . . 0.0 117.362 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -161.66 152.99 18.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.43 177.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.27 4.73 7.93 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.881 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -90.34 54.55 2.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 117.395 0.597 . . . . 0.0 111.099 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.15 32.86 50.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.33 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.679 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 165.16 -158.7 31.64 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.307 -0.949 . . . . 0.0 114.921 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.851 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.0 mmt180 -117.33 154.08 31.87 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.017 0.437 . . . . 0.0 110.922 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.964 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 38.2 t -60.17 167.0 2.57 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.815 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.493 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -165.76 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.824 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.671 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.46 -169.7 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.827 0.851 . . . . 0.0 112.884 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.772 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.07 96.21 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.851 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 51.87 29.15 26.11 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.162 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -91.46 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 121.872 0.844 . . . . 0.0 111.397 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.727 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 44.6 t -139.6 108.4 5.96 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.619 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.9 t -91.04 155.9 18.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.501 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -128.97 -179.6 1.04 Allowed Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 114.062 -1.427 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.8 Cg_exo -72.22 -11.05 26.59 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.427 2.084 . . . . 0.0 112.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.97 -27.1 13.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.59 170.19 24.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.135 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 26' ' ' ILE . 3.9 m -94.98 163.26 13.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 111.039 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.667 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -150.21 148.73 29.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.068 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.89 93.14 0.18 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.727 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.0 m-20 -91.4 128.57 46.4 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.848 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 31.4 Cg_exo -60.58 -2.45 2.0 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.445 2.763 . . . . 0.0 109.721 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.94 -24.99 58.57 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.034 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.851 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.4 m -128.98 -21.01 3.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 7.1 t70 171.67 -26.33 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.406 1 N-CA-C 122.163 4.134 . . . . 0.0 122.163 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.805 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 5.4 Cg_endo -102.18 -70.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.635 0 CA-C-N 122.693 1.997 . . . . 0.0 111.788 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.3 tt0 -72.89 -6.66 46.64 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.153 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.848 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.19 -157.81 0.08 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.646 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.33 -178.32 1.68 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.15 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -74.92 61.99 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.658 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.312 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.774 0.321 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.97 152.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.83 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.593 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.59 166.05 24.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.04 -136.27 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.32 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.675 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -94.87 -124.5 0.11 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -73.06 -47.72 42.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.675 ' H ' HD11 ' A' ' 5' ' ' LEU . 18.7 m -87.36 85.87 2.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 57.4 mtt180 -74.8 -162.98 0.18 Allowed 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.451 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 41.38 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.767 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.769 -179.521 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.4 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 CA-C-O 121.338 0.474 . . . . 0.0 113.207 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.695 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.5 t -156.89 -172.39 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.752 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 57.79 -139.49 47.12 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.637 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.9 Cg_endo -88.92 98.16 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.371 3.381 . . . . 0.0 112.721 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -73.66 1.39 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.59 34.36 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 121.637 0.576 . . . . 0.0 111.878 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.68 -37.9 67.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.284 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.02 -168.14 22.28 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.758 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.662 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.41 -179.22 6.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.26 148.58 33.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.681 ' HB2' HG21 ' A' ' 26' ' ' ILE . 17.6 m-85 -128.1 -19.71 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 169.67 -104.21 0.2 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 118.999 -1.572 . . . . 0.0 114.81 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 28.8 Cg_endo -101.74 107.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.717 2.945 . . . . 0.0 113.12 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.52 22.6 1.58 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.182 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.681 HG21 ' HB2' ' A' ' 22' ' ' PHE . 3.3 tt -115.13 157.1 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 122.258 1.028 . . . . 0.0 113.029 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.572 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -160.43 138.45 9.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.356 -1.747 . . . . 0.0 107.35 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 20.4 m -150.1 128.35 12.06 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.097 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.859 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -107.02 126.63 8.51 Favored Glycine 0 N--CA 1.407 -3.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 37.3 t0 -59.16 -59.57 5.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.998 1.399 . . . . 0.0 108.722 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -81.09 15.15 1.98 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.859 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -144.16 31.49 1.24 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.083 -175.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 45.33 175.61 0.01 OUTLIER Glycine 0 CA--C 1.521 0.445 0 N-CA-C 114.899 0.719 . . . . 0.0 114.899 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -100.11 134.45 43.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.844 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 30.2 m-85 -131.04 101.66 5.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.404 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.679 HG22 HD13 ' A' ' 26' ' ' ILE . 4.5 t -97.16 107.36 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.253 0.549 . . . . 0.0 110.23 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.47 -0.0 44.5 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.394 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.844 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.9 p -70.13 -168.24 0.21 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 117.338 0.569 . . . . 0.0 110.245 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -76.61 -39.08 53.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.323 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.558 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -74.7 7.27 3.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.295 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.572 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -112.91 -21.12 11.3 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -51.15 -15.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.02 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.69 -21.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.254 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.86 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 44.4 Cg_exo -38.81 154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.761 2.307 . . . . 0.0 115.648 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -162.11 154.58 19.62 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.881 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 7.11 7.72 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.287 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 t -91.53 51.72 1.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.42 32.91 61.25 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.624 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.712 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.42 -153.96 24.67 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.533 -0.842 . . . . 0.0 115.202 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.86 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.0 mmt-85 -120.89 159.24 25.92 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.594 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.6 t -55.86 155.8 5.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 72' ' ' ILE . . . -150.89 -26.82 0.21 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -157.67 -171.35 3.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.397 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.878 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.33 86.31 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.024 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 57.27 65.54 3.49 Favored Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.939 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.851 HG23 ' HB1' ' A' ' 68' ' ' ALA . 3.3 mm -136.77 136.6 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 16.1 t -122.98 109.58 14.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -96.23 158.59 15.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -173.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.2 m -128.26 -179.92 1.1 Allowed Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.315 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.526 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -72.14 -9.42 24.44 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.376 2.051 . . . . 0.0 112.687 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.88 -32.42 8.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.255 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.25 170.21 36.58 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.664 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 27.0 m -96.88 167.4 11.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.394 0.616 . . . . 0.0 111.87 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.98 142.92 21.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.596 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.573 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -62.87 117.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.024 0.44 . . . . 0.0 110.947 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 47.5 p30 -101.04 108.25 53.66 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.906 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 53.1 Cg_exo -56.37 -15.69 15.78 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.855 3.037 . . . . 0.0 110.084 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.04 64.13 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.66 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.942 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -109.54 -27.42 9.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -176.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.3 t70 172.56 -29.44 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.633 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.024 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.3 Cg_endo -108.97 -71.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 123.099 2.533 . . . . 0.0 112.767 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -67.74 -5.85 18.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -73.49 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 112.047 -2.342 . . . . 0.0 111.057 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.71 -178.82 0.32 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -74.42 62.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' A' ' 86' ' ' ASP . 12.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.41 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.798 0.332 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 3' ' ' LEU . 4.0 t 64.05 168.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.536 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -69.66 156.85 38.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.668 0.747 . . . . 0.0 112.73 -178.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.54 -77.0 0.23 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.708 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.86 -139.59 0.13 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.474 -178.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.541 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -76.24 -38.43 56.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.73 0.3 . . . . 0.0 110.923 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.673 ' CG2' HD12 ' A' ' 5' ' ' LEU . 19.3 m -93.33 85.0 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 121.367 0.603 . . . . 0.0 110.677 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.537 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 56.4 mtt85 -74.33 -178.73 3.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.183 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m 57.38 101.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.572 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.481 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 23.8 Cg_exo . . . . . 0 N--CA 1.461 -0.386 0 CA-C-O 121.042 0.351 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.4 t -157.5 -179.98 8.69 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.903 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.752 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 60.89 -134.79 49.28 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.637 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 7.7 Cg_endo -91.89 99.5 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.562 3.508 . . . . 0.0 112.951 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.87 -69.13 3.13 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.481 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.56 32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 CA-C-O 121.533 0.518 . . . . 0.0 112.332 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -33.8 71.66 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.848 0.832 . . . . 0.0 109.862 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.8 -174.84 20.93 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.807 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.548 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.94 -178.95 5.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.6 m -77.57 141.21 39.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 8.8 m-85 -119.11 -23.67 6.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' HG21 ' A' ' 26' ' ' ILE . . . -171.56 -110.54 0.24 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.586 -1.293 . . . . 0.0 114.317 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.91 101.37 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 112.643 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 21.45 3.64 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.752 -0.379 . . . . 0.0 109.991 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.612 HD13 HG13 ' A' ' 36' ' ' VAL . 2.3 tt -107.76 166.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.832 0.825 . . . . 0.0 112.742 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.725 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -153.76 140.45 18.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.37 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.88 100.91 3.57 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.876 -177.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.935 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.13 117.82 5.01 Favored Glycine 0 N--CA 1.405 -3.407 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.295 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 21.0 t0 -58.75 -57.27 13.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -83.87 20.14 1.56 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.935 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.61 33.22 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.679 ' C ' ' HB3' ' A' ' 69' ' ' ALA . . . 42.53 176.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.6 t -115.83 134.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.65 125.88 31.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.568 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.612 HG13 HD13 ' A' ' 26' ' ' ILE . 3.0 t -93.81 101.71 12.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.131 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.84 19.51 50.08 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.12 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.745 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m -83.27 174.73 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.893 0.477 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -43.75 -55.8 4.21 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.15 -7.61 50.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -103.99 -16.96 15.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -19.0 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.523 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.47 -24.01 2.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.126 0.421 . . . . 0.0 111.26 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.828 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -38.74 155.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.133 3.222 . . . . 0.0 117.619 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -165.04 153.31 11.83 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.824 177.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 5.53 3.01 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.97 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.7 t -90.66 54.03 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 117.425 0.612 . . . . 0.0 111.164 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.98 33.21 56.92 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.861 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.645 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.0 -154.09 24.96 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.642 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.828 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.3 mmt180 -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.153 0.502 . . . . 0.0 110.986 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 46.2 t -62.32 157.94 18.56 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.039 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -155.39 -91.65 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.66 -171.18 2.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.926 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.37 90.68 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.941 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.88 62.4 6.36 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 119.062 -1.542 . . . . 0.0 110.89 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -129.99 149.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.4 t -136.63 102.99 5.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -91.37 160.11 15.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.507 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -127.85 -179.49 0.98 Allowed Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.261 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.507 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.51 -10.08 24.89 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.364 2.042 . . . . 0.0 112.634 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -31.2 8.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.482 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.1 167.73 34.05 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.465 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.584 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 16.3 m -96.0 167.11 11.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.383 0.611 . . . . 0.0 112.4 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.57 140.77 21.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -62.18 116.68 5.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.894 0.378 . . . . 0.0 110.534 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.737 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 52.2 p30 -99.06 109.32 53.72 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-O 121.573 0.701 . . . . 0.0 111.702 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.83 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.82 -14.61 14.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.064 3.176 . . . . 0.0 110.06 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.96 -27.84 62.06 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.123 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.859 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -109.89 -28.45 8.75 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -176.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 173.6 -29.18 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.253 1 N-CA-C 122.371 4.211 . . . . 0.0 122.371 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.941 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -106.01 -70.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.459 0 C-N-CA 122.628 2.219 . . . . 0.0 112.568 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.711 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.3 tt0 -69.04 -7.07 32.19 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -75.5 -157.76 0.07 Allowed 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.635 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.01 -179.3 1.18 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -74.76 62.36 1.07 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.06 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.853 0.359 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -67.8 156.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.126 0.488 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.728 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.64 169.69 17.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 18.9 t0 -78.59 -137.55 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 113.952 -1.476 . . . . 0.0 108.192 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.744 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -91.28 -123.62 0.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.459 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -72.23 -45.6 59.58 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.744 ' H ' HD11 ' A' ' 5' ' ' LEU . 11.1 m -88.13 85.19 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.662 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.728 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 51.5 mtt85 -75.56 -177.12 3.51 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.475 HG21 HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 27.62 104.54 0.0 OUTLIER 'General case' 0 C--N 1.34 0.17 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.972 179.661 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 22.7 Cg_exo . . . . . 0 N--CA 1.445 -1.366 0 CA-C-O 121.061 0.359 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.0 t -158.85 -172.39 3.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 65.02 -141.34 43.28 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.14 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.95 89.6 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.018 3.145 . . . . 0.0 112.881 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.48 -68.28 0.94 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.301 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.99 34.12 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-O 121.632 0.573 . . . . 0.0 112.022 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -73.0 -35.82 66.92 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.339 -0.93 . . . . 0.0 110.61 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -111.1 -162.04 17.57 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.293 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.86 174.28 13.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -89.18 170.34 10.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.823 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.729 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 67.5 m-85 -144.02 -12.05 0.65 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.42 -95.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 118.691 -1.718 . . . . 0.0 115.055 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -101.07 99.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.378 2.718 . . . . 0.0 113.481 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.59 21.84 1.98 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.316 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.704 HD13 HG22 ' A' ' 36' ' ' VAL . 3.8 tt -108.95 160.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -157.32 145.47 19.23 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 113.745 -1.57 . . . . 0.0 108.653 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.95 106.25 3.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.553 -178.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.843 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.23 128.22 8.96 Favored Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.63 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 35.9 t70 -58.5 -65.84 0.59 Allowed 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.532 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 pt-20 -81.36 26.87 0.44 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.843 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.58 31.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.687 ' CA ' ' HB2' ' A' ' 69' ' ' ALA . . . 36.49 -166.7 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.5 142.88 38.25 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.714 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 10.3 m-85 -131.93 98.0 4.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.391 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.704 HG22 HD13 ' A' ' 26' ' ' ILE . 3.5 t -95.75 130.71 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.211 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.76 28.53 5.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.811 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -109.23 170.25 8.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.46 0.304 . . . . 0.0 110.66 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -54.95 -55.12 34.21 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.56 8.89 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -107.05 -37.3 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.604 ' CD1' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -56.83 -11.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.613 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.8 -13.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 18.0 t . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.496 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' H ' ' CD ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 120.874 0.369 . . . . 0.0 111.99 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.742 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 27.3 Cg_exo -61.72 179.56 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.277 2.651 . . . . 0.0 115.615 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.74 154.32 9.51 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.256 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.07 -0.03 6.77 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.277 -0.874 . . . . 0.0 114.141 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.7 t -92.08 50.79 1.7 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 117.478 0.639 . . . . 0.0 111.369 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.69 40.91 49.36 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.083 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.626 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.68 -159.44 32.44 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.742 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.4 mmt180 -114.68 155.99 25.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.094 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 23.9 t -61.11 144.89 52.71 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.523 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.695 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -139.85 -97.82 0.16 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.271 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.51 -170.21 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -43.73 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.912 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 54.8 71.61 0.69 Allowed Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.179 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.758 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -137.01 145.47 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 33.8 t -132.08 103.67 6.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -91.44 152.36 20.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.478 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -125.07 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.892 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -71.72 -9.71 25.35 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -33.0 8.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.021 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA2' HD12 ' A' ' 26' ' ' ILE . . . 171.09 169.92 34.65 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.562 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 3.3 m -98.68 164.43 12.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.102 0.477 . . . . 0.0 111.132 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.67 141.81 21.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.03 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -58.81 111.3 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.853 0.358 . . . . 0.0 110.102 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.675 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.1 p30 -92.03 110.5 44.46 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.751 . . . . 0.0 111.683 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.754 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -57.49 -13.02 12.3 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.188 3.258 . . . . 0.0 110.086 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.33 -30.0 57.51 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.561 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.912 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -108.93 -27.27 9.78 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 5.4 t70 175.37 -29.97 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 1 N-CA-C 122.28 4.178 . . . . 0.0 122.28 -177.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.908 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.2 Cg_endo -104.28 -70.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.46 0 C-N-CA 122.45 2.1 . . . . 0.0 112.242 -172.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.754 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 28.9 tt0 -70.36 -8.48 50.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 175.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -75.85 -157.64 0.08 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.89 -2.414 . . . . 0.0 112.741 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.46 -178.7 1.46 Allowed 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.929 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -74.42 62.39 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.6 t . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.027 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.342 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.94 -172.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.55 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.09 159.92 33.83 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.709 0.766 . . . . 0.0 112.723 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.29 -124.98 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.721 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.748 HD12 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -95.16 -136.79 0.22 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.561 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -73.99 -39.85 63.37 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.748 ' CG2' HD12 ' A' ' 5' ' ' LEU . 19.3 m -95.04 85.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 20.4 mtt180 -73.92 -163.2 0.16 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.272 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.461 ' O ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER 41.69 85.74 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.529 0.165 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.303 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.5 Cg_exo . . . . . 0 N--CA 1.462 -0.367 0 CA-C-O 121.567 0.57 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' GLY . 2.0 t -156.84 -175.81 5.63 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.242 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.733 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.01 -138.68 48.7 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.657 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.7 Cg_endo -90.32 100.23 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.371 3.381 . . . . 0.0 112.808 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.14 -69.08 3.09 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.152 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.57 31.4 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 121.386 0.437 . . . . 0.0 112.489 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.09 -36.69 72.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.646 0.736 . . . . 0.0 109.946 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.07 -174.44 23.56 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.155 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.58 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.3 -178.79 5.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 151.53 37.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 11.3 m-85 -133.51 -17.72 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -179.0 -112.07 0.33 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.937 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -101.15 107.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.572 2.848 . . . . 0.0 112.744 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.48 24.12 2.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.523 HD13 ' SG ' ' A' ' 79' ' ' CYS . 1.9 tt -114.6 161.79 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.922 0.868 . . . . 0.0 113.118 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.45 141.4 22.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.371 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.522 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -144.13 102.66 3.9 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.839 -177.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.872 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.43 118.72 5.28 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.023 -1.561 . . . . 0.0 109.42 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -57.93 -61.67 2.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -81.31 19.9 0.91 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.437 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.872 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -150.48 32.77 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.619 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 43.34 175.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.448 0.539 . . . . 0.0 114.448 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.486 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -111.39 136.54 50.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.852 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.23 119.74 21.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.327 178.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.5 HG13 ' CD1' ' A' ' 26' ' ' ILE . 3.2 t -93.98 102.08 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.725 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.46 50.89 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.843 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.852 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 m -86.29 179.42 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.304 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.61 -61.07 1.7 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.67 5.76 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -107.01 -24.28 12.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.728 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.85 -15.42 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -51.58 -23.21 3.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.77 0.319 . . . . 0.0 111.334 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.439 179.558 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.834 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 49.6 Cg_exo -39.76 154.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.242 3.294 . . . . 0.0 117.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.58 152.89 12.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.478 177.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.02 5.8 4.45 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.735 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -90.97 53.71 2.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 117.252 0.526 . . . . 0.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.13 61.04 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.923 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.82 -151.23 20.93 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.629 -0.796 . . . . 0.0 114.87 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.834 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -118.11 152.87 34.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.7 t -63.91 149.64 46.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -146.92 -93.32 0.09 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.901 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.31 -170.74 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.883 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.95 91.04 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.956 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.73 60.51 8.73 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.798 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -128.96 146.55 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 17.0 t -134.48 101.78 5.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -90.08 160.19 16.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.456 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.2 m -129.59 -179.46 1.02 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.92 -10.94 25.29 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.326 2.017 . . . . 0.0 112.144 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.81 -30.55 9.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.312 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.68 169.96 34.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.551 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.4 m -96.75 166.71 11.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.436 0.636 . . . . 0.0 112.147 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.06 17.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.715 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 72' ' ' ILE . 1.3 pt-20 -59.52 116.53 4.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.961 0.41 . . . . 0.0 110.42 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.796 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.5 p30 -98.8 109.74 54.69 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-O 121.578 0.704 . . . . 0.0 111.552 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.68 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 51.1 Cg_exo -56.67 -16.08 18.18 Favored 'Trans proline' 0 CA--C 1.503 -1.038 0 C-N-CA 123.92 3.08 . . . . 0.0 110.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.68 -29.37 64.52 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.161 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.804 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.94 -27.88 9.44 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -176.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.9 t70 173.88 -27.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.158 1 N-CA-C 122.38 4.215 . . . . 0.0 122.38 -178.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.956 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.4 Cg_endo -107.18 -71.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.5 0 C-N-CA 122.476 2.117 . . . . 0.0 112.734 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 29.5 tt0 -68.87 -6.74 28.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.68 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.2 -155.83 0.05 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.093 -2.321 . . . . 0.0 111.924 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.78 -178.51 0.96 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.809 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -73.81 62.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.241 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.761 0.315 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.31 156.13 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.212 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.71 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.78 171.19 10.96 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.991 0.9 . . . . 0.0 113.228 -178.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 13.0 t0 -80.11 -139.54 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.46 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.632 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.88 -119.98 0.08 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 122.393 -0.192 . . . . 0.0 110.773 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.504 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.57 -47.09 43.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.632 ' H ' HD12 ' A' ' 5' ' ' LEU . 14.5 m -88.61 84.01 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.914 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.71 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 62.3 mtt180 -82.18 160.99 22.93 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.518 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' CYS . 5.9 m 60.98 129.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.589 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.959 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 20.9 Cg_exo . . . . . 0 N--CA 1.461 -0.425 0 N-CA-C 114.127 0.78 . . . . 0.0 114.127 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' GLY . 3.4 t -153.74 -174.24 4.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.456 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.606 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 65.22 -149.61 51.69 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.073 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -82.52 87.56 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.772 2.981 . . . . 0.0 112.564 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.32 -67.5 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.042 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.8 34.1 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 121.645 0.581 . . . . 0.0 111.955 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.82 -36.71 70.31 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.84 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.57 -167.92 18.42 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.502 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -165.52 179.5 6.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 32.4 m -77.08 149.45 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.705 ' HE2' ' HB3' ' A' ' 28' ' ' CYS . 15.9 m-30 -139.09 26.43 2.43 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 139.53 -106.2 0.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.272 -1.442 . . . . 0.0 114.643 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 24.1 Cg_endo -104.81 100.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.46 2.773 . . . . 0.0 113.466 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.88 26.24 4.49 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.369 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.548 HD11 ' HA2' ' A' ' 78' ' ' GLY . 2.3 tt -111.52 160.13 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -156.09 138.96 15.28 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.52 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.705 ' HB3' ' HE2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -146.48 105.61 3.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.477 -178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.878 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.29 129.87 9.36 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.337 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 12.7 t70 -58.83 -63.34 1.33 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -82.03 13.9 3.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.878 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -142.56 38.55 1.52 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.799 -174.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.742 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 29.22 -163.34 0.0 OUTLIER Glycine 0 CA--C 1.531 1.091 0 N-CA-C 115.995 1.158 . . . . 0.0 115.995 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.11 137.16 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.8 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 6.8 m-85 -132.89 106.73 7.88 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.583 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' CG2' HD12 ' A' ' 26' ' ' ILE . 6.6 t -94.62 103.73 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.783 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.45 16.81 55.61 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.937 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -85.44 173.11 10.5 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -43.22 -55.57 3.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.802 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.503 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.9 -3.0 13.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -104.25 -21.8 13.47 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.776 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.78 -20.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.66 -19.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.816 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 36.2 Cg_exo -40.09 155.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.826 3.017 . . . . 0.0 116.659 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.6 154.52 20.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.505 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.45 4.0 5.49 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 114.051 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.2 t -90.58 54.67 2.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 117.382 0.591 . . . . 0.0 111.424 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.95 61.86 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.121 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.618 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 160.87 -152.17 22.76 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.994 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.762 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.5 mmt-85 -116.91 157.47 25.63 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.593 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.816 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 17.0 t -63.26 160.9 14.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.109 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 30' ' ' ASP . . . -153.07 -97.26 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.34 -169.83 1.54 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.87 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.4 88.48 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.957 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 55.86 72.06 0.63 Allowed Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 118.854 -1.641 . . . . 0.0 110.439 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.7 mm -138.37 145.97 27.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.9 t -133.25 104.72 6.61 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -91.07 147.91 22.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -174.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.483 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -116.42 -179.47 0.64 Allowed Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.996 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.1 Cg_exo -72.62 -11.18 25.98 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.503 2.136 . . . . 0.0 112.223 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.71 -31.19 9.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.018 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.548 ' HA2' HD11 ' A' ' 26' ' ' ILE . . . 174.05 170.45 37.4 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.855 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.5 m -98.24 163.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.191 0.519 . . . . 0.0 110.956 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 140.11 19.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.917 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.12 114.14 2.24 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.968 0.413 . . . . 0.0 110.001 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.666 ' CG ' ' HB2' ' A' ' 85' ' ' CYS . 50.4 p30 -95.21 110.16 48.82 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-O 121.712 0.767 . . . . 0.0 111.423 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.806 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 50.8 Cg_exo -57.59 -13.8 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 124.109 3.206 . . . . 0.0 109.973 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.23 -26.35 60.19 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.281 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.957 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -110.85 -29.82 7.8 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -175.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.42 -29.75 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.33 1 N-CA-C 122.31 4.189 . . . . 0.0 122.31 -176.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.87 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -105.21 -71.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 122.61 2.207 . . . . 0.0 112.423 -172.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -70.71 -5.7 31.82 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.806 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -76.09 -158.23 0.09 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 111.861 -2.427 . . . . 0.0 112.769 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -178.8 1.1 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.73 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.01 61.78 0.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.956 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.557 ' CG2' ' H ' ' A' ' 3' ' ' LEU . 2.6 p -84.05 -159.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.0 111.52 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -72.44 168.3 18.76 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.869 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.532 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 2.2 t70 -76.87 -90.99 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.789 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.65 -75.68 0.32 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.71 0.767 . . . . 0.0 110.138 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.789 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.67 -44.86 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.26 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.58 ' H ' HD22 ' A' ' 5' ' ' LEU . 34.3 m -115.96 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.524 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HD2' HD12 ' A' ' 3' ' ' LEU . 5.3 mtt-85 -75.42 175.35 8.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.277 0.56 . . . . 0.0 112.224 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.6 40.83 0.17 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.224 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.87 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.2 Cg_exo . . . . . 0 N--CA 1.459 -0.521 0 CA-C-O 121.108 0.378 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -157.36 -178.17 7.15 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.64 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.674 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 61.71 -134.54 47.1 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.556 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.424 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 6.5 Cg_endo -92.31 100.15 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.607 3.538 . . . . 0.0 112.763 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 -68.71 3.38 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.965 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.72 31.58 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.369 0.427 . . . . 0.0 112.739 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.11 -36.02 74.55 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.641 0.734 . . . . 0.0 109.792 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.12 -172.59 22.48 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.077 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -163.75 179.28 7.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.15 154.9 35.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.545 ' HB2' HG23 ' A' ' 26' ' ' ILE . 9.4 m-85 -131.08 -43.18 1.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.659 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -158.73 -103.44 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.189 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -98.16 104.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.069 2.513 . . . . 0.0 112.844 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.61 26.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.801 0.334 . . . . 0.0 110.401 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.659 HG21 ' H ' ' A' ' 23' ' ' GLY . 1.7 tt -114.17 164.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.064 0.935 . . . . 0.0 113.361 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.54 140.94 21.51 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.316 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.503 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -146.5 102.06 3.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.908 -177.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.91 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -87.71 113.56 4.02 Favored Glycine 0 N--CA 1.402 -3.597 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.055 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.3 t0 -57.97 -54.3 48.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.7 pt-20 -83.65 15.97 2.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.91 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.6 41.81 0.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 39.96 -167.67 0.01 OUTLIER Glycine 0 N--CA 1.463 0.445 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 1.4 t -129.92 134.15 47.3 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.799 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -132.35 124.5 28.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.466 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.483 ' CG2' HD13 ' A' ' 26' ' ' ILE . 4.9 t -94.11 101.59 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.096 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.35 24.95 47.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.775 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.799 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 5.2 m -87.39 173.41 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.895 0.478 . . . . 0.0 109.757 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' H ' HG23 ' A' ' 38' ' ' THR . . . -42.75 -53.58 4.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 111.254 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.539 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -72.98 -7.96 53.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -103.73 -14.86 15.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.66 -16.47 0.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.97 -26.47 4.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.093 0.473 . . . . 0.0 111.041 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.497 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.79 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 61.8 Cg_exo -41.52 157.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.915 3.077 . . . . 0.0 117.585 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.628 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.63 153.21 12.6 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.358 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.51 2.85 4.02 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.288 -0.869 . . . . 0.0 114.038 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.8 t -89.24 54.59 3.0 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.556 0.678 . . . . 0.0 111.557 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.66 32.3 58.39 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.235 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.598 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.15 -150.86 20.17 Favored Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 120.659 -0.782 . . . . 0.0 114.763 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.79 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.6 mmt180 -116.94 154.16 31.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.066 0.46 . . . . 0.0 110.971 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -63.49 161.04 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.509 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -160.64 -92.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -73.94 -170.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.858 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.47 90.95 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.9 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.22 62.94 5.63 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 118.57 -1.776 . . . . 0.0 109.893 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.5 mm -129.99 146.26 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.4 t -134.24 103.92 5.96 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.51 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -117.31 -179.36 0.63 Allowed Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.51 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -72.35 -11.46 26.69 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.331 2.021 . . . . 0.0 112.732 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -30.47 8.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 111.329 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.65 170.15 36.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.302 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' A' ' 26' ' ' ILE . 4.6 m -95.76 165.98 12.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.182 0.515 . . . . 0.0 112.184 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 141.26 21.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.445 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.524 ' CD ' ' HB2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -56.91 113.13 1.54 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.838 0.351 . . . . 0.0 110.296 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.804 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.6 p30 -97.91 110.86 57.42 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 121.878 0.847 . . . . 0.0 112.307 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.763 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -56.75 -17.36 22.85 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 124.174 3.25 . . . . 0.0 110.025 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.48 63.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.628 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.855 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -110.88 -27.83 8.65 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 -175.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.6 t70 174.32 -28.95 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.213 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.9 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.5 Cg_endo -105.66 -71.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.54 2.16 . . . . 0.0 112.518 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.763 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.8 tp10 -69.37 -7.39 36.98 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -75.01 -155.21 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.113 -2.312 . . . . 0.0 112.493 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.45 -178.55 1.13 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.868 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -75.04 62.02 1.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t 61.55 167.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.633 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.501 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.53 168.4 17.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 122.117 0.961 . . . . 0.0 113.591 -178.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.52 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.25 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.729 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.0 -123.87 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.413 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -73.16 -44.13 60.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.729 ' H ' HD11 ' A' ' 5' ' ' LEU . 9.4 m -88.71 86.69 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.095 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.501 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 41.4 mtt180 -70.88 -167.3 0.19 Allowed 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.977 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 43.87 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.968 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.235 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 39.4 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 CA-C-O 121.22 0.425 . . . . 0.0 112.775 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.8 t -157.31 -172.93 4.19 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.305 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 60.98 -139.31 47.94 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.445 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.0 Cg_endo -90.21 97.02 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.304 3.336 . . . . 0.0 112.771 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.2 -70.32 1.75 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.031 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.478 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.74 33.18 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.578 0.543 . . . . 0.0 112.133 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.96 -34.8 69.26 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.568 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -110.57 -167.73 19.32 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.732 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.31 177.25 9.13 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.86 156.09 30.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.59 ' HB2' HG21 ' A' ' 26' ' ' ILE . 17.6 m-85 -130.55 -83.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.122 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.598 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -114.46 -103.74 2.53 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.816 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.8 118.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.65 2.9 . . . . 0.0 113.214 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.6 27.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.598 ' CG2' ' H ' ' A' ' 23' ' ' GLY . 2.6 tt -118.8 163.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.242 1.02 . . . . 0.0 113.453 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.62 140.99 21.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.529 -1.669 . . . . 0.0 108.284 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -144.9 106.65 4.27 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.718 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.889 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.65 116.41 5.09 Favored Glycine 0 N--CA 1.401 -3.65 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 22.8 t0 -57.94 -56.94 15.53 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.46 19.64 1.22 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.889 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -151.68 34.15 0.55 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 43.24 -169.55 0.01 OUTLIER Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.316 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 140.24 52.5 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.667 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 19.1 m-85 -131.16 115.18 16.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.141 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 t -94.14 101.72 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.436 0.636 . . . . 0.0 110.27 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.54 20.25 55.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.067 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.667 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.6 p -77.73 -173.15 2.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.07 -42.19 99.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.402 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -75.82 -10.83 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.456 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -100.93 -12.93 18.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.847 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -53.48 -14.28 0.77 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.24 -25.31 3.55 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.062 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.726 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.794 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 64.0 Cg_exo -41.36 157.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.278 3.319 . . . . 0.0 117.668 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -165.85 153.27 10.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.784 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.19 5.5 3.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.035 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -90.79 55.88 3.08 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 117.415 0.607 . . . . 0.0 111.25 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.26 31.96 56.95 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.953 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.619 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.34 -149.78 18.29 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.864 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.794 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.4 mmt180 -119.03 155.35 31.58 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.871 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.1 t -63.24 162.75 11.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.4 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -162.56 -91.59 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -73.83 -171.5 1.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.711 0.804 . . . . 0.0 112.929 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.885 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -47.49 91.14 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.912 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.44 60.74 8.32 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 118.605 -1.76 . . . . 0.0 110.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.2 mm -128.58 147.49 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 24.3 t -136.18 103.59 5.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -87.31 152.19 22.49 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -173.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.493 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -121.24 -179.27 0.71 Allowed Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.963 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.493 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_exo -73.73 -13.22 24.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.501 2.134 . . . . 0.0 112.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.81 -26.96 12.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.967 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.88 171.21 32.73 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.89 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 26' ' ' ILE . 13.3 m -93.42 166.21 12.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.398 0.618 . . . . 0.0 112.059 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.76 141.29 21.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -60.9 118.14 6.32 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.914 0.388 . . . . 0.0 110.89 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.0 p30 -99.75 109.39 55.43 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 121.577 0.703 . . . . 0.0 111.556 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.713 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.3 Cg_exo -56.55 -15.67 16.43 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 124.036 3.157 . . . . 0.0 110.192 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.49 63.51 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.141 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.835 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.91 -28.69 9.0 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -176.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.53 -29.16 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.164 1 N-CA-C 122.17 4.137 . . . . 0.0 122.17 -177.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.912 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -107.38 -71.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.409 0 C-N-CA 122.684 2.256 . . . . 0.0 112.926 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.75 -6.71 28.08 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.686 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -72.8 -152.95 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.731 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.81 -178.54 0.43 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.617 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -74.05 62.15 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.414 ' OG ' ' CG ' ' A' ' 86' ' ' ASP . 3.5 t . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.047 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.96 0.409 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.75 129.81 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.529 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.882 ' HG ' ' H ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.94 170.67 15.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.308 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.963 ' HB3' ' HD2' ' A' ' 8' ' ' ARG . 22.4 t70 -79.22 -74.13 0.3 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.979 HD22 ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -77.6 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.954 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.956 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -84.48 -77.12 0.28 Allowed 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.668 ' N ' HD23 ' A' ' 5' ' ' LEU . 18.7 m -121.72 82.16 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.979 ' HG3' HD22 ' A' ' 5' ' ' LEU . 34.9 mtt85 -84.68 -167.91 1.99 Allowed 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.247 -0.908 . . . . 0.0 111.214 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.35 80.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.965 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.152 179.714 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.623 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 53.4 Cg_exo . . . . . 0 C--O 1.233 0.263 0 N-CA-C 114.491 0.919 . . . . 0.0 114.491 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 7.3 t -160.18 -169.47 2.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.9 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 56.5 -142.83 39.67 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.491 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -86.24 93.43 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.972 3.115 . . . . 0.0 112.545 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.97 -69.7 1.13 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.689 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.623 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.26 32.22 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.43 0.461 . . . . 0.0 112.095 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.618 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.07 -36.4 69.55 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.753 0.787 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.53 -167.4 20.19 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.023 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.903 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.04 -179.51 6.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 41.8 t -83.87 155.76 22.75 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.497 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.903 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 45.6 m-85 -142.5 8.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 149.27 -103.09 0.25 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.016 -1.564 . . . . 0.0 115.351 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.4 Cg_endo -105.53 105.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.914 3.076 . . . . 0.0 113.31 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 52.46 18.92 1.03 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.558 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.692 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.8 tt -108.01 153.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.225 1.012 . . . . 0.0 113.533 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.897 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -160.36 138.03 9.65 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.48 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.4 m -147.9 110.03 4.56 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.524 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.87 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -90.62 131.16 10.62 Favored Glycine 0 N--CA 1.415 -2.702 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.482 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 17.2 t70 -59.51 -62.59 1.76 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.329 1.064 . . . . 0.0 109.462 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.618 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -75.57 -0.84 21.8 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.87 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -125.61 31.44 5.52 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.601 -176.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 40.9 -177.27 0.01 OUTLIER Glycine 0 N--CA 1.465 0.608 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -99.33 140.49 33.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CE1' HD11 ' A' ' 32' ' ' LEU . 49.4 m-85 -130.91 143.5 50.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.164 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.558 HG12 ' CD1' ' A' ' 26' ' ' ILE . 2.6 t -142.83 119.73 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.025 0.44 . . . . 0.0 109.949 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.5 5.23 11.34 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.406 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.72 HG23 ' H ' ' A' ' 39' ' ' ALA . 3.3 m -87.32 179.27 6.63 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.72 ' H ' HG23 ' A' ' 38' ' ' THR . . . -61.37 -54.27 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.69 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.89 8.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.897 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -108.97 -38.67 5.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.26 -15.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.548 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.35 -18.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.482 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.678 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 34.7 Cg_exo -38.6 176.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.829 3.02 . . . . 0.0 114.077 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.27 154.77 19.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.72 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.8 6.26 5.18 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.142 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.542 ' HB3' ' SG ' ' A' ' 73' ' ' CYS . 18.3 t -92.15 51.0 1.72 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.006 0.431 . . . . 0.0 111.081 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.33 25.79 63.16 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.072 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 74' ' ' CYS . . . 164.63 -152.37 22.0 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.713 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 5.6 mmt-85 -115.31 157.17 24.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.179 -0.51 . . . . 0.0 111.444 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 30.6 t -58.28 143.54 44.28 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.933 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -137.46 -95.23 0.21 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.323 0.583 . . . . 0.0 112.085 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.577 ' HB1' HG13 ' A' ' 72' ' ' ILE . . . -76.98 -172.54 2.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.419 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.92 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.978 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.3 71.11 0.76 Allowed Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 118.93 -1.605 . . . . 0.0 110.188 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 3.9 mm -138.53 146.25 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 23.4 t -135.14 104.19 5.83 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.725 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.6 t -91.33 152.87 20.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.7 m -119.6 -179.25 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.606 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.526 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.9 Cg_exo -72.18 -10.66 26.14 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.393 2.062 . . . . 0.0 112.154 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.92 -33.0 7.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.453 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.81 168.22 37.07 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' A' ' 26' ' ' ILE . 5.2 m -98.28 165.36 11.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 111.853 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 141.57 21.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.399 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.692 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.78 114.72 2.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.5 p30 -95.98 106.42 27.99 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 121.303 0.573 . . . . 0.0 111.296 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.828 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.84 -9.88 3.43 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 124.142 3.228 . . . . 0.0 110.495 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.18 -29.13 57.55 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.651 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.862 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -109.72 -27.77 9.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 118.122 2.638 . . . . 0.0 118.122 -176.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 175.6 -31.19 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.334 1 N-CA-C 122.179 4.14 . . . . 0.0 122.179 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.978 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.8 Cg_endo -105.46 -70.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.717 2.278 . . . . 0.0 112.097 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.828 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 65.0 tt0 -69.97 -6.65 34.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -76.25 -157.48 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.237 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.45 -178.82 0.72 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.48 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.36 62.36 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.204 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.791 0.329 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.73 162.37 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.201 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.572 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.53 166.66 23.16 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.583 0.706 . . . . 0.0 112.564 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.648 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 50.1 t0 -78.78 -79.0 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.348 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.735 HD21 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -84.07 -150.78 0.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.735 ' H ' HD21 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -82.47 -51.84 7.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.714 ' N ' HD13 ' A' ' 5' ' ' LEU . 32.5 m -119.44 84.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.648 ' HD2' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -81.87 158.99 23.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.89 65.25 0.3 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.553 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.7 Cg_exo . . . . . 0 N--CA 1.46 -0.448 0 CA-C-O 121.243 0.434 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.577 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.2 t -157.87 -176.38 5.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.898 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.792 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 61.37 -138.17 47.36 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.748 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 14.3 Cg_endo -89.6 98.15 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 124.456 3.437 . . . . 0.0 112.551 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.31 -69.04 2.84 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.129 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.69 32.86 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 121.54 0.522 . . . . 0.0 112.478 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.618 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.69 -35.49 72.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.043 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.91 -171.87 22.59 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.984 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.66 179.98 7.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 120.799 0.333 . . . . 0.0 110.135 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -80.44 145.12 32.1 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.7 m-85 -118.51 -60.3 1.79 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.699 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -142.12 -100.16 0.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.268 -0.967 . . . . 0.0 114.02 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.8 Cg_endo -100.85 105.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.344 2.696 . . . . 0.0 113.387 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.46 25.42 1.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 110.464 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.7 HD11 ' SG ' ' A' ' 79' ' ' CYS . 3.0 tt -112.9 164.75 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.949 0.881 . . . . 0.0 112.922 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.44 141.28 22.81 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.033 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.38 108.76 4.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.708 -177.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.904 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -97.59 117.13 5.71 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.708 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 36.9 t0 -57.92 -56.56 20.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.553 1.177 . . . . 0.0 108.33 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.618 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -83.85 15.27 3.39 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.904 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -145.36 32.92 1.07 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.587 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.94 173.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.085 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t -112.98 136.84 52.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.909 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.67 125.28 29.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.822 177.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.677 HG13 HD13 ' A' ' 26' ' ' ILE . 4.8 t -95.18 97.7 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.53 14.19 56.95 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.854 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.811 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 4.7 m -78.54 -177.4 5.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' H ' HG23 ' A' ' 38' ' ' THR . . . -53.58 -55.55 24.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.267 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.5 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -72.66 4.21 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.909 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -114.25 -21.42 10.45 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.811 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.84 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.577 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -50.29 -25.84 4.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 118.305 0.502 . . . . 0.0 110.865 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.697 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 120.648 0.261 . . . . 0.0 111.376 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.84 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 25.8 Cg_exo -40.82 157.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.577 3.518 . . . . 0.0 118.563 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -164.62 153.99 13.37 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.869 176.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.7 7.01 1.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.54 -0.754 . . . . 0.0 114.122 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 24.2 t -92.85 52.08 1.79 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.397 0.598 . . . . 0.0 111.265 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.06 34.89 58.67 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.752 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.713 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.05 -151.44 21.13 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.604 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.84 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 2.9 mmt180 -117.99 154.17 32.42 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.922 0.391 . . . . 0.0 111.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -61.86 155.32 23.59 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.71 -99.16 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.384 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.03 -170.78 1.48 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.924 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.901 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.51 86.61 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.958 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.94 70.76 0.88 Allowed Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.967 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 68' ' ' ALA . 3.3 mm -142.64 116.25 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 121.643 0.735 . . . . 0.0 109.028 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.2 t -104.88 106.3 16.73 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -92.72 161.58 14.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.462 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -128.04 -179.92 1.09 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.176 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.462 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -73.47 -10.12 23.53 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.38 2.054 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -32.52 7.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.423 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 167.1 35.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.912 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 26' ' ' ILE . 29.2 m -97.08 167.21 11.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.0 111.935 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.54 142.22 20.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.996 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -60.98 113.07 2.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.077 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.624 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 35.4 p30 -95.05 108.63 39.58 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-O 121.667 0.746 . . . . 0.0 111.769 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.813 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 48.5 Cg_exo -58.51 -12.09 13.03 Favored 'Trans proline' 0 CA--C 1.504 -0.985 0 C-N-CA 123.99 3.126 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -75.37 -29.58 59.93 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.32 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.685 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.6 -24.09 10.73 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -175.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 6.9 t70 173.77 -29.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.391 1 N-CA-C 122.262 4.171 . . . . 0.0 122.262 -178.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.958 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.8 Cg_endo -107.56 -71.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.481 2.121 . . . . 0.0 112.465 -171.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.1 tt0 -69.56 -6.68 32.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.813 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -75.31 -155.53 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.073 -2.331 . . . . 0.0 111.613 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.24 -178.85 0.69 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.445 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -74.48 62.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 8.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.745 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.849 0.356 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.13 163.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.795 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -67.86 168.72 11.08 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.465 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 12.0 t0 -74.87 -134.44 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.943 HD12 ' HG3' ' A' ' 66' ' ' ARG . 1.1 pp -91.1 -125.64 0.08 Allowed 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 122.029 -0.419 . . . . 0.0 111.103 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.553 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 1.1 t70 -73.12 -52.68 13.31 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.815 ' H ' HD11 ' A' ' 5' ' ' LEU . 6.4 m -85.85 85.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.43 176.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.795 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 33.1 mtt85 -76.13 123.86 26.5 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.729 HG21 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -75.36 -151.26 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.966 178.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' SG ' ' C ' ' A' ' 9' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.365 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.668 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 51.6 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 CA-C-O 121.371 0.488 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.585 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 5.2 t -158.3 -171.86 3.65 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 57.88 -149.78 33.2 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.013 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.37 85.49 1.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.669 2.913 . . . . 0.0 112.836 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -71.52 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.668 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.7 31.9 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 121.416 0.453 . . . . 0.0 112.578 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -75.01 -37.38 61.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.884 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -105.54 -163.54 23.46 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.526 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HD3' HG21 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.92 153.69 45.77 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.187 0.994 . . . . 0.0 112.881 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.421 ' HB2' ' CA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.06 127.13 36.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.209 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.81 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -102.07 -102.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -113.13 -87.71 1.64 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 26' ' ' ILE . 30.7 Cg_endo -101.91 113.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.171 2.58 . . . . 0.0 114.451 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.42 23.27 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.725 0.298 . . . . 0.0 110.622 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.81 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 6.6 tt -112.8 161.85 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.556 1.169 . . . . 0.0 114.036 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 49.2 t -159.4 159.54 33.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.763 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -154.1 106.15 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.876 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -96.76 122.54 7.43 Favored Glycine 0 N--CA 1.414 -2.814 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 25.8 t70 -58.78 -59.15 5.89 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.61 1.205 . . . . 0.0 107.942 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.2 pt-20 -81.82 11.62 4.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.876 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.49 41.66 1.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.197 -175.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 27.89 -164.39 0.0 OUTLIER Glycine 0 N--CA 1.472 1.066 0 N-CA-C 115.398 0.919 . . . . 0.0 115.398 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -114.81 144.34 43.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.693 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.6 m-85 -131.46 98.23 4.46 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.818 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.69 131.46 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.037 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 53.18 31.76 42.04 Favored Glycine 0 C--N 1.319 -0.406 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.809 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -112.28 -177.69 3.23 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -69.55 -49.15 57.01 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -68.99 8.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -106.3 -27.19 11.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.78 -11.2 2.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.585 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.86 -19.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.421 ' CA ' ' HB2' ' A' ' 21' ' ' CYS . 1.2 t . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 120.927 0.394 . . . . 0.0 110.086 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt . . . . . 0 N--CA 1.433 -1.32 0 CA-C-O 120.488 0.185 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.802 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 68.6 Cg_exo -40.3 155.17 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.221 2.614 . . . . 0.0 115.576 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -161.46 153.9 20.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.19 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.46 4.18 5.33 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.174 -0.921 . . . . 0.0 114.06 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 31.9 t -90.51 57.02 3.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.434 0.617 . . . . 0.0 111.5 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.63 29.07 57.39 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.879 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.723 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.61 -149.05 16.6 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.443 -0.885 . . . . 0.0 115.307 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.943 ' HG3' HD12 ' A' ' 5' ' ' LEU . 6.7 mmt180 -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.22 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 34.8 t -60.38 154.25 20.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.3 -92.7 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.571 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -77.2 -171.24 1.98 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.895 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.64 89.18 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.91 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.21 68.46 1.69 Allowed Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.787 -1.673 . . . . 0.0 110.202 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 68' ' ' ALA . 1.4 mm -138.52 141.2 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.3 t -128.89 104.96 7.9 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.3 t -90.21 153.13 20.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.481 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -119.76 -179.61 0.73 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.403 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -72.87 -11.58 25.77 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.189 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -29.97 9.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.078 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.19 171.06 36.77 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -97.54 164.34 12.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.267 0.556 . . . . 0.0 111.925 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.38 139.51 20.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.664 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.13 118.84 5.88 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.911 0.386 . . . . 0.0 110.503 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.69 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 45.7 p30 -98.97 108.31 48.57 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.673 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.9 Cg_exo -55.91 -16.57 16.35 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 123.868 3.045 . . . . 0.0 109.941 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -28.23 63.93 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.859 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -111.38 -27.39 8.66 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -176.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.5 t70 174.58 -28.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 1 N-CA-C 122.432 4.234 . . . . 0.0 122.432 -177.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.91 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.8 Cg_endo -106.39 -71.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.559 2.173 . . . . 0.0 112.542 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.659 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.5 tt0 -69.75 -6.18 30.25 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.673 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.23 -158.1 0.06 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.958 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.03 -178.11 0.57 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.541 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -73.0 62.11 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.0 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m 44.56 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.413 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -78.13 171.22 15.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.645 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 4.8 t0 -81.65 -87.88 0.09 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.46 ' CG ' ' H ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -81.4 -74.1 0.35 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.175 0.988 . . . . 0.0 109.294 177.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.46 ' H ' ' CG ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -152.75 -59.51 0.14 Allowed 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.827 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 7' ' ' VAL . 31.4 m -106.49 86.49 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.012 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.645 ' NE ' ' HB2' ' A' ' 4' ' ' ASP . 4.9 mtt-85 -73.44 -178.32 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.578 0.704 . . . . 0.0 112.678 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.81 41.65 0.06 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.741 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.716 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo . . . . . 0 N--CA 1.455 -0.766 0 CA-C-O 121.164 0.402 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -158.8 -177.16 6.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.775 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.675 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 62.67 -136.67 44.34 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.555 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.9 Cg_endo -91.8 101.04 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.519 3.48 . . . . 0.0 112.599 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.59 -71.65 2.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.75 33.64 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.578 0.543 . . . . 0.0 112.267 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.94 -35.63 69.67 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.48 -0.86 . . . . 0.0 110.228 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -104.37 -172.22 24.95 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.151 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.29 178.82 8.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.98 154.6 35.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 15.1 m-85 -135.01 -28.02 1.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -170.72 -110.24 0.23 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.593 -1.289 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -98.51 103.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.293 2.662 . . . . 0.0 112.793 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.79 22.95 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.036 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.645 HD13 HG12 ' A' ' 36' ' ' VAL . 2.5 tt -111.63 163.16 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 122.0 0.905 . . . . 0.0 113.016 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.31 143.23 23.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.608 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -145.82 103.11 3.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.066 -177.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.88 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.01 116.04 4.59 Favored Glycine 0 N--CA 1.402 -3.603 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.822 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.648 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 27.0 t70 -58.42 -55.27 37.25 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.9 pt-20 -83.63 11.78 6.74 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.88 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.05 37.75 1.16 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 40.51 -175.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -118.13 138.52 52.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.687 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 0.9 OUTLIER -132.19 129.82 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.419 178.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.645 HG12 HD13 ' A' ' 26' ' ' ILE . 6.3 t -103.79 97.61 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.183 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.54 17.52 62.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.005 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.687 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 10.0 p -74.15 -170.92 1.03 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.022 0.411 . . . . 0.0 109.933 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.25 -45.75 83.36 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.15 -14.27 61.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.331 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -102.21 -9.84 20.11 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.851 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -17.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.36 -28.81 8.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.484 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.927 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.827 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 77.8 Cg_exo -44.29 155.76 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.018 3.146 . . . . 0.0 117.018 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.21 168.59 20.48 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.734 1.254 . . . . 0.0 112.591 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.55 -2.18 33.94 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 112.465 -2.152 . . . . 0.0 116.317 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.583 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 41.5 t -94.21 56.52 2.21 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 117.745 0.772 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.43 38.89 35.45 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.29 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.568 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.96 -153.72 24.38 Favored Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.329 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.827 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -111.68 147.89 34.58 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.194 0.521 . . . . 0.0 111.816 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 t -62.23 156.04 23.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.708 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -157.69 -94.05 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -73.99 -171.16 1.05 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.746 0.819 . . . . 0.0 112.747 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.45 89.66 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.909 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.4 63.29 5.41 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.505 -1.807 . . . . 0.0 110.289 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.0 mm -130.19 146.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 1.9 t -135.97 104.4 5.7 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.4 t -89.49 159.16 17.39 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -173.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.513 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.5 m -127.49 -179.27 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.2 Cg_exo -71.92 -10.13 25.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.336 2.024 . . . . 0.0 112.697 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -33.2 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 111.304 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.8 169.95 37.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.466 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 26' ' ' ILE . 8.0 m -96.38 165.8 12.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.4 0.619 . . . . 0.0 112.111 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.79 140.81 21.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.694 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.469 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.85 117.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.0 110.006 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.753 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.7 p30 -99.01 109.7 54.98 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.907 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.794 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -57.24 -14.78 16.37 Favored 'Trans proline' 0 CA--C 1.504 -1.0 0 C-N-CA 123.682 2.921 . . . . 0.0 109.887 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.24 -29.36 62.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.251 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.755 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.32 -26.6 9.49 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.7 t70 174.52 -29.22 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.245 1 N-CA-C 122.481 4.252 . . . . 0.0 122.481 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.909 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.0 Cg_endo -106.31 -70.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -171.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 30.6 tt0 -69.47 -6.55 31.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -75.99 -154.83 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.059 -2.337 . . . . 0.0 112.549 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -178.7 1.29 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.817 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -74.62 62.04 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.252 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 3' ' ' LEU . 13.4 t -56.86 173.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.762 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.18 173.17 5.89 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.884 0.85 . . . . 0.0 112.923 -178.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.777 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 43.5 t0 -81.45 -144.87 0.05 Allowed 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.895 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.566 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -88.96 -116.98 0.06 Allowed 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.495 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -74.69 -47.88 29.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.566 ' H ' HD11 ' A' ' 5' ' ' LEU . 11.1 m -87.68 84.19 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.365 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.777 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 45.5 mtt180 -80.09 167.33 20.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 21.4 m 69.98 97.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.666 -1.152 . . . . 0.0 113.19 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 94.4 Cg_exo . . . . . 0 N--CA 1.46 -0.5 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.645 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.6 t -157.42 -172.02 3.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.103 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.669 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 58.44 -142.59 45.06 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.664 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.564 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 26.3 Cg_endo -85.63 95.84 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.148 3.232 . . . . 0.0 112.796 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.46 -66.68 3.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.025 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 12' ' ' PRO . . . 178.29 32.02 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 121.591 0.551 . . . . 0.0 112.438 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.727 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.47 -34.85 72.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -0.827 . . . . 0.0 109.866 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.24 -169.11 15.77 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.721 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.55 -178.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 34.3 m -76.03 159.87 30.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 63.2 m-85 -148.24 16.94 1.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 142.73 -113.56 0.8 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.263 -1.446 . . . . 0.0 114.879 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.5 Cg_endo -105.75 111.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.878 3.052 . . . . 0.0 112.986 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.79 22.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.388 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.627 HD13 ' SG ' ' A' ' 79' ' ' CYS . 1.5 tt -115.76 154.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 122.177 0.989 . . . . 0.0 112.486 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -158.63 134.04 8.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.76 -1.563 . . . . 0.0 107.324 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.576 ' HB3' ' CB ' ' A' ' 69' ' ' ALA . 33.2 m -150.38 108.95 3.81 Favored 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.187 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.11 123.08 5.96 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.185 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.649 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 22.9 t70 -58.21 -57.62 12.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.32 18.04 1.21 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -152.2 39.36 0.59 Allowed 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 45.4 178.67 0.01 OUTLIER Glycine 0 N--CA 1.464 0.561 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -105.32 129.08 53.74 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.786 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.7 m-85 -132.1 105.63 7.5 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.68 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 26' ' ' ILE . 8.1 t -95.25 110.28 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.232 0.539 . . . . 0.0 109.599 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.46 21.08 53.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.919 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -94.38 178.26 5.68 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.29 -53.85 31.72 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 111.589 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -71.09 8.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -108.25 -24.95 11.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.735 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -16.91 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.472 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 1.2 mpp_? -55.15 -18.14 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.749 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 90.9 Cg_exo -40.7 158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.199 2.6 . . . . 0.0 116.386 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.09 154.17 14.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.539 177.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.35 3.87 7.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.747 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 11.0 t -91.08 54.07 2.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 117.222 0.511 . . . . 0.0 111.311 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.07 33.18 60.5 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.133 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.88 -151.35 21.08 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.0 mmt85 -118.35 156.01 29.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.992 -0.604 . . . . 0.0 111.26 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 24.6 t -61.25 151.73 30.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -149.07 -94.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.649 ' C ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.7 -171.68 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.651 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.934 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.05 91.76 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.94 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.95 68.21 1.8 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.006 -1.569 . . . . 0.0 110.206 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.0 mm -136.12 142.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.6 t -128.93 104.47 7.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -88.5 154.42 20.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.538 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.8 m -123.16 -179.24 0.77 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -72.04 -9.68 24.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.334 2.023 . . . . 0.0 112.927 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -34.07 7.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.691 0.282 . . . . 0.0 110.984 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.83 170.17 38.31 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.282 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.627 ' SG ' HD13 ' A' ' 26' ' ' ILE . 11.6 m -94.03 165.95 12.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.482 0.658 . . . . 0.0 112.666 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.82 140.0 21.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.597 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.468 ' CA ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -60.41 117.93 5.84 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.985 0.422 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.703 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.7 p30 -99.19 108.53 50.33 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.281 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.797 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.23 -12.74 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.014 3.142 . . . . 0.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -75.22 -29.64 60.36 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.35 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.89 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -108.88 -27.56 9.65 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -176.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.33 -29.36 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.362 1 N-CA-C 122.321 4.193 . . . . 0.0 122.321 -178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.94 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.7 Cg_endo -106.2 -70.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.495 0 C-N-CA 122.345 2.03 . . . . 0.0 112.29 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.686 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 62.1 tt0 -69.49 -6.83 33.18 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -75.76 -158.04 0.08 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 111.79 -2.459 . . . . 0.0 112.11 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.67 -177.97 0.85 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.613 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.92 61.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.545 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.455 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.8 t -65.71 167.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.812 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.15 173.97 6.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.0 112.641 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.537 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.9 t0 -80.14 -78.49 0.17 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.584 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.761 ' CD2' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.65 -127.64 0.06 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.826 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.761 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.01 -41.85 73.78 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.735 ' CG2' HD13 ' A' ' 5' ' ' LEU . 34.3 m -91.62 109.22 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.783 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.812 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 86.2 mtt180 -71.4 126.66 30.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -104.09 -162.85 0.93 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.922 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.458 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 26.8 Cg_exo . . . . . 0 N--CA 1.462 -0.365 0 CA-C-O 120.964 0.318 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.579 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 3.9 t -157.86 -175.02 5.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.732 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 59.53 -137.47 49.88 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.85 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 11.3 Cg_endo -89.76 94.94 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.437 3.425 . . . . 0.0 112.667 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.05 -68.61 2.48 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.418 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.497 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.56 32.41 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.504 0.502 . . . . 0.0 112.32 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -69.8 -35.5 74.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.573 -0.813 . . . . 0.0 110.109 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -114.94 -165.38 14.85 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.809 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.581 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.59 177.0 10.41 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -79.43 153.71 29.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.672 ' CE2' ' HB2' ' A' ' 68' ' ' ALA . 15.6 m-85 -125.71 -94.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.695 -0.402 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.621 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -98.86 -106.84 2.67 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.575 -0.822 . . . . 0.0 114.565 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -101.95 113.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.798 2.999 . . . . 0.0 113.559 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 50.9 21.02 0.87 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.719 HD11 ' SG ' ' A' ' 79' ' ' CYS . 4.2 tt -111.74 166.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 122.134 0.968 . . . . 0.0 113.316 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.77 143.08 18.2 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.751 -1.568 . . . . 0.0 107.886 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -147.5 104.88 3.67 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.908 -177.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.912 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.14 119.58 5.96 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.637 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 36.3 t0 -58.22 -58.63 7.6 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.607 1.203 . . . . 0.0 108.009 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.3 pt-20 -81.18 20.39 0.83 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.912 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -152.08 35.21 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.218 -175.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 37.3 -164.81 0.01 OUTLIER Glycine 0 C--N 1.33 0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 114.164 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.75 140.29 53.07 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -131.91 114.88 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.582 178.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 26' ' ' ILE . 3.2 t -97.17 113.8 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.409 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 58.92 19.86 46.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.738 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.793 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.2 m -94.47 163.76 13.27 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.411 0.284 . . . . 0.0 110.384 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.83 -53.62 7.28 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.282 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.3 mp0 -69.06 7.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.858 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -116.03 -26.69 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -43.37 -19.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.579 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.23 -21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.572 0.624 . . . . 0.0 111.702 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 13.7 t . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.013 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.826 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 57.9 Cg_exo -42.83 160.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.134 3.223 . . . . 0.0 117.662 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -164.75 154.06 13.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.155 177.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.93 3.37 3.07 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.044 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.03 54.74 2.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.562 0.681 . . . . 0.0 111.339 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.99 35.85 49.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.947 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.682 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.8 -154.84 25.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.973 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.826 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.6 mmt180 -115.43 155.46 27.4 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.207 -0.497 . . . . 0.0 111.587 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 25.1 t -60.98 153.03 26.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.043 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.712 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -151.39 -92.62 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.637 ' C ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.23 -173.86 2.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.6 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.78 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.934 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.68 66.02 3.14 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 118.601 -1.761 . . . . 0.0 110.215 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.9 mm -134.25 144.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.576 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 14.6 t -132.38 105.96 7.6 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -92.0 153.59 19.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -173.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.513 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.3 m -119.03 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.66 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -71.94 -10.22 25.86 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.313 2.008 . . . . 0.0 112.562 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 -32.24 7.62 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.656 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.92 168.49 36.92 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.703 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.719 ' SG ' HD11 ' A' ' 26' ' ' ILE . 8.6 m -96.44 165.89 11.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.482 0.658 . . . . 0.0 112.442 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.18 142.46 22.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.555 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.514 ' CA ' HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -61.11 117.88 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.58 -178.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 45.1 p30 -98.32 108.08 45.37 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-O 121.549 0.69 . . . . 0.0 111.285 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.765 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -56.24 -11.02 5.31 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 124.099 3.199 . . . . 0.0 110.147 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -77.02 -28.86 55.07 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.165 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.854 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -109.44 -27.37 9.49 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -175.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.4 t70 174.36 -29.35 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.246 1 N-CA-C 122.428 4.233 . . . . 0.0 122.428 -178.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.42 -70.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.746 2.297 . . . . 0.0 112.306 -172.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.765 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -70.96 -5.88 34.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 175.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.706 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.72 -160.3 0.15 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 111.767 -2.469 . . . . 0.0 112.371 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.11 -177.58 0.38 Allowed 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.675 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -74.23 61.77 0.89 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.248 0.993 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.235 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.868 0.366 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -83.41 143.52 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.2 0.524 . . . . 0.0 111.98 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.623 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -75.07 175.64 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.781 0.801 . . . . 0.0 112.975 -178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 20.0 t0 -77.95 -140.77 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.944 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -91.12 -123.8 0.07 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.495 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -68.93 -47.98 64.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.662 ' H ' HD12 ' A' ' 5' ' ' LEU . 15.9 m -85.92 90.43 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.947 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.623 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 58.6 mtt85 -69.26 -168.33 0.15 Allowed 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.67 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.4 m 67.22 111.61 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.791 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.28 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 20.0 Cg_exo . . . . . 0 N--CA 1.459 -0.518 0 CA-C-O 121.34 0.475 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -156.67 -176.74 6.14 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.102 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.668 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 61.09 -133.08 49.01 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.876 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HD3' HD23 ' A' ' 32' ' ' LEU . 8.2 Cg_endo -92.71 100.31 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.905 3.737 . . . . 0.0 112.446 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 -68.27 3.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.919 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.459 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.68 31.63 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 121.416 0.453 . . . . 0.0 112.792 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.92 -37.85 69.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.764 0.792 . . . . 0.0 109.797 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -101.11 -176.58 29.1 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.783 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.441 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -162.14 -179.38 7.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.83 0.348 . . . . 0.0 110.655 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 m -80.91 144.88 31.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.649 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.6 m-85 -119.68 -43.47 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.599 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -165.01 -95.27 0.1 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.277 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.9 Cg_endo -101.91 103.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.567 2.844 . . . . 0.0 113.554 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.69 25.53 1.01 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 110.62 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.699 HD13 ' SG ' ' A' ' 79' ' ' CYS . 1.7 tt -113.86 160.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.85 0.833 . . . . 0.0 112.852 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -153.42 136.94 15.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.169 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 2.2 m -148.39 117.29 6.72 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.513 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.871 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -104.93 119.36 6.18 Favored Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.162 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.65 ' HA ' ' CA ' ' A' ' 69' ' ' ALA . 8.6 t70 -57.79 -57.02 14.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.552 1.176 . . . . 0.0 108.21 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -83.06 26.53 0.61 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.871 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -159.77 33.01 0.19 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.536 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.835 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 40.58 176.14 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 1.2 m -106.03 132.25 52.34 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.859 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -131.92 117.08 17.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.627 HG22 HD12 ' A' ' 26' ' ' ILE . 4.9 t -94.19 98.28 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.021 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.83 10.72 40.12 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.984 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -76.41 174.5 10.18 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.079 0.552 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.55 -56.14 4.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.344 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -73.7 6.98 2.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -112.87 -23.25 10.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.99 -18.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.37 -23.99 1.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.55 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.281 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.454 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 111.261 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.837 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 71.9 Cg_exo -44.01 160.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.873 3.049 . . . . 0.0 117.306 -176.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -165.17 155.02 13.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.805 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.12 7.14 3.46 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.4 t -93.38 51.94 1.68 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.124 0.462 . . . . 0.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.16 34.6 58.8 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.982 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.725 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.61 -151.85 21.53 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.837 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.6 mmt180 -118.82 155.41 31.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.758 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.69 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 27.0 t -62.89 155.59 26.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.04 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -143.58 -89.85 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.369 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.835 ' HB2' ' C ' ' A' ' 33' ' ' GLY . . . -73.34 -169.59 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 114.829 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 86' ' ' ASP . . . -28.44 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.36 1.03 0 CA-C-O 122.253 1.025 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.79 ' C ' ' OD1' ' A' ' 82' ' ' ASP . . . -177.01 78.53 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.847 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.0 mm -132.41 149.83 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 114.202 -0.999 . . . . 0.0 108.888 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 29.8 t -132.95 102.88 5.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -85.35 146.57 26.95 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.471 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -113.58 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.443 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 7.9 Cg_exo -74.67 -11.83 22.18 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.467 2.111 . . . . 0.0 112.271 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -28.14 11.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.015 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.04 168.2 33.2 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.699 ' SG ' HD13 ' A' ' 26' ' ' ILE . 9.1 m -94.17 165.93 12.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.276 0.56 . . . . 0.0 112.264 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 141.64 20.27 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.96 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.513 ' N ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 122.1 12.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.79 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 54.0 p30 -101.55 106.65 47.39 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.438 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.894 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 52.8 Cg_exo -57.1 -17.64 25.83 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.786 2.991 . . . . 0.0 109.61 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.3 69.28 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.26 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 m -103.52 -33.76 8.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 9.2 t70 167.84 -24.84 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.457 0 N-CA-C 121.703 3.964 . . . . 0.0 121.703 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.679 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_endo -101.67 -69.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.263 1.975 . . . . 0.0 112.347 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.1 tt0 -71.85 -5.7 36.35 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -74.16 -155.3 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.207 -2.27 . . . . 0.0 111.44 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.24 -178.72 1.11 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -74.93 62.53 1.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.473 ' OG ' ' OD2' ' A' ' 86' ' ' ASP . 3.4 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.568 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.482 0.182 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 1' ' ' ALA . 17.1 m 36.51 -163.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.657 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.01 174.73 6.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.641 0.734 . . . . 0.0 112.706 -178.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -78.27 -89.89 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.238 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.704 ' C ' HD11 ' A' ' 5' ' ' LEU . 1.3 pp -152.52 -42.37 0.1 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.692 ' HB2' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.53 -48.73 0.14 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.416 176.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 7' ' ' VAL . 4.4 m -82.68 92.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.232 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.657 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.5 mtt85 -67.26 171.04 6.24 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 23.2 90.19 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.327 0.584 . . . . 0.0 111.06 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 13.9 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.939 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 11.0 Cg_exo . . . . . 0 N--CA 1.453 -0.88 0 CA-C-O 121.708 0.628 . . . . 0.0 113.296 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.5 t -157.35 -169.77 3.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.673 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.698 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 58.6 -144.05 44.06 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.469 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 17.5 Cg_endo -87.92 90.91 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 124.206 3.271 . . . . 0.0 112.462 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.54 -70.69 0.61 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.101 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.491 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.87 32.2 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.868 0 CA-C-O 121.449 0.472 . . . . 0.0 112.447 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.482 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.43 -38.03 74.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.87 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.04 -164.54 18.47 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.569 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.68 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.71 179.07 9.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.59 151.96 37.76 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.68 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 24.2 m-85 -132.98 -1.13 3.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.18 -114.55 0.59 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.324 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -101.07 105.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.701 2.934 . . . . 0.0 112.571 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.48 23.78 3.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.948 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.668 HD11 ' SG ' ' A' ' 79' ' ' CYS . 2.9 tt -111.66 162.83 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.363 1.078 . . . . 0.0 113.584 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 49.3 t -147.83 149.92 33.22 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.227 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -154.45 96.08 1.87 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.589 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.925 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.48 119.08 5.27 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 119.445 -1.359 . . . . 0.0 110.005 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.576 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 15.2 t70 -58.77 -55.7 31.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.595 1.198 . . . . 0.0 107.809 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.482 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.8 pt-20 -81.15 1.3 32.52 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.893 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.925 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -134.18 39.19 3.11 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.614 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 36.72 -172.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.768 0 N-CA-C 114.769 0.668 . . . . 0.0 114.769 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.4 t -120.87 133.68 55.3 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.859 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.43 126.68 33.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.844 178.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.589 HG12 HD13 ' A' ' 26' ' ' ILE . 3.4 t -99.77 106.43 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.18 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.86 24.16 62.21 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.0 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.4 m -94.74 172.01 8.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.58 0.352 . . . . 0.0 110.535 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -44.11 -54.99 5.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.55 -10.99 60.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.751 0.31 . . . . 0.0 111.642 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.859 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -102.48 -14.55 16.78 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -18.37 0.15 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.652 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -51.7 -26.98 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.627 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.442 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.576 0.227 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.787 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -41.88 158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.122 3.215 . . . . 0.0 117.649 -176.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.41 154.13 13.99 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.371 177.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.87 4.39 4.38 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.452 -0.794 . . . . 0.0 114.143 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 14.0 t -91.42 53.28 2.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.485 0.642 . . . . 0.0 111.223 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.58 57.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.912 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.562 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.75 -154.5 25.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.964 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.787 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.9 mmt-85 -115.9 153.98 30.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -62.87 153.21 34.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.984 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -153.69 -91.91 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.576 ' C ' ' HA ' ' A' ' 30' ' ' ASP . . . -74.81 -171.67 1.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.923 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.6 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.921 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.46 64.74 4.1 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 118.879 -1.629 . . . . 0.0 110.165 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.8 mm -131.28 146.11 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 20.1 t -133.62 101.22 5.04 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -83.05 146.93 28.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.64 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.2 m -111.32 -179.47 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.561 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 34.7 Cg_endo -74.01 -22.51 17.1 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.552 1.501 . . . . 0.0 112.238 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.9 -27.2 15.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.266 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.22 168.87 33.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.425 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.668 ' SG ' HD11 ' A' ' 26' ' ' ILE . 4.1 m -94.28 165.71 12.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.442 0.639 . . . . 0.0 112.434 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.98 140.89 21.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.497 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -59.94 119.31 7.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.961 0.41 . . . . 0.0 110.616 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.732 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.3 p30 -98.93 109.21 52.98 Favored Pre-proline 0 N--CA 1.438 -1.067 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.78 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -56.98 -12.24 9.07 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 124.061 3.174 . . . . 0.0 110.146 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -75.69 -28.11 58.51 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.268 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.803 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.68 -25.88 9.71 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -175.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.7 t70 174.2 -30.44 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.42 1 N-CA-C 122.194 4.146 . . . . 0.0 122.194 -177.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.923 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -106.66 -71.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.391 0 C-N-CA 122.636 2.224 . . . . 0.0 112.74 -171.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.719 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.7 tt0 -69.5 -6.11 28.43 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -74.88 -157.5 0.06 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.86 -2.427 . . . . 0.0 112.443 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.69 -178.19 0.53 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.2 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.84 62.27 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.929 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.707 0.289 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.12 143.24 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.798 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.85 169.06 18.69 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 37.1 t0 -79.8 -137.81 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.814 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.726 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -92.37 -120.58 0.08 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.538 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.73 -48.45 31.84 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.726 ' H ' HD11 ' A' ' 5' ' ' LEU . 11.7 m -86.75 83.7 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.053 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.798 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 39.3 mtt180 -82.29 147.44 28.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.726 ' CG2' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m 59.47 115.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.203 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 81.3 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.251 -179.747 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HG3' ' CG2' ' A' ' 9' ' ' THR . 7.6 Cg_exo . . . . . 0 N--CA 1.46 -0.472 0 N-CA-C 114.857 1.061 . . . . 0.0 114.857 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.517 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.0 t -155.56 -170.88 3.58 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.113 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.746 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 58.36 -137.62 49.86 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.063 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.5 Cg_endo -90.19 93.19 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.598 3.532 . . . . 0.0 113.13 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.54 -68.3 2.12 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.324 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.87 34.34 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.775 0.653 . . . . 0.0 112.267 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.905 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.8 -35.08 69.86 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.916 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.62 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -117.12 -163.49 13.06 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.197 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -158.2 176.87 11.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -86.68 158.33 19.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.078 178.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.704 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.1 m-85 -131.11 -90.76 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.63 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -120.51 -93.43 1.36 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -99.53 104.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.545 2.83 . . . . 0.0 114.177 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 51.65 19.97 1.0 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.363 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.7 tt -109.24 163.09 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.146 0.974 . . . . 0.0 113.327 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.41 145.01 20.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.229 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.672 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -149.05 115.37 5.82 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.995 -177.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.76 122.0 7.39 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.941 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 3.4 t70 -58.62 -56.91 16.08 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -84.98 24.09 1.12 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.223 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.11 36.35 0.29 Allowed 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.732 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 38.31 -170.81 0.01 OUTLIER Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 139.7 49.9 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.759 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 1.7 m-85 -131.19 104.38 7.03 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.09 177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 HG23 HG13 ' A' ' 26' ' ' ILE . 5.0 t -95.03 115.17 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.495 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 62.89 8.28 21.18 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.422 -0.895 . . . . 0.0 112.038 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.5 m -82.86 172.69 12.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.362 0.265 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -56.09 -54.33 46.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -65.39 8.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.879 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.544 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -109.0 -33.37 6.92 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.89 -17.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.01 -20.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.451 -0.403 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.807 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 33.8 Cg_exo -41.32 155.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 125.258 3.972 . . . . 0.0 115.932 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.08 156.69 19.84 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.191 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.61 6.34 3.59 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.846 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.22 51.65 1.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 117.267 0.534 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.16 30.68 61.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.878 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.729 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.55 -152.72 22.83 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.8 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.3 mmt-85 -118.17 165.38 13.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.977 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 5.8 t -59.43 149.11 30.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.843 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -143.49 -25.6 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.941 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -161.32 -170.84 2.78 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 122.727 0.411 . . . . 0.0 111.786 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.879 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -41.0 86.58 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 1.042 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.96 67.71 2.07 Favored Glycine 0 N--CA 1.419 -2.485 0 C-N-CA 118.627 -1.749 . . . . 0.0 111.124 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.843 HG21 ' HB2' ' A' ' 68' ' ' ALA . 3.4 mm -137.62 135.3 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.2 t -124.18 108.92 12.8 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.67 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.8 t -95.23 154.62 17.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.485 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -122.26 -179.37 0.76 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.837 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -71.78 -9.66 25.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.38 2.053 . . . . 0.0 112.147 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.7 -34.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.32 169.77 38.86 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.812 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.3 m -99.13 164.95 11.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.369 0.604 . . . . 0.0 111.668 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.02 22.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.467 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HA ' HD11 ' A' ' 72' ' ' ILE . 1.4 pt-20 -61.7 116.63 4.94 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.778 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 41.0 p30 -97.34 107.01 36.12 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.001 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.706 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.7 Cg_exo -55.03 -13.84 7.25 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.569 2.846 . . . . 0.0 110.445 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -72.71 -29.25 63.22 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.169 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.925 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -106.55 -30.11 9.24 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 -176.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 174.66 -28.62 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.325 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -177.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 1.042 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.2 Cg_endo -106.11 -70.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.525 0 C-N-CA 122.376 2.051 . . . . 0.0 112.276 -172.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.706 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.7 tt0 -70.27 -6.23 33.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.006 -1.906 . . . . 0.0 106.029 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.675 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.7 -155.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.695 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.48 -178.48 0.52 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.877 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.71 62.67 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 4.5 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.476 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -68.07 149.59 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.666 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.91 170.02 14.62 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.677 0.751 . . . . 0.0 112.937 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HB3' HD12 ' A' ' 5' ' ' LEU . 40.9 t0 -82.43 -77.03 0.24 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.986 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.959 HD13 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -148.95 -133.96 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.048 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.676 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -73.13 -38.52 66.26 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.959 HG23 HD13 ' A' ' 5' ' ' LEU . 27.2 m -97.69 104.44 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.666 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.2 mtt85 -71.74 178.65 3.5 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.2 m 67.09 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.546 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 112.245 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 26.4 Cg_exo . . . . . 0 N--CA 1.454 -0.812 0 CA-C-O 121.13 0.387 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.653 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.5 t -157.69 -176.67 6.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.687 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.733 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 64.93 -139.4 40.65 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.833 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.8 Cg_endo -91.78 95.23 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.667 3.578 . . . . 0.0 112.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 -72.08 0.78 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.85 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 175.51 35.58 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.69 0.606 . . . . 0.0 111.985 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.89 -36.05 69.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.353 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.18 -167.3 18.74 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.829 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.79 -179.89 6.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 151.53 34.81 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.903 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -127.0 -24.53 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -174.91 -105.75 0.19 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.466 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -99.52 103.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.263 2.642 . . . . 0.0 112.789 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.39 24.68 2.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.775 0.321 . . . . 0.0 110.139 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.663 HD13 HG11 ' A' ' 36' ' ' VAL . 1.2 tt -112.18 162.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.976 0.893 . . . . 0.0 113.324 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -152.11 140.4 20.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.744 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.618 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -145.28 101.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.793 -177.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.911 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.58 120.0 5.54 Favored Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.688 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 32.3 t0 -58.4 -58.19 9.62 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.633 1.217 . . . . 0.0 108.211 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.4 pt-20 -81.34 6.33 14.68 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.911 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -136.65 37.34 2.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.338 -174.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.618 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 37.21 -172.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.01 136.4 54.99 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.17 115.26 15.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.133 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.663 HG11 HD13 ' A' ' 26' ' ' ILE . 5.7 t -93.71 107.91 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.984 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.96 24.82 55.27 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.808 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.834 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.1 m -94.38 175.24 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 122.568 0.347 . . . . 0.0 110.661 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.35 -59.12 2.55 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.998 0.428 . . . . 0.0 111.509 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -72.9 7.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -110.71 -22.74 11.43 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.69 -12.27 0.73 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.77 -24.7 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.22 0.463 . . . . 0.0 111.811 -179.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.187 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.796 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 74.6 Cg_exo -43.08 160.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.084 3.189 . . . . 0.0 117.779 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.54 153.41 10.99 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.329 -1.759 . . . . 0.0 110.33 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.9 4.65 5.37 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.736 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -90.91 52.48 2.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 117.183 0.491 . . . . 0.0 111.554 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.97 31.2 61.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.029 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.606 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.42 -154.42 25.25 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.889 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.796 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -115.79 153.09 32.07 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.078 0.466 . . . . 0.0 111.153 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 40.1 t -61.89 156.31 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.385 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.618 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -152.39 -92.67 0.05 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.688 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -78.48 -170.5 2.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.886 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.82 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.931 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.43 65.43 3.57 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.537 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.8 mm -134.44 143.26 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.594 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 21.5 t -131.46 104.7 7.13 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -91.85 158.6 16.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.488 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.6 m -127.1 -179.22 0.89 Allowed Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.248 -1.796 . . . . 0.0 109.287 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.488 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.85 -9.97 24.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.278 1.985 . . . . 0.0 112.459 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.4 -33.04 8.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.458 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.4 168.91 35.84 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.517 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.58 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 15.1 m -96.12 166.59 11.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.457 0.646 . . . . 0.0 112.343 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.21 141.92 21.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.621 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.446 ' CA ' HD12 ' A' ' 72' ' ' ILE . 1.4 pm0 -61.26 117.36 5.51 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.729 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.8 p30 -100.16 108.19 51.04 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-O 121.626 0.727 . . . . 0.0 111.18 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.922 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 66.0 Cg_exo -55.49 -16.09 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.07 3.18 . . . . 0.0 110.095 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.26 64.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.09 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.823 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -108.75 -27.55 9.71 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -176.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' ' OG ' ' A' ' 92' ' ' SER . 3.3 t70 173.67 -26.0 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.354 1 N-CA-C 122.853 4.39 . . . . 0.0 122.853 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.931 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -109.64 -72.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 -171.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.717 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.4 tt0 -70.62 -3.97 21.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.505 -1.679 . . . . 0.0 106.766 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.922 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -70.95 -160.82 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 112.448 -2.16 . . . . 0.0 114.892 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.31 -175.18 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.335 -2.212 . . . . 0.0 108.308 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.84 66.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ALA . 1.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.371 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.605 ' O ' HG11 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -157.07 -169.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.96 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.486 ' HG ' ' NE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.17 170.17 12.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.519 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.769 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 56.3 t0 -79.11 -127.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.744 HD13 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -93.61 -126.59 0.11 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.407 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -74.45 -54.91 6.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.744 ' H ' HD13 ' A' ' 5' ' ' LEU . 16.5 m -90.32 112.5 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.157 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 27.3 mtt85 -69.15 121.32 16.52 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.792 0.806 . . . . 0.0 113.067 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.524 ' H ' ' CB ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -173.96 56.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.829 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 4' ' ' ASP . 5.3 p . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 2.8 Cg_exo . . . . . 0 N--CA 1.462 -0.369 0 N-CA-C 113.907 0.695 . . . . 0.0 113.907 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.588 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.9 t -155.16 -177.45 6.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 61.58 -134.48 47.46 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.509 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 14.0 Cg_endo -89.56 101.3 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.603 3.536 . . . . 0.0 112.677 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.68 -66.04 3.79 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.015 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.485 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.06 32.66 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 121.529 0.516 . . . . 0.0 112.324 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.41 -36.11 73.84 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.972 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -108.36 -171.27 21.38 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.226 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.7 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 177.87 10.03 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 11.4 m -79.01 163.81 24.88 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.7 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 35.1 m-85 -141.55 -30.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -170.78 -103.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.886 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -101.32 102.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.485 2.79 . . . . 0.0 112.971 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.36 23.54 2.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.4 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.629 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -111.57 159.28 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.0 0.905 . . . . 0.0 112.882 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.84 140.38 21.56 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.859 -1.518 . . . . 0.0 108.504 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.99 99.23 3.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.759 -176.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.926 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.43 117.55 4.51 Favored Glycine 0 N--CA 1.406 -3.307 0 C-N-CA 118.973 -1.584 . . . . 0.0 110.058 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.6 t0 -59.03 -57.42 13.17 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.6 pt-20 -82.02 11.98 4.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.926 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.17 37.89 1.15 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.693 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 36.35 -178.15 0.01 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.5 t -114.84 136.76 52.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -133.12 119.34 19.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.278 177.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.6 HG11 HD11 ' A' ' 26' ' ' ILE . 5.6 t -91.84 103.21 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.106 178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.66 47.98 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.829 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -86.27 -176.94 6.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.217 0.607 . . . . 0.0 110.025 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.13 -58.8 4.77 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -72.02 -2.32 17.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.65 -21.14 14.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.29 -14.65 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -51.19 -23.63 3.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.433 0.56 . . . . 0.0 111.3 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.159 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.584 0.23 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.743 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 47.2 Cg_exo -43.32 158.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.287 3.325 . . . . 0.0 117.406 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -163.93 153.38 14.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.3 177.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.52 3.69 4.55 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.331 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 t -91.42 57.08 3.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 117.656 0.728 . . . . 0.0 111.268 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.65 34.46 50.14 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 114.03 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.725 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.0 -154.38 25.37 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.743 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.8 mmt180 -115.62 154.6 29.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.3 -0.45 . . . . 0.0 111.21 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -62.0 158.19 16.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.171 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -155.3 -95.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.693 ' HB2' ' C ' ' A' ' 33' ' ' GLY . . . -76.43 -171.23 1.74 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.958 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.48 86.51 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.774 0.671 . . . . 0.0 109.341 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.897 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.72 67.38 2.25 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.4 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.2 mm -132.8 145.98 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -132.09 104.27 6.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -87.46 141.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -173.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.504 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.1 m -105.23 -179.76 0.8 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.817 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.504 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -73.08 -11.39 25.26 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.584 2.19 . . . . 0.0 112.523 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 -31.85 7.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.58 170.04 39.39 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.224 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 26' ' ' ILE . 6.3 m -93.83 166.14 12.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.533 0.682 . . . . 0.0 112.326 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 141.45 21.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.654 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.26 117.67 5.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.063 0.458 . . . . 0.0 110.568 -179.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.688 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.6 p30 -99.56 110.02 57.23 Favored Pre-proline 0 N--CA 1.44 -0.974 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.813 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 50.3 Cg_exo -56.93 -14.85 15.21 Favored 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 124.099 3.199 . . . . 0.0 109.764 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.63 -27.5 62.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.255 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.879 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -111.07 -27.56 8.69 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -175.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.0 t70 173.05 -29.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.413 1 N-CA-C 122.311 4.189 . . . . 0.0 122.311 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.958 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.4 Cg_endo -106.22 -71.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 112.576 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.615 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -69.35 -5.77 25.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.813 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -76.36 -157.94 0.09 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.941 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.2 -178.9 0.69 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.682 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.17 62.4 0.92 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.787 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -93.82 -170.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.82 162.9 28.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.658 0.742 . . . . 0.0 112.971 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.412 ' OD2' HD12 ' A' ' 5' ' ' LEU . 37.9 t70 -83.18 -76.57 0.27 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.404 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.74 HD13 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -146.35 -136.56 0.09 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.81 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.637 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.9 -40.57 68.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.74 ' CG2' HD13 ' A' ' 5' ' ' LEU . 19.4 m -94.58 101.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.586 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 87.0 mtt180 -67.65 -164.76 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.904 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER 46.75 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.213 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -50.56 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.041 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 137.95 89.68 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.925 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.496 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -62.55 -169.75 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.241 1.96 . . . . 0.0 112.233 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.6 t -158.06 -176.54 5.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.268 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 59.79 -136.06 50.42 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.36 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 12.7 Cg_endo -89.79 108.53 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 112.847 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.17 -67.39 2.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.068 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.27 32.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.439 0.466 . . . . 0.0 112.686 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.69 -36.88 73.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.063 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -103.01 -174.56 26.55 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.786 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.23 179.5 7.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -84.03 146.99 27.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.596 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 13.0 m-85 -120.96 -101.98 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.938 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.68 -98.56 0.35 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.669 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.505 ' HD2' ' HB ' ' A' ' 26' ' ' ILE . 26.3 Cg_endo -99.7 -119.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.617 2.878 . . . . 0.0 111.627 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.98 51.38 0.4 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.596 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -128.07 157.12 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 122.251 1.024 . . . . 0.0 113.35 -176.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -154.97 134.16 12.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.607 178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 32.2 m -152.1 119.38 5.94 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.783 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.83 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.96 122.55 7.35 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.369 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 44.1 t0 -58.08 -56.32 23.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.73 1.265 . . . . 0.0 107.824 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.02 24.82 0.74 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.83 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.84 33.17 0.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' A' ' 70' ' ' ALA . . . 51.08 172.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.661 ' SG ' ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -104.17 129.77 51.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.804 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.53 116.66 17.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.55 177.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.4 t -97.95 106.89 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.065 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.39 26.41 56.56 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.895 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.804 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.6 m -95.95 173.46 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.611 0.364 . . . . 0.0 110.62 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.72 -56.57 4.33 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.327 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.4 mp0 -73.07 6.16 2.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.486 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -113.27 -21.62 10.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.785 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.87 -19.15 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.6 -23.67 6.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.886 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -2.45 39.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.401 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -58.72 -25.41 62.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -78.88 -15.77 57.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.859 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.55 2.52 18.91 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.151 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -141.14 20.35 2.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.674 0.273 . . . . 0.0 110.84 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -111.99 -17.01 12.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.184 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.44 95.18 6.0 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.201 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -45.69 100.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.804 2.336 . . . . 0.0 112.664 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.3 p -156.41 171.52 7.27 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.48 177.27 6.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.658 2.239 . . . . 0.0 111.923 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 43.2 t -176.66 158.26 1.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 56' ' ' SER . 5.1 tp60 -138.02 159.71 41.29 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.463 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 62.3 m -131.67 -174.58 3.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.503 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -138.56 82.68 0.25 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.776 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.01 89.25 2.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.582 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -64.41 107.17 1.21 Allowed Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.724 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.5 Cg_exo -40.01 159.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.237 3.291 . . . . 0.0 116.982 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.19 152.64 10.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.767 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.94 3.25 6.97 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.955 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -90.27 57.29 3.67 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 117.33 0.565 . . . . 0.0 111.135 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.8 34.31 36.83 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.85 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.74 -156.57 28.6 Favored Glycine 0 CA--C 1.502 -0.739 0 C-N-CA 120.449 -0.882 . . . . 0.0 115.128 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.776 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.7 mmt-85 -116.32 152.94 32.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.189 0.519 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -63.61 160.54 16.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.579 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -159.97 -96.1 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.782 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.661 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -75.9 -169.81 1.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.876 0.87 . . . . 0.0 112.558 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.734 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -38.16 97.46 0.01 OUTLIER 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.508 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.884 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 50.81 30.47 21.75 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.099 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 5.1 mm -90.34 155.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 122.097 0.951 . . . . 0.0 111.628 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.739 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 19.0 t -141.81 106.52 4.88 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -91.61 160.56 15.33 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.485 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -127.11 -179.83 1.04 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 113.996 -1.457 . . . . 0.0 110.052 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.2 Cg_exo -72.67 -10.83 25.58 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.453 2.102 . . . . 0.0 112.352 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.91 -29.5 9.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.87 31.27 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.437 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.581 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.2 m -97.81 167.94 10.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.097 0.475 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.708 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -151.87 144.61 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.391 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -61.92 94.29 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.739 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.1 m-20 -91.85 126.78 52.43 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.84 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 34.0 Cg_exo -59.83 -3.25 2.01 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 123.658 2.905 . . . . 0.0 109.716 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.39 -25.76 59.68 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.309 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.884 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.3 m -127.46 -20.14 4.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.8 t70 171.18 -26.15 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.068 1 N-CA-C 121.909 4.04 . . . . 0.0 121.909 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.786 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.1 Cg_endo -103.1 -70.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.656 0 C-N-CA 122.335 2.024 . . . . 0.0 112.135 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -72.52 -6.97 47.56 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.051 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.84 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.67 -157.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 112.436 -2.166 . . . . 0.0 112.546 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.79 -178.32 1.49 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.122 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -74.37 62.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.257 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.573 ' CG2' ' H ' ' A' ' 3' ' ' LEU . 3.6 p -144.69 -162.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.383 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.581 ' HG ' ' HE ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.47 157.3 38.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.84 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.33 -122.69 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.185 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -94.97 -139.44 0.24 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.535 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.97 -36.15 49.36 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.722 ' H ' HD23 ' A' ' 5' ' ' LEU . 28.0 m -100.98 85.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.33 0.586 . . . . 0.0 111.495 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 9.2 mtt180 -73.09 123.97 24.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.048 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.447 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -173.35 74.38 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.667 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -75.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.8 tp -115.0 90.83 24.45 Favored Pre-proline 0 N--CA 1.462 0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.744 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 6.6 Cg_exo -68.79 176.88 5.46 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.448 2.098 . . . . 0.0 114.121 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.64 ' N ' ' O ' ' A' ' 19' ' ' GLY . 8.2 t -153.75 -171.21 3.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.747 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.05 -136.93 49.97 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.555 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.8 Cg_endo -89.06 98.71 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.641 3.561 . . . . 0.0 112.965 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.07 -67.18 3.71 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.9 34.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-O 121.744 0.636 . . . . 0.0 112.282 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.773 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.83 -34.41 69.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.371 -0.915 . . . . 0.0 110.264 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.74 -168.34 15.32 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.821 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.733 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.52 -179.54 7.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.726 0.263 . . . . 0.0 110.612 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.443 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 1.7 m -78.59 158.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.733 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 37.6 m-85 -138.99 -69.52 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.749 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -132.5 -105.05 0.95 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.177 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -100.28 105.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.444 2.763 . . . . 0.0 113.037 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 52.5 21.98 1.98 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.756 0.313 . . . . 0.0 110.264 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.749 HG22 ' H ' ' A' ' 23' ' ' GLY . 4.8 tt -110.84 160.93 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.22 1.009 . . . . 0.0 112.763 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 145.62 27.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.736 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -146.43 103.84 3.72 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.897 -177.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.897 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.86 118.84 5.71 Favored Glycine 0 N--CA 1.409 -3.133 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.804 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 26.0 t0 -58.25 -57.72 11.65 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -83.09 21.78 1.04 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.897 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.24 35.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 39.23 -169.97 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.289 0.476 . . . . 0.0 114.289 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.3 t -125.17 138.24 54.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.792 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.03 119.32 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.493 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.535 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.4 t -95.2 105.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.804 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.25 22.15 55.17 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.855 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -89.09 178.64 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.553 0.341 . . . . 0.0 110.163 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -50.21 -56.42 11.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.827 0.346 . . . . 0.0 111.171 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.85 5.12 3.44 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.05 -23.91 12.15 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.98 -17.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.625 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.86 -23.18 1.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 111.482 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -6.94 54.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.71 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -26.27 62.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 42.9 mt-10 -75.36 -17.03 60.33 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.237 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -74.71 4.21 6.65 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.336 179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 50.5 p-10 -82.73 -4.45 57.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -160.3 44.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 111.367 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 47' ' ' GLU . 4.3 pp -143.99 129.88 9.93 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-O 120.682 0.277 . . . . 0.0 110.783 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.43 179.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.085 2.523 . . . . 0.0 113.2 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.77 160.91 9.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.699 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -86.95 161.93 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.524 2.149 . . . . 0.0 111.885 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.33 -164.54 1.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.777 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 53.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.377 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -61.52 174.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.485 ' HA2' HH21 ' A' ' 20' ' ' ARG . . . -175.03 -98.77 0.11 Allowed Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 119.579 -1.296 . . . . 0.0 111.366 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.836 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 3.6 mt-30 -83.86 87.36 7.09 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.964 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -70.3 108.72 3.77 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.851 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 31.5 Cg_exo -37.23 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.979 3.12 . . . . 0.0 117.362 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -161.66 152.99 18.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.43 177.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.27 4.73 7.93 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.881 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -90.34 54.55 2.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 117.395 0.597 . . . . 0.0 111.099 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.15 32.86 50.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.33 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.679 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 165.16 -158.7 31.64 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.307 -0.949 . . . . 0.0 114.921 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.851 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.0 mmt180 -117.33 154.08 31.87 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.017 0.437 . . . . 0.0 110.922 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.964 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 38.2 t -60.17 167.0 2.57 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.815 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.493 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . . . -165.76 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.824 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.671 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.46 -169.7 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.827 0.851 . . . . 0.0 112.884 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.772 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.07 96.21 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.851 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 51.87 29.15 26.11 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.162 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -91.46 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 121.872 0.844 . . . . 0.0 111.397 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.727 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 44.6 t -139.6 108.4 5.96 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.619 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.9 t -91.04 155.9 18.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.501 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -128.97 -179.6 1.04 Allowed Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 114.062 -1.427 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.8 Cg_exo -72.22 -11.05 26.59 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.427 2.084 . . . . 0.0 112.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.97 -27.1 13.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.59 170.19 24.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.135 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.686 ' SG ' HD11 ' A' ' 26' ' ' ILE . 3.9 m -94.98 163.26 13.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 111.039 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.667 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -150.21 148.73 29.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.068 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.89 93.14 0.18 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.727 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.0 m-20 -91.4 128.57 46.4 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.848 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 31.4 Cg_exo -60.58 -2.45 2.0 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.445 2.763 . . . . 0.0 109.721 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.94 -24.99 58.57 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.034 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.851 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.4 m -128.98 -21.01 3.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.658 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 7.1 t70 171.67 -26.33 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.406 1 N-CA-C 122.163 4.134 . . . . 0.0 122.163 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.805 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 5.4 Cg_endo -102.18 -70.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.635 0 CA-C-N 122.693 1.997 . . . . 0.0 111.788 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.3 tt0 -72.89 -6.66 46.64 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.153 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.848 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.19 -157.81 0.08 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.646 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.33 -178.32 1.68 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.15 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -74.92 61.99 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.658 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.312 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.774 0.321 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 7.0 m -70.97 152.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.83 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.593 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.59 166.05 24.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.04 -136.27 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.32 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.675 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -94.87 -124.5 0.11 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -73.06 -47.72 42.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.675 ' H ' HD11 ' A' ' 5' ' ' LEU . 18.7 m -87.36 85.87 2.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 57.4 mtt180 -74.8 -162.98 0.18 Allowed 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.451 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.65 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER 41.38 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.767 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -63.66 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.769 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 6.0 mp -114.12 90.53 20.16 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 120.836 0.35 . . . . 0.0 111.646 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 7.4 Cg_exo -68.69 -175.75 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.362 2.041 . . . . 0.0 113.207 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.695 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.5 t -156.89 -172.39 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.752 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 57.79 -139.49 47.12 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.637 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.9 Cg_endo -88.92 98.16 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.371 3.381 . . . . 0.0 112.721 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -73.66 1.39 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.59 34.36 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 121.637 0.576 . . . . 0.0 111.878 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.68 -37.9 67.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.284 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.02 -168.14 22.28 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.758 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.662 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.41 -179.22 6.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.26 148.58 33.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.681 ' HB2' HG21 ' A' ' 26' ' ' ILE . 17.6 m-85 -128.1 -19.71 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 169.67 -104.21 0.2 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 118.999 -1.572 . . . . 0.0 114.81 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 28.8 Cg_endo -101.74 107.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.717 2.945 . . . . 0.0 113.12 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.52 22.6 1.58 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.182 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.681 HG21 ' HB2' ' A' ' 22' ' ' PHE . 3.3 tt -115.13 157.1 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 122.258 1.028 . . . . 0.0 113.029 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.572 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -160.43 138.45 9.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.356 -1.747 . . . . 0.0 107.35 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 20.4 m -150.1 128.35 12.06 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.097 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.859 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -107.02 126.63 8.51 Favored Glycine 0 N--CA 1.407 -3.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 37.3 t0 -59.16 -59.57 5.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.998 1.399 . . . . 0.0 108.722 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -81.09 15.15 1.98 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.859 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -144.16 31.49 1.24 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.083 -175.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 45.33 175.61 0.01 OUTLIER Glycine 0 CA--C 1.521 0.445 0 N-CA-C 114.899 0.719 . . . . 0.0 114.899 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -100.11 134.45 43.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.844 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 30.2 m-85 -131.04 101.66 5.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.404 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.679 HG22 HD13 ' A' ' 26' ' ' ILE . 4.5 t -97.16 107.36 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.253 0.549 . . . . 0.0 110.23 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.47 -0.0 44.5 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.394 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.844 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.9 p -70.13 -168.24 0.21 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 117.338 0.569 . . . . 0.0 110.245 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -76.61 -39.08 53.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.323 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.558 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -74.7 7.27 3.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.295 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.572 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -112.91 -21.12 11.3 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -51.15 -15.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.02 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.69 -21.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -3.42 30.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.254 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 5.7 pt20 -54.19 -36.51 63.5 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.057 0.932 . . . . 0.0 108.489 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -74.55 -7.41 53.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.74 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -71.64 1.8 6.16 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.57 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -66.79 -6.94 17.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.082 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.433 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 99.8 m-85 -92.6 -105.22 0.12 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.528 0.204 . . . . 0.0 110.814 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.7 107.15 6.44 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-O 120.621 0.248 . . . . 0.0 110.65 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -44.61 159.25 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.024 2.482 . . . . 0.0 113.546 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.5 t -172.28 90.52 0.41 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.245 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -91.89 72.46 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.128 2.552 . . . . 0.0 113.299 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 55' ' ' GLN . 19.5 p -93.4 -178.16 4.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.928 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.65 ' HG2' ' HA ' ' A' ' 9' ' ' THR . 0.0 OUTLIER 60.0 160.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.432 178.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 1.2 p -56.22 148.73 17.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.71 -79.17 0.05 OUTLIER Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.301 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.81 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -89.43 88.82 7.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -68.12 105.72 1.06 Allowed Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.935 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.86 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 44.4 Cg_exo -38.81 154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.761 2.307 . . . . 0.0 115.648 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -162.11 154.58 19.62 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.881 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 7.11 7.72 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.287 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 t -91.53 51.72 1.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.42 32.91 61.25 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.624 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.712 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.42 -153.96 24.67 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.533 -0.842 . . . . 0.0 115.202 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.86 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.0 mmt-85 -120.89 159.24 25.92 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.594 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.6 t -55.86 155.8 5.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 72' ' ' ILE . . . -150.89 -26.82 0.21 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -157.67 -171.35 3.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.397 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.878 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.33 86.31 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.024 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 57.27 65.54 3.49 Favored Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.939 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.851 HG23 ' HB1' ' A' ' 68' ' ' ALA . 3.3 mm -136.77 136.6 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 16.1 t -122.98 109.58 14.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -96.23 158.59 15.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -173.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.2 m -128.26 -179.92 1.1 Allowed Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.315 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.526 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -72.14 -9.42 24.44 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.376 2.051 . . . . 0.0 112.687 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.88 -32.42 8.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.255 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.25 170.21 36.58 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.664 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 27.0 m -96.88 167.4 11.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.394 0.616 . . . . 0.0 111.87 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.98 142.92 21.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.596 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.573 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -62.87 117.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.024 0.44 . . . . 0.0 110.947 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 47.5 p30 -101.04 108.25 53.66 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.906 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 53.1 Cg_exo -56.37 -15.69 15.78 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.855 3.037 . . . . 0.0 110.084 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.04 64.13 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.66 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.942 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -109.54 -27.42 9.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -176.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.3 t70 172.56 -29.44 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.633 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.024 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.3 Cg_endo -108.97 -71.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 123.099 2.533 . . . . 0.0 112.767 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.638 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -67.74 -5.85 18.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 83' ' ' PRO . . . -73.49 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 112.047 -2.342 . . . . 0.0 111.057 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.71 -178.82 0.32 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -74.42 62.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' A' ' 86' ' ' ASP . 12.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.41 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.798 0.332 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 3' ' ' LEU . 4.0 t 64.05 168.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.536 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -69.66 156.85 38.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.668 0.747 . . . . 0.0 112.73 -178.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.54 -77.0 0.23 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.708 ' C ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -139.86 -139.59 0.13 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.474 -178.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.541 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -76.24 -38.43 56.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.73 0.3 . . . . 0.0 110.923 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.673 ' CG2' HD12 ' A' ' 5' ' ' LEU . 19.3 m -93.33 85.0 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 121.367 0.603 . . . . 0.0 110.677 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.537 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 56.4 mtt85 -74.33 -178.73 3.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.183 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m 57.38 101.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' CA ' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -82.71 -161.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.572 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.527 ' HG ' ' HD2' ' A' ' 12' ' ' PRO . 4.5 tp -97.81 137.07 20.94 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 111.216 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.527 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 23.8 Cg_exo -57.71 -171.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.176 1.917 . . . . 0.0 112.347 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.4 t -157.5 -179.98 8.69 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.903 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.752 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 60.89 -134.79 49.28 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.637 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 7.7 Cg_endo -91.89 99.5 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.562 3.508 . . . . 0.0 112.951 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.87 -69.13 3.13 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.481 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.56 32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 CA-C-O 121.533 0.518 . . . . 0.0 112.332 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -33.8 71.66 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.848 0.832 . . . . 0.0 109.862 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.8 -174.84 20.93 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.807 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.548 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.94 -178.95 5.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.6 m -77.57 141.21 39.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 8.8 m-85 -119.11 -23.67 6.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.549 ' N ' HG21 ' A' ' 26' ' ' ILE . . . -171.56 -110.54 0.24 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.586 -1.293 . . . . 0.0 114.317 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.91 101.37 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 112.643 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 21.45 3.64 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.752 -0.379 . . . . 0.0 109.991 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.612 HD13 HG13 ' A' ' 36' ' ' VAL . 2.3 tt -107.76 166.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.832 0.825 . . . . 0.0 112.742 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.725 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -153.76 140.45 18.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.37 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.88 100.91 3.57 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.876 -177.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.935 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.13 117.82 5.01 Favored Glycine 0 N--CA 1.405 -3.407 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.295 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 21.0 t0 -58.75 -57.27 13.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -83.87 20.14 1.56 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.935 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.61 33.22 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.679 ' C ' ' HB3' ' A' ' 69' ' ' ALA . . . 42.53 176.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 69' ' ' ALA . 1.6 t -115.83 134.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.65 125.88 31.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.568 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.612 HG13 HD13 ' A' ' 26' ' ' ILE . 3.0 t -93.81 101.71 12.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.131 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.84 19.51 50.08 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.12 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.745 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.0 m -83.27 174.73 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.893 0.477 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -43.75 -55.8 4.21 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.15 -7.61 50.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -103.99 -16.96 15.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -19.0 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.523 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.47 -24.01 2.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.126 0.421 . . . . 0.0 111.26 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 1.58 14.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -56.54 -26.02 53.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.5 -19.61 49.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.51 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 -1.04 35.97 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.029 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -9.45 59.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.07 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.9 m-30 -111.91 -6.7 14.22 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.305 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.62 85.71 9.18 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 120.807 0.337 . . . . 0.0 111.175 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -44.79 161.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.855 2.37 . . . . 0.0 112.748 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m 64.61 153.21 0.12 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.857 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.58 -164.18 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.566 2.177 . . . . 0.0 112.143 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.456 ' HB2' ' CA ' ' A' ' 10' ' ' CYS . 3.0 m -133.61 -7.96 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.499 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.474 ' HG3' HD13 ' A' ' 3' ' ' LEU . 15.2 tt0 177.82 -57.24 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.115 0.483 . . . . 0.0 109.723 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.529 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 3.8 m 57.49 166.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.08 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.579 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -141.38 75.95 0.32 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.837 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 mt-30 -107.11 88.77 2.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -68.07 105.78 1.07 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 122.961 0.504 . . . . 0.0 110.366 177.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.828 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -38.74 155.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.133 3.222 . . . . 0.0 117.619 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -165.04 153.31 11.83 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.824 177.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 5.53 3.01 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.97 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 6.7 t -90.66 54.03 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 117.425 0.612 . . . . 0.0 111.164 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.98 33.21 56.92 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.861 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.645 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.0 -154.09 24.96 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.642 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.837 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.3 mmt180 -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.153 0.502 . . . . 0.0 110.986 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 46.2 t -62.32 157.94 18.56 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.039 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -155.39 -91.65 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.66 -171.18 2.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.926 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.37 90.68 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.941 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.88 62.4 6.36 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 119.062 -1.542 . . . . 0.0 110.89 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -129.99 149.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.4 t -136.63 102.99 5.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -91.37 160.11 15.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.507 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -127.85 -179.49 0.98 Allowed Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.261 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.507 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.51 -10.08 24.89 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.364 2.042 . . . . 0.0 112.634 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -31.2 8.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.482 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.1 167.73 34.05 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.465 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.584 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 16.3 m -96.0 167.11 11.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.383 0.611 . . . . 0.0 112.4 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.57 140.77 21.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.977 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.481 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -62.18 116.68 5.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.894 0.378 . . . . 0.0 110.534 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.737 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 52.2 p30 -99.06 109.32 53.72 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-O 121.573 0.701 . . . . 0.0 111.702 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.83 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.82 -14.61 14.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.064 3.176 . . . . 0.0 110.06 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.96 -27.84 62.06 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.123 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.859 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -109.89 -28.45 8.75 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -176.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 173.6 -29.18 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.253 1 N-CA-C 122.371 4.211 . . . . 0.0 122.371 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.941 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -106.01 -70.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.459 0 C-N-CA 122.628 2.219 . . . . 0.0 112.568 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.711 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.3 tt0 -69.04 -7.07 32.19 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -75.5 -157.76 0.07 Allowed 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.635 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.01 -179.3 1.18 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -74.76 62.36 1.07 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.06 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.853 0.359 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -67.8 156.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.126 0.488 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.728 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.64 169.69 17.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' OD1' ' HG3' ' A' ' 58' ' ' GLN . 18.9 t0 -78.59 -137.55 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 113.952 -1.476 . . . . 0.0 108.192 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.744 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -91.28 -123.62 0.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.459 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -72.23 -45.6 59.58 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.744 ' H ' HD11 ' A' ' 5' ' ' LEU . 11.1 m -88.13 85.19 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.662 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.728 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 51.5 mtt85 -75.56 -177.12 3.51 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 27.62 104.54 0.0 OUTLIER 'General case' 0 C--N 1.34 0.17 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.592 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -130.06 134.48 47.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.972 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.931 ' HB2' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.99 168.15 10.16 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 121.731 0.777 . . . . 0.0 112.516 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 22.7 Cg_exo -50.28 179.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.008 1.806 . . . . 0.0 111.767 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.63 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.0 t -158.85 -172.39 3.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 65.02 -141.34 43.28 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.14 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.95 89.6 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.018 3.145 . . . . 0.0 112.881 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.48 -68.28 0.94 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.301 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.99 34.12 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-O 121.632 0.573 . . . . 0.0 112.022 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -73.0 -35.82 66.92 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.339 -0.93 . . . . 0.0 110.61 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -111.1 -162.04 17.57 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.293 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.86 174.28 13.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 0.5 OUTLIER -89.18 170.34 10.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.823 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.729 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 67.5 m-85 -144.02 -12.05 0.65 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.42 -95.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 118.691 -1.718 . . . . 0.0 115.055 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -101.07 99.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.378 2.718 . . . . 0.0 113.481 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.59 21.84 1.98 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.316 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.704 HD13 HG22 ' A' ' 36' ' ' VAL . 3.8 tt -108.95 160.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -157.32 145.47 19.23 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 113.745 -1.57 . . . . 0.0 108.653 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.95 106.25 3.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.553 -178.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.843 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.23 128.22 8.96 Favored Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.63 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 35.9 t70 -58.5 -65.84 0.59 Allowed 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 pt-20 -81.36 26.87 0.44 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.843 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.58 31.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.687 ' CA ' ' HB2' ' A' ' 69' ' ' ALA . . . 36.49 -166.7 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.5 142.88 38.25 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.714 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 10.3 m-85 -131.93 98.0 4.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.391 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.704 HG22 HD13 ' A' ' 26' ' ' ILE . 3.5 t -95.75 130.71 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.211 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.76 28.53 5.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.811 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -109.23 170.25 8.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.46 0.304 . . . . 0.0 110.66 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -54.95 -55.12 34.21 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.56 8.89 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -107.05 -37.3 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.604 ' CD1' ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -56.83 -11.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.714 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -49.8 -13.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 47' ' ' GLU . 18.0 t -69.27 -5.4 22.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -56.48 -32.88 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 122.466 1.127 . . . . 0.0 107.979 177.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.714 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 2.1 pt-20 -70.84 -8.36 52.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.431 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.931 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -57.39 -2.95 0.13 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 46' ' ' GLU . 1.7 m-80 -50.37 -20.73 1.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.3 -0.25 . . . . 0.0 111.451 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.578 ' HB2' HD11 ' A' ' 11' ' ' LEU . 12.0 m-30 -101.91 -161.16 0.83 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.638 0.375 . . . . 0.0 111.594 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 1.6 pp -144.4 83.52 9.86 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.928 ' HG2' ' HA ' ' A' ' 11' ' ' LEU . 49.8 Cg_exo -65.34 -159.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.703 2.935 . . . . 0.0 113.638 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.789 ' O ' ' HB2' ' A' ' 56' ' ' SER . 10.7 t -85.85 -58.21 0.33 Allowed Pre-proline 0 C--O 1.226 -0.156 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.419 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 52' ' ' SER . 41.5 Cg_exo -55.5 167.25 2.1 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 120.944 1.096 . . . . 0.0 111.454 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.636 ' HA ' ' HG3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER 63.51 -79.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.138 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.673 ' HG3' ' CD1' ' A' ' 3' ' ' LEU . 2.0 tt0 -83.53 51.45 2.0 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.323 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.789 ' HB2' ' O ' ' A' ' 52' ' ' SER . 0.4 OUTLIER 172.08 -77.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.34 98.89 0.87 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.43 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.696 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -120.69 89.77 3.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.982 0.42 . . . . 0.0 110.962 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' H ' ' CD ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -59.39 100.3 0.21 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.99 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.742 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 27.3 Cg_exo -61.72 179.56 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.277 2.651 . . . . 0.0 115.615 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.74 154.32 9.51 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.256 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.07 -0.03 6.77 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.277 -0.874 . . . . 0.0 114.141 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.7 t -92.08 50.79 1.7 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 117.478 0.639 . . . . 0.0 111.369 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.69 40.91 49.36 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.083 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.626 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.68 -159.44 32.44 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.742 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.4 mmt180 -114.68 155.99 25.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.094 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 23.9 t -61.11 144.89 52.71 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.523 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.695 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -139.85 -97.82 0.16 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.271 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.51 -170.21 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -43.73 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.912 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 54.8 71.61 0.69 Allowed Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.179 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.758 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -137.01 145.47 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 33.8 t -132.08 103.67 6.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -91.44 152.36 20.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.478 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -125.07 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.892 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -71.72 -9.71 25.35 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -33.0 8.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.021 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA2' HD12 ' A' ' 26' ' ' ILE . . . 171.09 169.92 34.65 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.562 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 3.3 m -98.68 164.43 12.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.102 0.477 . . . . 0.0 111.132 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.67 141.81 21.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.03 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -58.81 111.3 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.853 0.358 . . . . 0.0 110.102 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.675 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.1 p30 -92.03 110.5 44.46 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.751 . . . . 0.0 111.683 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.754 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -57.49 -13.02 12.3 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.188 3.258 . . . . 0.0 110.086 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.33 -30.0 57.51 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.561 177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.912 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -108.93 -27.27 9.78 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 5.4 t70 175.37 -29.97 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 1 N-CA-C 122.28 4.178 . . . . 0.0 122.28 -177.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.908 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.2 Cg_endo -104.28 -70.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.46 0 C-N-CA 122.45 2.1 . . . . 0.0 112.242 -172.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.754 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 28.9 tt0 -70.36 -8.48 50.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 175.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -75.85 -157.64 0.08 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.89 -2.414 . . . . 0.0 112.741 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.46 -178.7 1.46 Allowed 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.929 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -74.42 62.39 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.622 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.6 t . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.027 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.342 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.94 -172.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.55 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.09 159.92 33.83 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.709 0.766 . . . . 0.0 112.723 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.29 -124.98 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.721 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.748 HD12 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -95.16 -136.79 0.22 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.561 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -73.99 -39.85 63.37 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.748 ' CG2' HD12 ' A' ' 5' ' ' LEU . 19.3 m -95.04 85.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 20.4 mtt180 -73.92 -163.2 0.16 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.272 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.658 ' HA ' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 41.69 85.74 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . 8.1 m -77.99 -43.72 28.8 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.493 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 1.3 mp -118.22 91.82 41.38 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-O 121.353 0.597 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.5 Cg_exo -62.84 -173.4 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.496 2.131 . . . . 0.0 113.189 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' GLY . 2.0 t -156.84 -175.81 5.63 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.242 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.733 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.01 -138.68 48.7 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.657 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.7 Cg_endo -90.32 100.23 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.371 3.381 . . . . 0.0 112.808 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.14 -69.08 3.09 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.152 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.57 31.4 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 121.386 0.437 . . . . 0.0 112.489 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -71.09 -36.69 72.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.646 0.736 . . . . 0.0 109.946 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.07 -174.44 23.56 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.155 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.58 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.3 -178.79 5.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 151.53 37.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 11.3 m-85 -133.51 -17.72 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -179.0 -112.07 0.33 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.937 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -101.15 107.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.572 2.848 . . . . 0.0 112.744 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.48 24.12 2.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.523 HD13 ' SG ' ' A' ' 79' ' ' CYS . 1.9 tt -114.6 161.79 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.922 0.868 . . . . 0.0 113.118 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.45 141.4 22.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.371 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.522 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -144.13 102.66 3.9 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.839 -177.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.872 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.43 118.72 5.28 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.023 -1.561 . . . . 0.0 109.42 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -57.93 -61.67 2.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -81.31 19.9 0.91 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.437 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.872 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -150.48 32.77 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.619 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 43.34 175.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.448 0.539 . . . . 0.0 114.448 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.486 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -111.39 136.54 50.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.852 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.23 119.74 21.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.327 178.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.5 HG13 ' CD1' ' A' ' 26' ' ' ILE . 3.2 t -93.98 102.08 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.725 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.46 50.89 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.843 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.852 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 m -86.29 179.42 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.304 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.61 -61.07 1.7 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.67 5.76 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -107.01 -24.28 12.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.728 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.85 -15.42 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -51.58 -23.21 3.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.77 0.319 . . . . 0.0 111.334 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 47' ' ' GLU . 55.0 m -75.43 -4.51 39.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.439 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -26.51 34.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.92 -27.71 60.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.049 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 44' ' ' CYS . 0.7 OUTLIER -80.76 7.62 9.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.265 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.82 -17.15 15.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.463 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -100.77 -19.19 16.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.727 0.299 . . . . 0.0 111.776 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.23 78.81 13.34 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.33 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.99 106.7 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.792 2.328 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -127.26 124.64 23.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 1.0 OUTLIER -82.87 32.88 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.966 2.444 . . . . 0.0 112.765 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 2.1 t -81.34 -165.81 1.03 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.658 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 0.6 OUTLIER 35.84 -147.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 5.4 m 76.33 115.22 0.06 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.64 0.376 . . . . 0.0 110.284 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.15 100.43 0.24 Allowed Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.681 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -117.14 88.18 2.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -68.02 106.58 1.36 Allowed Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 122.972 0.509 . . . . 0.0 110.093 177.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.834 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 49.6 Cg_exo -39.76 154.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.242 3.294 . . . . 0.0 117.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.58 152.89 12.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.478 177.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.02 5.8 4.45 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.735 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -90.97 53.71 2.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 117.252 0.526 . . . . 0.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.13 61.04 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.923 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.82 -151.23 20.93 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.629 -0.796 . . . . 0.0 114.87 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.834 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -118.11 152.87 34.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.7 t -63.91 149.64 46.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -146.92 -93.32 0.09 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.901 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.31 -170.74 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.883 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.95 91.04 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.956 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.73 60.51 8.73 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.798 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -128.96 146.55 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 17.0 t -134.48 101.78 5.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -90.08 160.19 16.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.456 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.2 m -129.59 -179.46 1.02 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.92 -10.94 25.29 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.326 2.017 . . . . 0.0 112.144 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.81 -30.55 9.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.312 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.68 169.96 34.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.551 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.4 m -96.75 166.71 11.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.436 0.636 . . . . 0.0 112.147 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.27 138.06 17.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.715 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 72' ' ' ILE . 1.3 pt-20 -59.52 116.53 4.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.961 0.41 . . . . 0.0 110.42 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.796 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.5 p30 -98.8 109.74 54.69 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-O 121.578 0.704 . . . . 0.0 111.552 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.68 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 51.1 Cg_exo -56.67 -16.08 18.18 Favored 'Trans proline' 0 CA--C 1.503 -1.038 0 C-N-CA 123.92 3.08 . . . . 0.0 110.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.68 -29.37 64.52 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.161 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.804 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.94 -27.88 9.44 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -176.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.9 t70 173.88 -27.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.158 1 N-CA-C 122.38 4.215 . . . . 0.0 122.38 -178.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.956 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.4 Cg_endo -107.18 -71.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.5 0 C-N-CA 122.476 2.117 . . . . 0.0 112.734 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 29.5 tt0 -68.87 -6.74 28.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.68 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.2 -155.83 0.05 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.093 -2.321 . . . . 0.0 111.924 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.78 -178.51 0.96 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.809 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -73.81 62.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.241 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.761 0.315 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.31 156.13 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.212 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.71 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.78 171.19 10.96 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.991 0.9 . . . . 0.0 113.228 -178.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 13.0 t0 -80.11 -139.54 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.46 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.632 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.88 -119.98 0.08 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 122.393 -0.192 . . . . 0.0 110.773 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.57 -47.09 43.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.632 ' H ' HD12 ' A' ' 5' ' ' LEU . 14.5 m -88.61 84.01 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.914 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.71 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 62.3 mtt180 -82.18 160.99 22.93 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.518 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' CYS . 5.9 m 60.98 129.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.589 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.7 -160.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.959 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 6.8 tp -91.56 103.22 7.23 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.549 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 20.9 Cg_exo -59.04 173.23 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.111 1.874 . . . . 0.0 114.127 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' GLY . 3.4 t -153.74 -174.24 4.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.456 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.606 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 65.22 -149.61 51.69 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.073 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -82.52 87.56 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.772 2.981 . . . . 0.0 112.564 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.32 -67.5 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.042 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.8 34.1 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 121.645 0.581 . . . . 0.0 111.955 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.423 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.82 -36.71 70.31 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.84 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.57 -167.92 18.42 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.502 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -165.52 179.5 6.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 32.4 m -77.08 149.45 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.705 ' HE2' ' HB3' ' A' ' 28' ' ' CYS . 15.9 m-30 -139.09 26.43 2.43 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 139.53 -106.2 0.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.272 -1.442 . . . . 0.0 114.643 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 24.1 Cg_endo -104.81 100.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.46 2.773 . . . . 0.0 113.466 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.88 26.24 4.49 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.369 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.548 HD11 ' HA2' ' A' ' 78' ' ' GLY . 2.3 tt -111.52 160.13 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -156.09 138.96 15.28 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.52 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.705 ' HB3' ' HE2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -146.48 105.61 3.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.477 -178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.878 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.29 129.87 9.36 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.337 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.875 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 12.7 t70 -58.83 -63.34 1.33 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -82.03 13.9 3.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.878 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -142.56 38.55 1.52 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.799 -174.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.742 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 29.22 -163.34 0.0 OUTLIER Glycine 0 CA--C 1.531 1.091 0 N-CA-C 115.995 1.158 . . . . 0.0 115.995 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.11 137.16 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.8 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 6.8 m-85 -132.89 106.73 7.88 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.583 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' CG2' HD12 ' A' ' 26' ' ' ILE . 6.6 t -94.62 103.73 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.783 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.45 16.81 55.61 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.937 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -85.44 173.11 10.5 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -43.22 -55.57 3.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.802 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.503 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.9 -3.0 13.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -104.25 -21.8 13.47 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.776 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.78 -20.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.66 -19.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -0.19 13.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.63 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 4.3 pt20 -54.2 -35.14 62.05 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 11' ' ' LEU . 21.7 mt-10 -74.71 -11.58 60.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.538 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -69.54 -4.13 17.7 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.792 0.33 . . . . 0.0 110.796 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' OD1' ' CD1' ' A' ' 49' ' ' TYR . 6.1 p30 -52.12 -24.92 7.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.813 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.474 ' CD1' ' OD1' ' A' ' 48' ' ' ASN . 13.2 m-30 -75.77 -171.26 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.28 122.73 45.65 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.201 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -46.37 149.33 2.74 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.77 2.313 . . . . 0.0 112.897 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.43 154.46 66.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.926 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.82 93.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.697 2.265 . . . . 0.0 112.067 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.1 p -96.18 -171.94 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.659 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.451 ' HG2' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -72.85 172.9 9.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.828 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 59.8 p -59.33 171.7 0.74 Allowed 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.41 -59.31 0.23 Allowed Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.86 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -95.23 88.7 5.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.816 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -67.57 110.05 4.74 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.739 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.762 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 36.2 Cg_exo -40.09 155.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.826 3.017 . . . . 0.0 116.659 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.6 154.52 20.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.505 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.45 4.0 5.49 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 114.051 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.2 t -90.58 54.67 2.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 117.382 0.591 . . . . 0.0 111.424 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.95 61.86 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.121 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.618 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 160.87 -152.17 22.76 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.994 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.86 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 5.5 mmt-85 -116.91 157.47 25.63 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.593 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.816 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 17.0 t -63.26 160.9 14.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.109 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 30' ' ' ASP . . . -153.07 -97.26 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.34 -169.83 1.54 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.87 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.4 88.48 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.957 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 55.86 72.06 0.63 Allowed Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 118.854 -1.641 . . . . 0.0 110.439 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.7 mm -138.37 145.97 27.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.9 t -133.25 104.72 6.61 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -91.07 147.91 22.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -174.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.483 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -116.42 -179.47 0.64 Allowed Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.996 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.1 Cg_exo -72.62 -11.18 25.98 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.503 2.136 . . . . 0.0 112.223 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.71 -31.19 9.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.018 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.548 ' HA2' HD11 ' A' ' 26' ' ' ILE . . . 174.05 170.45 37.4 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.855 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.5 m -98.24 163.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.191 0.519 . . . . 0.0 110.956 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 140.11 19.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.917 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.53 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.12 114.14 2.24 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.968 0.413 . . . . 0.0 110.001 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.666 ' CG ' ' HB2' ' A' ' 85' ' ' CYS . 50.4 p30 -95.21 110.16 48.82 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-O 121.712 0.767 . . . . 0.0 111.423 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.806 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 50.8 Cg_exo -57.59 -13.8 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 124.109 3.206 . . . . 0.0 109.973 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.23 -26.35 60.19 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.281 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.957 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -110.85 -29.82 7.8 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -175.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.42 -29.75 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.33 1 N-CA-C 122.31 4.189 . . . . 0.0 122.31 -176.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.87 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -105.21 -71.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 122.61 2.207 . . . . 0.0 112.423 -172.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.649 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -70.71 -5.7 31.82 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.806 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -76.09 -158.23 0.09 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 111.861 -2.427 . . . . 0.0 112.769 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.13 -178.8 1.1 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.73 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.01 61.78 0.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.956 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.557 ' CG2' ' H ' ' A' ' 3' ' ' LEU . 2.6 p -84.05 -159.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.0 111.52 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -72.44 168.3 18.76 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.869 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.532 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 2.2 t70 -76.87 -90.99 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.789 ' CD1' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.65 -75.68 0.32 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.71 0.767 . . . . 0.0 110.138 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.789 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.67 -44.86 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.26 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.58 ' H ' HD22 ' A' ' 5' ' ' LEU . 34.3 m -115.96 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.524 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.7 ' HD2' HD12 ' A' ' 3' ' ' LEU . 5.3 mtt-85 -75.42 175.35 8.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.277 0.56 . . . . 0.0 112.224 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.6 40.83 0.17 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.224 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -67.81 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.87 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -129.61 95.53 29.35 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.2 Cg_exo -62.57 -171.37 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.985 1.79 . . . . 0.0 111.803 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -157.36 -178.17 7.15 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.64 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.674 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 61.71 -134.54 47.1 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.556 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 6.5 Cg_endo -92.31 100.15 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.607 3.538 . . . . 0.0 112.763 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 -68.71 3.38 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.965 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.72 31.58 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.369 0.427 . . . . 0.0 112.739 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.11 -36.02 74.55 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.641 0.734 . . . . 0.0 109.792 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.12 -172.59 22.48 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.077 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -163.75 179.28 7.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.15 154.9 35.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.545 ' HB2' HG23 ' A' ' 26' ' ' ILE . 9.4 m-85 -131.08 -43.18 1.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.659 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -158.73 -103.44 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.189 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -98.16 104.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.069 2.513 . . . . 0.0 112.844 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.61 26.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.801 0.334 . . . . 0.0 110.401 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.659 HG21 ' H ' ' A' ' 23' ' ' GLY . 1.7 tt -114.17 164.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.064 0.935 . . . . 0.0 113.361 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.54 140.94 21.51 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.316 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.503 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -146.5 102.06 3.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.908 -177.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.91 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -87.71 113.56 4.02 Favored Glycine 0 N--CA 1.402 -3.597 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.055 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.3 t0 -57.97 -54.3 48.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.7 pt-20 -83.65 15.97 2.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.91 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.6 41.81 0.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 39.96 -167.67 0.01 OUTLIER Glycine 0 N--CA 1.463 0.445 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 69' ' ' ALA . 1.4 t -129.92 134.15 47.3 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.799 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -132.35 124.5 28.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.466 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.483 ' CG2' HD13 ' A' ' 26' ' ' ILE . 4.9 t -94.11 101.59 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.096 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.35 24.95 47.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.775 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.799 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 5.2 m -87.39 173.41 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.895 0.478 . . . . 0.0 109.757 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' H ' HG23 ' A' ' 38' ' ' THR . . . -42.75 -53.58 4.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 111.254 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.539 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -72.98 -7.96 53.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -103.73 -14.86 15.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.66 -16.47 0.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.97 -26.47 4.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.093 0.473 . . . . 0.0 111.041 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 1.85 12.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.514 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.64 -29.68 53.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' HG2' ' HG ' ' A' ' 11' ' ' LEU . 1.3 pp20? -80.28 -18.26 49.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.312 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.66 1.33 23.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 -23.46 15.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.767 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.7 m-30 -90.38 -74.32 0.49 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.281 0.562 . . . . 0.0 111.51 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.16 94.17 6.42 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.356 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 68.6 Cg_exo -46.04 109.62 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.514 2.143 . . . . 0.0 112.219 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 97.2 5.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 51' ' ' PRO . 90.7 Cg_endo -80.65 72.97 6.24 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.416 2.077 . . . . 0.0 111.39 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.743 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 26.5 p -153.49 -177.46 6.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.429 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.743 ' HG2' ' O ' ' A' ' 54' ' ' CYS . 5.1 pt20 48.47 -152.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.491 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.422 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 5.4 m 73.46 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.25 105.75 0.3 Allowed Glycine 0 CA--C 1.499 -0.935 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.359 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.696 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -117.55 89.11 3.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -66.52 107.3 1.52 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.995 177.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.79 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 61.8 Cg_exo -41.52 157.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.915 3.077 . . . . 0.0 117.585 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.628 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.63 153.21 12.6 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.358 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.51 2.85 4.02 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.288 -0.869 . . . . 0.0 114.038 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.8 t -89.24 54.59 3.0 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.556 0.678 . . . . 0.0 111.557 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.66 32.3 58.39 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.235 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.598 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.15 -150.86 20.17 Favored Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 120.659 -0.782 . . . . 0.0 114.763 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.79 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.6 mmt180 -116.94 154.16 31.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.066 0.46 . . . . 0.0 110.971 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -63.49 161.04 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.509 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -160.64 -92.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -73.94 -170.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.858 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.47 90.95 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.9 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.22 62.94 5.63 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 118.57 -1.776 . . . . 0.0 109.893 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.5 mm -129.99 146.26 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.4 t -134.24 103.92 5.96 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.51 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -117.31 -179.36 0.63 Allowed Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.51 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -72.35 -11.46 26.69 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.331 2.021 . . . . 0.0 112.732 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -30.47 8.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 111.329 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.65 170.15 36.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.302 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' A' ' 26' ' ' ILE . 4.6 m -95.76 165.98 12.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.182 0.515 . . . . 0.0 112.184 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 141.26 21.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.445 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.524 ' CD ' ' HB2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -56.91 113.13 1.54 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.838 0.351 . . . . 0.0 110.296 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.804 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.6 p30 -97.91 110.86 57.42 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 121.878 0.847 . . . . 0.0 112.307 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.763 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.0 Cg_exo -56.75 -17.36 22.85 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 124.174 3.25 . . . . 0.0 110.025 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.48 63.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.628 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.855 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -110.88 -27.83 8.65 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 -175.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.6 t70 174.32 -28.95 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.213 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.9 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.5 Cg_endo -105.66 -71.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.54 2.16 . . . . 0.0 112.518 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.763 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.8 tp10 -69.37 -7.39 36.98 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -75.01 -155.21 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.113 -2.312 . . . . 0.0 112.493 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.45 -178.55 1.13 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.868 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -75.04 62.02 1.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.517 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t 61.55 167.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.633 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.501 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.53 168.4 17.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 122.117 0.961 . . . . 0.0 113.591 -178.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' PRO . 10.8 t70 -80.52 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.25 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.729 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.0 -123.87 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.413 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -73.16 -44.13 60.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.729 ' H ' HD11 ' A' ' 5' ' ' LEU . 9.4 m -88.71 86.69 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.095 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.501 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 41.4 mtt180 -70.88 -167.3 0.19 Allowed 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.977 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 43.87 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.968 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -46.28 177.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.235 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -94.68 159.89 32.54 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 112.068 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 39.4 Cg_exo -53.51 -173.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.725 2.283 . . . . 0.0 112.775 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.8 t -157.31 -172.93 4.19 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.305 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 60.98 -139.31 47.94 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.445 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.0 Cg_endo -90.21 97.02 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.304 3.336 . . . . 0.0 112.771 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.2 -70.32 1.75 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.031 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.478 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.74 33.18 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.578 0.543 . . . . 0.0 112.133 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.96 -34.8 69.26 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.568 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -110.57 -167.73 19.32 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.732 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.31 177.25 9.13 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.86 156.09 30.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.59 ' HB2' HG21 ' A' ' 26' ' ' ILE . 17.6 m-85 -130.55 -83.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.122 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.598 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -114.46 -103.74 2.53 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.816 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.8 118.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.65 2.9 . . . . 0.0 113.214 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.6 27.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.598 ' CG2' ' H ' ' A' ' 23' ' ' GLY . 2.6 tt -118.8 163.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.242 1.02 . . . . 0.0 113.453 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.62 140.99 21.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.529 -1.669 . . . . 0.0 108.284 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -144.9 106.65 4.27 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.718 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.889 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.65 116.41 5.09 Favored Glycine 0 N--CA 1.401 -3.65 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 22.8 t0 -57.94 -56.94 15.53 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.46 19.64 1.22 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.889 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -151.68 34.15 0.55 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 43.24 -169.55 0.01 OUTLIER Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.316 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 140.24 52.5 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.667 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 19.1 m-85 -131.16 115.18 16.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.141 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG12 ' CD1' ' A' ' 26' ' ' ILE . 4.0 t -94.14 101.72 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.436 0.636 . . . . 0.0 110.27 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.54 20.25 55.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.067 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.667 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.6 p -77.73 -173.15 2.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.07 -42.19 99.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.402 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -75.82 -10.83 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.456 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -100.93 -12.93 18.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.847 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -53.48 -14.28 0.77 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.24 -25.31 3.55 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.062 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -7.67 57.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.726 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.56 -24.32 60.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -17.74 56.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.499 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -81.21 -1.15 43.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.709 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.47 -6.64 25.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.575 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -141.78 46.28 1.68 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.724 0.297 . . . . 0.0 111.776 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.6 HD11 ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -138.37 145.15 45.76 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 120.967 0.413 . . . . 0.0 110.756 178.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.513 ' HB2' HD21 ' A' ' 5' ' ' LEU . 86.2 Cg_exo -48.38 114.84 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.646 2.231 . . . . 0.0 112.804 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB3' ' CD ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 57.22 178.6 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.941 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 52' ' ' SER . 98.5 Cg_endo -90.65 168.21 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.84 2.36 . . . . 0.0 112.095 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.93 -158.85 0.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.251 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 3.5 tt0 -140.01 153.33 46.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.038 0.447 . . . . 0.0 111.312 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . 98.9 p -121.27 -159.35 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.937 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.432 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -139.32 89.14 0.2 Allowed Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.785 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -110.99 89.68 3.11 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -63.64 107.25 1.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.155 178.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.794 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 64.0 Cg_exo -41.36 157.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.278 3.319 . . . . 0.0 117.668 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -165.85 153.27 10.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.784 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.19 5.5 3.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.035 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -90.79 55.88 3.08 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 117.415 0.607 . . . . 0.0 111.25 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.26 31.96 56.95 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.953 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.619 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.34 -149.78 18.29 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.864 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.794 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.4 mmt180 -119.03 155.35 31.58 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.871 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.646 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.1 t -63.24 162.75 11.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.4 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -162.56 -91.59 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -73.83 -171.5 1.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.711 0.804 . . . . 0.0 112.929 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.885 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -47.49 91.14 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.912 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.44 60.74 8.32 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 118.605 -1.76 . . . . 0.0 110.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.2 mm -128.58 147.49 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 24.3 t -136.18 103.59 5.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -87.31 152.19 22.49 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -173.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.493 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -121.24 -179.27 0.71 Allowed Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.963 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.493 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_exo -73.73 -13.22 24.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.501 2.134 . . . . 0.0 112.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.81 -26.96 12.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.967 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.88 171.21 32.73 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.89 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 26' ' ' ILE . 13.3 m -93.42 166.21 12.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.398 0.618 . . . . 0.0 112.059 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.76 141.29 21.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.662 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -60.9 118.14 6.32 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.914 0.388 . . . . 0.0 110.89 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.0 p30 -99.75 109.39 55.43 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 121.577 0.703 . . . . 0.0 111.556 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.713 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.3 Cg_exo -56.55 -15.67 16.43 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 124.036 3.157 . . . . 0.0 110.192 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.49 63.51 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.141 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.835 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.91 -28.69 9.0 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -176.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.53 -29.16 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.164 1 N-CA-C 122.17 4.137 . . . . 0.0 122.17 -177.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.912 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -107.38 -71.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.409 0 C-N-CA 122.684 2.256 . . . . 0.0 112.926 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.75 -6.71 28.08 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.686 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -72.8 -152.95 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.731 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.81 -178.54 0.43 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.617 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -74.05 62.15 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.414 ' OG ' ' CG ' ' A' ' 86' ' ' ASP . 3.5 t . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.047 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.529 ' HA ' ' CD ' ' A' ' 53' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.96 0.409 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.562 ' N ' ' HB3' ' A' ' 53' ' ' PRO . 12.1 m -82.75 129.81 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.529 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.882 ' HG ' ' H ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.94 170.67 15.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.308 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.963 ' HB3' ' HD2' ' A' ' 8' ' ' ARG . 22.4 t70 -79.22 -74.13 0.3 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.979 HD22 ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -77.6 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.954 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.956 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -84.48 -77.12 0.28 Allowed 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.668 ' N ' HD23 ' A' ' 5' ' ' LEU . 18.7 m -121.72 82.16 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.984 ' HD3' ' HB2' ' A' ' 55' ' ' GLN . 34.9 mtt85 -84.68 -167.91 1.99 Allowed 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.247 -0.908 . . . . 0.0 111.214 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.687 HG21 ' HG3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -163.35 80.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.965 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 54' ' ' CYS . 32.0 p -83.63 101.7 11.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.152 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.624 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 6.4 mp -127.06 96.27 34.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.458 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.623 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 53.4 Cg_exo -48.69 172.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 114.491 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 7.3 t -160.18 -169.47 2.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.9 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.497 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 56.5 -142.83 39.67 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.491 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -86.24 93.43 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.972 3.115 . . . . 0.0 112.545 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.97 -69.7 1.13 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.689 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.623 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.26 32.22 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.43 0.461 . . . . 0.0 112.095 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.618 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.07 -36.4 69.55 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.753 0.787 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.53 -167.4 20.19 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.023 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.903 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.04 -179.51 6.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 41.8 t -83.87 155.76 22.75 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.497 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.903 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 45.6 m-85 -142.5 8.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 149.27 -103.09 0.25 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.016 -1.564 . . . . 0.0 115.351 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.4 Cg_endo -105.53 105.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.914 3.076 . . . . 0.0 113.31 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 52.46 18.92 1.03 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.558 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.692 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.8 tt -108.01 153.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.225 1.012 . . . . 0.0 113.533 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.897 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -160.36 138.03 9.65 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.48 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 21.4 m -147.9 110.03 4.56 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.524 -177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.87 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -90.62 131.16 10.62 Favored Glycine 0 N--CA 1.415 -2.702 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.482 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 17.2 t70 -59.51 -62.59 1.76 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.329 1.064 . . . . 0.0 109.462 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.618 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -75.57 -0.84 21.8 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.87 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -125.61 31.44 5.52 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.601 -176.07 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 40.9 -177.27 0.01 OUTLIER Glycine 0 N--CA 1.465 0.608 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' SG ' HG23 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -99.33 140.49 33.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' CE1' HD11 ' A' ' 32' ' ' LEU . 49.4 m-85 -130.91 143.5 50.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.164 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.558 HG12 ' CD1' ' A' ' 26' ' ' ILE . 2.6 t -142.83 119.73 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.025 0.44 . . . . 0.0 109.949 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.5 5.23 11.34 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.406 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.72 HG23 ' H ' ' A' ' 39' ' ' ALA . 3.3 m -87.32 179.27 6.63 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.72 ' H ' HG23 ' A' ' 38' ' ' THR . . . -61.37 -54.27 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.69 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.89 8.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.897 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -108.97 -38.67 5.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.7 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.26 -15.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.548 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.35 -18.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 t -70.8 -11.93 61.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.482 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -28.39 65.05 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.8 mt-10 -75.85 -9.58 58.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.752 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.624 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 3.7 tt0 -74.18 -1.11 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -84.65 8.11 18.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.288 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -103.51 -123.9 0.2 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.356 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 132.31 13.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 120.749 0.309 . . . . 0.0 110.824 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HG3' HG21 ' A' ' 9' ' ' THR . 93.0 Cg_exo -49.12 -179.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.209 2.606 . . . . 0.0 113.351 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.593 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -144.79 178.22 1.52 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.811 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 62.6 Cg_endo -90.67 79.05 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.745 2.297 . . . . 0.0 111.675 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' CYS . 31.8 p -162.09 59.97 0.24 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.283 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.984 ' HB2' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -122.12 178.75 4.79 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.242 -178.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 81.58 112.03 0.06 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -177.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.622 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . 166.57 -45.01 0.26 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.82 HE22 ' HA ' ' A' ' 68' ' ' ALA . 1.7 mt-30 -95.66 88.96 5.17 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -67.89 121.29 79.07 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.314 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.678 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 34.7 Cg_exo -38.6 176.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.829 3.02 . . . . 0.0 114.077 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.27 154.77 19.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.72 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.8 6.26 5.18 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.142 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.542 ' HB3' ' SG ' ' A' ' 73' ' ' CYS . 18.3 t -92.15 51.0 1.72 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.006 0.431 . . . . 0.0 111.081 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.33 25.79 63.16 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.072 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.725 ' HA3' ' O ' ' A' ' 74' ' ' CYS . . . 164.63 -152.37 22.0 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.713 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 5.6 mmt-85 -115.31 157.17 24.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.179 -0.51 . . . . 0.0 111.444 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 30.6 t -58.28 143.54 44.28 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.933 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.82 ' HA ' HE22 ' A' ' 58' ' ' GLN . . . -137.46 -95.23 0.21 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.323 0.583 . . . . 0.0 112.085 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.577 ' HB1' HG13 ' A' ' 72' ' ' ILE . . . -76.98 -172.54 2.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.419 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.92 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.978 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.3 71.11 0.76 Allowed Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 118.93 -1.605 . . . . 0.0 110.188 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 3.9 mm -138.53 146.25 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 23.4 t -135.14 104.19 5.83 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.725 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.6 t -91.33 152.87 20.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.7 m -119.6 -179.25 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.606 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.526 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.9 Cg_exo -72.18 -10.66 26.14 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.393 2.062 . . . . 0.0 112.154 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.92 -33.0 7.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.453 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.81 168.22 37.07 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' A' ' 26' ' ' ILE . 5.2 m -98.28 165.36 11.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 111.853 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 141.57 21.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.399 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.692 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.78 114.72 2.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.5 p30 -95.98 106.42 27.99 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 121.303 0.573 . . . . 0.0 111.296 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.828 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.84 -9.88 3.43 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 124.142 3.228 . . . . 0.0 110.495 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.18 -29.13 57.55 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.651 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.862 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -109.72 -27.77 9.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 118.122 2.638 . . . . 0.0 118.122 -176.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 175.6 -31.19 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.334 1 N-CA-C 122.179 4.14 . . . . 0.0 122.179 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.978 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.8 Cg_endo -105.46 -70.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.717 2.278 . . . . 0.0 112.097 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.828 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 65.0 tt0 -69.97 -6.65 34.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -76.25 -157.48 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.237 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.45 -178.82 0.72 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.48 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.36 62.36 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.204 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.791 0.329 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.73 162.37 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.201 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD11 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.53 166.66 23.16 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.583 0.706 . . . . 0.0 112.564 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.648 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 50.1 t0 -78.78 -79.0 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.348 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.735 HD21 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -84.07 -150.78 0.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.735 ' H ' HD21 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -82.47 -51.84 7.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.714 ' N ' HD13 ' A' ' 5' ' ' LEU . 32.5 m -119.44 84.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.648 ' HD2' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -81.87 158.99 23.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.89 65.25 0.3 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -57.37 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.553 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.505 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.2 mp -110.58 136.08 20.66 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 111.943 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.7 Cg_exo -66.01 -166.73 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.455 2.103 . . . . 0.0 112.239 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.577 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.2 t -157.87 -176.38 5.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.898 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.792 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 61.37 -138.17 47.36 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.748 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 14.3 Cg_endo -89.6 98.15 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 124.456 3.437 . . . . 0.0 112.551 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.31 -69.04 2.84 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.129 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.69 32.86 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 121.54 0.522 . . . . 0.0 112.478 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.618 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.69 -35.49 72.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.043 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.91 -171.87 22.59 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.984 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.66 179.98 7.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 120.799 0.333 . . . . 0.0 110.135 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -80.44 145.12 32.1 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.7 m-85 -118.51 -60.3 1.79 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.699 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -142.12 -100.16 0.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.268 -0.967 . . . . 0.0 114.02 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.8 Cg_endo -100.85 105.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.344 2.696 . . . . 0.0 113.387 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.46 25.42 1.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 110.464 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.7 HD11 ' SG ' ' A' ' 79' ' ' CYS . 3.0 tt -112.9 164.75 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.949 0.881 . . . . 0.0 112.922 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.44 141.28 22.81 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.033 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -145.38 108.76 4.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.708 -177.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.904 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -97.59 117.13 5.71 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.708 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 36.9 t0 -57.92 -56.56 20.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.553 1.177 . . . . 0.0 108.33 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.618 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -83.85 15.27 3.39 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.904 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -145.36 32.92 1.07 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.587 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.94 173.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.085 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t -112.98 136.84 52.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.909 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.67 125.28 29.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.822 177.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.677 HG13 HD13 ' A' ' 26' ' ' ILE . 4.8 t -95.18 97.7 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.53 14.19 56.95 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.854 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.811 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 4.7 m -78.54 -177.4 5.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' H ' HG23 ' A' ' 38' ' ' THR . . . -53.58 -55.55 24.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.267 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.5 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -72.66 4.21 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.909 ' HB1' ' HB2' ' A' ' 35' ' ' PHE . . . -114.25 -21.42 10.45 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.811 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.84 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.577 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.2 OUTLIER -50.29 -25.84 4.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 118.305 0.502 . . . . 0.0 110.865 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.91 2.26 15.21 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.697 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -57.82 -25.66 60.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HG2' HD22 ' A' ' 11' ' ' LEU . 2.3 pp20? -78.84 -17.44 55.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.819 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -2.63 31.02 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -78.23 -5.02 50.64 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.101 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -136.02 30.45 3.04 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.109 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 tp -141.0 142.31 27.21 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.778 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -44.53 174.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.4 . . . . 0.0 113.084 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.527 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 22.2 m -65.87 -50.95 50.81 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.633 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 52' ' ' SER . 92.0 Cg_endo -86.2 153.98 9.53 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.364 2.043 . . . . 0.0 112.389 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.432 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 43.9 t -177.63 80.16 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.605 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 55' ' ' GLN . 48.4 tt0 55.2 12.72 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.686 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -50.59 150.59 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.017 -0.427 . . . . 0.0 110.922 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.7 97.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.731 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.729 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 5.0 mm-40 -117.02 88.89 2.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -66.85 102.68 0.39 Allowed Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.623 0.769 . . . . 0.0 111.376 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.84 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 25.8 Cg_exo -40.82 157.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.577 3.518 . . . . 0.0 118.563 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -164.62 153.99 13.37 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.869 176.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.7 7.01 1.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.54 -0.754 . . . . 0.0 114.122 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 24.2 t -92.85 52.08 1.79 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.397 0.598 . . . . 0.0 111.265 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.06 34.89 58.67 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.752 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.713 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.05 -151.44 21.13 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.604 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.84 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 2.9 mmt180 -117.99 154.17 32.42 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.922 0.391 . . . . 0.0 111.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -61.86 155.32 23.59 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.71 -99.16 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.384 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.03 -170.78 1.48 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.924 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.901 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.51 86.61 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.958 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.94 70.76 0.88 Allowed Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.967 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 68' ' ' ALA . 3.3 mm -142.64 116.25 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 121.643 0.735 . . . . 0.0 109.028 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.2 t -104.88 106.3 16.73 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 1.8 t -92.72 161.58 14.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.462 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -128.04 -179.92 1.09 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.176 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.462 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -73.47 -10.12 23.53 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.38 2.054 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -32.52 7.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.423 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 167.1 35.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.912 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.7 ' SG ' HD11 ' A' ' 26' ' ' ILE . 29.2 m -97.08 167.21 11.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.0 111.935 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.54 142.22 20.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.996 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.604 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -60.98 113.07 2.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.077 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.624 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 35.4 p30 -95.05 108.63 39.58 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-O 121.667 0.746 . . . . 0.0 111.769 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.813 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 48.5 Cg_exo -58.51 -12.09 13.03 Favored 'Trans proline' 0 CA--C 1.504 -0.985 0 C-N-CA 123.99 3.126 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -75.37 -29.58 59.93 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.32 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.685 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.6 -24.09 10.73 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -175.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.606 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 6.9 t70 173.77 -29.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.391 1 N-CA-C 122.262 4.171 . . . . 0.0 122.262 -178.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.958 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.8 Cg_endo -107.56 -71.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.481 2.121 . . . . 0.0 112.465 -171.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.1 tt0 -69.56 -6.68 32.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.813 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -75.31 -155.53 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.073 -2.331 . . . . 0.0 111.613 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.24 -178.85 0.69 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.445 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -74.48 62.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 8.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.745 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.849 0.356 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.13 163.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.795 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -67.86 168.72 11.08 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.465 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 12.0 t0 -74.87 -134.44 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.943 HD12 ' HG3' ' A' ' 66' ' ' ARG . 1.1 pp -91.1 -125.64 0.08 Allowed 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 122.029 -0.419 . . . . 0.0 111.103 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.553 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 1.1 t70 -73.12 -52.68 13.31 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.815 ' H ' HD11 ' A' ' 5' ' ' LEU . 6.4 m -85.85 85.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.43 176.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.795 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 33.1 mtt85 -76.13 123.86 26.5 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.729 HG21 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -75.36 -151.26 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.966 178.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 54' ' ' CYS . 0.6 OUTLIER 73.59 -15.94 0.53 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.365 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.6 mp -110.19 91.79 12.08 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.24 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.668 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 51.6 Cg_exo -49.08 168.55 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.157 1.904 . . . . 0.0 112.778 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.585 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 5.2 t -158.3 -171.86 3.65 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 57.88 -149.78 33.2 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.013 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.37 85.49 1.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.669 2.913 . . . . 0.0 112.836 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -71.52 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.668 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.7 31.9 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 121.416 0.453 . . . . 0.0 112.578 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -75.01 -37.38 61.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.884 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -105.54 -163.54 23.46 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.526 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.729 ' HD3' HG21 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.92 153.69 45.77 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.187 0.994 . . . . 0.0 112.881 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.421 ' HB2' ' CA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.06 127.13 36.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.209 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.81 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -102.07 -102.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -113.13 -87.71 1.64 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 26' ' ' ILE . 30.7 Cg_endo -101.91 113.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.171 2.58 . . . . 0.0 114.451 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.42 23.27 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.725 0.298 . . . . 0.0 110.622 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.81 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 6.6 tt -112.8 161.85 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.556 1.169 . . . . 0.0 114.036 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.779 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 49.2 t -159.4 159.54 33.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.763 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.58 ' CB ' ' CZ ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -154.1 106.15 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.876 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -96.76 122.54 7.43 Favored Glycine 0 N--CA 1.414 -2.814 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 25.8 t70 -58.78 -59.15 5.89 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.61 1.205 . . . . 0.0 107.942 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.2 pt-20 -81.82 11.62 4.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.876 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.49 41.66 1.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.197 -175.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 27.89 -164.39 0.0 OUTLIER Glycine 0 N--CA 1.472 1.066 0 N-CA-C 115.398 0.919 . . . . 0.0 115.398 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -114.81 144.34 43.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.693 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.6 m-85 -131.46 98.23 4.46 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.818 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.69 131.46 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.037 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 53.18 31.76 42.04 Favored Glycine 0 C--N 1.319 -0.406 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.809 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -112.28 -177.69 3.23 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -69.55 -49.15 57.01 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -68.99 8.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -106.3 -27.19 11.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.78 -11.2 2.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.585 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.86 -19.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.421 ' CA ' ' HB2' ' A' ' 21' ' ' CYS . 1.2 t -69.47 -21.96 63.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.927 0.394 . . . . 0.0 110.086 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -60.16 -24.19 64.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.11 -7.68 57.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.031 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -69.86 -6.26 31.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.896 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.82 -34.65 69.88 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 110.318 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 3.6 m-30 -80.32 174.43 11.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.653 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -121.49 95.21 48.35 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.92 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 50' ' ' LEU . 99.2 Cg_exo -50.79 -165.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.202 2.601 . . . . 0.0 113.253 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.445 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -141.68 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.73 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 52' ' ' SER . 71.7 Cg_endo -77.57 83.02 2.25 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.439 2.093 . . . . 0.0 112.702 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -64.48 -171.86 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.687 -179.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 54' ' ' CYS . 8.5 tt0 172.12 158.77 0.1 Allowed 'General case' 0 C--N 1.346 0.456 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.705 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 2.0 p -73.91 -172.78 1.39 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.81 -79.88 0.12 Allowed Glycine 0 CA--C 1.489 -1.536 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.789 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.503 ' NE2' ' HB ' ' A' ' 7' ' ' VAL . 19.7 mt-30 -69.22 88.66 0.44 Allowed 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -69.78 113.5 17.82 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.676 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.802 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 68.6 Cg_exo -40.3 155.17 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.221 2.614 . . . . 0.0 115.576 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -161.46 153.9 20.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.19 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.46 4.18 5.33 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.174 -0.921 . . . . 0.0 114.06 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 31.9 t -90.51 57.02 3.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.434 0.617 . . . . 0.0 111.5 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.63 29.07 57.39 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.879 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.723 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.61 -149.05 16.6 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.443 -0.885 . . . . 0.0 115.307 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.943 ' HG3' HD12 ' A' ' 5' ' ' LEU . 6.7 mmt180 -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.22 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 34.8 t -60.38 154.25 20.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.3 -92.7 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.571 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -77.2 -171.24 1.98 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.895 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.64 89.18 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.91 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.21 68.46 1.69 Allowed Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.787 -1.673 . . . . 0.0 110.202 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.649 ' O ' ' N ' ' A' ' 68' ' ' ALA . 1.4 mm -138.52 141.2 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.3 t -128.89 104.96 7.9 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.3 t -90.21 153.13 20.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.481 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -119.76 -179.61 0.73 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.403 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -72.87 -11.58 25.77 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.189 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -29.97 9.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.078 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.19 171.06 36.77 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -97.54 164.34 12.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.267 0.556 . . . . 0.0 111.925 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.38 139.51 20.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.664 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.13 118.84 5.88 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.911 0.386 . . . . 0.0 110.503 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.69 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 45.7 p30 -98.97 108.31 48.57 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.673 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.9 Cg_exo -55.91 -16.57 16.35 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 123.868 3.045 . . . . 0.0 109.941 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -28.23 63.93 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.859 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -111.38 -27.39 8.66 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -176.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.5 t70 174.58 -28.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 1 N-CA-C 122.432 4.234 . . . . 0.0 122.432 -177.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.91 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.8 Cg_endo -106.39 -71.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.559 2.173 . . . . 0.0 112.542 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.659 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.5 tt0 -69.75 -6.18 30.25 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.673 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.23 -158.1 0.06 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.958 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.03 -178.11 0.57 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.541 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -73.0 62.11 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.0 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m 44.56 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.413 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -78.13 171.22 15.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.645 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 4.8 t0 -81.65 -87.88 0.09 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.46 ' CG ' ' H ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -81.4 -74.1 0.35 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.175 0.988 . . . . 0.0 109.294 177.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.46 ' H ' ' CG ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -152.75 -59.51 0.14 Allowed 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.827 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 7' ' ' VAL . 31.4 m -106.49 86.49 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.012 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.645 ' NE ' ' HB2' ' A' ' 4' ' ' ASP . 4.9 mtt-85 -73.44 -178.32 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.578 0.704 . . . . 0.0 112.678 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.81 41.65 0.06 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.741 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -77.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.716 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD22 ' CG ' ' A' ' 46' ' ' GLU . 5.2 tp -125.05 91.39 49.41 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 121.316 0.579 . . . . 0.0 112.177 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo -69.74 -167.77 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.517 2.145 . . . . 0.0 111.736 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -158.8 -177.16 6.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.775 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.675 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 62.67 -136.67 44.34 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.555 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.9 Cg_endo -91.8 101.04 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.519 3.48 . . . . 0.0 112.599 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.59 -71.65 2.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.75 33.64 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.578 0.543 . . . . 0.0 112.267 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.94 -35.63 69.67 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.48 -0.86 . . . . 0.0 110.228 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -104.37 -172.22 24.95 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.151 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.29 178.82 8.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' SG ' HD23 ' A' ' 11' ' ' LEU . 1.3 m -75.98 154.6 35.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 15.1 m-85 -135.01 -28.02 1.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -170.72 -110.24 0.23 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.593 -1.289 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -98.51 103.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.293 2.662 . . . . 0.0 112.793 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.79 22.95 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.036 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.645 HD13 HG12 ' A' ' 36' ' ' VAL . 2.5 tt -111.63 163.16 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 122.0 0.905 . . . . 0.0 113.016 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.31 143.23 23.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.608 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -145.82 103.11 3.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.066 -177.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.88 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.01 116.04 4.59 Favored Glycine 0 N--CA 1.402 -3.603 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.822 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.648 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 27.0 t70 -58.42 -55.27 37.25 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.9 pt-20 -83.63 11.78 6.74 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.88 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.05 37.75 1.16 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 40.51 -175.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -118.13 138.52 52.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.687 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 0.9 OUTLIER -132.19 129.82 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.419 178.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.645 HG12 HD13 ' A' ' 26' ' ' ILE . 6.3 t -103.79 97.61 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.183 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.54 17.52 62.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.005 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.687 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 10.0 p -74.15 -170.92 1.03 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.022 0.411 . . . . 0.0 109.933 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.25 -45.75 83.36 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.15 -14.27 61.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.331 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -102.21 -9.84 20.11 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.851 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -17.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.36 -28.81 8.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.484 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -2.76 38.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.927 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.545 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.5 mt-30 -57.32 -26.56 61.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' CG ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.18 -22.65 41.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.807 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -0.44 38.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.711 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.32 -13.43 55.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.973 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -84.83 -106.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tp -103.19 102.26 27.36 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 120.632 0.254 . . . . 0.0 110.996 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -43.28 127.65 5.54 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.856 2.371 . . . . 0.0 112.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.2 t -123.67 124.07 26.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.73 55.77 3.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.343 2.028 . . . . 0.0 112.161 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.2 t -119.01 122.01 41.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.331 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.568 ' CA ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 51.13 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.024 0.44 . . . . 0.0 111.54 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.9 p 178.56 125.65 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.958 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 146.27 11.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.174 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.579 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -130.29 89.63 2.82 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -58.61 103.86 0.39 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.088 0.555 . . . . 0.0 110.783 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.827 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 77.8 Cg_exo -44.29 155.76 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.018 3.146 . . . . 0.0 117.018 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.21 168.59 20.48 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.734 1.254 . . . . 0.0 112.591 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.55 -2.18 33.94 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 112.465 -2.152 . . . . 0.0 116.317 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.583 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 41.5 t -94.21 56.52 2.21 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 117.745 0.772 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.43 38.89 35.45 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.29 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.568 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.96 -153.72 24.38 Favored Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.329 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.827 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -111.68 147.89 34.58 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.194 0.521 . . . . 0.0 111.816 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 t -62.23 156.04 23.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.708 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -157.69 -94.05 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -73.99 -171.16 1.05 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.746 0.819 . . . . 0.0 112.747 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.45 89.66 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.909 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.4 63.29 5.41 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.505 -1.807 . . . . 0.0 110.289 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.0 mm -130.19 146.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 1.9 t -135.97 104.4 5.7 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.4 t -89.49 159.16 17.39 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -173.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.513 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.5 m -127.49 -179.27 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.2 Cg_exo -71.92 -10.13 25.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.336 2.024 . . . . 0.0 112.697 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -33.2 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 111.304 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.8 169.95 37.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.466 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 26' ' ' ILE . 8.0 m -96.38 165.8 12.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.4 0.619 . . . . 0.0 112.111 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.79 140.81 21.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.694 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.469 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.85 117.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.0 110.006 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.753 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.7 p30 -99.01 109.7 54.98 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.907 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.794 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -57.24 -14.78 16.37 Favored 'Trans proline' 0 CA--C 1.504 -1.0 0 C-N-CA 123.682 2.921 . . . . 0.0 109.887 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.24 -29.36 62.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.251 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.755 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.32 -26.6 9.49 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.7 t70 174.52 -29.22 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.245 1 N-CA-C 122.481 4.252 . . . . 0.0 122.481 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.909 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.0 Cg_endo -106.31 -70.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -171.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 30.6 tt0 -69.47 -6.55 31.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -75.99 -154.83 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.059 -2.337 . . . . 0.0 112.549 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.96 -178.7 1.29 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.817 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -74.62 62.04 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.252 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 3' ' ' LEU . 13.4 t -56.86 173.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.762 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.18 173.17 5.89 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.884 0.85 . . . . 0.0 112.923 -178.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.777 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 43.5 t0 -81.45 -144.87 0.05 Allowed 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.895 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.566 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -88.96 -116.98 0.06 Allowed 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.495 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -74.69 -47.88 29.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.566 ' H ' HD11 ' A' ' 5' ' ' LEU . 11.1 m -87.68 84.19 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.365 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.777 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 45.5 mtt180 -80.09 167.33 20.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.772 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 21.4 m 69.98 97.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.666 -1.152 . . . . 0.0 113.19 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.5 ' N ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -38.12 105.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 178.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -108.76 91.75 9.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 121.254 0.55 . . . . 0.0 110.179 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 94.4 Cg_exo -41.57 164.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.041 2.494 . . . . 0.0 114.869 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.645 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.6 t -157.42 -172.02 3.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.103 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.669 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 58.44 -142.59 45.06 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.664 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.564 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 26.3 Cg_endo -85.63 95.84 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.148 3.232 . . . . 0.0 112.796 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.46 -66.68 3.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.025 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 12' ' ' PRO . . . 178.29 32.02 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 121.591 0.551 . . . . 0.0 112.438 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.727 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.47 -34.85 72.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -0.827 . . . . 0.0 109.866 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.24 -169.11 15.77 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.721 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.55 -178.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 34.3 m -76.03 159.87 30.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 63.2 m-85 -148.24 16.94 1.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 142.73 -113.56 0.8 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.263 -1.446 . . . . 0.0 114.879 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.5 Cg_endo -105.75 111.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.878 3.052 . . . . 0.0 112.986 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.79 22.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.388 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.627 HD13 ' SG ' ' A' ' 79' ' ' CYS . 1.5 tt -115.76 154.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 122.177 0.989 . . . . 0.0 112.486 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -158.63 134.04 8.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.76 -1.563 . . . . 0.0 107.324 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.576 ' HB3' ' CB ' ' A' ' 69' ' ' ALA . 33.2 m -150.38 108.95 3.81 Favored 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.187 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.11 123.08 5.96 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.185 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.649 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 22.9 t70 -58.21 -57.62 12.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.32 18.04 1.21 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -152.2 39.36 0.59 Allowed 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 45.4 178.67 0.01 OUTLIER Glycine 0 N--CA 1.464 0.561 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -105.32 129.08 53.74 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.786 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.7 m-85 -132.1 105.63 7.5 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.68 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 26' ' ' ILE . 8.1 t -95.25 110.28 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.232 0.539 . . . . 0.0 109.599 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.46 21.08 53.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.919 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -94.38 178.26 5.68 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.29 -53.85 31.72 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 111.589 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -71.09 8.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -108.25 -24.95 11.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -16.91 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.472 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 1.2 mpp_? -55.15 -18.14 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -72.13 -8.15 53.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -26.68 65.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -12.96 60.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.908 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.1 tm-20 -66.69 -4.27 8.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.763 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.61 -44.16 65.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.796 0.332 . . . . 0.0 110.253 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -97.26 165.83 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.16 74.58 15.85 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-O 120.814 0.34 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.42 -168.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.178 2.585 . . . . 0.0 113.299 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 72.0 m -59.99 173.26 0.58 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.707 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 87.1 Cg_exo -48.63 -179.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.628 2.219 . . . . 0.0 113.103 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.772 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 44.2 t -161.38 -60.48 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.576 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.677 ' HG2' ' H ' ' A' ' 56' ' ' SER . 3.9 tt0 173.88 -175.62 0.07 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.94 0.336 . . . . 0.0 111.203 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.677 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -60.62 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.507 ' HA2' ' CZ ' ' A' ' 20' ' ' ARG . . . 179.39 -100.63 0.14 Allowed Glycine 0 CA--C 1.489 -1.556 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.839 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.785 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -74.33 90.4 2.13 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.003 -0.599 . . . . 0.0 109.456 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -64.52 107.48 1.4 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.22 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.749 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 90.9 Cg_exo -40.7 158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.199 2.6 . . . . 0.0 116.386 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.09 154.17 14.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.539 177.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.35 3.87 7.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.747 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 11.0 t -91.08 54.07 2.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 117.222 0.511 . . . . 0.0 111.311 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.07 33.18 60.5 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.133 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.88 -151.35 21.08 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.785 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.0 mmt85 -118.35 156.01 29.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.992 -0.604 . . . . 0.0 111.26 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 24.6 t -61.25 151.73 30.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . . . -149.07 -94.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.649 ' C ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.7 -171.68 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.651 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.934 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.05 91.76 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.94 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.95 68.21 1.8 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.006 -1.569 . . . . 0.0 110.206 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.0 mm -136.12 142.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.6 t -128.93 104.47 7.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -88.5 154.42 20.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.538 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.8 m -123.16 -179.24 0.77 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -72.04 -9.68 24.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.334 2.023 . . . . 0.0 112.927 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -34.07 7.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.691 0.282 . . . . 0.0 110.984 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.83 170.17 38.31 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.282 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.627 ' SG ' HD13 ' A' ' 26' ' ' ILE . 11.6 m -94.03 165.95 12.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.482 0.658 . . . . 0.0 112.666 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.82 140.0 21.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.597 178.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.468 ' CA ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -60.41 117.93 5.84 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.985 0.422 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.703 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.7 p30 -99.19 108.53 50.33 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.281 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.797 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.23 -12.74 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.014 3.142 . . . . 0.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -75.22 -29.64 60.36 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.35 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.89 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -108.88 -27.56 9.65 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -176.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.33 -29.36 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.362 1 N-CA-C 122.321 4.193 . . . . 0.0 122.321 -178.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.94 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.7 Cg_endo -106.2 -70.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.495 0 C-N-CA 122.345 2.03 . . . . 0.0 112.29 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.686 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 62.1 tt0 -69.49 -6.83 33.18 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -75.76 -158.04 0.08 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 111.79 -2.459 . . . . 0.0 112.11 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.67 -177.97 0.85 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.613 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.92 61.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.545 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.455 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.8 t -65.71 167.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.812 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.15 173.97 6.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.0 112.641 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.537 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.9 t0 -80.14 -78.49 0.17 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.584 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.761 ' CD2' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.65 -127.64 0.06 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.826 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.761 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.01 -41.85 73.78 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.735 ' CG2' HD13 ' A' ' 5' ' ' LEU . 34.3 m -91.62 109.22 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.783 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.812 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 86.2 mtt180 -71.4 126.66 30.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.635 ' HB ' ' HA ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -104.09 -162.85 0.93 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.922 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.594 ' H ' ' HA ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER 65.88 62.72 0.61 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' CD2' ' HG2' ' A' ' 46' ' ' GLU . 1.8 tp -89.66 132.25 37.4 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.493 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 26.8 Cg_exo -55.76 -173.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.081 1.854 . . . . 0.0 112.677 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.579 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 3.9 t -157.86 -175.02 5.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.732 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 59.53 -137.47 49.88 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.85 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 11.3 Cg_endo -89.76 94.94 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.437 3.425 . . . . 0.0 112.667 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.05 -68.61 2.48 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.418 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.497 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.56 32.41 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.504 0.502 . . . . 0.0 112.32 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -69.8 -35.5 74.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.573 -0.813 . . . . 0.0 110.109 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -114.94 -165.38 14.85 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.809 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.581 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.59 177.0 10.41 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -79.43 153.71 29.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.672 ' CE2' ' HB2' ' A' ' 68' ' ' ALA . 15.6 m-85 -125.71 -94.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.695 -0.402 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.621 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -98.86 -106.84 2.67 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.575 -0.822 . . . . 0.0 114.565 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -101.95 113.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.798 2.999 . . . . 0.0 113.559 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 50.9 21.02 0.87 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.719 HD11 ' SG ' ' A' ' 79' ' ' CYS . 4.2 tt -111.74 166.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 122.134 0.968 . . . . 0.0 113.316 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.77 143.08 18.2 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.751 -1.568 . . . . 0.0 107.886 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -147.5 104.88 3.67 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.908 -177.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.912 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.14 119.58 5.96 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.637 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 36.3 t0 -58.22 -58.63 7.6 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.607 1.203 . . . . 0.0 108.009 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.3 pt-20 -81.18 20.39 0.83 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.912 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -152.08 35.21 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.218 -175.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 37.3 -164.81 0.01 OUTLIER Glycine 0 C--N 1.33 0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 114.164 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.75 140.29 53.07 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -131.91 114.88 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.582 178.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 26' ' ' ILE . 3.2 t -97.17 113.8 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.409 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 58.92 19.86 46.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.738 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.793 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.2 m -94.47 163.76 13.27 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.411 0.284 . . . . 0.0 110.384 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.83 -53.62 7.28 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.282 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.3 mp0 -69.06 7.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.858 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . . . -116.03 -26.69 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -43.37 -19.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.579 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.23 -21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.572 0.624 . . . . 0.0 111.702 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 13.7 t -77.68 -4.69 47.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.013 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -59.12 -25.08 63.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 2.1 pp20? -76.49 -14.05 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.518 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 1.6 tt0 -68.6 0.6 3.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.278 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.64 -19.35 15.82 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 12.4 m-30 -61.57 -168.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -107.56 84.71 1.98 Allowed Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 120.879 0.371 . . . . 0.0 111.903 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.69 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 44.2 Cg_exo -43.57 147.85 0.95 Allowed 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.834 2.356 . . . . 0.0 113.374 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -172.66 -64.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.69 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 52' ' ' SER . 63.9 Cg_endo -82.15 -86.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.132 1.888 . . . . 0.0 112.928 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.435 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 t -100.3 -84.02 0.43 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.576 0.226 . . . . 0.0 111.339 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.69 ' HG2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER 37.39 29.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.612 ' HB3' ' O ' ' A' ' 55' ' ' GLN . 64.6 p 165.67 -177.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.027 0.441 . . . . 0.0 110.663 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -162.93 87.08 0.1 Allowed Glycine 0 CA--C 1.5 -0.898 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.66 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mt-30 -113.6 89.54 3.11 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -63.65 103.2 0.38 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.238 178.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.826 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 57.9 Cg_exo -42.83 160.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.134 3.223 . . . . 0.0 117.662 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -164.75 154.06 13.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.155 177.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.93 3.37 3.07 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.044 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.03 54.74 2.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.562 0.681 . . . . 0.0 111.339 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.99 35.85 49.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.947 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.682 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.8 -154.84 25.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.973 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.826 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.6 mmt180 -115.43 155.46 27.4 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.207 -0.497 . . . . 0.0 111.587 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 25.1 t -60.98 153.03 26.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.043 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.712 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -151.39 -92.62 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' C ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.23 -173.86 2.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.6 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.78 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.934 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.68 66.02 3.14 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 118.601 -1.761 . . . . 0.0 110.215 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.9 mm -134.25 144.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.576 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 14.6 t -132.38 105.96 7.6 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -92.0 153.59 19.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -173.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.513 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.3 m -119.03 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.66 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -71.94 -10.22 25.86 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.313 2.008 . . . . 0.0 112.562 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 -32.24 7.62 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.656 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.92 168.49 36.92 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.703 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.719 ' SG ' HD11 ' A' ' 26' ' ' ILE . 8.6 m -96.44 165.89 11.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.482 0.658 . . . . 0.0 112.442 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.18 142.46 22.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.555 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.514 ' CA ' HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -61.11 117.88 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.58 -178.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 45.1 p30 -98.32 108.08 45.37 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-O 121.549 0.69 . . . . 0.0 111.285 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.765 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -56.24 -11.02 5.31 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 124.099 3.199 . . . . 0.0 110.147 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -77.02 -28.86 55.07 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.165 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.854 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -109.44 -27.37 9.49 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -175.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.4 t70 174.36 -29.35 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.246 1 N-CA-C 122.428 4.233 . . . . 0.0 122.428 -178.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.935 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.42 -70.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.746 2.297 . . . . 0.0 112.306 -172.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.765 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -70.96 -5.88 34.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 175.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.706 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.72 -160.3 0.15 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 111.767 -2.469 . . . . 0.0 112.371 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.11 -177.58 0.38 Allowed 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.675 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -74.23 61.77 0.89 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.248 0.993 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.235 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.868 0.366 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -83.41 143.52 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.2 0.524 . . . . 0.0 111.98 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.623 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -75.07 175.64 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.781 0.801 . . . . 0.0 112.975 -178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.589 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 20.0 t0 -77.95 -140.77 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.944 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -91.12 -123.8 0.07 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.495 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -68.93 -47.98 64.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.662 ' H ' HD12 ' A' ' 5' ' ' LEU . 15.9 m -85.92 90.43 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.947 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.623 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 58.6 mtt85 -69.26 -168.33 0.15 Allowed 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.67 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.4 m 67.22 111.61 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.791 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -48.17 -178.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.28 -178.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 11.0 mp -68.8 118.6 62.49 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.737 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 20.0 Cg_exo -58.84 -174.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.264 1.976 . . . . 0.0 112.241 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -156.67 -176.74 6.14 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.102 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.668 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 61.09 -133.08 49.01 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.876 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HD3' HD23 ' A' ' 32' ' ' LEU . 8.2 Cg_endo -92.71 100.31 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.905 3.737 . . . . 0.0 112.446 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 -68.27 3.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.919 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.68 31.63 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 121.416 0.453 . . . . 0.0 112.792 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.92 -37.85 69.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.764 0.792 . . . . 0.0 109.797 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -101.11 -176.58 29.1 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.783 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.441 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -162.14 -179.38 7.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.83 0.348 . . . . 0.0 110.655 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 m -80.91 144.88 31.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.649 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.6 m-85 -119.68 -43.47 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.599 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -165.01 -95.27 0.1 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.277 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.9 Cg_endo -101.91 103.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.567 2.844 . . . . 0.0 113.554 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.69 25.53 1.01 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 110.62 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.699 HD13 ' SG ' ' A' ' 79' ' ' CYS . 1.7 tt -113.86 160.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.85 0.833 . . . . 0.0 112.852 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -153.42 136.94 15.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.169 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 2.2 m -148.39 117.29 6.72 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.513 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.871 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -104.93 119.36 6.18 Favored Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.162 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.65 ' HA ' ' CA ' ' A' ' 69' ' ' ALA . 8.6 t70 -57.79 -57.02 14.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.552 1.176 . . . . 0.0 108.21 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -83.06 26.53 0.61 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.871 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -159.77 33.01 0.19 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.536 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.835 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 40.58 176.14 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 1.2 m -106.03 132.25 52.34 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.859 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -131.92 117.08 17.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.627 HG22 HD12 ' A' ' 26' ' ' ILE . 4.9 t -94.19 98.28 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.021 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.83 10.72 40.12 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.984 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -76.41 174.5 10.18 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.079 0.552 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.55 -56.14 4.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.344 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -73.7 6.98 2.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -112.87 -23.25 10.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.99 -18.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.37 -23.99 1.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.55 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.79 -5.2 49.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.281 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -59.97 -23.18 63.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 29.3 mt-10 -76.8 -13.83 59.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.192 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.5 mt-10 -75.49 2.02 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.75 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.58 -7.0 59.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.727 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -56.74 -163.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.224 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HG ' ' HD2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -92.67 155.87 41.54 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.782 -179.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 21.9 Cg_exo -39.0 122.17 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.093 2.529 . . . . 0.0 113.38 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -143.38 160.26 52.19 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -93.03 72.89 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.083 2.522 . . . . 0.0 112.725 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -175.54 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.256 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -137.8 171.09 14.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.172 0.511 . . . . 0.0 111.476 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.514 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 1.2 m -154.75 -170.82 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.92 102.29 0.21 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.356 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.674 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -124.65 88.95 2.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 120.902 0.382 . . . . 0.0 111.411 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -63.7 102.0 0.3 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.261 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.837 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 71.9 Cg_exo -44.01 160.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.873 3.049 . . . . 0.0 117.306 -176.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -165.17 155.02 13.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.805 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.12 7.14 3.46 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.4 t -93.38 51.94 1.68 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.124 0.462 . . . . 0.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.16 34.6 58.8 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.982 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.725 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.61 -151.85 21.53 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.837 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.6 mmt180 -118.82 155.41 31.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.758 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.69 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 27.0 t -62.89 155.59 26.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.04 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -143.58 -89.85 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.369 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.835 ' HB2' ' C ' ' A' ' 33' ' ' GLY . . . -73.34 -169.59 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 114.829 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 86' ' ' ASP . . . -28.44 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.36 1.03 0 CA-C-O 122.253 1.025 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.79 ' C ' ' OD1' ' A' ' 82' ' ' ASP . . . -177.01 78.53 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.847 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.0 mm -132.41 149.83 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 114.202 -0.999 . . . . 0.0 108.888 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 29.8 t -132.95 102.88 5.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -85.35 146.57 26.95 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.471 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -113.58 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.443 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 7.9 Cg_exo -74.67 -11.83 22.18 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.467 2.111 . . . . 0.0 112.271 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -28.14 11.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.015 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.04 168.2 33.2 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.699 ' SG ' HD13 ' A' ' 26' ' ' ILE . 9.1 m -94.17 165.93 12.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.276 0.56 . . . . 0.0 112.264 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 141.64 20.27 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.96 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.513 ' N ' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 122.1 12.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.79 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 54.0 p30 -101.55 106.65 47.39 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.438 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.894 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 52.8 Cg_exo -57.1 -17.64 25.83 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.786 2.991 . . . . 0.0 109.61 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.3 69.28 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.26 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 m -103.52 -33.76 8.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.719 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 9.2 t70 167.84 -24.84 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.457 0 N-CA-C 121.703 3.964 . . . . 0.0 121.703 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.679 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_endo -101.67 -69.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.263 1.975 . . . . 0.0 112.347 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.564 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.1 tt0 -71.85 -5.7 36.35 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -74.16 -155.3 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.207 -2.27 . . . . 0.0 111.44 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.24 -178.72 1.11 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -74.93 62.53 1.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.473 ' OG ' ' OD2' ' A' ' 86' ' ' ASP . 3.4 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.568 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.482 0.182 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 1' ' ' ALA . 17.1 m 36.51 -163.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.657 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.01 174.73 6.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.641 0.734 . . . . 0.0 112.706 -178.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.628 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . 66.9 t0 -78.27 -89.89 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.238 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.704 ' C ' HD11 ' A' ' 5' ' ' LEU . 1.3 pp -152.52 -42.37 0.1 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.692 ' HB2' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.53 -48.73 0.14 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.416 176.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 7' ' ' VAL . 4.4 m -82.68 92.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.232 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.657 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.5 mtt85 -67.26 171.04 6.24 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.509 ' H ' ' HB3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER 23.2 90.19 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.327 0.584 . . . . 0.0 111.06 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 13.9 p -145.15 17.33 1.56 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.939 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 4.6 tp -109.23 90.2 7.89 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.016 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 11.0 Cg_exo -63.63 179.11 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.901 1.734 . . . . 0.0 113.296 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.5 t -157.35 -169.77 3.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.673 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.698 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 58.6 -144.05 44.06 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.469 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 17.5 Cg_endo -87.92 90.91 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 124.206 3.271 . . . . 0.0 112.462 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.54 -70.69 0.61 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.101 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.491 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.87 32.2 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.868 0 CA-C-O 121.449 0.472 . . . . 0.0 112.447 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.482 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.43 -38.03 74.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.87 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.04 -164.54 18.47 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.569 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.68 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.71 179.07 9.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.59 151.96 37.76 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.68 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 24.2 m-85 -132.98 -1.13 3.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.18 -114.55 0.59 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.324 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -101.07 105.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.701 2.934 . . . . 0.0 112.571 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.48 23.78 3.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.948 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.668 HD11 ' SG ' ' A' ' 79' ' ' CYS . 2.9 tt -111.66 162.83 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.363 1.078 . . . . 0.0 113.584 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 49.3 t -147.83 149.92 33.22 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.227 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -154.45 96.08 1.87 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.589 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.925 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.48 119.08 5.27 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 119.445 -1.359 . . . . 0.0 110.005 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.576 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 15.2 t70 -58.77 -55.7 31.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.595 1.198 . . . . 0.0 107.809 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.8 pt-20 -81.15 1.3 32.52 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.893 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.925 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -134.18 39.19 3.11 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.614 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 29' ' ' GLY . . . 36.72 -172.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.768 0 N-CA-C 114.769 0.668 . . . . 0.0 114.769 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.4 t -120.87 133.68 55.3 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.859 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.43 126.68 33.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.844 178.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.589 HG12 HD13 ' A' ' 26' ' ' ILE . 3.4 t -99.77 106.43 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.18 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.86 24.16 62.21 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.0 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.4 m -94.74 172.01 8.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.58 0.352 . . . . 0.0 110.535 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -44.11 -54.99 5.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.446 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.55 -10.99 60.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.751 0.31 . . . . 0.0 111.642 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.859 ' HB3' ' HB2' ' A' ' 35' ' ' PHE . . . -102.48 -14.55 16.78 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD11 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -18.37 0.15 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.652 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -51.7 -26.98 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.627 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -4.13 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.442 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 4.0 mt-30 -58.48 -24.42 60.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -23.33 52.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.209 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -1.94 44.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.594 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.26 -7.1 59.65 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.314 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.8 m-85 -95.53 -99.97 0.16 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.572 0.225 . . . . 0.0 111.431 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -106.62 96.85 15.08 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.946 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 78.0 Cg_exo -47.88 86.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.992 2.461 . . . . 0.0 113.286 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.513 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 179.95 59.3 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 52' ' ' SER . 44.2 Cg_endo -93.32 -72.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.958 2.439 . . . . 0.0 112.51 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 4' ' ' ASP . 38.1 t -146.26 -107.99 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.006 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' A' ' 56' ' ' SER . 5.2 tp60 -157.52 163.6 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.011 0.434 . . . . 0.0 111.832 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.517 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 3.4 p -110.44 -168.5 1.32 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.02 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -155.33 89.16 0.12 Allowed Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.709 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.57 89.37 3.07 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -65.65 105.61 0.82 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.084 0.553 . . . . 0.0 110.526 178.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.787 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -41.88 158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.122 3.215 . . . . 0.0 117.649 -176.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.41 154.13 13.99 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.371 177.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.87 4.39 4.38 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.452 -0.794 . . . . 0.0 114.143 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 14.0 t -91.42 53.28 2.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.485 0.642 . . . . 0.0 111.223 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.58 57.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.912 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.562 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.75 -154.5 25.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.964 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.787 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.9 mmt-85 -115.9 153.98 30.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -62.87 153.21 34.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.984 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -153.69 -91.91 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.576 ' C ' ' HA ' ' A' ' 30' ' ' ASP . . . -74.81 -171.67 1.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.923 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.6 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.921 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.46 64.74 4.1 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 118.879 -1.629 . . . . 0.0 110.165 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.8 mm -131.28 146.11 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 20.1 t -133.62 101.22 5.04 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -83.05 146.93 28.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.64 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.2 m -111.32 -179.47 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.561 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 34.7 Cg_endo -74.01 -22.51 17.1 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.552 1.501 . . . . 0.0 112.238 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.9 -27.2 15.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.266 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.22 168.87 33.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.425 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.668 ' SG ' HD11 ' A' ' 26' ' ' ILE . 4.1 m -94.28 165.71 12.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.442 0.639 . . . . 0.0 112.434 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.98 140.89 21.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.497 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -59.94 119.31 7.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.961 0.41 . . . . 0.0 110.616 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.732 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.3 p30 -98.93 109.21 52.98 Favored Pre-proline 0 N--CA 1.438 -1.067 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.78 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -56.98 -12.24 9.07 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 124.061 3.174 . . . . 0.0 110.146 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -75.69 -28.11 58.51 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.268 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.803 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.68 -25.88 9.71 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -175.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.7 t70 174.2 -30.44 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.42 1 N-CA-C 122.194 4.146 . . . . 0.0 122.194 -177.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.923 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -106.66 -71.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.391 0 C-N-CA 122.636 2.224 . . . . 0.0 112.74 -171.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.719 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.7 tt0 -69.5 -6.11 28.43 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -74.88 -157.5 0.06 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.86 -2.427 . . . . 0.0 112.443 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.69 -178.19 0.53 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.2 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.84 62.27 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.929 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.707 0.289 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.12 143.24 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.798 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.85 169.06 18.69 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' CG ' ' HB2' ' A' ' 54' ' ' CYS . 37.1 t0 -79.8 -137.81 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.814 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.726 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.7 OUTLIER -92.37 -120.58 0.08 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.538 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.73 -48.45 31.84 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.726 ' H ' HD11 ' A' ' 5' ' ' LEU . 11.7 m -86.75 83.7 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.053 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.798 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 39.3 mtt180 -82.29 147.44 28.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.726 ' CG2' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m 59.47 115.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.203 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 52' ' ' SER . 81.3 m -85.2 -84.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 7.3 mp -121.4 91.49 48.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.981 0.419 . . . . 0.0 110.318 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.726 ' HG3' ' CG2' ' A' ' 9' ' ' THR . 7.6 Cg_exo -68.95 -177.82 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.386 2.057 . . . . 0.0 114.857 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.517 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.0 t -155.56 -170.88 3.58 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.113 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.746 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 58.36 -137.62 49.86 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.063 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.5 Cg_endo -90.19 93.19 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.598 3.532 . . . . 0.0 113.13 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.54 -68.3 2.12 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.324 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.87 34.34 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.775 0.653 . . . . 0.0 112.267 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.905 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.8 -35.08 69.86 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.916 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.62 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -117.12 -163.49 13.06 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.197 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -158.2 176.87 11.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -86.68 158.33 19.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.078 178.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.704 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.1 m-85 -131.11 -90.76 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.63 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -120.51 -93.43 1.36 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -99.53 104.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.545 2.83 . . . . 0.0 114.177 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 51.65 19.97 1.0 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.363 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.7 tt -109.24 163.09 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.146 0.974 . . . . 0.0 113.327 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.544 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.41 145.01 20.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.229 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.672 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -149.05 115.37 5.82 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.995 -177.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.76 122.0 7.39 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.941 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 3.4 t70 -58.62 -56.91 16.08 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -84.98 24.09 1.12 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.223 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.11 36.35 0.29 Allowed 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.732 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 38.31 -170.81 0.01 OUTLIER Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 139.7 49.9 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.759 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 1.7 m-85 -131.19 104.38 7.03 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.09 177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 HG23 HG13 ' A' ' 26' ' ' ILE . 5.0 t -95.03 115.17 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.495 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 62.89 8.28 21.18 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.422 -0.895 . . . . 0.0 112.038 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.5 m -82.86 172.69 12.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.362 0.265 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -56.09 -54.33 46.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -65.39 8.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.879 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.544 ' HA ' ' CB ' ' A' ' 27' ' ' CYS . . . -109.0 -33.37 6.92 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.89 -17.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.01 -20.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 52.9 t -72.25 -13.22 61.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -26.52 64.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -9.0 58.46 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -70.41 0.67 6.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -67.37 -4.77 11.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.575 0.226 . . . . 0.0 111.082 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.479 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 10.3 m-30 -88.58 -143.37 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.455 0.302 . . . . 0.0 110.6 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' H ' ' HB3' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -102.27 98.07 9.81 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-O 120.566 0.222 . . . . 0.0 110.542 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 83.9 Cg_exo -48.63 175.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.653 2.235 . . . . 0.0 112.828 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.629 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.9 t -174.06 132.74 0.55 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.66 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -94.84 83.87 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.354 2.703 . . . . 0.0 113.385 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.45 ' HB2' ' CG ' ' A' ' 4' ' ' ASP . 26.3 p -125.74 -161.4 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.317 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.475 HE21 ' HE ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 56.64 161.04 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.624 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.55 ' OG ' ' HE3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER 60.24 -164.65 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.627 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.65 -127.82 2.84 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.478 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 mt-30 -75.33 88.15 2.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.807 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -75.7 -34.36 1.52 Allowed Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.8 -177.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 33.8 Cg_exo -41.32 155.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 125.258 3.972 . . . . 0.0 115.932 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.08 156.69 19.84 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.191 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.61 6.34 3.59 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.846 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.22 51.65 1.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 117.267 0.534 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.16 30.68 61.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.878 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.729 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.55 -152.72 22.83 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.8 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.3 mmt-85 -118.17 165.38 13.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.977 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 5.8 t -59.43 149.11 30.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.843 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -143.49 -25.6 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.941 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -161.32 -170.84 2.78 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 122.727 0.411 . . . . 0.0 111.786 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.879 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -41.0 86.58 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.042 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.96 67.71 2.07 Favored Glycine 0 N--CA 1.419 -2.485 0 C-N-CA 118.627 -1.749 . . . . 0.0 111.124 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.843 HG21 ' HB2' ' A' ' 68' ' ' ALA . 3.4 mm -137.62 135.3 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 14.2 t -124.18 108.92 12.8 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.67 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.8 t -95.23 154.62 17.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.485 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -122.26 -179.37 0.76 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.837 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -71.78 -9.66 25.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.38 2.053 . . . . 0.0 112.147 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.7 -34.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.32 169.77 38.86 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.812 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.3 m -99.13 164.95 11.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.369 0.604 . . . . 0.0 111.668 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.7 144.02 22.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.467 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HA ' HD11 ' A' ' 72' ' ' ILE . 1.4 pt-20 -61.7 116.63 4.94 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.778 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 41.0 p30 -97.34 107.01 36.12 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.001 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.706 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 57.7 Cg_exo -55.03 -13.84 7.25 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.569 2.846 . . . . 0.0 110.445 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -72.71 -29.25 63.22 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.169 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.925 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -106.55 -30.11 9.24 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 -176.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 174.66 -28.62 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.325 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -177.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 1.042 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.2 Cg_endo -106.11 -70.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.525 0 C-N-CA 122.376 2.051 . . . . 0.0 112.276 -172.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.706 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.7 tt0 -70.27 -6.23 33.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.006 -1.906 . . . . 0.0 106.029 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.675 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.7 -155.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.695 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.48 -178.48 0.52 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.877 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.71 62.67 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 4.5 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.476 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -68.07 149.59 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.666 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.91 170.02 14.62 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.677 0.751 . . . . 0.0 112.937 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.652 ' HB2' ' HA ' ' A' ' 54' ' ' CYS . 40.9 t0 -82.43 -77.03 0.24 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.986 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.959 HD13 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -148.95 -133.96 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.048 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.676 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -73.13 -38.52 66.26 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.959 HG23 HD13 ' A' ' 5' ' ' LEU . 27.2 m -97.69 104.44 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.666 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.2 mtt85 -71.74 178.65 3.5 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.2 m 67.09 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.546 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -45.86 177.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 112.245 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.555 ' CD2' ' HG2' ' A' ' 46' ' ' GLU . 1.3 tp -71.23 139.9 84.97 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.368 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 26.4 Cg_exo -55.82 -171.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.923 1.749 . . . . 0.0 111.934 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.653 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.5 t -157.69 -176.67 6.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.687 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.733 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 64.93 -139.4 40.65 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.833 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.8 Cg_endo -91.78 95.23 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.667 3.578 . . . . 0.0 112.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 -72.08 0.78 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.85 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 175.51 35.58 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.69 0.606 . . . . 0.0 111.985 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.89 -36.05 69.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.353 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.18 -167.3 18.74 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.829 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.79 -179.89 6.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 151.53 34.81 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.903 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -127.0 -24.53 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -174.91 -105.75 0.19 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.466 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -99.52 103.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.263 2.642 . . . . 0.0 112.789 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.39 24.68 2.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.775 0.321 . . . . 0.0 110.139 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.663 HD13 HG11 ' A' ' 36' ' ' VAL . 1.2 tt -112.18 162.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.976 0.893 . . . . 0.0 113.324 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -152.11 140.4 20.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.744 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.618 ' SG ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -145.28 101.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.793 -177.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.911 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.58 120.0 5.54 Favored Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.688 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 32.3 t0 -58.4 -58.19 9.62 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.633 1.217 . . . . 0.0 108.211 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.4 pt-20 -81.34 6.33 14.68 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.911 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -136.65 37.34 2.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.338 -174.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.618 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 37.21 -172.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.01 136.4 54.99 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.834 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.17 115.26 15.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.133 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.663 HG11 HD13 ' A' ' 26' ' ' ILE . 5.7 t -93.71 107.91 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.984 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.96 24.82 55.27 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.808 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.834 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.1 m -94.38 175.24 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 122.568 0.347 . . . . 0.0 110.661 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.35 -59.12 2.55 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.998 0.428 . . . . 0.0 111.509 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -72.9 7.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 27' ' ' CYS . . . -110.71 -22.74 11.43 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.69 -12.27 0.73 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.653 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.77 -24.7 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.22 0.463 . . . . 0.0 111.811 -179.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.56 -3.05 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.187 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.38 -28.99 60.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' HG2' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -77.82 -15.23 59.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.19 179.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 0.39 22.63 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 23.1 p30 -117.71 -13.22 10.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.373 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -90.96 -5.65 55.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 0.0 111.278 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -143.2 85.85 9.45 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.115 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.25 95.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.975 2.45 . . . . 0.0 112.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p -152.44 145.68 17.66 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -92.89 78.17 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 111.762 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.652 ' HA ' ' HB2' ' A' ' 4' ' ' ASP . 15.2 p -65.65 -163.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.828 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.3 tp60 -143.02 148.29 36.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 m -115.08 -163.99 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.258 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.92 93.7 0.15 Allowed Glycine 0 CA--C 1.503 -0.711 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.611 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 1.4 mm-40 -114.4 89.56 3.12 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -63.66 104.73 0.54 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.326 0.65 . . . . 0.0 110.315 177.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.796 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 74.6 Cg_exo -43.08 160.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.084 3.189 . . . . 0.0 117.779 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.54 153.41 10.99 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.329 -1.759 . . . . 0.0 110.33 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.9 4.65 5.37 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.736 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -90.91 52.48 2.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 117.183 0.491 . . . . 0.0 111.554 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.97 31.2 61.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.029 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.606 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.42 -154.42 25.25 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.889 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.796 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -115.79 153.09 32.07 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.078 0.466 . . . . 0.0 111.153 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 40.1 t -61.89 156.31 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.385 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.618 ' HB1' ' SG ' ' A' ' 28' ' ' CYS . . . -152.39 -92.67 0.05 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.688 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -78.48 -170.5 2.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.886 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.82 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.931 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.43 65.43 3.57 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.537 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 1.8 mm -134.44 143.26 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.594 ' HB2' ' OD2' ' A' ' 82' ' ' ASP . 21.5 t -131.46 104.7 7.13 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -91.85 158.6 16.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.488 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.6 m -127.1 -179.22 0.89 Allowed Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.248 -1.796 . . . . 0.0 109.287 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.85 -9.97 24.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.278 1.985 . . . . 0.0 112.459 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.4 -33.04 8.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.458 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.4 168.91 35.84 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.517 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.58 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 15.1 m -96.12 166.59 11.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.457 0.646 . . . . 0.0 112.343 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.21 141.92 21.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.621 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' CA ' HD12 ' A' ' 72' ' ' ILE . 1.4 pm0 -61.26 117.36 5.51 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.729 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.8 p30 -100.16 108.19 51.04 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-O 121.626 0.727 . . . . 0.0 111.18 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.922 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 66.0 Cg_exo -55.49 -16.09 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.07 3.18 . . . . 0.0 110.095 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.26 64.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.09 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.823 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -108.75 -27.55 9.71 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -176.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' ' OG ' ' A' ' 92' ' ' SER . 3.3 t70 173.67 -26.0 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.354 1 N-CA-C 122.853 4.39 . . . . 0.0 122.853 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.931 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -109.64 -72.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 -171.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.717 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.4 tt0 -70.62 -3.97 21.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.505 -1.679 . . . . 0.0 106.766 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.922 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -70.95 -160.82 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 112.448 -2.16 . . . . 0.0 114.892 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.31 -175.18 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.335 -2.212 . . . . 0.0 108.308 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.84 66.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 90' ' ' ALA . 1.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.371 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' A' ' 52' ' ' SER . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -157.07 -169.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.96 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.486 ' HG ' ' NE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.17 170.17 12.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.519 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.769 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 56.3 t0 -79.11 -127.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.744 HD13 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -93.61 -126.59 0.11 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' H ' ' CD1' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -74.45 -54.91 6.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.744 ' H ' HD13 ' A' ' 5' ' ' LEU . 16.5 m -90.32 112.5 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.157 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.769 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 27.3 mtt85 -69.15 121.32 16.52 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.792 0.806 . . . . 0.0 113.067 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.524 ' H ' ' CB ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -173.96 56.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.829 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.509 ' HB3' ' CG ' ' A' ' 4' ' ' ASP . 5.3 p -109.88 34.5 3.81 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 54' ' ' CYS . 4.1 tp -129.77 90.18 44.05 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 118.361 0.528 . . . . 0.0 110.966 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -73.55 177.25 8.23 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.619 2.213 . . . . 0.0 113.907 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.588 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.9 t -155.16 -177.45 6.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . 61.58 -134.48 47.46 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.509 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 14.0 Cg_endo -89.56 101.3 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.603 3.536 . . . . 0.0 112.677 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.68 -66.04 3.79 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.015 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.485 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.06 32.66 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 121.529 0.516 . . . . 0.0 112.324 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.41 -36.11 73.84 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.972 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -108.36 -171.27 21.38 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.226 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.7 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 177.87 10.03 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 11.4 m -79.01 163.81 24.88 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.7 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 35.1 m-85 -141.55 -30.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -170.78 -103.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.886 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -101.32 102.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.485 2.79 . . . . 0.0 112.971 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.36 23.54 2.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.4 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.629 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -111.57 159.28 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.0 0.905 . . . . 0.0 112.882 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.84 140.38 21.56 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.859 -1.518 . . . . 0.0 108.504 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.99 99.23 3.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.759 -176.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.926 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.43 117.55 4.51 Favored Glycine 0 N--CA 1.406 -3.307 0 C-N-CA 118.973 -1.584 . . . . 0.0 110.058 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.6 t0 -59.03 -57.42 13.17 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.6 pt-20 -82.02 11.98 4.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.926 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.17 37.89 1.15 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.693 ' C ' ' HB2' ' A' ' 69' ' ' ALA . . . 36.35 -178.15 0.01 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.5 t -114.84 136.76 52.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -133.12 119.34 19.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.278 177.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.6 HG11 HD11 ' A' ' 26' ' ' ILE . 5.6 t -91.84 103.21 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.106 178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.66 47.98 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.829 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -86.27 -176.94 6.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.217 0.607 . . . . 0.0 110.025 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.13 -58.8 4.77 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -72.02 -2.32 17.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.65 -21.14 14.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.29 -14.65 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -51.19 -23.63 3.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.433 0.56 . . . . 0.0 111.3 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -13.95 60.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.159 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -60.55 -22.74 63.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -74.6 -24.05 58.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 19.9 tp10 -83.0 22.77 0.9 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.105 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -158.57 0.25 0.09 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.259 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -132.41 -9.84 3.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.598 0.237 . . . . 0.0 110.936 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 102.47 5.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -42.27 101.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.789 2.326 . . . . 0.0 112.801 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.714 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 5.3 t -163.74 93.6 1.07 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.031 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.69 69.76 5.03 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.486 2.124 . . . . 0.0 113.02 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.571 ' HB2' HD12 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.27 -162.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.672 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -131.19 176.89 7.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -135.37 -153.27 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.3 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.61 118.77 0.82 Allowed Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.018 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -130.15 89.41 2.79 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -61.53 104.32 0.46 Allowed Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.568 178.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.743 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 47.2 Cg_exo -43.32 158.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.287 3.325 . . . . 0.0 117.406 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -163.93 153.38 14.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.3 177.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.52 3.69 4.55 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.331 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 t -91.42 57.08 3.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 117.656 0.728 . . . . 0.0 111.268 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.65 34.46 50.14 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 114.03 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.725 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.0 -154.38 25.37 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.743 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.8 mmt180 -115.62 154.6 29.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.3 -0.45 . . . . 0.0 111.21 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -62.0 158.19 16.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.171 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.652 ' HB3' ' SG ' ' A' ' 28' ' ' CYS . . . -155.3 -95.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.693 ' HB2' ' C ' ' A' ' 33' ' ' GLY . . . -76.43 -171.23 1.74 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.958 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.48 86.51 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.774 0.671 . . . . 0.0 109.341 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.897 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.72 67.38 2.25 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.4 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.2 mm -132.8 145.98 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -132.09 104.27 6.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -87.46 141.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -173.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.504 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.1 m -105.23 -179.76 0.8 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.817 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.504 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -73.08 -11.39 25.26 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.584 2.19 . . . . 0.0 112.523 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 -31.85 7.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.58 170.04 39.39 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.224 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 26' ' ' ILE . 6.3 m -93.83 166.14 12.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.533 0.682 . . . . 0.0 112.326 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 141.45 21.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.654 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HA ' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.26 117.67 5.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.063 0.458 . . . . 0.0 110.568 -179.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.688 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.6 p30 -99.56 110.02 57.23 Favored Pre-proline 0 N--CA 1.44 -0.974 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.813 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 50.3 Cg_exo -56.93 -14.85 15.21 Favored 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 124.099 3.199 . . . . 0.0 109.764 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.63 -27.5 62.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.255 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.879 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -111.07 -27.56 8.69 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -175.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.0 t70 173.05 -29.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.413 1 N-CA-C 122.311 4.189 . . . . 0.0 122.311 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.958 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.4 Cg_endo -106.22 -71.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 112.576 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.615 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -69.35 -5.77 25.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.813 ' HB1' ' O ' ' A' ' 83' ' ' PRO . . . -76.36 -157.94 0.09 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.941 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.2 -178.9 0.69 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.682 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.17 62.4 0.92 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.787 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -93.82 -170.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.598 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.82 162.9 28.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.658 0.742 . . . . 0.0 112.971 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -83.18 -76.57 0.27 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.404 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.35 -136.56 0.09 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.81 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.94 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.9 -40.57 68.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' CG2' HD11 ' A' ' 5' ' ' LEU . 19.4 m -94.58 101.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 87.0 mtt180 -67.65 -164.76 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.904 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER 46.75 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.213 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.041 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 19.6 Cg_exo . . . . . 0 N--CA 1.459 -0.54 0 CA-C-O 121.322 0.468 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.6 t -158.06 -176.54 5.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.268 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.79 -136.06 50.42 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.36 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 12.7 Cg_endo -89.79 108.53 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 112.847 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.17 -67.39 2.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.068 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.27 32.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.439 0.466 . . . . 0.0 112.686 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.69 -36.88 73.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.063 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -103.01 -174.56 26.55 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.786 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.23 179.5 7.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -84.03 146.99 27.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 13.0 m-85 -120.96 -101.98 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.938 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.68 -98.56 0.35 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.669 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 26' ' ' ILE . 26.3 Cg_endo -99.7 -119.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.617 2.878 . . . . 0.0 111.627 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.98 51.38 0.4 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -128.07 157.12 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 122.251 1.024 . . . . 0.0 113.35 -176.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -154.97 134.16 12.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.607 178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 32.2 m -152.1 119.38 5.94 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.783 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.96 122.55 7.35 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.369 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 44.1 t0 -58.08 -56.32 23.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.73 1.265 . . . . 0.0 107.824 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.02 24.82 0.74 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.87 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -157.84 33.17 0.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.764 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 51.08 172.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -104.17 129.77 51.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.53 116.66 17.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.55 177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -97.95 106.89 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.065 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.39 26.41 56.56 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.895 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.6 m -95.95 173.46 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.611 0.364 . . . . 0.0 110.62 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.72 -56.57 4.33 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.327 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.4 mp0 -73.07 6.16 2.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -113.27 -21.62 10.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.87 -19.15 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.585 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.6 -23.67 6.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.886 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.401 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.658 0.266 . . . . 0.0 110.486 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.5 Cg_exo -40.01 159.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.237 3.291 . . . . 0.0 116.982 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.19 152.64 10.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.767 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.94 3.25 6.97 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.955 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -90.27 57.29 3.67 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 117.33 0.565 . . . . 0.0 111.135 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.8 34.31 36.83 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.85 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.74 -156.57 28.6 Favored Glycine 0 CA--C 1.502 -0.739 0 C-N-CA 120.449 -0.882 . . . . 0.0 115.128 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.7 mmt-85 -116.32 152.94 32.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.189 0.519 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -63.61 160.54 16.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.579 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -159.97 -96.1 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.782 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -75.9 -169.81 1.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.876 0.87 . . . . 0.0 112.558 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.793 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -38.16 97.46 0.01 OUTLIER 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.508 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.947 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 50.81 30.47 21.75 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.099 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.05 HG13 ' HB3' ' A' ' 69' ' ' ALA . 5.1 mm -90.34 155.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 122.097 0.951 . . . . 0.0 111.628 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.728 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 19.0 t -141.81 106.52 4.88 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -91.61 160.56 15.33 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.505 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -127.11 -179.83 1.04 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 113.996 -1.457 . . . . 0.0 110.052 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.2 Cg_exo -72.67 -10.83 25.58 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.453 2.102 . . . . 0.0 112.352 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.91 -29.5 9.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.87 31.27 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.437 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.597 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.2 m -97.81 167.94 10.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.097 0.475 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.708 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -151.87 144.61 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.391 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -61.92 94.29 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.1 m-20 -91.85 126.78 52.43 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.881 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 34.0 Cg_exo -59.83 -3.25 2.01 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 123.658 2.905 . . . . 0.0 109.716 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.39 -25.76 59.68 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.309 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.947 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.3 m -127.46 -20.14 4.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.8 t70 171.18 -26.15 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.068 1 N-CA-C 121.909 4.04 . . . . 0.0 121.909 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.814 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.1 Cg_endo -103.1 -70.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.656 0 C-N-CA 122.335 2.024 . . . . 0.0 112.135 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.628 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -72.52 -6.97 47.56 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.051 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.881 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.67 -157.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 112.436 -2.166 . . . . 0.0 112.546 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.79 -178.32 1.49 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.122 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -74.37 62.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.257 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.912 HG22 ' H ' ' A' ' 3' ' ' LEU . 3.6 p -144.69 -162.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.383 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.912 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -70.47 157.3 38.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.84 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.33 -122.69 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.185 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.855 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -94.97 -139.44 0.24 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.007 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.855 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.97 -36.15 49.36 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.817 HG22 HD21 ' A' ' 5' ' ' LEU . 28.0 m -100.98 85.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.33 0.586 . . . . 0.0 111.495 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HE ' ' HG ' ' A' ' 3' ' ' LEU . 9.2 mtt180 -73.09 123.97 24.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.048 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -173.35 74.38 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.667 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 6.6 Cg_exo . . . . . 0 N--CA 1.458 -0.613 0 N-CA-C 114.121 0.777 . . . . 0.0 114.121 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 8.2 t -153.75 -171.21 3.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.05 -136.93 49.97 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.555 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.8 Cg_endo -89.06 98.71 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.641 3.561 . . . . 0.0 112.965 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.07 -67.18 3.71 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.558 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.9 34.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-O 121.744 0.636 . . . . 0.0 112.282 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.83 -34.41 69.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.371 -0.915 . . . . 0.0 110.264 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.74 -168.34 15.32 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.821 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.52 -179.54 7.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.726 0.263 . . . . 0.0 110.612 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.443 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 1.7 m -78.59 158.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 37.6 m-85 -138.99 -69.52 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.919 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -132.5 -105.05 0.95 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.177 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -100.28 105.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.444 2.763 . . . . 0.0 113.037 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 52.5 21.98 1.98 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.756 0.313 . . . . 0.0 110.264 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.919 HG22 ' H ' ' A' ' 23' ' ' GLY . 4.8 tt -110.84 160.93 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.22 1.009 . . . . 0.0 112.763 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 145.62 27.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.736 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.43 103.84 3.72 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.897 -177.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.86 118.84 5.71 Favored Glycine 0 N--CA 1.409 -3.133 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.804 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 26.0 t0 -58.25 -57.72 11.65 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -83.09 21.78 1.04 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.24 35.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.71 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.23 -169.97 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.289 0.476 . . . . 0.0 114.289 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.3 t -125.17 138.24 54.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.764 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.03 119.32 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.493 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.4 t -95.2 105.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.804 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.25 22.15 55.17 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.855 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -89.09 178.64 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.553 0.341 . . . . 0.0 110.163 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -50.21 -56.42 11.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.827 0.346 . . . . 0.0 111.171 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.85 5.12 3.44 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.05 -23.91 12.15 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.98 -17.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.86 -23.18 1.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 111.482 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.71 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.01 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.77 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 31.5 Cg_exo -37.23 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.979 3.12 . . . . 0.0 117.362 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -161.66 152.99 18.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.43 177.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.27 4.73 7.93 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.881 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -90.34 54.55 2.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 117.395 0.597 . . . . 0.0 111.099 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.15 32.86 50.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.33 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.699 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 165.16 -158.7 31.64 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.307 -0.949 . . . . 0.0 114.921 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.77 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.0 mmt180 -117.33 154.08 31.87 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.017 0.437 . . . . 0.0 110.922 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 1.01 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 38.2 t -60.17 167.0 2.57 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.815 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -165.76 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.824 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.023 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.46 -169.7 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.827 0.851 . . . . 0.0 112.884 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.822 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.07 96.21 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 51.87 29.15 26.11 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.162 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.023 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -91.46 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 121.872 0.844 . . . . 0.0 111.397 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.714 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 44.6 t -139.6 108.4 5.96 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.648 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.9 t -91.04 155.9 18.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.52 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -128.97 -179.6 1.04 Allowed Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 114.062 -1.427 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.8 Cg_exo -72.22 -11.05 26.59 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.427 2.084 . . . . 0.0 112.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.97 -27.1 13.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.59 170.19 24.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.135 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.614 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.9 m -94.98 163.26 13.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 111.039 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.76 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.21 148.73 29.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.068 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.89 93.14 0.18 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.714 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.0 m-20 -91.4 128.57 46.4 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.89 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 31.4 Cg_exo -60.58 -2.45 2.0 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.445 2.763 . . . . 0.0 109.721 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.94 -24.99 58.57 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.034 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.914 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.4 m -128.98 -21.01 3.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.1 t70 171.67 -26.33 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.406 1 N-CA-C 122.163 4.134 . . . . 0.0 122.163 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.836 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 5.4 Cg_endo -102.18 -70.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.635 0 CA-C-N 122.693 1.997 . . . . 0.0 111.788 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.598 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.3 tt0 -72.89 -6.66 46.64 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.153 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.89 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.19 -157.81 0.08 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.646 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -70.33 -178.32 1.68 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.15 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -74.92 61.99 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.312 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.774 0.321 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.97 152.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.83 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.599 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.59 166.05 24.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.04 -136.27 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.32 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -94.87 -124.5 0.11 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.703 ' H ' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -73.06 -47.72 42.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.588 HG22 HD11 ' A' ' 5' ' ' LEU . 18.7 m -87.36 85.87 2.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.599 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 57.4 mtt180 -74.8 -162.98 0.18 Allowed 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.451 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 41.38 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.767 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.769 -179.521 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.586 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 CA-C-O 121.338 0.474 . . . . 0.0 113.207 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.5 t -156.89 -172.39 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.752 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.79 -139.49 47.12 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.637 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.9 Cg_endo -88.92 98.16 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.371 3.381 . . . . 0.0 112.721 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -73.66 1.39 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.59 34.36 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 121.637 0.576 . . . . 0.0 111.878 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.68 -37.9 67.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.284 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.02 -168.14 22.28 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.758 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.698 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.41 -179.22 6.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.26 148.58 33.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.857 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -128.1 -19.71 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 169.67 -104.21 0.2 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 118.999 -1.572 . . . . 0.0 114.81 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 28.8 Cg_endo -101.74 107.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.717 2.945 . . . . 0.0 113.12 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.52 22.6 1.58 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.182 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.857 HG23 ' HB2' ' A' ' 22' ' ' PHE . 3.3 tt -115.13 157.1 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 122.258 1.028 . . . . 0.0 113.029 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.557 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -160.43 138.45 9.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.356 -1.747 . . . . 0.0 107.35 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 20.4 m -150.1 128.35 12.06 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.097 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -107.02 126.63 8.51 Favored Glycine 0 N--CA 1.407 -3.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 37.3 t0 -59.16 -59.57 5.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.998 1.399 . . . . 0.0 108.722 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -81.09 15.15 1.98 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -144.16 31.49 1.24 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.083 -175.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.651 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.33 175.61 0.01 OUTLIER Glycine 0 CA--C 1.521 0.445 0 N-CA-C 114.899 0.719 . . . . 0.0 114.899 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -100.11 134.45 43.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.857 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 30.2 m-85 -131.04 101.66 5.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.404 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG13 HG13 ' A' ' 26' ' ' ILE . 4.5 t -97.16 107.36 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.253 0.549 . . . . 0.0 110.23 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.47 -0.0 44.5 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.394 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.9 p -70.13 -168.24 0.21 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 117.338 0.569 . . . . 0.0 110.245 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -76.61 -39.08 53.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.323 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -74.7 7.27 3.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.295 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -112.91 -21.12 11.3 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -51.15 -15.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.02 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.742 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.69 -21.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.254 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 44.4 Cg_exo -38.81 154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.761 2.307 . . . . 0.0 115.648 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -162.11 154.58 19.62 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.881 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 7.11 7.72 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.287 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 t -91.53 51.72 1.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.42 32.91 61.25 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.624 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.728 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.42 -153.96 24.67 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.533 -0.842 . . . . 0.0 115.202 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.785 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.0 mmt-85 -120.89 159.24 25.92 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.594 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.6 t -55.86 155.8 5.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -150.89 -26.82 0.21 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -157.67 -171.35 3.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.397 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.33 86.31 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 57.27 65.54 3.49 Favored Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.939 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.759 HG21 ' SG ' ' A' ' 34' ' ' CYS . 3.3 mm -136.77 136.6 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.1 t -122.98 109.58 14.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -96.23 158.59 15.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -173.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.542 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.2 m -128.26 -179.92 1.1 Allowed Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.315 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -72.14 -9.42 24.44 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.376 2.051 . . . . 0.0 112.687 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.88 -32.42 8.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.255 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.25 170.21 36.58 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.684 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 27.0 m -96.88 167.4 11.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.394 0.616 . . . . 0.0 111.87 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.556 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.98 142.92 21.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.596 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -62.87 117.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.024 0.44 . . . . 0.0 110.947 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 47.5 p30 -101.04 108.25 53.66 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.681 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.1 Cg_exo -56.37 -15.69 15.78 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.855 3.037 . . . . 0.0 110.084 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.04 64.13 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.66 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.986 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -109.54 -27.42 9.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -176.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.3 t70 172.56 -29.44 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.633 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.051 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.3 Cg_endo -108.97 -71.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 123.099 2.533 . . . . 0.0 112.767 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -67.74 -5.85 18.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.681 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -73.49 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 112.047 -2.342 . . . . 0.0 111.057 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -63.71 -178.82 0.32 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -74.42 62.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.41 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.798 0.332 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.0 t 64.05 168.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.536 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.552 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -69.66 156.85 38.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.668 0.747 . . . . 0.0 112.73 -178.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.54 -77.0 0.23 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.882 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -139.86 -139.59 0.13 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.474 -178.252 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.882 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -76.24 -38.43 56.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.73 0.3 . . . . 0.0 110.923 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -93.33 85.0 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 121.367 0.603 . . . . 0.0 110.677 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 56.4 mtt85 -74.33 -178.73 3.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.183 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m 57.38 101.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.572 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.524 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 23.8 Cg_exo . . . . . 0 N--CA 1.461 -0.386 0 CA-C-O 121.042 0.351 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.4 t -157.5 -179.98 8.69 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.903 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.89 -134.79 49.28 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.637 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 7.7 Cg_endo -91.89 99.5 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.562 3.508 . . . . 0.0 112.951 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.87 -69.13 3.13 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.56 32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 CA-C-O 121.533 0.518 . . . . 0.0 112.332 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -33.8 71.66 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.848 0.832 . . . . 0.0 109.862 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.8 -174.84 20.93 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.807 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.94 -178.95 5.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.6 m -77.57 141.21 39.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-85 -119.11 -23.67 6.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.567 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.56 -110.54 0.24 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.586 -1.293 . . . . 0.0 114.317 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.91 101.37 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 112.643 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 21.45 3.64 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.752 -0.379 . . . . 0.0 109.991 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 23' ' ' GLY . 2.3 tt -107.76 166.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.832 0.825 . . . . 0.0 112.742 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -153.76 140.45 18.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.37 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -144.88 100.91 3.57 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.876 -177.153 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.969 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.13 117.82 5.01 Favored Glycine 0 N--CA 1.405 -3.407 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.295 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.688 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 21.0 t0 -58.75 -57.27 13.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -83.87 20.14 1.56 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.969 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.61 33.22 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.691 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.53 176.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 t -115.83 134.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.65 125.88 31.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.568 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -93.81 101.71 12.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.131 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.84 19.51 50.08 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.12 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.706 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 2.0 m -83.27 174.73 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.893 0.477 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -43.75 -55.8 4.21 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.15 -7.61 50.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.99 -16.96 15.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -19.0 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.638 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.47 -24.01 2.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.126 0.421 . . . . 0.0 111.26 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -38.74 155.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.133 3.222 . . . . 0.0 117.619 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -165.04 153.31 11.83 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.824 177.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 5.53 3.01 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.97 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.7 t -90.66 54.03 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 117.425 0.612 . . . . 0.0 111.164 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.98 33.21 56.92 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.861 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.662 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.0 -154.09 24.96 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.642 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.726 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.3 mmt180 -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.153 0.502 . . . . 0.0 110.986 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 46.2 t -62.32 157.94 18.56 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.039 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -155.39 -91.65 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 33' ' ' GLY . . . -77.66 -171.18 2.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.959 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.37 90.68 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.004 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.88 62.4 6.36 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 119.062 -1.542 . . . . 0.0 110.89 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -129.99 149.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.4 t -136.63 102.99 5.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -91.37 160.11 15.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.524 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -127.85 -179.49 0.98 Allowed Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.261 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.51 -10.08 24.89 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.364 2.042 . . . . 0.0 112.634 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -31.2 8.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.482 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.1 167.73 34.05 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.465 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 16.3 m -96.0 167.11 11.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.383 0.611 . . . . 0.0 112.4 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.641 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -151.57 140.77 21.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.977 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -62.18 116.68 5.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.894 0.378 . . . . 0.0 110.534 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.777 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 52.2 p30 -99.06 109.32 53.72 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-O 121.573 0.701 . . . . 0.0 111.702 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.82 -14.61 14.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.064 3.176 . . . . 0.0 110.06 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.96 -27.84 62.06 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.123 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -109.89 -28.45 8.75 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -176.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 173.6 -29.18 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.253 1 N-CA-C 122.371 4.211 . . . . 0.0 122.371 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.004 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -106.01 -70.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.459 0 C-N-CA 122.628 2.219 . . . . 0.0 112.568 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.709 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.3 tt0 -69.04 -7.07 32.19 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.733 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.5 -157.76 0.07 Allowed 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.635 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.01 -179.3 1.18 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -74.76 62.36 1.07 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.57 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.06 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.853 0.359 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -67.8 156.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.126 0.488 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.747 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.64 169.69 17.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.449 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 18.9 t0 -78.59 -137.55 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 113.952 -1.476 . . . . 0.0 108.192 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.676 HD11 HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -91.28 -123.62 0.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -72.23 -45.6 59.58 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.676 HG22 HD11 ' A' ' 5' ' ' LEU . 11.1 m -88.13 85.19 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.662 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.747 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 51.5 mtt85 -75.56 -177.12 3.51 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 27.62 104.54 0.0 OUTLIER 'General case' 0 C--N 1.34 0.17 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.972 179.661 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 22.7 Cg_exo . . . . . 0 N--CA 1.445 -1.366 0 CA-C-O 121.061 0.359 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 43' ' ' ARG . 4.0 t -158.85 -172.39 3.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 65.02 -141.34 43.28 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.14 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.95 89.6 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.018 3.145 . . . . 0.0 112.881 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.48 -68.28 0.94 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.301 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.99 34.12 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-O 121.632 0.573 . . . . 0.0 112.022 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -73.0 -35.82 66.92 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.339 -0.93 . . . . 0.0 110.61 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.74 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -111.1 -162.04 17.57 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.293 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.86 174.28 13.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -89.18 170.34 10.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.823 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 67.5 m-85 -144.02 -12.05 0.65 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.42 -95.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 118.691 -1.718 . . . . 0.0 115.055 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -101.07 99.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.378 2.718 . . . . 0.0 113.481 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.59 21.84 1.98 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.316 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.667 HG13 HG13 ' A' ' 36' ' ' VAL . 3.8 tt -108.95 160.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -157.32 145.47 19.23 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 113.745 -1.57 . . . . 0.0 108.653 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.836 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.95 106.25 3.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.553 -178.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.883 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.23 128.22 8.96 Favored Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.63 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.909 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 35.9 t70 -58.5 -65.84 0.59 Allowed 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 pt-20 -81.36 26.87 0.44 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.883 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.58 31.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 36.49 -166.7 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.5 142.88 38.25 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.724 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 10.3 m-85 -131.93 98.0 4.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.391 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.667 HG13 HG13 ' A' ' 26' ' ' ILE . 3.5 t -95.75 130.71 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.211 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.76 28.53 5.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.811 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -109.23 170.25 8.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.46 0.304 . . . . 0.0 110.66 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -54.95 -55.12 34.21 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.56 8.89 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -107.05 -37.3 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -56.83 -11.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.676 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.8 -13.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 18.0 t . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 120.874 0.369 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 27.3 Cg_exo -61.72 179.56 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.277 2.651 . . . . 0.0 115.615 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.74 154.32 9.51 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.256 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.07 -0.03 6.77 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.277 -0.874 . . . . 0.0 114.141 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.7 t -92.08 50.79 1.7 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 117.478 0.639 . . . . 0.0 111.369 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.69 40.91 49.36 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.083 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.644 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.68 -159.44 32.44 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.4 mmt180 -114.68 155.99 25.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.094 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 23.9 t -61.11 144.89 52.71 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.523 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ASP . . . -139.85 -97.82 0.16 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.271 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.909 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.51 -170.21 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -43.73 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.958 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 54.8 71.61 0.69 Allowed Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.179 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.836 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.2 mm -137.01 145.47 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 33.8 t -132.08 103.67 6.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -91.44 152.36 20.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.493 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -125.07 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.892 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.493 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -71.72 -9.71 25.35 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -33.0 8.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.021 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.09 169.92 34.65 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.562 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 3.3 m -98.68 164.43 12.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.102 0.477 . . . . 0.0 111.132 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.63 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.67 141.81 21.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.03 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -58.81 111.3 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.853 0.358 . . . . 0.0 110.102 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.675 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.1 p30 -92.03 110.5 44.46 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.751 . . . . 0.0 111.683 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.734 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -57.49 -13.02 12.3 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.188 3.258 . . . . 0.0 110.086 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.33 -30.0 57.51 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.561 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.958 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -108.93 -27.27 9.78 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 5.4 t70 175.37 -29.97 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 1 N-CA-C 122.28 4.178 . . . . 0.0 122.28 -177.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.94 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.2 Cg_endo -104.28 -70.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.46 0 C-N-CA 122.45 2.1 . . . . 0.0 112.242 -172.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 28.9 tt0 -70.36 -8.48 50.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.717 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.85 -157.64 0.08 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.89 -2.414 . . . . 0.0 112.741 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.46 -178.7 1.46 Allowed 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.929 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -74.42 62.39 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.6 t . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.027 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.342 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.94 -172.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.556 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.09 159.92 33.83 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.709 0.766 . . . . 0.0 112.723 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.29 -124.98 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.721 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.833 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -95.16 -136.79 0.22 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.833 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -73.99 -39.85 63.37 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.77 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -95.04 85.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.556 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 20.4 mtt180 -73.92 -163.2 0.16 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.272 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.461 ' O ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER 41.69 85.74 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.529 0.165 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.303 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.511 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.5 Cg_exo . . . . . 0 N--CA 1.462 -0.367 0 CA-C-O 121.567 0.57 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' GLY . 2.0 t -156.84 -175.81 5.63 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.242 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.01 -138.68 48.7 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.657 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.7 Cg_endo -90.32 100.23 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.371 3.381 . . . . 0.0 112.808 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.14 -69.08 3.09 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.152 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.57 31.4 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 121.386 0.437 . . . . 0.0 112.489 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.09 -36.69 72.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.646 0.736 . . . . 0.0 109.946 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.07 -174.44 23.56 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.155 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.3 -178.79 5.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 151.53 37.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 11.3 m-85 -133.51 -17.72 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -179.0 -112.07 0.33 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.937 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -101.15 107.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.572 2.848 . . . . 0.0 112.744 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.48 24.12 2.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 36' ' ' VAL . 1.9 tt -114.6 161.79 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.922 0.868 . . . . 0.0 113.118 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 141.4 22.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.371 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.646 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -144.13 102.66 3.9 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.839 -177.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.906 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.43 118.72 5.28 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.023 -1.561 . . . . 0.0 109.42 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.706 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -57.93 -61.67 2.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -81.31 19.9 0.91 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.437 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.906 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -150.48 32.77 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.657 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.34 175.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.448 0.539 . . . . 0.0 114.448 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -111.39 136.54 50.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.23 119.74 21.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.327 178.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -93.98 102.08 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.725 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.46 50.89 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.843 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 m -86.29 179.42 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.304 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.61 -61.07 1.7 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.67 5.76 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.01 -24.28 12.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.85 -15.42 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -51.58 -23.21 3.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.77 0.319 . . . . 0.0 111.334 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.439 179.558 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 49.6 Cg_exo -39.76 154.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.242 3.294 . . . . 0.0 117.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.58 152.89 12.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.478 177.025 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.02 5.8 4.45 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.735 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -90.97 53.71 2.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 117.252 0.526 . . . . 0.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.13 61.04 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.923 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.82 -151.23 20.93 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.629 -0.796 . . . . 0.0 114.87 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.712 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -118.11 152.87 34.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.7 t -63.91 149.64 46.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.583 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -146.92 -93.32 0.09 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.901 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.31 -170.74 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.919 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.95 91.04 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.988 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.73 60.51 8.73 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.798 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -128.96 146.55 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 17.0 t -134.48 101.78 5.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -90.08 160.19 16.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.468 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.2 m -129.59 -179.46 1.02 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.92 -10.94 25.29 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.326 2.017 . . . . 0.0 112.144 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.81 -30.55 9.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.312 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.68 169.96 34.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.551 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.4 m -96.75 166.71 11.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.436 0.636 . . . . 0.0 112.147 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.27 138.06 17.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.715 178.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.3 pt-20 -59.52 116.53 4.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.961 0.41 . . . . 0.0 110.42 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.796 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.5 p30 -98.8 109.74 54.69 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-O 121.578 0.704 . . . . 0.0 111.552 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 51.1 Cg_exo -56.67 -16.08 18.18 Favored 'Trans proline' 0 CA--C 1.503 -1.038 0 C-N-CA 123.92 3.08 . . . . 0.0 110.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.68 -29.37 64.52 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.161 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.85 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.94 -27.88 9.44 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -176.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.9 t70 173.88 -27.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.158 1 N-CA-C 122.38 4.215 . . . . 0.0 122.38 -178.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.988 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.4 Cg_endo -107.18 -71.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.5 0 C-N-CA 122.476 2.117 . . . . 0.0 112.734 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 29.5 tt0 -68.87 -6.74 28.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.2 -155.83 0.05 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.093 -2.321 . . . . 0.0 111.924 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.78 -178.51 0.96 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.809 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -73.81 62.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.241 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.761 0.315 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.31 156.13 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.212 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.734 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.78 171.19 10.96 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.991 0.9 . . . . 0.0 113.228 -178.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 13.0 t0 -80.11 -139.54 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.46 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -91.88 -119.98 0.08 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 122.393 -0.192 . . . . 0.0 110.773 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.659 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.57 -47.09 43.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 7' ' ' VAL . 14.5 m -88.61 84.01 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.914 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.734 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 62.3 mtt180 -82.18 160.99 22.93 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.518 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' CYS . 5.9 m 60.98 129.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.959 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 20.9 Cg_exo . . . . . 0 N--CA 1.461 -0.425 0 N-CA-C 114.127 0.78 . . . . 0.0 114.127 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' GLY . 3.4 t -153.74 -174.24 4.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.456 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.61 51.69 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.073 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -82.52 87.56 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.772 2.981 . . . . 0.0 112.564 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 100.32 -67.5 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.042 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.585 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.8 34.1 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 121.645 0.581 . . . . 0.0 111.955 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.82 -36.71 70.31 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.84 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.57 -167.92 18.42 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.502 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -165.52 179.5 6.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 32.4 m -77.08 149.45 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.741 ' HE2' ' HB3' ' A' ' 28' ' ' CYS . 15.9 m-30 -139.09 26.43 2.43 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 139.53 -106.2 0.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.272 -1.442 . . . . 0.0 114.643 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 24.1 Cg_endo -104.81 100.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.46 2.773 . . . . 0.0 113.466 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.88 26.24 4.49 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.369 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.621 HG23 ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -111.52 160.13 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -156.09 138.96 15.28 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.52 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -146.48 105.61 3.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.477 -178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.29 129.87 9.36 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.337 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.907 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 12.7 t70 -58.83 -63.34 1.33 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -82.03 13.9 3.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -142.56 38.55 1.52 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.799 -174.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.863 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 29.22 -163.34 0.0 OUTLIER Glycine 0 CA--C 1.531 1.091 0 N-CA-C 115.995 1.158 . . . . 0.0 115.995 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.11 137.16 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.808 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 6.8 m-85 -132.89 106.73 7.88 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.583 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 26' ' ' ILE . 6.6 t -94.62 103.73 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.783 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.45 16.81 55.61 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.937 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.723 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -85.44 173.11 10.5 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -43.22 -55.57 3.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.802 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.9 -3.0 13.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -104.25 -21.8 13.47 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.78 -20.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.66 -19.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 36.2 Cg_exo -40.09 155.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.826 3.017 . . . . 0.0 116.659 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.6 154.52 20.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.505 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.45 4.0 5.49 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 114.051 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.2 t -90.58 54.67 2.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 117.382 0.591 . . . . 0.0 111.424 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.95 61.86 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.121 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.63 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 160.87 -152.17 22.76 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.994 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.5 mmt-85 -116.91 157.47 25.63 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.593 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.869 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 17.0 t -63.26 160.9 14.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.109 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -153.07 -97.26 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.34 -169.83 1.54 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.4 88.48 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.006 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 55.86 72.06 0.63 Allowed Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 118.854 -1.641 . . . . 0.0 110.439 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.7 mm -138.37 145.97 27.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.9 t -133.25 104.72 6.61 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -91.07 147.91 22.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -174.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -116.42 -179.47 0.64 Allowed Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.996 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.1 Cg_exo -72.62 -11.18 25.98 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.503 2.136 . . . . 0.0 112.223 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.71 -31.19 9.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.018 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 26' ' ' ILE . . . 174.05 170.45 37.4 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.855 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.5 m -98.24 163.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.191 0.519 . . . . 0.0 110.956 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.576 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.95 140.11 19.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.917 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.12 114.14 2.24 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.968 0.413 . . . . 0.0 110.001 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 85' ' ' CYS . 50.4 p30 -95.21 110.16 48.82 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-O 121.712 0.767 . . . . 0.0 111.423 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.8 Cg_exo -57.59 -13.8 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 124.109 3.206 . . . . 0.0 109.973 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.23 -26.35 60.19 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.281 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.006 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -110.85 -29.82 7.8 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -175.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.42 -29.75 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.33 1 N-CA-C 122.31 4.189 . . . . 0.0 122.31 -176.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.902 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -105.21 -71.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 122.61 2.207 . . . . 0.0 112.423 -172.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.63 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -70.71 -5.7 31.82 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.09 -158.23 0.09 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 111.861 -2.427 . . . . 0.0 112.769 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.13 -178.8 1.1 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.73 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.01 61.78 0.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.956 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.836 HG22 ' H ' ' A' ' 3' ' ' LEU . 2.6 p -84.05 -159.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.0 111.52 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.836 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -72.44 168.3 18.76 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.869 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.568 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 2.2 t70 -76.87 -90.99 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.65 -75.68 0.32 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.71 0.767 . . . . 0.0 110.138 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.968 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.67 -44.86 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.26 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.733 HG22 HD21 ' A' ' 5' ' ' LEU . 34.3 m -115.96 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.524 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.639 ' HD2' HD12 ' A' ' 3' ' ' LEU . 5.3 mtt-85 -75.42 175.35 8.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.277 0.56 . . . . 0.0 112.224 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.6 40.83 0.17 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.224 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.87 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.2 Cg_exo . . . . . 0 N--CA 1.459 -0.521 0 CA-C-O 121.108 0.378 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -157.36 -178.17 7.15 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.64 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.71 -134.54 47.1 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.556 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.5 Cg_endo -92.31 100.15 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.607 3.538 . . . . 0.0 112.763 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 -68.71 3.38 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.965 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.72 31.58 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.369 0.427 . . . . 0.0 112.739 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.11 -36.02 74.55 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.641 0.734 . . . . 0.0 109.792 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.12 -172.59 22.48 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.077 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -163.75 179.28 7.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.15 154.9 35.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' HG23 ' A' ' 26' ' ' ILE . 9.4 m-85 -131.08 -43.18 1.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.749 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -158.73 -103.44 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.189 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -98.16 104.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.069 2.513 . . . . 0.0 112.844 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.61 26.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.801 0.334 . . . . 0.0 110.401 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.749 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.7 tt -114.17 164.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.064 0.935 . . . . 0.0 113.361 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.54 140.94 21.51 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.316 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -146.5 102.06 3.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.908 -177.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -87.71 113.56 4.02 Favored Glycine 0 N--CA 1.402 -3.597 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.055 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.3 t0 -57.97 -54.3 48.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.7 pt-20 -83.65 15.97 2.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.93 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.6 41.81 0.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.712 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.96 -167.67 0.01 OUTLIER Glycine 0 N--CA 1.463 0.445 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -129.92 134.15 47.3 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.835 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.35 124.5 28.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.466 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.516 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.11 101.59 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.096 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.35 24.95 47.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.775 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.781 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 5.2 m -87.39 173.41 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.895 0.478 . . . . 0.0 109.757 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -42.75 -53.58 4.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 111.254 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -72.98 -7.96 53.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.73 -14.86 15.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.66 -16.47 0.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.97 -26.47 4.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.093 0.473 . . . . 0.0 111.041 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.497 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.662 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 61.8 Cg_exo -41.52 157.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.915 3.077 . . . . 0.0 117.585 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.628 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.63 153.21 12.6 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.358 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.51 2.85 4.02 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.288 -0.869 . . . . 0.0 114.038 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.8 t -89.24 54.59 3.0 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.556 0.678 . . . . 0.0 111.557 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.66 32.3 58.39 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.235 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.612 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.15 -150.86 20.17 Favored Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 120.659 -0.782 . . . . 0.0 114.763 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 7.6 mmt180 -116.94 154.16 31.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.066 0.46 . . . . 0.0 110.971 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -63.49 161.04 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.509 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -160.64 -92.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.8 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.94 -170.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.47 90.95 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.923 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.22 62.94 5.63 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 118.57 -1.776 . . . . 0.0 109.893 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.8 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm -129.99 146.26 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.4 t -134.24 103.92 5.96 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.525 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -117.31 -179.36 0.63 Allowed Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -72.35 -11.46 26.69 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.331 2.021 . . . . 0.0 112.732 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -30.47 8.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 111.329 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.65 170.15 36.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.302 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.6 m -95.76 165.98 12.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.182 0.515 . . . . 0.0 112.184 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.616 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -151.69 141.26 21.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.445 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -56.91 113.13 1.54 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.838 0.351 . . . . 0.0 110.296 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.804 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.6 p30 -97.91 110.86 57.42 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 121.878 0.847 . . . . 0.0 112.307 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.769 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.0 Cg_exo -56.75 -17.36 22.85 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 124.174 3.25 . . . . 0.0 110.025 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.48 63.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.628 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.898 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -110.88 -27.83 8.65 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 -175.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.6 t70 174.32 -28.95 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.213 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.923 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.5 Cg_endo -105.66 -71.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.54 2.16 . . . . 0.0 112.518 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.8 tp10 -69.37 -7.39 36.98 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.769 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.01 -155.21 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.113 -2.312 . . . . 0.0 112.493 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.45 -178.55 1.13 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.868 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -75.04 62.02 1.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' LEU . 2.7 t 61.55 167.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.633 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.53 168.4 17.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 122.117 0.961 . . . . 0.0 113.591 -178.307 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 10.8 t70 -80.52 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.25 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.748 HD11 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.0 -123.87 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.591 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -73.16 -44.13 60.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 HD11 ' A' ' 5' ' ' LEU . 9.4 m -88.71 86.69 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.095 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.635 ' HB3' HD12 ' A' ' 3' ' ' LEU . 41.4 mtt180 -70.88 -167.3 0.19 Allowed 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.977 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 43.87 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.968 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.235 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 39.4 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 CA-C-O 121.22 0.425 . . . . 0.0 112.775 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.8 t -157.31 -172.93 4.19 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.305 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.98 -139.31 47.94 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.445 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.0 Cg_endo -90.21 97.02 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.304 3.336 . . . . 0.0 112.771 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.2 -70.32 1.75 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.031 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.74 33.18 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.578 0.543 . . . . 0.0 112.133 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.96 -34.8 69.26 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.568 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -110.57 -167.73 19.32 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.732 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.566 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.31 177.25 9.13 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.86 156.09 30.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.643 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -130.55 -83.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.122 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -114.46 -103.74 2.53 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.816 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.8 118.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.65 2.9 . . . . 0.0 113.214 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.6 27.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 23' ' ' GLY . 2.6 tt -118.8 163.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.242 1.02 . . . . 0.0 113.453 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.62 140.99 21.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.529 -1.669 . . . . 0.0 108.284 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.9 106.65 4.27 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.718 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.65 116.41 5.09 Favored Glycine 0 N--CA 1.401 -3.65 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 22.8 t0 -57.94 -56.94 15.53 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.46 19.64 1.22 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -151.68 34.15 0.55 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.24 -169.55 0.01 OUTLIER Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.316 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 140.24 52.5 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.685 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 19.1 m-85 -131.16 115.18 16.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.141 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.0 t -94.14 101.72 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.436 0.636 . . . . 0.0 110.27 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.54 20.25 55.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.067 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.685 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.6 p -77.73 -173.15 2.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.07 -42.19 99.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -75.82 -10.83 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.456 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -100.93 -12.93 18.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -53.48 -14.28 0.77 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.24 -25.31 3.55 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.062 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.726 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 64.0 Cg_exo -41.36 157.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.278 3.319 . . . . 0.0 117.668 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -165.85 153.27 10.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.784 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.19 5.5 3.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.035 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -90.79 55.88 3.08 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 117.415 0.607 . . . . 0.0 111.25 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.26 31.96 56.95 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.953 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.34 -149.78 18.29 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.864 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.705 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.4 mmt180 -119.03 155.35 31.58 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.871 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 49.1 t -63.24 162.75 11.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.4 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -162.56 -91.59 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.78 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.83 -171.5 1.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.711 0.804 . . . . 0.0 112.929 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -47.49 91.14 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.936 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.44 60.74 8.32 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 118.605 -1.76 . . . . 0.0 110.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.78 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -128.58 147.49 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 24.3 t -136.18 103.59 5.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -87.31 152.19 22.49 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -173.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -121.24 -179.27 0.71 Allowed Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.963 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_exo -73.73 -13.22 24.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.501 2.134 . . . . 0.0 112.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.81 -26.96 12.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.967 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.88 171.21 32.73 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.89 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.3 m -93.42 166.21 12.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.398 0.618 . . . . 0.0 112.059 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.625 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -151.76 141.29 21.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.662 178.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -60.9 118.14 6.32 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.914 0.388 . . . . 0.0 110.89 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.0 p30 -99.75 109.39 55.43 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 121.577 0.703 . . . . 0.0 111.556 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.3 Cg_exo -56.55 -15.67 16.43 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 124.036 3.157 . . . . 0.0 110.192 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.49 63.51 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.141 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.882 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.91 -28.69 9.0 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -176.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.53 -29.16 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.164 1 N-CA-C 122.17 4.137 . . . . 0.0 122.17 -177.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.936 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -107.38 -71.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.409 0 C-N-CA 122.684 2.256 . . . . 0.0 112.926 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.696 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.75 -6.71 28.08 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.421 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -72.8 -152.95 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.731 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.81 -178.54 0.43 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.617 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -74.05 62.15 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.5 t . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.047 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.96 0.409 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.75 129.81 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.529 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.882 ' HG ' ' H ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.94 170.67 15.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.308 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 1.005 ' HB3' ' HD2' ' A' ' 8' ' ' ARG . 22.4 t70 -79.22 -74.13 0.3 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.039 HD22 ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -77.6 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.954 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 1.035 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -84.48 -77.12 0.28 Allowed 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 7' ' ' VAL . 18.7 m -121.72 82.16 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 1.039 ' HG3' HD22 ' A' ' 5' ' ' LEU . 34.9 mtt85 -84.68 -167.91 1.99 Allowed 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.247 -0.908 . . . . 0.0 111.214 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.35 80.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.965 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.152 179.714 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.656 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 53.4 Cg_exo . . . . . 0 C--O 1.233 0.263 0 N-CA-C 114.491 0.919 . . . . 0.0 114.491 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 7.3 t -160.18 -169.47 2.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.9 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 56.5 -142.83 39.67 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.491 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -86.24 93.43 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.972 3.115 . . . . 0.0 112.545 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.97 -69.7 1.13 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.689 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.26 32.22 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.43 0.461 . . . . 0.0 112.095 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.07 -36.4 69.55 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.753 0.787 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.53 -167.4 20.19 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.023 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.953 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.04 -179.51 6.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 41.8 t -83.87 155.76 22.75 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.497 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.953 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 45.6 m-85 -142.5 8.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 149.27 -103.09 0.25 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.016 -1.564 . . . . 0.0 115.351 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.4 Cg_endo -105.53 105.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.914 3.076 . . . . 0.0 113.31 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 52.46 18.92 1.03 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.558 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.716 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.8 tt -108.01 153.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.225 1.012 . . . . 0.0 113.533 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.902 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -160.36 138.03 9.65 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.48 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 21.4 m -147.9 110.03 4.56 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.524 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -90.62 131.16 10.62 Favored Glycine 0 N--CA 1.415 -2.702 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.482 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 17.2 t70 -59.51 -62.59 1.76 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.329 1.064 . . . . 0.0 109.462 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.654 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -75.57 -0.84 21.8 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -125.61 31.44 5.52 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.601 -176.07 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.9 -177.27 0.01 OUTLIER Glycine 0 N--CA 1.465 0.608 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -99.33 140.49 33.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.626 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 49.4 m-85 -130.91 143.5 50.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.164 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -142.83 119.73 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.025 0.44 . . . . 0.0 109.949 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.5 5.23 11.34 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.406 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.3 m -87.32 179.27 6.63 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 38' ' ' THR . . . -61.37 -54.27 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.69 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -60.89 8.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -108.97 -38.67 5.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.26 -15.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.35 -18.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.482 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.703 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 34.7 Cg_exo -38.6 176.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.829 3.02 . . . . 0.0 114.077 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.27 154.77 19.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.72 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.8 6.26 5.18 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.142 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.555 ' HB3' ' SG ' ' A' ' 73' ' ' CYS . 18.3 t -92.15 51.0 1.72 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.006 0.431 . . . . 0.0 111.081 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.33 25.79 63.16 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.072 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 74' ' ' CYS . . . 164.63 -152.37 22.0 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.733 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 5.6 mmt-85 -115.31 157.17 24.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.179 -0.51 . . . . 0.0 111.444 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.718 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 30.6 t -58.28 143.54 44.28 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.933 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.646 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -137.46 -95.23 0.21 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.323 0.583 . . . . 0.0 112.085 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.919 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.98 -172.54 2.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.419 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.941 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.92 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.029 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.3 71.11 0.76 Allowed Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 118.93 -1.605 . . . . 0.0 110.188 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.919 HG13 ' HB3' ' A' ' 69' ' ' ALA . 3.9 mm -138.53 146.25 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 23.4 t -135.14 104.19 5.83 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.751 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.6 t -91.33 152.87 20.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.544 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.7 m -119.6 -179.25 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.606 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.9 Cg_exo -72.18 -10.66 26.14 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.393 2.062 . . . . 0.0 112.154 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.92 -33.0 7.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.453 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.81 168.22 37.07 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -98.28 165.36 11.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 111.853 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.624 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.3 141.57 21.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.399 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.605 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.78 114.72 2.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.5 p30 -95.98 106.42 27.99 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 121.303 0.573 . . . . 0.0 111.296 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.817 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.84 -9.88 3.43 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 124.142 3.228 . . . . 0.0 110.495 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.18 -29.13 57.55 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.651 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -109.72 -27.77 9.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 118.122 2.638 . . . . 0.0 118.122 -176.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 175.6 -31.19 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.334 1 N-CA-C 122.179 4.14 . . . . 0.0 122.179 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.029 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.8 Cg_endo -105.46 -70.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.717 2.278 . . . . 0.0 112.097 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 65.0 tt0 -69.97 -6.65 34.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.735 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.25 -157.48 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.237 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.45 -178.82 0.72 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.48 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.36 62.36 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.204 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.791 0.329 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.73 162.37 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.201 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.53 166.66 23.16 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.583 0.706 . . . . 0.0 112.564 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.763 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 50.1 t0 -78.78 -79.0 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.348 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -84.07 -150.78 0.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.815 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -82.47 -51.84 7.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 7' ' ' VAL . 32.5 m -119.44 84.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG3' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -81.87 158.99 23.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.89 65.25 0.3 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.553 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.665 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.7 Cg_exo . . . . . 0 N--CA 1.46 -0.448 0 CA-C-O 121.243 0.434 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.2 t -157.87 -176.38 5.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.898 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.37 -138.17 47.36 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.748 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 14.3 Cg_endo -89.6 98.15 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 124.456 3.437 . . . . 0.0 112.551 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.31 -69.04 2.84 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.129 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.69 32.86 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 121.54 0.522 . . . . 0.0 112.478 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.69 -35.49 72.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.043 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.91 -171.87 22.59 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.984 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.66 179.98 7.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 120.799 0.333 . . . . 0.0 110.135 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -80.44 145.12 32.1 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.7 m-85 -118.51 -60.3 1.79 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.871 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -142.12 -100.16 0.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.268 -0.967 . . . . 0.0 114.02 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.8 Cg_endo -100.85 105.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.344 2.696 . . . . 0.0 113.387 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.46 25.42 1.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 110.464 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 23' ' ' GLY . 3.0 tt -112.9 164.75 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.949 0.881 . . . . 0.0 112.922 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.44 141.28 22.81 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.033 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -145.38 108.76 4.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.708 -177.013 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -97.59 117.13 5.71 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.744 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 36.9 t0 -57.92 -56.56 20.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.553 1.177 . . . . 0.0 108.33 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.635 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -83.85 15.27 3.39 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -145.36 32.92 1.07 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.94 173.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.085 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t -112.98 136.84 52.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.67 125.28 29.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.822 177.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.8 t -95.18 97.7 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.53 14.19 56.95 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.854 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 4.7 m -78.54 -177.4 5.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 38' ' ' THR . . . -53.58 -55.55 24.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.267 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -72.66 4.21 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -114.25 -21.42 10.45 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.84 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.63 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.29 -25.84 4.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 118.305 0.502 . . . . 0.0 110.865 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.697 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.583 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 120.648 0.261 . . . . 0.0 111.376 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 25.8 Cg_exo -40.82 157.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.577 3.518 . . . . 0.0 118.563 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -164.62 153.99 13.37 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.869 176.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.7 7.01 1.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.54 -0.754 . . . . 0.0 114.122 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 24.2 t -92.85 52.08 1.79 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.397 0.598 . . . . 0.0 111.265 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.06 34.89 58.67 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.752 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.731 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.05 -151.44 21.13 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.604 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.731 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 2.9 mmt180 -117.99 154.17 32.42 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.922 0.391 . . . . 0.0 111.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -61.86 155.32 23.59 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.71 -99.16 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.384 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.03 -170.78 1.48 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.924 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.942 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.51 86.61 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.011 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.94 70.76 0.88 Allowed Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.967 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 68' ' ' ALA . 3.3 mm -142.64 116.25 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 121.643 0.735 . . . . 0.0 109.028 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.2 t -104.88 106.3 16.73 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -92.72 161.58 14.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -128.04 -179.92 1.09 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.176 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -73.47 -10.12 23.53 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.38 2.054 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -32.52 7.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.423 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 167.1 35.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.912 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.638 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 29.2 m -97.08 167.21 11.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.0 111.935 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.587 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.54 142.22 20.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.996 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.514 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -60.98 113.07 2.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.077 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 35.4 p30 -95.05 108.63 39.58 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-O 121.667 0.746 . . . . 0.0 111.769 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 48.5 Cg_exo -58.51 -12.09 13.03 Favored 'Trans proline' 0 CA--C 1.504 -0.985 0 C-N-CA 123.99 3.126 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.58 59.93 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.32 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.724 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.6 -24.09 10.73 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -175.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 6.9 t70 173.77 -29.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.391 1 N-CA-C 122.262 4.171 . . . . 0.0 122.262 -178.085 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.011 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.8 Cg_endo -107.56 -71.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.481 2.121 . . . . 0.0 112.465 -171.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.733 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.1 tt0 -69.56 -6.68 32.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.692 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.31 -155.53 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.073 -2.331 . . . . 0.0 111.613 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.24 -178.85 0.69 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.445 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -74.48 62.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 8.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.745 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.849 0.356 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.13 163.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.818 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -67.86 168.72 11.08 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.465 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 12.0 t0 -74.87 -134.44 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.779 HD13 ' HE ' ' A' ' 66' ' ' ARG . 1.1 pp -91.1 -125.64 0.08 Allowed 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 122.029 -0.419 . . . . 0.0 111.103 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 5' ' ' LEU . 1.1 t70 -73.12 -52.68 13.31 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.697 ' H ' HD12 ' A' ' 5' ' ' LEU . 6.4 m -85.85 85.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.43 176.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.818 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 33.1 mtt85 -76.13 123.86 26.5 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.749 HG22 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -75.36 -151.26 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.966 178.166 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' SG ' ' C ' ' A' ' 9' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.365 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.697 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 51.6 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 CA-C-O 121.371 0.488 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.644 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 5.2 t -158.3 -171.86 3.65 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.88 -149.78 33.2 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.013 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.37 85.49 1.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.669 2.913 . . . . 0.0 112.836 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -71.52 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.697 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.7 31.9 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 121.416 0.453 . . . . 0.0 112.578 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -75.01 -37.38 61.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.884 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -105.54 -163.54 23.46 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.526 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.749 ' HD3' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.92 153.69 45.77 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.187 0.994 . . . . 0.0 112.881 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' CA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.06 127.13 36.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.209 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.834 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -102.07 -102.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -113.13 -87.71 1.64 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 26' ' ' ILE . 30.7 Cg_endo -101.91 113.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.171 2.58 . . . . 0.0 114.451 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.42 23.27 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.725 0.298 . . . . 0.0 110.622 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.834 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 6.6 tt -112.8 161.85 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.556 1.169 . . . . 0.0 114.036 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.795 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 49.2 t -159.4 159.54 33.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.763 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.1 106.15 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.892 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -96.76 122.54 7.43 Favored Glycine 0 N--CA 1.414 -2.814 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 25.8 t70 -58.78 -59.15 5.89 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.61 1.205 . . . . 0.0 107.942 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.2 pt-20 -81.82 11.62 4.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.892 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.49 41.66 1.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.197 -175.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 27.89 -164.39 0.0 OUTLIER Glycine 0 N--CA 1.472 1.066 0 N-CA-C 115.398 0.919 . . . . 0.0 115.398 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -114.81 144.34 43.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.701 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.6 m-85 -131.46 98.23 4.46 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.818 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 26' ' ' ILE . 3.2 t -94.69 131.46 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.037 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 53.18 31.76 42.04 Favored Glycine 0 C--N 1.319 -0.406 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.809 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.28 -177.69 3.23 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -69.55 -49.15 57.01 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -68.99 8.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -106.3 -27.19 11.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.706 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.78 -11.2 2.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.86 -19.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' CA ' ' HB2' ' A' ' 21' ' ' CYS . 1.2 t . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 120.927 0.394 . . . . 0.0 110.086 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt . . . . . 0 N--CA 1.433 -1.32 0 CA-C-O 120.488 0.185 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.746 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 68.6 Cg_exo -40.3 155.17 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.221 2.614 . . . . 0.0 115.576 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -161.46 153.9 20.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.19 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.46 4.18 5.33 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.174 -0.921 . . . . 0.0 114.06 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.9 t -90.51 57.02 3.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.434 0.617 . . . . 0.0 111.5 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.63 29.07 57.39 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.879 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.741 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.61 -149.05 16.6 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.443 -0.885 . . . . 0.0 115.307 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.779 ' HE ' HD13 ' A' ' 5' ' ' LEU . 6.7 mmt180 -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.22 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 34.8 t -60.38 154.25 20.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.3 -92.7 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.2 -171.24 1.98 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.939 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.64 89.18 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.953 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.21 68.46 1.69 Allowed Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.787 -1.673 . . . . 0.0 110.202 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.734 HG21 ' SG ' ' A' ' 28' ' ' CYS . 1.4 mm -138.52 141.2 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.3 t -128.89 104.96 7.9 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.3 t -90.21 153.13 20.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -119.76 -179.61 0.73 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.403 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -72.87 -11.58 25.77 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.189 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -29.97 9.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.078 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.19 171.06 36.77 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -97.54 164.34 12.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.267 0.556 . . . . 0.0 111.925 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.642 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -151.38 139.51 20.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.664 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.539 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.13 118.84 5.88 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.911 0.386 . . . . 0.0 110.503 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.69 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 45.7 p30 -98.97 108.31 48.57 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.732 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.9 Cg_exo -55.91 -16.57 16.35 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 123.868 3.045 . . . . 0.0 109.941 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -28.23 63.93 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -111.38 -27.39 8.66 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -176.218 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.5 t70 174.58 -28.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 1 N-CA-C 122.432 4.234 . . . . 0.0 122.432 -177.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.8 Cg_endo -106.39 -71.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.559 2.173 . . . . 0.0 112.542 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.5 tt0 -69.75 -6.18 30.25 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.732 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.23 -158.1 0.06 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.958 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.03 -178.11 0.57 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.541 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -73.0 62.11 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.0 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 1' ' ' ALA . 35.3 m 44.56 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.413 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -78.13 171.22 15.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.681 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 4.8 t0 -81.65 -87.88 0.09 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -81.4 -74.1 0.35 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.175 0.988 . . . . 0.0 109.294 177.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.639 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -152.75 -59.51 0.14 Allowed 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.827 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.688 ' H ' HD12 ' A' ' 5' ' ' LEU . 31.4 m -106.49 86.49 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.012 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.681 ' NE ' ' HB2' ' A' ' 4' ' ' ASP . 4.9 mtt-85 -73.44 -178.32 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.578 0.704 . . . . 0.0 112.678 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.81 41.65 0.06 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.741 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.716 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.714 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo . . . . . 0 N--CA 1.455 -0.766 0 CA-C-O 121.164 0.402 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -158.8 -177.16 6.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.775 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 62.67 -136.67 44.34 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.555 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.9 Cg_endo -91.8 101.04 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.519 3.48 . . . . 0.0 112.599 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.59 -71.65 2.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.75 33.64 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.578 0.543 . . . . 0.0 112.267 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.94 -35.63 69.67 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.48 -0.86 . . . . 0.0 110.228 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -104.37 -172.22 24.95 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.151 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.29 178.82 8.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.98 154.6 35.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 15.1 m-85 -135.01 -28.02 1.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -170.72 -110.24 0.23 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.593 -1.289 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 42.1 Cg_endo -98.51 103.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.293 2.662 . . . . 0.0 112.793 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.79 22.95 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.036 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.614 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -111.63 163.16 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 122.0 0.905 . . . . 0.0 113.016 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.31 143.23 23.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.608 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.82 103.11 3.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.066 -177.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.01 116.04 4.59 Favored Glycine 0 N--CA 1.402 -3.603 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.822 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 27.0 t70 -58.42 -55.27 37.25 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.525 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.9 pt-20 -83.63 11.78 6.74 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.05 37.75 1.16 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.51 -175.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -118.13 138.52 52.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 1.055 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -132.19 129.82 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.419 178.034 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.614 HG22 HD11 ' A' ' 26' ' ' ILE . 6.3 t -103.79 97.61 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.183 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.54 17.52 62.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.005 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 10.0 p -74.15 -170.92 1.03 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.022 0.411 . . . . 0.0 109.933 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.25 -45.75 83.36 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.15 -14.27 61.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.331 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 1.055 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.21 -9.84 20.11 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -17.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.214 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.689 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.36 -28.81 8.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.484 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.927 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.711 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 77.8 Cg_exo -44.29 155.76 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.018 3.146 . . . . 0.0 117.018 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.21 168.59 20.48 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.734 1.254 . . . . 0.0 112.591 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.55 -2.18 33.94 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 112.465 -2.152 . . . . 0.0 116.317 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.598 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 41.5 t -94.21 56.52 2.21 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 117.745 0.772 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.43 38.89 35.45 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.29 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.585 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.96 -153.72 24.38 Favored Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.329 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 mmt180 -111.68 147.89 34.58 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.194 0.521 . . . . 0.0 111.816 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 t -62.23 156.04 23.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.708 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -157.69 -94.05 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.99 -171.16 1.05 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.746 0.819 . . . . 0.0 112.747 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.944 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.45 89.66 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.929 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.4 63.29 5.41 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.505 -1.807 . . . . 0.0 110.289 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.743 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -130.19 146.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.775 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 1.9 t -135.97 104.4 5.7 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.4 t -89.49 159.16 17.39 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -173.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.527 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.5 m -127.49 -179.27 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.527 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.2 Cg_exo -71.92 -10.13 25.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.336 2.024 . . . . 0.0 112.697 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -33.2 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 111.304 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.8 169.95 37.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.466 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 8.0 m -96.38 165.8 12.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.4 0.619 . . . . 0.0 112.111 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.637 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.79 140.81 21.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.694 178.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.85 117.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.0 110.006 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 55.7 p30 -99.01 109.7 54.98 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.907 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.756 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -57.24 -14.78 16.37 Favored 'Trans proline' 0 CA--C 1.504 -1.0 0 C-N-CA 123.682 2.921 . . . . 0.0 109.887 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.24 -29.36 62.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.251 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.8 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.32 -26.6 9.49 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.28 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.7 t70 174.52 -29.22 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.245 1 N-CA-C 122.481 4.252 . . . . 0.0 122.481 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.944 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.31 -70.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -171.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 30.6 tt0 -69.47 -6.55 31.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.756 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.99 -154.83 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.059 -2.337 . . . . 0.0 112.549 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.96 -178.7 1.29 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.817 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -74.62 62.04 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.252 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 3' ' ' LEU . 13.4 t -56.86 173.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.779 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.18 173.17 5.89 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.884 0.85 . . . . 0.0 112.923 -178.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.843 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 43.5 t0 -81.45 -144.87 0.05 Allowed 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.895 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.684 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -88.96 -116.98 0.06 Allowed 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.684 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -74.69 -47.88 29.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.1 m -87.68 84.19 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.365 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.843 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 45.5 mtt180 -80.09 167.33 20.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 21.4 m 69.98 97.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.666 -1.152 . . . . 0.0 113.19 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 94.4 Cg_exo . . . . . 0 N--CA 1.46 -0.5 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.645 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.6 t -157.42 -172.02 3.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.103 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.44 -142.59 45.06 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.664 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 26.3 Cg_endo -85.63 95.84 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.148 3.232 . . . . 0.0 112.796 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.46 -66.68 3.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.025 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' PRO . . . 178.29 32.02 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 121.591 0.551 . . . . 0.0 112.438 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.47 -34.85 72.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -0.827 . . . . 0.0 109.866 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.24 -169.11 15.77 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.721 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.55 -178.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 34.3 m -76.03 159.87 30.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.809 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 63.2 m-85 -148.24 16.94 1.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 142.73 -113.56 0.8 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.263 -1.446 . . . . 0.0 114.879 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.5 Cg_endo -105.75 111.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.878 3.052 . . . . 0.0 112.986 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.79 22.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.388 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.722 HG13 HG13 ' A' ' 36' ' ' VAL . 1.5 tt -115.76 154.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 122.177 0.989 . . . . 0.0 112.486 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -158.63 134.04 8.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.76 -1.563 . . . . 0.0 107.324 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.977 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 33.2 m -150.38 108.95 3.81 Favored 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.187 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.11 123.08 5.96 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.185 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.652 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 22.9 t70 -58.21 -57.62 12.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.32 18.04 1.21 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -152.2 39.36 0.59 Allowed 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.766 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.4 178.67 0.01 OUTLIER Glycine 0 N--CA 1.464 0.561 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -105.32 129.08 53.74 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.7 m-85 -132.1 105.63 7.5 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.68 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.722 HG13 HG13 ' A' ' 26' ' ' ILE . 8.1 t -95.25 110.28 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.232 0.539 . . . . 0.0 109.599 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.46 21.08 53.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.919 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -94.38 178.26 5.68 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.29 -53.85 31.72 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 111.589 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -71.09 8.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -108.25 -24.95 11.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -16.91 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 1.2 mpp_? -55.15 -18.14 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 90.9 Cg_exo -40.7 158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.199 2.6 . . . . 0.0 116.386 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.09 154.17 14.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.539 177.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.35 3.87 7.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.747 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 11.0 t -91.08 54.07 2.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 117.222 0.511 . . . . 0.0 111.311 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.07 33.18 60.5 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.133 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.553 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.88 -151.35 21.08 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.646 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.0 mmt85 -118.35 156.01 29.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.992 -0.604 . . . . 0.0 111.26 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 24.6 t -61.25 151.73 30.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -149.07 -94.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.977 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . . . -76.7 -171.68 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.651 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.975 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.05 91.76 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.982 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.95 68.21 1.8 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.006 -1.569 . . . . 0.0 110.206 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -136.12 142.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.6 t -128.93 104.47 7.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -88.5 154.42 20.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.555 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.8 m -123.16 -179.24 0.77 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.555 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -72.04 -9.68 24.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.334 2.023 . . . . 0.0 112.927 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -34.07 7.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.691 0.282 . . . . 0.0 110.984 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.83 170.17 38.31 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.282 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.622 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 11.6 m -94.03 165.95 12.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.482 0.658 . . . . 0.0 112.666 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.645 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -150.82 140.0 21.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.597 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -60.41 117.93 5.84 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.985 0.422 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.703 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.7 p30 -99.19 108.53 50.33 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.281 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.23 -12.74 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.014 3.142 . . . . 0.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.64 60.36 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.35 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.939 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -108.88 -27.56 9.65 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -176.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.33 -29.36 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.362 1 N-CA-C 122.321 4.193 . . . . 0.0 122.321 -178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.7 Cg_endo -106.2 -70.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.495 0 C-N-CA 122.345 2.03 . . . . 0.0 112.29 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 62.1 tt0 -69.49 -6.83 33.18 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.76 -158.04 0.08 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 111.79 -2.459 . . . . 0.0 112.11 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.67 -177.97 0.85 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.613 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.92 61.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.455 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.8 t -65.71 167.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.827 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.15 173.97 6.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.0 112.641 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.567 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.9 t0 -80.14 -78.49 0.17 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.584 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.046 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.65 -127.64 0.06 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.826 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 1.046 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.01 -41.85 73.78 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.015 HG22 HD11 ' A' ' 5' ' ' LEU . 34.3 m -91.62 109.22 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.783 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.827 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 86.2 mtt180 -71.4 126.66 30.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -104.09 -162.85 0.93 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.922 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.458 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 26.8 Cg_exo . . . . . 0 N--CA 1.462 -0.365 0 CA-C-O 120.964 0.318 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 3.9 t -157.86 -175.02 5.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.53 -137.47 49.88 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.85 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.3 Cg_endo -89.76 94.94 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.437 3.425 . . . . 0.0 112.667 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.05 -68.61 2.48 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.418 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.56 32.41 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.504 0.502 . . . . 0.0 112.32 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.562 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -69.8 -35.5 74.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.573 -0.813 . . . . 0.0 110.109 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -114.94 -165.38 14.85 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.809 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.613 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.59 177.0 10.41 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.67 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -79.43 153.71 29.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.684 ' HB2' HG23 ' A' ' 26' ' ' ILE . 15.6 m-85 -125.71 -94.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.695 -0.402 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.691 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -98.86 -106.84 2.67 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.575 -0.822 . . . . 0.0 114.565 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -101.95 113.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.798 2.999 . . . . 0.0 113.559 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 50.9 21.02 0.87 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.691 ' CG2' ' H ' ' A' ' 23' ' ' GLY . 4.2 tt -111.74 166.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 122.134 0.968 . . . . 0.0 113.316 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.77 143.08 18.2 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.751 -1.568 . . . . 0.0 107.886 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.848 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -147.5 104.88 3.67 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.908 -177.15 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.14 119.58 5.96 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.646 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 36.3 t0 -58.22 -58.63 7.6 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.607 1.203 . . . . 0.0 108.009 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.562 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.3 pt-20 -81.18 20.39 0.83 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -152.08 35.21 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.218 -175.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.681 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.3 -164.81 0.01 OUTLIER Glycine 0 C--N 1.33 0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 114.164 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.75 140.29 53.07 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.756 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -131.91 114.88 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.582 178.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -97.17 113.8 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.409 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 58.92 19.86 46.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.738 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.2 m -94.47 163.76 13.27 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.411 0.284 . . . . 0.0 110.384 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.83 -53.62 7.28 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.282 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.3 mp0 -69.06 7.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.858 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -116.03 -26.69 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -43.37 -19.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.601 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.23 -21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.572 0.624 . . . . 0.0 111.702 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 13.7 t . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.013 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 57.9 Cg_exo -42.83 160.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.134 3.223 . . . . 0.0 117.662 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -164.75 154.06 13.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.155 177.259 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.93 3.37 3.07 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.044 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.03 54.74 2.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.562 0.681 . . . . 0.0 111.339 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.99 35.85 49.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.947 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.701 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.8 -154.84 25.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.973 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 5.6 mmt180 -115.43 155.46 27.4 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.207 -0.497 . . . . 0.0 111.587 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 25.1 t -60.98 153.03 26.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.043 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -151.39 -92.62 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.23 -173.86 2.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.6 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.981 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.78 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.944 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.68 66.02 3.14 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 118.601 -1.761 . . . . 0.0 110.215 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.871 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.9 mm -134.25 144.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.6 t -132.38 105.96 7.6 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -92.0 153.59 19.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -173.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.531 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.3 m -119.03 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.66 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -71.94 -10.22 25.86 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.313 2.008 . . . . 0.0 112.562 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 -32.24 7.62 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.656 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.92 168.49 36.92 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.703 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.591 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 8.6 m -96.44 165.89 11.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.482 0.658 . . . . 0.0 112.442 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.705 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -152.18 142.46 22.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.555 178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.591 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -61.11 117.88 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.58 -178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.723 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 45.1 p30 -98.32 108.08 45.37 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-O 121.549 0.69 . . . . 0.0 111.285 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.766 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -56.24 -11.02 5.31 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 124.099 3.199 . . . . 0.0 110.147 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -77.02 -28.86 55.07 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.165 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -109.44 -27.37 9.49 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -175.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.4 t70 174.36 -29.35 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.246 1 N-CA-C 122.428 4.233 . . . . 0.0 122.428 -178.123 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.981 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.42 -70.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.746 2.297 . . . . 0.0 112.306 -172.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -70.96 -5.88 34.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 175.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.766 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.72 -160.3 0.15 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 111.767 -2.469 . . . . 0.0 112.371 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.11 -177.58 0.38 Allowed 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.675 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -74.23 61.77 0.89 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.248 0.993 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.235 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.868 0.366 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -83.41 143.52 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.2 0.524 . . . . 0.0 111.98 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.633 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -75.07 175.64 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.781 0.801 . . . . 0.0 112.975 -178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 20.0 t0 -77.95 -140.77 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.944 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -91.12 -123.8 0.07 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.652 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -68.93 -47.98 64.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 7' ' ' VAL . 15.9 m -85.92 90.43 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.947 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.633 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 58.6 mtt85 -69.26 -168.33 0.15 Allowed 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.67 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.4 m 67.22 111.61 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.791 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.28 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 20.0 Cg_exo . . . . . 0 N--CA 1.459 -0.518 0 CA-C-O 121.34 0.475 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -156.67 -176.74 6.14 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.102 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.09 -133.08 49.01 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.876 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 8.2 Cg_endo -92.71 100.31 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.905 3.737 . . . . 0.0 112.446 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 -68.27 3.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.919 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.68 31.63 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 121.416 0.453 . . . . 0.0 112.792 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.92 -37.85 69.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.764 0.792 . . . . 0.0 109.797 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -101.11 -176.58 29.1 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.783 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -162.14 -179.38 7.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.83 0.348 . . . . 0.0 110.655 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 m -80.91 144.88 31.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.676 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.6 m-85 -119.68 -43.47 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -165.01 -95.27 0.1 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.277 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.9 Cg_endo -101.91 103.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.567 2.844 . . . . 0.0 113.554 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.69 25.53 1.01 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 110.62 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -113.86 160.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.85 0.833 . . . . 0.0 112.852 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -153.42 136.94 15.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.169 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 2.2 m -148.39 117.29 6.72 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.513 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.893 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -104.93 119.36 6.18 Favored Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.162 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.6 t70 -57.79 -57.02 14.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.552 1.176 . . . . 0.0 108.21 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -83.06 26.53 0.61 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.893 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -159.77 33.01 0.19 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.536 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.965 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 40.58 176.14 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' HG21 ' A' ' 72' ' ' ILE . 1.2 m -106.03 132.25 52.34 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.838 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -131.92 117.08 17.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.19 98.28 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.021 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.83 10.72 40.12 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.984 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -76.41 174.5 10.18 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.079 0.552 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.55 -56.14 4.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.344 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -73.7 6.98 2.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -112.87 -23.25 10.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.99 -18.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.37 -23.99 1.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.55 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.281 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.463 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 111.261 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 71.9 Cg_exo -44.01 160.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.873 3.049 . . . . 0.0 117.306 -176.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -165.17 155.02 13.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.805 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.12 7.14 3.46 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.4 t -93.38 51.94 1.68 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.124 0.462 . . . . 0.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.16 34.6 58.8 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.982 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.744 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.61 -151.85 21.53 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.744 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.6 mmt180 -118.82 155.41 31.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.758 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 27.0 t -62.89 155.59 26.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.04 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.58 -89.85 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.369 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.965 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -73.34 -169.59 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 114.829 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . -28.44 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.36 1.03 0 CA-C-O 122.253 1.025 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.79 ' C ' ' OD1' ' A' ' 82' ' ' ASP . . . -177.01 78.53 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.847 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.751 HG21 ' SG ' ' A' ' 34' ' ' CYS . 2.0 mm -132.41 149.83 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 114.202 -0.999 . . . . 0.0 108.888 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 29.8 t -132.95 102.88 5.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -85.35 146.57 26.95 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.49 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -113.58 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.443 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.49 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 7.9 Cg_exo -74.67 -11.83 22.18 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.467 2.111 . . . . 0.0 112.271 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -28.14 11.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.015 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.04 168.2 33.2 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.642 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.1 m -94.17 165.93 12.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.276 0.56 . . . . 0.0 112.264 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.62 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.64 141.64 20.27 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.96 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.629 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 122.1 12.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.79 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 54.0 p30 -101.55 106.65 47.39 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.438 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.695 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 52.8 Cg_exo -57.1 -17.64 25.83 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.786 2.991 . . . . 0.0 109.61 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.3 69.28 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.26 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.744 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 m -103.52 -33.76 8.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 9.2 t70 167.84 -24.84 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.457 0 N-CA-C 121.703 3.964 . . . . 0.0 121.703 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.705 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_endo -101.67 -69.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.263 1.975 . . . . 0.0 112.347 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.1 tt0 -71.85 -5.7 36.35 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -74.16 -155.3 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.207 -2.27 . . . . 0.0 111.44 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.24 -178.72 1.11 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -74.93 62.53 1.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.473 ' OG ' ' OD2' ' A' ' 86' ' ' ASP . 3.4 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.568 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.482 0.182 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m 36.51 -163.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.01 174.73 6.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.641 0.734 . . . . 0.0 112.706 -178.154 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -78.27 -89.89 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.238 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 6' ' ' ASP . 1.3 pp -152.52 -42.37 0.1 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.53 -48.73 0.14 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.416 176.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 7' ' ' VAL . 4.4 m -82.68 92.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.232 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.5 mtt85 -67.26 171.04 6.24 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 23.2 90.19 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.327 0.584 . . . . 0.0 111.06 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 13.9 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.939 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 11.0 Cg_exo . . . . . 0 N--CA 1.453 -0.88 0 CA-C-O 121.708 0.628 . . . . 0.0 113.296 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.5 t -157.35 -169.77 3.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.673 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.6 -144.05 44.06 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.469 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 17.5 Cg_endo -87.92 90.91 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 124.206 3.271 . . . . 0.0 112.462 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.54 -70.69 0.61 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.101 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.87 32.2 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.868 0 CA-C-O 121.449 0.472 . . . . 0.0 112.447 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.43 -38.03 74.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.87 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.04 -164.54 18.47 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.569 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.717 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.71 179.07 9.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.59 151.96 37.76 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.717 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 24.2 m-85 -132.98 -1.13 3.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 166.18 -114.55 0.59 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.324 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -101.07 105.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.701 2.934 . . . . 0.0 112.571 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.48 23.78 3.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.948 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.583 HG13 HG13 ' A' ' 36' ' ' VAL . 2.9 tt -111.66 162.83 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.363 1.078 . . . . 0.0 113.584 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.475 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 49.3 t -147.83 149.92 33.22 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.227 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.45 96.08 1.87 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.589 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.48 119.08 5.27 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 119.445 -1.359 . . . . 0.0 110.005 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.583 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 15.2 t70 -58.77 -55.7 31.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.595 1.198 . . . . 0.0 107.809 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.8 pt-20 -81.15 1.3 32.52 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.893 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.939 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -134.18 39.19 3.11 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.614 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.687 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.72 -172.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.768 0 N-CA-C 114.769 0.668 . . . . 0.0 114.769 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -120.87 133.68 55.3 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.862 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.43 126.68 33.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.844 178.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.583 HG13 HG13 ' A' ' 26' ' ' ILE . 3.4 t -99.77 106.43 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.18 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.86 24.16 62.21 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.0 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.4 m -94.74 172.01 8.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.58 0.352 . . . . 0.0 110.535 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -44.11 -54.99 5.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.55 -10.99 60.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.751 0.31 . . . . 0.0 111.642 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.48 -14.55 16.78 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -18.37 0.15 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -51.7 -26.98 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.627 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.442 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.576 0.227 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -41.88 158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.122 3.215 . . . . 0.0 117.649 -176.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.41 154.13 13.99 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.371 177.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.87 4.39 4.38 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.452 -0.794 . . . . 0.0 114.143 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.0 t -91.42 53.28 2.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.485 0.642 . . . . 0.0 111.223 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.58 57.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.912 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.75 -154.5 25.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.964 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 7.9 mmt-85 -115.9 153.98 30.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -62.87 153.21 34.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.984 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.69 -91.91 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -74.81 -171.67 1.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.968 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.6 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.941 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.46 64.74 4.1 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 118.879 -1.629 . . . . 0.0 110.165 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.865 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -131.28 146.11 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 20.1 t -133.62 101.22 5.04 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -83.05 146.93 28.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.7 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.2 m -111.32 -179.47 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.561 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 34.7 Cg_endo -74.01 -22.51 17.1 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.552 1.501 . . . . 0.0 112.238 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.9 -27.2 15.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.266 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.22 168.87 33.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.425 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.1 m -94.28 165.71 12.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.442 0.639 . . . . 0.0 112.434 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.628 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.98 140.89 21.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.497 178.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.563 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.94 119.31 7.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.961 0.41 . . . . 0.0 110.616 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.732 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.3 p30 -98.93 109.21 52.98 Favored Pre-proline 0 N--CA 1.438 -1.067 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.722 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -56.98 -12.24 9.07 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 124.061 3.174 . . . . 0.0 110.146 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.69 -28.11 58.51 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.268 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.846 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.68 -25.88 9.71 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -175.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.7 t70 174.2 -30.44 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.42 1 N-CA-C 122.194 4.146 . . . . 0.0 122.194 -177.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.968 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -106.66 -71.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.391 0 C-N-CA 122.636 2.224 . . . . 0.0 112.74 -171.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.712 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.7 tt0 -69.5 -6.11 28.43 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.722 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.88 -157.5 0.06 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.86 -2.427 . . . . 0.0 112.443 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.69 -178.19 0.53 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.2 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.84 62.27 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.929 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.707 0.289 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.12 143.24 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.802 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.85 169.06 18.69 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.282 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 37.1 t0 -79.8 -137.81 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.814 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -92.37 -120.58 0.08 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.679 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.73 -48.45 31.84 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.272 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 5' ' ' LEU . 11.7 m -86.75 83.7 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.053 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 39.3 mtt180 -82.29 147.44 28.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.754 ' CG2' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m 59.47 115.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.203 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 81.3 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.251 -179.747 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HG3' ' CG2' ' A' ' 9' ' ' THR . 7.6 Cg_exo . . . . . 0 N--CA 1.46 -0.472 0 N-CA-C 114.857 1.061 . . . . 0.0 114.857 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.0 t -155.56 -170.88 3.58 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.113 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 58.36 -137.62 49.86 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.063 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.5 Cg_endo -90.19 93.19 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.598 3.532 . . . . 0.0 113.13 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.54 -68.3 2.12 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.324 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.87 34.34 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.775 0.653 . . . . 0.0 112.267 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.949 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.8 -35.08 69.86 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.916 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.682 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -117.12 -163.49 13.06 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.197 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -158.2 176.87 11.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -86.68 158.33 19.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.078 178.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.1 m-85 -131.11 -90.76 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.723 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -120.51 -93.43 1.36 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -99.53 104.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.545 2.83 . . . . 0.0 114.177 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 51.65 19.97 1.0 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.363 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.7 tt -109.24 163.09 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.146 0.974 . . . . 0.0 113.327 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.41 145.01 20.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.229 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -149.05 115.37 5.82 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.995 -177.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.949 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.76 122.0 7.39 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.966 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 3.4 t70 -58.62 -56.91 16.08 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -84.98 24.09 1.12 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.223 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.949 ' HB2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -157.11 36.35 0.29 Allowed 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.762 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 38.31 -170.81 0.01 OUTLIER Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 139.7 49.9 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.728 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 1.7 m-85 -131.19 104.38 7.03 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.09 177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.553 HG13 HG13 ' A' ' 26' ' ' ILE . 5.0 t -95.03 115.17 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.495 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 62.89 8.28 21.18 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.422 -0.895 . . . . 0.0 112.038 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.5 m -82.86 172.69 12.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.362 0.265 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -56.09 -54.33 46.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -65.39 8.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.879 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -109.0 -33.37 6.92 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.89 -17.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.396 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.01 -20.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.451 -0.403 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.807 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 33.8 Cg_exo -41.32 155.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 125.258 3.972 . . . . 0.0 115.932 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.08 156.69 19.84 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.191 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.61 6.34 3.59 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.846 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.22 51.65 1.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 117.267 0.534 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.16 30.68 61.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.878 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.55 -152.72 22.83 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.3 mmt-85 -118.17 165.38 13.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.977 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 5.8 t -59.43 149.11 30.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.49 -25.6 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.966 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -161.32 -170.84 2.78 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 122.727 0.411 . . . . 0.0 111.786 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -41.0 86.58 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.96 67.71 2.07 Favored Glycine 0 N--CA 1.419 -2.485 0 C-N-CA 118.627 -1.749 . . . . 0.0 111.124 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 68' ' ' ALA . 3.4 mm -137.62 135.3 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -124.18 108.92 12.8 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.698 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.8 t -95.23 154.62 17.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.503 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -122.26 -179.37 0.76 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.837 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -71.78 -9.66 25.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.38 2.053 . . . . 0.0 112.147 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.7 -34.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.32 169.77 38.86 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.812 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.645 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.3 m -99.13 164.95 11.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.369 0.604 . . . . 0.0 111.668 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.592 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.7 144.02 22.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.467 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.55 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pt-20 -61.7 116.63 4.94 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.778 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 41.0 p30 -97.34 107.01 36.12 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.001 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 57.7 Cg_exo -55.03 -13.84 7.25 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.569 2.846 . . . . 0.0 110.445 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -72.71 -29.25 63.22 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.169 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.975 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -106.55 -30.11 9.24 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 -176.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.648 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 7.2 t70 174.66 -28.62 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.325 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -177.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.2 Cg_endo -106.11 -70.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.525 0 C-N-CA 122.376 2.051 . . . . 0.0 112.276 -172.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.695 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.7 tt0 -70.27 -6.23 33.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.006 -1.906 . . . . 0.0 106.029 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.7 -155.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.695 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.48 -178.48 0.52 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.877 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.71 62.67 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 4.5 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.476 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -68.07 149.59 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.676 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.91 170.02 14.62 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.677 0.751 . . . . 0.0 112.937 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 5' ' ' LEU . 40.9 t0 -82.43 -77.03 0.24 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.986 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.008 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -148.95 -133.96 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.048 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 1.008 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -73.13 -38.52 66.26 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.626 ' CG2' HD11 ' A' ' 5' ' ' LEU . 27.2 m -97.69 104.44 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.676 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.2 mtt85 -71.74 178.65 3.5 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.2 m 67.09 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.546 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 112.245 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 26.4 Cg_exo . . . . . 0 N--CA 1.454 -0.812 0 CA-C-O 121.13 0.387 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.5 t -157.69 -176.67 6.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.687 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.515 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 64.93 -139.4 40.65 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.833 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.8 Cg_endo -91.78 95.23 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.667 3.578 . . . . 0.0 112.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 -72.08 0.78 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.85 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 175.51 35.58 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.69 0.606 . . . . 0.0 111.985 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.89 -36.05 69.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.353 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.18 -167.3 18.74 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.829 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.79 -179.89 6.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 151.53 34.81 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.903 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -127.0 -24.53 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -174.91 -105.75 0.19 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.466 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 38.8 Cg_endo -99.52 103.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.263 2.642 . . . . 0.0 112.789 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.39 24.68 2.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.775 0.321 . . . . 0.0 110.139 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.605 HD11 HG22 ' A' ' 36' ' ' VAL . 1.2 tt -112.18 162.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.976 0.893 . . . . 0.0 113.324 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 140.4 20.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.744 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.28 101.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.793 -177.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.58 120.0 5.54 Favored Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 32.3 t0 -58.4 -58.19 9.62 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.633 1.217 . . . . 0.0 108.211 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.4 pt-20 -81.34 6.33 14.68 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -136.65 37.34 2.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.338 -174.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.632 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.21 -172.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.01 136.4 54.99 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.17 115.26 15.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.133 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.605 HG22 HD11 ' A' ' 26' ' ' ILE . 5.7 t -93.71 107.91 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.984 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.96 24.82 55.27 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.808 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.793 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.1 m -94.38 175.24 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 122.568 0.347 . . . . 0.0 110.661 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.35 -59.12 2.55 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.998 0.428 . . . . 0.0 111.509 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -72.9 7.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -110.71 -22.74 11.43 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.69 -12.27 0.73 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.77 -24.7 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.22 0.463 . . . . 0.0 111.811 -179.464 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.187 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 74.6 Cg_exo -43.08 160.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.084 3.189 . . . . 0.0 117.779 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.54 153.41 10.99 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.329 -1.759 . . . . 0.0 110.33 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.9 4.65 5.37 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.736 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -90.91 52.48 2.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 117.183 0.491 . . . . 0.0 111.554 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.97 31.2 61.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.029 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.617 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.42 -154.42 25.25 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.889 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.709 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -115.79 153.09 32.07 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.078 0.466 . . . . 0.0 111.153 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 40.1 t -61.89 156.31 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.385 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -152.39 -92.67 0.05 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -78.48 -170.5 2.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.82 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.96 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.43 65.43 3.57 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.537 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' C ' ' A' ' 80' ' ' GLU . 1.8 mm -134.44 143.26 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.5 t -131.46 104.7 7.13 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -91.85 158.6 16.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.506 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.6 m -127.1 -179.22 0.89 Allowed Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.248 -1.796 . . . . 0.0 109.287 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.85 -9.97 24.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.278 1.985 . . . . 0.0 112.459 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.4 -33.04 8.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.458 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.4 168.91 35.84 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.517 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.594 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 15.1 m -96.12 166.59 11.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.457 0.646 . . . . 0.0 112.343 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.716 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -152.21 141.92 21.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.621 178.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.604 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -61.26 117.36 5.51 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.729 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.8 p30 -100.16 108.19 51.04 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-O 121.626 0.727 . . . . 0.0 111.18 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 66.0 Cg_exo -55.49 -16.09 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.07 3.18 . . . . 0.0 110.095 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.26 64.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.09 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.866 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -108.75 -27.55 9.71 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -176.403 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' ' OG ' ' A' ' 92' ' ' SER . 3.3 t70 173.67 -26.0 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.354 1 N-CA-C 122.853 4.39 . . . . 0.0 122.853 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.96 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -109.64 -72.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 -171.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.4 tt0 -70.62 -3.97 21.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.505 -1.679 . . . . 0.0 106.766 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.686 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -70.95 -160.82 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 112.448 -2.16 . . . . 0.0 114.892 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.31 -175.18 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.335 -2.212 . . . . 0.0 108.308 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.84 66.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 90' ' ' ALA . 1.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.371 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -157.07 -169.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.96 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HG ' ' NE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.17 170.17 12.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.519 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.82 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 56.3 t0 -79.11 -127.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -93.61 -126.59 0.11 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.041 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.563 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -74.45 -54.91 6.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.633 ' H ' HD12 ' A' ' 5' ' ' LEU . 16.5 m -90.32 112.5 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.157 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 27.3 mtt85 -69.15 121.32 16.52 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.792 0.806 . . . . 0.0 113.067 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.557 ' H ' ' CB ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -173.96 56.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.829 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.513 ' HB3' ' CG ' ' A' ' 4' ' ' ASP . 5.3 p . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 2.8 Cg_exo . . . . . 0 N--CA 1.462 -0.369 0 N-CA-C 113.907 0.695 . . . . 0.0 113.907 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.9 t -155.16 -177.45 6.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.58 -134.48 47.46 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.509 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 14.0 Cg_endo -89.56 101.3 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.603 3.536 . . . . 0.0 112.677 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.68 -66.04 3.79 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.015 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.06 32.66 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 121.529 0.516 . . . . 0.0 112.324 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.41 -36.11 73.84 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.972 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -108.36 -171.27 21.38 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.226 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.742 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 177.87 10.03 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 11.4 m -79.01 163.81 24.88 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 35.1 m-85 -141.55 -30.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -170.78 -103.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.886 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -101.32 102.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.485 2.79 . . . . 0.0 112.971 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.36 23.54 2.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.4 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -111.57 159.28 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.0 0.905 . . . . 0.0 112.882 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.84 140.38 21.56 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.859 -1.518 . . . . 0.0 108.504 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.708 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.99 99.23 3.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.759 -176.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.956 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.43 117.55 4.51 Favored Glycine 0 N--CA 1.406 -3.307 0 C-N-CA 118.973 -1.584 . . . . 0.0 110.058 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.6 t0 -59.03 -57.42 13.17 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.6 pt-20 -82.02 11.98 4.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.956 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.17 37.89 1.15 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.172 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.35 -178.15 0.01 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.5 t -114.84 136.76 52.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.804 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -133.12 119.34 19.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.278 177.475 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 26' ' ' ILE . 5.6 t -91.84 103.21 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.106 178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.66 47.98 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.829 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -86.27 -176.94 6.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.217 0.607 . . . . 0.0 110.025 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.13 -58.8 4.77 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -72.02 -2.32 17.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.65 -21.14 14.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.29 -14.65 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -51.19 -23.63 3.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.433 0.56 . . . . 0.0 111.3 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.159 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.584 0.23 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 47.2 Cg_exo -43.32 158.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.287 3.325 . . . . 0.0 117.406 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -163.93 153.38 14.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.3 177.156 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.52 3.69 4.55 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.331 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 t -91.42 57.08 3.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 117.656 0.728 . . . . 0.0 111.268 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.65 34.46 50.14 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 114.03 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.0 -154.38 25.37 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.8 mmt180 -115.62 154.6 29.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.3 -0.45 . . . . 0.0 111.21 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -62.0 158.19 16.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.171 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -155.3 -95.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.43 -171.23 1.74 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.994 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.48 86.51 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.774 0.671 . . . . 0.0 109.341 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 56.72 67.38 2.25 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.4 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -132.8 145.98 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -132.09 104.27 6.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -87.46 141.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -173.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.519 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.1 m -105.23 -179.76 0.8 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.817 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.519 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -73.08 -11.39 25.26 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.584 2.19 . . . . 0.0 112.523 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 -31.85 7.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.58 170.04 39.39 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.224 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 6.3 m -93.83 166.14 12.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.533 0.682 . . . . 0.0 112.326 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.605 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.16 141.45 21.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.654 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.26 117.67 5.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.063 0.458 . . . . 0.0 110.568 -179.202 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.724 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 50.6 p30 -99.56 110.02 57.23 Favored Pre-proline 0 N--CA 1.44 -0.974 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.3 Cg_exo -56.93 -14.85 15.21 Favored 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 124.099 3.199 . . . . 0.0 109.764 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.63 -27.5 62.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.255 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -111.07 -27.56 8.69 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -175.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.0 t70 173.05 -29.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.413 1 N-CA-C 122.311 4.189 . . . . 0.0 122.311 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.4 Cg_endo -106.22 -71.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 112.576 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -69.35 -5.77 25.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.36 -157.94 0.09 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.941 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.2 -178.9 0.69 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.682 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.17 62.4 0.92 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.787 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -93.82 -170.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.598 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.82 162.9 28.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.658 0.742 . . . . 0.0 112.971 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -83.18 -76.57 0.27 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.404 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.35 -136.56 0.09 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.81 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.94 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.9 -40.57 68.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' CG2' HD11 ' A' ' 5' ' ' LEU . 19.4 m -94.58 101.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 87.0 mtt180 -67.65 -164.76 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.904 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER 46.75 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.213 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -50.56 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.041 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 HD22 ' HG2' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -69.08 137.95 89.68 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.925 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -62.55 -169.75 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.241 1.96 . . . . 0.0 112.233 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.6 t -158.06 -176.54 5.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.268 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.79 -136.06 50.42 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.36 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 12.7 Cg_endo -89.79 108.53 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 112.847 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.17 -67.39 2.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.068 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.27 32.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.439 0.466 . . . . 0.0 112.686 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.69 -36.88 73.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.063 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -103.01 -174.56 26.55 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.786 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.23 179.5 7.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -84.03 146.99 27.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 13.0 m-85 -120.96 -101.98 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.938 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.68 -98.56 0.35 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.669 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 26' ' ' ILE . 26.3 Cg_endo -99.7 -119.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.617 2.878 . . . . 0.0 111.627 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.98 51.38 0.4 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -128.07 157.12 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 122.251 1.024 . . . . 0.0 113.35 -176.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -154.97 134.16 12.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.607 178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 32.2 m -152.1 119.38 5.94 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.783 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.96 122.55 7.35 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.369 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 44.1 t0 -58.08 -56.32 23.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.73 1.265 . . . . 0.0 107.824 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.02 24.82 0.74 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.87 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -157.84 33.17 0.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.764 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 51.08 172.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -104.17 129.77 51.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.53 116.66 17.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.55 177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -97.95 106.89 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.065 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.39 26.41 56.56 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.895 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.6 m -95.95 173.46 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.611 0.364 . . . . 0.0 110.62 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.72 -56.57 4.33 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.327 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.4 mp0 -73.07 6.16 2.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -113.27 -21.62 10.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.717 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.87 -19.15 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.585 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.6 -23.67 6.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.886 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -2.45 39.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.401 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -58.72 -25.41 62.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG2' HD22 ' A' ' 11' ' ' LEU . 1.7 pp20? -78.88 -15.77 57.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.859 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.55 2.52 18.91 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.151 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -141.14 20.35 2.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.674 0.273 . . . . 0.0 110.84 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -111.99 -17.01 12.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.184 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.44 95.18 6.0 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.201 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -45.69 100.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.804 2.336 . . . . 0.0 112.664 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.3 p -156.41 171.52 7.27 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.48 177.27 6.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.658 2.239 . . . . 0.0 111.923 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 43.2 t -176.66 158.26 1.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 5.1 tp60 -138.02 159.71 41.29 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 62.3 m -131.67 -174.58 3.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.513 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -138.56 82.68 0.25 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.811 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.01 89.25 2.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -64.41 107.17 1.21 Allowed Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.5 Cg_exo -40.01 159.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.237 3.291 . . . . 0.0 116.982 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.19 152.64 10.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.767 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.94 3.25 6.97 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.955 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -90.27 57.29 3.67 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 117.33 0.565 . . . . 0.0 111.135 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.8 34.31 36.83 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.85 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.74 -156.57 28.6 Favored Glycine 0 CA--C 1.502 -0.739 0 C-N-CA 120.449 -0.882 . . . . 0.0 115.128 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.811 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.7 mmt-85 -116.32 152.94 32.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.189 0.519 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -63.61 160.54 16.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.579 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -159.97 -96.1 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.782 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -75.9 -169.81 1.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.876 0.87 . . . . 0.0 112.558 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.793 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -38.16 97.46 0.01 OUTLIER 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.508 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.947 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 50.81 30.47 21.75 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.099 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.05 HG13 ' HB3' ' A' ' 69' ' ' ALA . 5.1 mm -90.34 155.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 122.097 0.951 . . . . 0.0 111.628 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.728 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 19.0 t -141.81 106.52 4.88 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -91.61 160.56 15.33 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.505 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -127.11 -179.83 1.04 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 113.996 -1.457 . . . . 0.0 110.052 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.2 Cg_exo -72.67 -10.83 25.58 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.453 2.102 . . . . 0.0 112.352 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.91 -29.5 9.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.87 31.27 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.437 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.597 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.2 m -97.81 167.94 10.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.097 0.475 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.708 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -151.87 144.61 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.391 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -61.92 94.29 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.1 m-20 -91.85 126.78 52.43 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.881 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 34.0 Cg_exo -59.83 -3.25 2.01 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 123.658 2.905 . . . . 0.0 109.716 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.39 -25.76 59.68 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.309 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.947 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.3 m -127.46 -20.14 4.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.8 t70 171.18 -26.15 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.068 1 N-CA-C 121.909 4.04 . . . . 0.0 121.909 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.814 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.1 Cg_endo -103.1 -70.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.656 0 C-N-CA 122.335 2.024 . . . . 0.0 112.135 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.628 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -72.52 -6.97 47.56 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.051 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.881 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.67 -157.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 112.436 -2.166 . . . . 0.0 112.546 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.79 -178.32 1.49 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.122 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -74.37 62.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.257 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.912 HG22 ' H ' ' A' ' 3' ' ' LEU . 3.6 p -144.69 -162.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.383 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.912 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -70.47 157.3 38.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.84 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.33 -122.69 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.185 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.855 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -94.97 -139.44 0.24 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.007 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.855 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.97 -36.15 49.36 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.817 HG22 HD21 ' A' ' 5' ' ' LEU . 28.0 m -100.98 85.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.33 0.586 . . . . 0.0 111.495 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.835 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 9.2 mtt180 -73.09 123.97 24.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.048 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.47 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -173.35 74.38 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.667 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -75.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.721 HD11 HD22 ' A' ' 50' ' ' LEU . 1.8 tp -115.0 90.83 24.45 Favored Pre-proline 0 N--CA 1.462 0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.744 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 6.6 Cg_exo -68.79 176.88 5.46 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.448 2.098 . . . . 0.0 114.121 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 8.2 t -153.75 -171.21 3.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.05 -136.93 49.97 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.555 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.8 Cg_endo -89.06 98.71 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.641 3.561 . . . . 0.0 112.965 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.07 -67.18 3.71 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.558 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.9 34.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-O 121.744 0.636 . . . . 0.0 112.282 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.83 -34.41 69.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.371 -0.915 . . . . 0.0 110.264 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.74 -168.34 15.32 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.821 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.52 -179.54 7.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.726 0.263 . . . . 0.0 110.612 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.443 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 1.7 m -78.59 158.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 37.6 m-85 -138.99 -69.52 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.919 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -132.5 -105.05 0.95 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.177 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -100.28 105.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.444 2.763 . . . . 0.0 113.037 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 52.5 21.98 1.98 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.756 0.313 . . . . 0.0 110.264 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.919 HG22 ' H ' ' A' ' 23' ' ' GLY . 4.8 tt -110.84 160.93 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.22 1.009 . . . . 0.0 112.763 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 145.62 27.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.736 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.43 103.84 3.72 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.897 -177.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.86 118.84 5.71 Favored Glycine 0 N--CA 1.409 -3.133 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.804 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 26.0 t0 -58.25 -57.72 11.65 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -83.09 21.78 1.04 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.24 35.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.71 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.23 -169.97 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.289 0.476 . . . . 0.0 114.289 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.3 t -125.17 138.24 54.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.764 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.03 119.32 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.493 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.4 t -95.2 105.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.804 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.25 22.15 55.17 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.855 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -89.09 178.64 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.553 0.341 . . . . 0.0 110.163 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -50.21 -56.42 11.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.827 0.346 . . . . 0.0 111.171 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.85 5.12 3.44 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.05 -23.91 12.15 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.98 -17.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.86 -23.18 1.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 111.482 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -6.94 54.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.71 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -26.27 62.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.785 ' O ' HD23 ' A' ' 50' ' ' LEU . 42.9 mt-10 -75.36 -17.03 60.33 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.237 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -74.71 4.21 6.65 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.336 179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 50.5 p-10 -82.73 -4.45 57.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -160.3 44.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 111.367 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 46' ' ' GLU . 4.3 pp -143.99 129.88 9.93 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-O 120.682 0.277 . . . . 0.0 110.783 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.614 ' O ' HD12 ' A' ' 50' ' ' LEU . 80.0 Cg_exo -48.43 179.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.085 2.523 . . . . 0.0 113.2 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.77 160.91 9.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.699 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -86.95 161.93 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.524 2.149 . . . . 0.0 111.885 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.33 -164.54 1.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.835 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 53.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.377 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.437 ' H ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.52 174.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.524 ' HA2' HH21 ' A' ' 20' ' ' ARG . . . -175.03 -98.77 0.11 Allowed Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 119.579 -1.296 . . . . 0.0 111.366 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.857 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 3.6 mt-30 -83.86 87.36 7.09 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.01 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -70.3 108.72 3.77 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.77 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 31.5 Cg_exo -37.23 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.979 3.12 . . . . 0.0 117.362 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -161.66 152.99 18.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.43 177.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.27 4.73 7.93 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.881 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -90.34 54.55 2.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 117.395 0.597 . . . . 0.0 111.099 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.15 32.86 50.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.33 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.699 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 165.16 -158.7 31.64 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.307 -0.949 . . . . 0.0 114.921 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.857 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.0 mmt180 -117.33 154.08 31.87 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.017 0.437 . . . . 0.0 110.922 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 1.01 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 38.2 t -60.17 167.0 2.57 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.815 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -165.76 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.824 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.023 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.46 -169.7 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.827 0.851 . . . . 0.0 112.884 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.822 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.07 96.21 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 51.87 29.15 26.11 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.162 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.023 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -91.46 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 121.872 0.844 . . . . 0.0 111.397 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.714 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 44.6 t -139.6 108.4 5.96 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.648 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.9 t -91.04 155.9 18.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.52 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -128.97 -179.6 1.04 Allowed Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 114.062 -1.427 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.8 Cg_exo -72.22 -11.05 26.59 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.427 2.084 . . . . 0.0 112.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.97 -27.1 13.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.59 170.19 24.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.135 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.614 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.9 m -94.98 163.26 13.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 111.039 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.76 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.21 148.73 29.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.068 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.89 93.14 0.18 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.714 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.0 m-20 -91.4 128.57 46.4 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.89 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 31.4 Cg_exo -60.58 -2.45 2.0 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.445 2.763 . . . . 0.0 109.721 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.94 -24.99 58.57 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.034 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.914 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.4 m -128.98 -21.01 3.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.1 t70 171.67 -26.33 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.406 1 N-CA-C 122.163 4.134 . . . . 0.0 122.163 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.836 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 5.4 Cg_endo -102.18 -70.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.635 0 CA-C-N 122.693 1.997 . . . . 0.0 111.788 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.598 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.3 tt0 -72.89 -6.66 46.64 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.153 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.89 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.19 -157.81 0.08 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.646 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -70.33 -178.32 1.68 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.15 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -74.92 61.99 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.312 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.774 0.321 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 7.0 m -70.97 152.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.83 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.604 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -74.59 166.05 24.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.04 -136.27 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.32 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -94.87 -124.5 0.11 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.703 ' H ' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -73.06 -47.72 42.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.588 HG22 HD11 ' A' ' 5' ' ' LEU . 18.7 m -87.36 85.87 2.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.599 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 57.4 mtt180 -74.8 -162.98 0.18 Allowed 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.451 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.659 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER 41.38 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.767 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -63.66 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.769 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 6.0 mp -114.12 90.53 20.16 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 120.836 0.35 . . . . 0.0 111.646 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.586 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo -68.69 -175.75 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.362 2.041 . . . . 0.0 113.207 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.5 t -156.89 -172.39 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.752 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.79 -139.49 47.12 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.637 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.9 Cg_endo -88.92 98.16 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.371 3.381 . . . . 0.0 112.721 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -73.66 1.39 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.59 34.36 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 121.637 0.576 . . . . 0.0 111.878 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.68 -37.9 67.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.284 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.02 -168.14 22.28 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.758 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.698 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.41 -179.22 6.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.26 148.58 33.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.857 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -128.1 -19.71 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 169.67 -104.21 0.2 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 118.999 -1.572 . . . . 0.0 114.81 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 28.8 Cg_endo -101.74 107.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.717 2.945 . . . . 0.0 113.12 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.52 22.6 1.58 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.182 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.857 HG23 ' HB2' ' A' ' 22' ' ' PHE . 3.3 tt -115.13 157.1 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 122.258 1.028 . . . . 0.0 113.029 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -160.43 138.45 9.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.356 -1.747 . . . . 0.0 107.35 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 20.4 m -150.1 128.35 12.06 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.097 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -107.02 126.63 8.51 Favored Glycine 0 N--CA 1.407 -3.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 37.3 t0 -59.16 -59.57 5.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.998 1.399 . . . . 0.0 108.722 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -81.09 15.15 1.98 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -144.16 31.49 1.24 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.083 -175.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.651 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.33 175.61 0.01 OUTLIER Glycine 0 CA--C 1.521 0.445 0 N-CA-C 114.899 0.719 . . . . 0.0 114.899 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -100.11 134.45 43.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.857 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 30.2 m-85 -131.04 101.66 5.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.404 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG13 HG13 ' A' ' 26' ' ' ILE . 4.5 t -97.16 107.36 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.253 0.549 . . . . 0.0 110.23 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.47 -0.0 44.5 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.394 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.9 p -70.13 -168.24 0.21 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 117.338 0.569 . . . . 0.0 110.245 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -76.61 -39.08 53.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.323 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -74.7 7.27 3.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.295 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -112.91 -21.12 11.3 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -51.15 -15.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.02 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.742 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.69 -21.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -74.55 -3.42 30.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.254 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 2.4 pt20 -54.19 -36.51 63.5 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.057 0.932 . . . . 0.0 108.489 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' HD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -74.55 -7.41 53.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.74 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 3.3 tt0 -71.64 1.8 6.16 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.57 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -66.79 -6.94 17.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.082 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 99.8 m-85 -92.6 -105.22 0.12 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.528 0.204 . . . . 0.0 110.814 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.7 107.15 6.44 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-O 120.621 0.248 . . . . 0.0 110.65 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -44.61 159.25 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.024 2.482 . . . . 0.0 113.546 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.5 t -172.28 90.52 0.41 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.245 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -91.89 72.46 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.128 2.552 . . . . 0.0 113.299 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 55' ' ' GLN . 19.5 p -93.4 -178.16 4.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.928 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER 60.0 160.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.432 178.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 1.2 p -56.22 148.73 17.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.71 -79.17 0.05 OUTLIER Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.301 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.834 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -89.43 88.82 7.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -68.12 105.72 1.06 Allowed Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.935 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 44.4 Cg_exo -38.81 154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.761 2.307 . . . . 0.0 115.648 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -162.11 154.58 19.62 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.881 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 7.11 7.72 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.287 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 t -91.53 51.72 1.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.42 32.91 61.25 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.624 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.728 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.42 -153.96 24.67 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.533 -0.842 . . . . 0.0 115.202 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.834 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.0 mmt-85 -120.89 159.24 25.92 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.594 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.6 t -55.86 155.8 5.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -150.89 -26.82 0.21 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -157.67 -171.35 3.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.397 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.33 86.31 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 57.27 65.54 3.49 Favored Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.939 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.759 HG21 ' SG ' ' A' ' 34' ' ' CYS . 3.3 mm -136.77 136.6 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.1 t -122.98 109.58 14.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -96.23 158.59 15.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -173.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.542 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.2 m -128.26 -179.92 1.1 Allowed Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.315 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -72.14 -9.42 24.44 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.376 2.051 . . . . 0.0 112.687 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.88 -32.42 8.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.255 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.25 170.21 36.58 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.684 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 27.0 m -96.88 167.4 11.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.394 0.616 . . . . 0.0 111.87 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.556 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.98 142.92 21.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.596 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -62.87 117.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.024 0.44 . . . . 0.0 110.947 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 47.5 p30 -101.04 108.25 53.66 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.681 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.1 Cg_exo -56.37 -15.69 15.78 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.855 3.037 . . . . 0.0 110.084 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.04 64.13 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.66 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.986 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -109.54 -27.42 9.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -176.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.3 t70 172.56 -29.44 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.633 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.051 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.3 Cg_endo -108.97 -71.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 123.099 2.533 . . . . 0.0 112.767 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -67.74 -5.85 18.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.681 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -73.49 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 112.047 -2.342 . . . . 0.0 111.057 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -63.71 -178.82 0.32 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -74.42 62.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.41 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.798 0.332 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.0 t 64.05 168.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.536 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.552 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -69.66 156.85 38.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.668 0.747 . . . . 0.0 112.73 -178.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.54 -77.0 0.23 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.882 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -139.86 -139.59 0.13 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.474 -178.252 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.882 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -76.24 -38.43 56.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.73 0.3 . . . . 0.0 110.923 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -93.33 85.0 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 121.367 0.603 . . . . 0.0 110.677 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 56.4 mtt85 -74.33 -178.73 3.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.183 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m 57.38 101.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' CA ' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -82.71 -161.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.572 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.831 HD22 ' HG2' ' A' ' 46' ' ' GLU . 4.5 tp -97.81 137.07 20.94 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 111.216 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 23.8 Cg_exo -57.71 -171.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.176 1.917 . . . . 0.0 112.347 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.4 t -157.5 -179.98 8.69 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.903 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.89 -134.79 49.28 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.637 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 7.7 Cg_endo -91.89 99.5 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.562 3.508 . . . . 0.0 112.951 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.87 -69.13 3.13 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.56 32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 CA-C-O 121.533 0.518 . . . . 0.0 112.332 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -33.8 71.66 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.848 0.832 . . . . 0.0 109.862 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.8 -174.84 20.93 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.807 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.94 -178.95 5.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.6 m -77.57 141.21 39.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-85 -119.11 -23.67 6.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.567 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.56 -110.54 0.24 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.586 -1.293 . . . . 0.0 114.317 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.91 101.37 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 112.643 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 21.45 3.64 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.752 -0.379 . . . . 0.0 109.991 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 23' ' ' GLY . 2.3 tt -107.76 166.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.832 0.825 . . . . 0.0 112.742 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -153.76 140.45 18.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.37 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -144.88 100.91 3.57 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.876 -177.153 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.969 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.13 117.82 5.01 Favored Glycine 0 N--CA 1.405 -3.407 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.295 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.688 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 21.0 t0 -58.75 -57.27 13.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -83.87 20.14 1.56 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.969 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.61 33.22 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.691 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.53 176.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 t -115.83 134.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.65 125.88 31.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.568 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -93.81 101.71 12.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.131 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.84 19.51 50.08 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.12 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.706 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 2.0 m -83.27 174.73 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.893 0.477 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -43.75 -55.8 4.21 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.15 -7.61 50.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.99 -16.96 15.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -19.0 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.638 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.47 -24.01 2.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.126 0.421 . . . . 0.0 111.26 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 1.58 14.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -26.02 53.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.831 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.5 -19.61 49.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.51 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 -1.04 35.97 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.029 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -9.45 59.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.07 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.9 m-30 -111.91 -6.7 14.22 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.305 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.62 85.71 9.18 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 120.807 0.337 . . . . 0.0 111.175 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -44.79 161.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.855 2.37 . . . . 0.0 112.748 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m 64.61 153.21 0.12 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.857 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.58 -164.18 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.566 2.177 . . . . 0.0 112.143 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.459 ' HB2' ' CA ' ' A' ' 10' ' ' CYS . 3.0 m -133.61 -7.96 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.499 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG3' HD13 ' A' ' 3' ' ' LEU . 15.2 tt0 177.82 -57.24 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.115 0.483 . . . . 0.0 109.723 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.563 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 3.8 m 57.49 166.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.08 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.592 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -141.38 75.95 0.32 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.869 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 mt-30 -107.11 88.77 2.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -68.07 105.78 1.07 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 122.961 0.504 . . . . 0.0 110.366 177.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -38.74 155.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.133 3.222 . . . . 0.0 117.619 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -165.04 153.31 11.83 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.824 177.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 5.53 3.01 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.97 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.7 t -90.66 54.03 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 117.425 0.612 . . . . 0.0 111.164 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.98 33.21 56.92 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.861 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.662 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.0 -154.09 24.96 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.642 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.869 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.3 mmt180 -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.153 0.502 . . . . 0.0 110.986 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 46.2 t -62.32 157.94 18.56 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.039 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -155.39 -91.65 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 33' ' ' GLY . . . -77.66 -171.18 2.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.959 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.37 90.68 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.004 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.88 62.4 6.36 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 119.062 -1.542 . . . . 0.0 110.89 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -129.99 149.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.4 t -136.63 102.99 5.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -91.37 160.11 15.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.524 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -127.85 -179.49 0.98 Allowed Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.261 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.51 -10.08 24.89 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.364 2.042 . . . . 0.0 112.634 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -31.2 8.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.482 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.1 167.73 34.05 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.465 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 16.3 m -96.0 167.11 11.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.383 0.611 . . . . 0.0 112.4 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.641 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -151.57 140.77 21.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.977 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -62.18 116.68 5.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.894 0.378 . . . . 0.0 110.534 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.777 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 52.2 p30 -99.06 109.32 53.72 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-O 121.573 0.701 . . . . 0.0 111.702 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.82 -14.61 14.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.064 3.176 . . . . 0.0 110.06 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.96 -27.84 62.06 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.123 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -109.89 -28.45 8.75 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -176.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 173.6 -29.18 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.253 1 N-CA-C 122.371 4.211 . . . . 0.0 122.371 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.004 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -106.01 -70.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.459 0 C-N-CA 122.628 2.219 . . . . 0.0 112.568 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.709 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.3 tt0 -69.04 -7.07 32.19 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.733 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.5 -157.76 0.07 Allowed 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.635 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.01 -179.3 1.18 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -74.76 62.36 1.07 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.57 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.06 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.853 0.359 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -67.8 156.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.126 0.488 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.747 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.64 169.69 17.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.465 ' OD1' ' HG3' ' A' ' 58' ' ' GLN . 18.9 t0 -78.59 -137.55 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 113.952 -1.476 . . . . 0.0 108.192 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.676 HD11 HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -91.28 -123.62 0.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -72.23 -45.6 59.58 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.676 HG22 HD11 ' A' ' 5' ' ' LEU . 11.1 m -88.13 85.19 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.662 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.747 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 51.5 mtt85 -75.56 -177.12 3.51 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.63 ' HA ' ' HB2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 27.62 104.54 0.0 OUTLIER 'General case' 0 C--N 1.34 0.17 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.63 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -130.06 134.48 47.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.972 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.99 168.15 10.16 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 121.731 0.777 . . . . 0.0 112.516 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 22.7 Cg_exo -50.28 179.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.008 1.806 . . . . 0.0 111.767 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 43' ' ' ARG . 4.0 t -158.85 -172.39 3.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 65.02 -141.34 43.28 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.14 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.95 89.6 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.018 3.145 . . . . 0.0 112.881 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.48 -68.28 0.94 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.301 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.99 34.12 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-O 121.632 0.573 . . . . 0.0 112.022 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -73.0 -35.82 66.92 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.339 -0.93 . . . . 0.0 110.61 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.74 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -111.1 -162.04 17.57 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.293 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.86 174.28 13.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -89.18 170.34 10.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.823 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 67.5 m-85 -144.02 -12.05 0.65 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.42 -95.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 118.691 -1.718 . . . . 0.0 115.055 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -101.07 99.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.378 2.718 . . . . 0.0 113.481 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.59 21.84 1.98 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.316 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.667 HG13 HG13 ' A' ' 36' ' ' VAL . 3.8 tt -108.95 160.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -157.32 145.47 19.23 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 113.745 -1.57 . . . . 0.0 108.653 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.836 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.95 106.25 3.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.553 -178.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.883 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.23 128.22 8.96 Favored Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.63 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.909 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 35.9 t70 -58.5 -65.84 0.59 Allowed 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 pt-20 -81.36 26.87 0.44 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.883 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.58 31.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 36.49 -166.7 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.5 142.88 38.25 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.724 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 10.3 m-85 -131.93 98.0 4.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.391 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.667 HG13 HG13 ' A' ' 26' ' ' ILE . 3.5 t -95.75 130.71 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.211 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.76 28.53 5.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.811 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -109.23 170.25 8.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.46 0.304 . . . . 0.0 110.66 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -54.95 -55.12 34.21 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.56 8.89 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -107.05 -37.3 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -56.83 -11.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.749 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -49.8 -13.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 47' ' ' GLU . 18.0 t -69.27 -5.4 22.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.527 ' H ' ' HG2' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -56.48 -32.88 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 122.466 1.127 . . . . 0.0 107.979 177.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.904 ' O ' HD22 ' A' ' 11' ' ' LEU . 2.1 pt-20 -70.84 -8.36 52.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.431 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -57.39 -2.95 0.13 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' GLU . 1.7 m-80 -50.37 -20.73 1.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.3 -0.25 . . . . 0.0 111.451 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.914 ' HB2' HD11 ' A' ' 11' ' ' LEU . 12.0 m-30 -101.91 -161.16 0.83 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.638 0.375 . . . . 0.0 111.594 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 50' ' ' LEU . 1.6 pp -144.4 83.52 9.86 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.942 ' HG2' ' HA ' ' A' ' 11' ' ' LEU . 49.8 Cg_exo -65.34 -159.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.703 2.935 . . . . 0.0 113.638 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 56' ' ' SER . 10.7 t -85.85 -58.21 0.33 Allowed Pre-proline 0 C--O 1.226 -0.156 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.419 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 52' ' ' SER . 41.5 Cg_exo -55.5 167.25 2.1 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 120.944 1.096 . . . . 0.0 111.454 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.67 ' HA ' ' HG3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER 63.51 -79.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.138 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.708 ' HG3' ' CD1' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -83.53 51.45 2.0 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.323 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.816 ' HB2' ' O ' ' A' ' 52' ' ' SER . 0.4 OUTLIER 172.08 -77.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.34 98.89 0.87 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.43 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.675 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -120.69 89.77 3.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.982 0.42 . . . . 0.0 110.962 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -59.39 100.3 0.21 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.99 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 27.3 Cg_exo -61.72 179.56 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.277 2.651 . . . . 0.0 115.615 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.74 154.32 9.51 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.256 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.07 -0.03 6.77 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.277 -0.874 . . . . 0.0 114.141 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.7 t -92.08 50.79 1.7 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 117.478 0.639 . . . . 0.0 111.369 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.69 40.91 49.36 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.083 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.644 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.68 -159.44 32.44 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.4 mmt180 -114.68 155.99 25.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.094 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 23.9 t -61.11 144.89 52.71 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.523 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ASP . . . -139.85 -97.82 0.16 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.271 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.909 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.51 -170.21 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -43.73 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.958 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 54.8 71.61 0.69 Allowed Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.179 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.836 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.2 mm -137.01 145.47 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 33.8 t -132.08 103.67 6.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -91.44 152.36 20.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.493 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -125.07 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.892 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.493 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -71.72 -9.71 25.35 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -33.0 8.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.021 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.09 169.92 34.65 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.562 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 3.3 m -98.68 164.43 12.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.102 0.477 . . . . 0.0 111.132 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.63 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.67 141.81 21.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.03 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -58.81 111.3 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.853 0.358 . . . . 0.0 110.102 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.675 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.1 p30 -92.03 110.5 44.46 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.751 . . . . 0.0 111.683 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.734 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -57.49 -13.02 12.3 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.188 3.258 . . . . 0.0 110.086 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.33 -30.0 57.51 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.561 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.958 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -108.93 -27.27 9.78 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 5.4 t70 175.37 -29.97 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 1 N-CA-C 122.28 4.178 . . . . 0.0 122.28 -177.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.94 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.2 Cg_endo -104.28 -70.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.46 0 C-N-CA 122.45 2.1 . . . . 0.0 112.242 -172.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 28.9 tt0 -70.36 -8.48 50.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.717 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.85 -157.64 0.08 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.89 -2.414 . . . . 0.0 112.741 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.46 -178.7 1.46 Allowed 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.929 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -74.42 62.39 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.6 t . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.027 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.342 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.94 -172.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.556 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.09 159.92 33.83 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.709 0.766 . . . . 0.0 112.723 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.29 -124.98 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.721 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.833 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -95.16 -136.79 0.22 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.833 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -73.99 -39.85 63.37 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.77 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -95.04 85.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.556 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 20.4 mtt180 -73.92 -163.2 0.16 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.272 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.711 ' HA ' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 41.69 85.74 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . 8.1 m -77.99 -43.72 28.8 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.22 91.82 41.38 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-O 121.353 0.597 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.511 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.5 Cg_exo -62.84 -173.4 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.496 2.131 . . . . 0.0 113.189 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' GLY . 2.0 t -156.84 -175.81 5.63 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.242 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.01 -138.68 48.7 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.657 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.7 Cg_endo -90.32 100.23 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.371 3.381 . . . . 0.0 112.808 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.14 -69.08 3.09 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.152 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.57 31.4 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 121.386 0.437 . . . . 0.0 112.489 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.09 -36.69 72.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.646 0.736 . . . . 0.0 109.946 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.07 -174.44 23.56 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.155 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.3 -178.79 5.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' CB ' HE22 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -75.63 151.53 37.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 11.3 m-85 -133.51 -17.72 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -179.0 -112.07 0.33 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.937 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -101.15 107.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.572 2.848 . . . . 0.0 112.744 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.48 24.12 2.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 36' ' ' VAL . 1.9 tt -114.6 161.79 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.922 0.868 . . . . 0.0 113.118 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 141.4 22.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.371 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.646 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -144.13 102.66 3.9 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.839 -177.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.906 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.43 118.72 5.28 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.023 -1.561 . . . . 0.0 109.42 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.706 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -57.93 -61.67 2.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -81.31 19.9 0.91 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.437 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.906 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -150.48 32.77 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.657 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.34 175.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.448 0.539 . . . . 0.0 114.448 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -111.39 136.54 50.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.23 119.74 21.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.327 178.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -93.98 102.08 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.725 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.46 50.89 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.843 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 m -86.29 179.42 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.304 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.61 -61.07 1.7 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.67 5.76 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.01 -24.28 12.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.85 -15.42 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -51.58 -23.21 3.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.77 0.319 . . . . 0.0 111.334 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 47' ' ' GLU . 55.0 m -75.43 -4.51 39.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.439 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -26.51 34.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.92 -27.71 60.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.049 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 44' ' ' CYS . 0.7 OUTLIER -80.76 7.62 9.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.265 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.82 -17.15 15.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.463 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -100.77 -19.19 16.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.727 0.299 . . . . 0.0 111.776 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.23 78.81 13.34 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.33 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.99 106.7 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.792 2.328 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -127.26 124.64 23.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 1.0 OUTLIER -82.87 32.88 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.966 2.444 . . . . 0.0 112.765 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 2.1 t -81.34 -165.81 1.03 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.711 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 0.0 OUTLIER 35.84 -147.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.489 ' H ' ' CD ' ' A' ' 20' ' ' ARG . 5.4 m 76.33 115.22 0.06 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.64 0.376 . . . . 0.0 110.284 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.15 100.43 0.24 Allowed Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.7 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -117.14 88.18 2.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -68.02 106.58 1.36 Allowed Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 122.972 0.509 . . . . 0.0 110.093 177.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 49.6 Cg_exo -39.76 154.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.242 3.294 . . . . 0.0 117.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.58 152.89 12.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.478 177.025 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.02 5.8 4.45 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.735 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -90.97 53.71 2.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 117.252 0.526 . . . . 0.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.13 61.04 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.923 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.82 -151.23 20.93 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.629 -0.796 . . . . 0.0 114.87 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.712 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -118.11 152.87 34.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.7 t -63.91 149.64 46.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.583 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -146.92 -93.32 0.09 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.901 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.31 -170.74 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.919 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.95 91.04 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.988 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.73 60.51 8.73 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.798 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -128.96 146.55 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 17.0 t -134.48 101.78 5.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -90.08 160.19 16.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.468 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.2 m -129.59 -179.46 1.02 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.92 -10.94 25.29 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.326 2.017 . . . . 0.0 112.144 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.81 -30.55 9.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.312 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.68 169.96 34.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.551 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.4 m -96.75 166.71 11.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.436 0.636 . . . . 0.0 112.147 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.27 138.06 17.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.715 178.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.3 pt-20 -59.52 116.53 4.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.961 0.41 . . . . 0.0 110.42 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.796 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.5 p30 -98.8 109.74 54.69 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-O 121.578 0.704 . . . . 0.0 111.552 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 51.1 Cg_exo -56.67 -16.08 18.18 Favored 'Trans proline' 0 CA--C 1.503 -1.038 0 C-N-CA 123.92 3.08 . . . . 0.0 110.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.68 -29.37 64.52 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.161 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.85 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.94 -27.88 9.44 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -176.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.9 t70 173.88 -27.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.158 1 N-CA-C 122.38 4.215 . . . . 0.0 122.38 -178.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.988 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.4 Cg_endo -107.18 -71.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.5 0 C-N-CA 122.476 2.117 . . . . 0.0 112.734 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 29.5 tt0 -68.87 -6.74 28.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.2 -155.83 0.05 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.093 -2.321 . . . . 0.0 111.924 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.78 -178.51 0.96 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.809 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -73.81 62.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.241 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.761 0.315 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 35.8 m -62.31 156.13 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.212 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.734 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.78 171.19 10.96 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.991 0.9 . . . . 0.0 113.228 -178.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 13.0 t0 -80.11 -139.54 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.46 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -91.88 -119.98 0.08 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 122.393 -0.192 . . . . 0.0 110.773 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.659 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.57 -47.09 43.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 7' ' ' VAL . 14.5 m -88.61 84.01 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.914 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.734 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 62.3 mtt180 -82.18 160.99 22.93 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.518 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' CYS . 5.9 m 60.98 129.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.7 -160.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.959 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD21 ' CB ' ' A' ' 46' ' ' GLU . 6.8 tp -91.56 103.22 7.23 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.549 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 20.9 Cg_exo -59.04 173.23 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.111 1.874 . . . . 0.0 114.127 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' GLY . 3.4 t -153.74 -174.24 4.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.456 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.61 51.69 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.073 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -82.52 87.56 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.772 2.981 . . . . 0.0 112.564 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 100.32 -67.5 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.042 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.585 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.8 34.1 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 121.645 0.581 . . . . 0.0 111.955 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.82 -36.71 70.31 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.84 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.57 -167.92 18.42 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.502 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -165.52 179.5 6.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 32.4 m -77.08 149.45 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.741 ' HE2' ' HB3' ' A' ' 28' ' ' CYS . 15.9 m-30 -139.09 26.43 2.43 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 139.53 -106.2 0.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.272 -1.442 . . . . 0.0 114.643 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 24.1 Cg_endo -104.81 100.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.46 2.773 . . . . 0.0 113.466 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.88 26.24 4.49 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.369 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.621 HG23 ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -111.52 160.13 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -156.09 138.96 15.28 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.52 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -146.48 105.61 3.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.477 -178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.29 129.87 9.36 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.337 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.907 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 12.7 t70 -58.83 -63.34 1.33 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -82.03 13.9 3.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -142.56 38.55 1.52 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.799 -174.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.863 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 29.22 -163.34 0.0 OUTLIER Glycine 0 CA--C 1.531 1.091 0 N-CA-C 115.995 1.158 . . . . 0.0 115.995 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.11 137.16 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.808 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 6.8 m-85 -132.89 106.73 7.88 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.583 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 26' ' ' ILE . 6.6 t -94.62 103.73 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.783 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.45 16.81 55.61 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.937 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.723 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -85.44 173.11 10.5 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -43.22 -55.57 3.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.802 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.9 -3.0 13.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -104.25 -21.8 13.47 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.78 -20.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.66 -19.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -0.19 13.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 4.3 pt20 -54.2 -35.14 62.05 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' CB ' HD21 ' A' ' 11' ' ' LEU . 21.7 mt-10 -74.71 -11.58 60.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.538 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -69.54 -4.13 17.7 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.792 0.33 . . . . 0.0 110.796 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' OD1' ' CD1' ' A' ' 49' ' ' TYR . 6.1 p30 -52.12 -24.92 7.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.813 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.474 ' CD1' ' OD1' ' A' ' 48' ' ' ASN . 13.2 m-30 -75.77 -171.26 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -102.28 122.73 45.65 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.201 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HD2' HD13 ' A' ' 50' ' ' LEU . 68.5 Cg_exo -46.37 149.33 2.74 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.77 2.313 . . . . 0.0 112.897 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.43 154.46 66.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.926 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.82 93.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.697 2.265 . . . . 0.0 112.067 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.1 p -96.18 -171.94 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.659 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -72.85 172.9 9.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.828 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.424 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 59.8 p -59.33 171.7 0.74 Allowed 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.41 -59.31 0.23 Allowed Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.895 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -95.23 88.7 5.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -67.57 110.05 4.74 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.739 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 36.2 Cg_exo -40.09 155.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.826 3.017 . . . . 0.0 116.659 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.6 154.52 20.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.505 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.45 4.0 5.49 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 114.051 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.2 t -90.58 54.67 2.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 117.382 0.591 . . . . 0.0 111.424 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.95 61.86 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.121 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.63 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 160.87 -152.17 22.76 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.994 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.895 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 5.5 mmt-85 -116.91 157.47 25.63 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.593 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.869 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 17.0 t -63.26 160.9 14.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.109 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -153.07 -97.26 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.34 -169.83 1.54 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.4 88.48 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.006 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 55.86 72.06 0.63 Allowed Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 118.854 -1.641 . . . . 0.0 110.439 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.7 mm -138.37 145.97 27.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.9 t -133.25 104.72 6.61 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -91.07 147.91 22.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -174.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -116.42 -179.47 0.64 Allowed Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.996 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.1 Cg_exo -72.62 -11.18 25.98 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.503 2.136 . . . . 0.0 112.223 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.71 -31.19 9.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.018 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 26' ' ' ILE . . . 174.05 170.45 37.4 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.855 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.5 m -98.24 163.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.191 0.519 . . . . 0.0 110.956 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.576 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.95 140.11 19.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.917 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.12 114.14 2.24 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.968 0.413 . . . . 0.0 110.001 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 85' ' ' CYS . 50.4 p30 -95.21 110.16 48.82 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-O 121.712 0.767 . . . . 0.0 111.423 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.8 Cg_exo -57.59 -13.8 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 124.109 3.206 . . . . 0.0 109.973 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.23 -26.35 60.19 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.281 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.006 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -110.85 -29.82 7.8 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -175.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.42 -29.75 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.33 1 N-CA-C 122.31 4.189 . . . . 0.0 122.31 -176.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.902 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -105.21 -71.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 122.61 2.207 . . . . 0.0 112.423 -172.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.63 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -70.71 -5.7 31.82 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.09 -158.23 0.09 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 111.861 -2.427 . . . . 0.0 112.769 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.13 -178.8 1.1 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.73 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.01 61.78 0.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.956 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.836 HG22 ' H ' ' A' ' 3' ' ' LEU . 2.6 p -84.05 -159.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.0 111.52 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.836 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -72.44 168.3 18.76 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.869 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.568 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 2.2 t70 -76.87 -90.99 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.65 -75.68 0.32 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.71 0.767 . . . . 0.0 110.138 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.968 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.67 -44.86 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.26 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.733 HG22 HD21 ' A' ' 5' ' ' LEU . 34.3 m -115.96 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.524 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.639 ' HD2' HD12 ' A' ' 3' ' ' LEU . 5.3 mtt-85 -75.42 175.35 8.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.277 0.56 . . . . 0.0 112.224 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.6 40.83 0.17 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.224 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -67.81 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.87 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HG ' ' CG ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -129.61 95.53 29.35 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.2 Cg_exo -62.57 -171.37 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.985 1.79 . . . . 0.0 111.803 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -157.36 -178.17 7.15 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.64 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.71 -134.54 47.1 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.556 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.5 Cg_endo -92.31 100.15 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.607 3.538 . . . . 0.0 112.763 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 -68.71 3.38 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.965 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.72 31.58 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.369 0.427 . . . . 0.0 112.739 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.11 -36.02 74.55 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.641 0.734 . . . . 0.0 109.792 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.12 -172.59 22.48 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.077 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -163.75 179.28 7.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.15 154.9 35.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' HG23 ' A' ' 26' ' ' ILE . 9.4 m-85 -131.08 -43.18 1.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.749 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -158.73 -103.44 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.189 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -98.16 104.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.069 2.513 . . . . 0.0 112.844 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.61 26.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.801 0.334 . . . . 0.0 110.401 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.749 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.7 tt -114.17 164.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.064 0.935 . . . . 0.0 113.361 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.54 140.94 21.51 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.316 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -146.5 102.06 3.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.908 -177.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -87.71 113.56 4.02 Favored Glycine 0 N--CA 1.402 -3.597 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.055 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.3 t0 -57.97 -54.3 48.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.7 pt-20 -83.65 15.97 2.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.93 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.6 41.81 0.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.712 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.96 -167.67 0.01 OUTLIER Glycine 0 N--CA 1.463 0.445 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -129.92 134.15 47.3 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.835 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.35 124.5 28.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.466 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.516 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.11 101.59 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.096 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.35 24.95 47.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.775 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.781 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 5.2 m -87.39 173.41 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.895 0.478 . . . . 0.0 109.757 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -42.75 -53.58 4.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 111.254 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -72.98 -7.96 53.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.73 -14.86 15.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.66 -16.47 0.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.97 -26.47 4.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.093 0.473 . . . . 0.0 111.041 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 1.85 12.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -54.64 -29.68 53.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' CG ' ' HG ' ' A' ' 11' ' ' LEU . 1.3 pp20? -80.28 -18.26 49.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.312 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.66 1.33 23.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 -23.46 15.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.767 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.7 m-30 -90.38 -74.32 0.49 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.281 0.562 . . . . 0.0 111.51 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.16 94.17 6.42 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.356 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 68.6 Cg_exo -46.04 109.62 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.514 2.143 . . . . 0.0 112.219 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 97.2 5.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 51' ' ' PRO . 90.7 Cg_endo -80.65 72.97 6.24 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.416 2.077 . . . . 0.0 111.39 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.758 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 26.5 p -153.49 -177.46 6.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.429 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.758 ' HG2' ' O ' ' A' ' 54' ' ' CYS . 5.1 pt20 48.47 -152.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.491 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 5.4 m 73.46 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.25 105.75 0.3 Allowed Glycine 0 CA--C 1.499 -0.935 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.359 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -117.55 89.11 3.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -66.52 107.3 1.52 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.995 177.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.662 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 61.8 Cg_exo -41.52 157.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.915 3.077 . . . . 0.0 117.585 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.628 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.63 153.21 12.6 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.358 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.51 2.85 4.02 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.288 -0.869 . . . . 0.0 114.038 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.8 t -89.24 54.59 3.0 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.556 0.678 . . . . 0.0 111.557 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.66 32.3 58.39 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.235 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.612 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.15 -150.86 20.17 Favored Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 120.659 -0.782 . . . . 0.0 114.763 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.6 mmt180 -116.94 154.16 31.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.066 0.46 . . . . 0.0 110.971 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -63.49 161.04 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.509 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -160.64 -92.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.8 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.94 -170.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.47 90.95 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.923 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.22 62.94 5.63 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 118.57 -1.776 . . . . 0.0 109.893 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.8 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm -129.99 146.26 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.4 t -134.24 103.92 5.96 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.525 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -117.31 -179.36 0.63 Allowed Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -72.35 -11.46 26.69 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.331 2.021 . . . . 0.0 112.732 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -30.47 8.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 111.329 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.65 170.15 36.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.302 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.6 m -95.76 165.98 12.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.182 0.515 . . . . 0.0 112.184 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.616 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -151.69 141.26 21.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.445 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -56.91 113.13 1.54 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.838 0.351 . . . . 0.0 110.296 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.804 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.6 p30 -97.91 110.86 57.42 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 121.878 0.847 . . . . 0.0 112.307 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.769 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.0 Cg_exo -56.75 -17.36 22.85 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 124.174 3.25 . . . . 0.0 110.025 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.48 63.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.628 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.898 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -110.88 -27.83 8.65 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 -175.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.6 t70 174.32 -28.95 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.213 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.923 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.5 Cg_endo -105.66 -71.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.54 2.16 . . . . 0.0 112.518 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.8 tp10 -69.37 -7.39 36.98 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.769 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.01 -155.21 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.113 -2.312 . . . . 0.0 112.493 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.45 -178.55 1.13 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.868 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -75.04 62.02 1.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' LEU . 2.7 t 61.55 167.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.633 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.53 168.4 17.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 122.117 0.961 . . . . 0.0 113.591 -178.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 53' ' ' PRO . 10.8 t70 -80.52 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.25 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.748 HD11 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.0 -123.87 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.591 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -73.16 -44.13 60.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 HD11 ' A' ' 5' ' ' LEU . 9.4 m -88.71 86.69 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.095 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.635 ' HB3' HD12 ' A' ' 3' ' ' LEU . 41.4 mtt180 -70.88 -167.3 0.19 Allowed 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.977 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 43.87 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.968 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -46.28 177.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.235 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -94.68 159.89 32.54 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 112.068 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 39.4 Cg_exo -53.51 -173.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.725 2.283 . . . . 0.0 112.775 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.8 t -157.31 -172.93 4.19 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.305 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.98 -139.31 47.94 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.445 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.0 Cg_endo -90.21 97.02 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.304 3.336 . . . . 0.0 112.771 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.2 -70.32 1.75 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.031 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.74 33.18 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.578 0.543 . . . . 0.0 112.133 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.96 -34.8 69.26 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.568 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -110.57 -167.73 19.32 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.732 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.566 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.31 177.25 9.13 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.86 156.09 30.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.643 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -130.55 -83.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.122 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -114.46 -103.74 2.53 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.816 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.8 118.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.65 2.9 . . . . 0.0 113.214 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.6 27.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 23' ' ' GLY . 2.6 tt -118.8 163.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.242 1.02 . . . . 0.0 113.453 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.62 140.99 21.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.529 -1.669 . . . . 0.0 108.284 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.9 106.65 4.27 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.718 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.65 116.41 5.09 Favored Glycine 0 N--CA 1.401 -3.65 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 22.8 t0 -57.94 -56.94 15.53 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.46 19.64 1.22 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -151.68 34.15 0.55 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.24 -169.55 0.01 OUTLIER Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.316 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 140.24 52.5 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.685 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 19.1 m-85 -131.16 115.18 16.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.141 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.0 t -94.14 101.72 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.436 0.636 . . . . 0.0 110.27 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.54 20.25 55.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.067 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.685 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.6 p -77.73 -173.15 2.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.07 -42.19 99.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -75.82 -10.83 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.456 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -100.93 -12.93 18.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -53.48 -14.28 0.77 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.24 -25.31 3.55 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.062 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -7.67 57.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.726 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 5.1 mt-30 -58.56 -24.32 60.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -17.74 56.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.499 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 53' ' ' PRO . 38.0 tp10 -81.21 -1.15 43.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.709 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.47 -6.64 25.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.575 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -141.78 46.28 1.68 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.724 0.297 . . . . 0.0 111.776 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.654 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -138.37 145.15 45.76 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 120.967 0.413 . . . . 0.0 110.756 178.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.38 114.84 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.646 2.231 . . . . 0.0 112.804 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 57.22 178.6 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.941 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 98.5 Cg_endo -90.65 168.21 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.84 2.36 . . . . 0.0 112.095 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.403 ' N ' ' OE2' ' A' ' 47' ' ' GLU . 26.4 p -105.93 -158.85 0.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.251 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 3.5 tt0 -140.01 153.33 46.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.038 0.447 . . . . 0.0 111.312 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . 98.9 p -121.27 -159.35 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.937 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -139.32 89.14 0.2 Allowed Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.819 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -110.99 89.68 3.11 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -63.64 107.25 1.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.155 178.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 64.0 Cg_exo -41.36 157.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.278 3.319 . . . . 0.0 117.668 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -165.85 153.27 10.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.784 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.19 5.5 3.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.035 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -90.79 55.88 3.08 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 117.415 0.607 . . . . 0.0 111.25 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.26 31.96 56.95 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.953 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.34 -149.78 18.29 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.864 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.819 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 mmt180 -119.03 155.35 31.58 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.871 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 49.1 t -63.24 162.75 11.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.4 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . . . -162.56 -91.59 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.78 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.83 -171.5 1.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.711 0.804 . . . . 0.0 112.929 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -47.49 91.14 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.936 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.44 60.74 8.32 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 118.605 -1.76 . . . . 0.0 110.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.78 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -128.58 147.49 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 24.3 t -136.18 103.59 5.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -87.31 152.19 22.49 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -173.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -121.24 -179.27 0.71 Allowed Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.963 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_exo -73.73 -13.22 24.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.501 2.134 . . . . 0.0 112.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.81 -26.96 12.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.967 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.88 171.21 32.73 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.89 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.3 m -93.42 166.21 12.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.398 0.618 . . . . 0.0 112.059 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.625 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -151.76 141.29 21.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.662 178.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -60.9 118.14 6.32 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.914 0.388 . . . . 0.0 110.89 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.0 p30 -99.75 109.39 55.43 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 121.577 0.703 . . . . 0.0 111.556 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.3 Cg_exo -56.55 -15.67 16.43 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 124.036 3.157 . . . . 0.0 110.192 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.49 63.51 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.141 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.882 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.91 -28.69 9.0 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -176.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.53 -29.16 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.164 1 N-CA-C 122.17 4.137 . . . . 0.0 122.17 -177.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.936 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -107.38 -71.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.409 0 C-N-CA 122.684 2.256 . . . . 0.0 112.926 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.696 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.75 -6.71 28.08 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -72.8 -152.95 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.731 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.81 -178.54 0.43 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.617 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -74.05 62.15 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.5 t . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.047 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.545 ' HA ' ' CG ' ' A' ' 53' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.96 0.409 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.579 ' N ' ' HB3' ' A' ' 53' ' ' PRO . 12.1 m -82.75 129.81 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.529 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.882 ' HG ' ' H ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.94 170.67 15.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.308 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 1.005 ' HB3' ' HD2' ' A' ' 8' ' ' ARG . 22.4 t70 -79.22 -74.13 0.3 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.039 HD22 ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -77.6 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.954 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.035 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -84.48 -77.12 0.28 Allowed 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 7' ' ' VAL . 18.7 m -121.72 82.16 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 1.039 ' HG3' HD22 ' A' ' 5' ' ' LEU . 34.9 mtt85 -84.68 -167.91 1.99 Allowed 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.247 -0.908 . . . . 0.0 111.214 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -163.35 80.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.965 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 54' ' ' CYS . 32.0 p -83.63 101.7 11.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.152 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.64 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 6.4 mp -127.06 96.27 34.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.458 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.656 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 53.4 Cg_exo -48.69 172.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 114.491 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 7.3 t -160.18 -169.47 2.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.9 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 56.5 -142.83 39.67 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.491 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -86.24 93.43 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.972 3.115 . . . . 0.0 112.545 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.97 -69.7 1.13 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.689 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.26 32.22 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.43 0.461 . . . . 0.0 112.095 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.07 -36.4 69.55 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.753 0.787 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.53 -167.4 20.19 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.023 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.953 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.04 -179.51 6.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 41.8 t -83.87 155.76 22.75 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.497 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.953 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 45.6 m-85 -142.5 8.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 149.27 -103.09 0.25 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.016 -1.564 . . . . 0.0 115.351 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.4 Cg_endo -105.53 105.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.914 3.076 . . . . 0.0 113.31 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 52.46 18.92 1.03 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.558 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.716 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.8 tt -108.01 153.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.225 1.012 . . . . 0.0 113.533 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.902 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -160.36 138.03 9.65 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.48 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 21.4 m -147.9 110.03 4.56 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.524 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -90.62 131.16 10.62 Favored Glycine 0 N--CA 1.415 -2.702 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.482 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 17.2 t70 -59.51 -62.59 1.76 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.329 1.064 . . . . 0.0 109.462 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.654 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -75.57 -0.84 21.8 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -125.61 31.44 5.52 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.601 -176.07 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.9 -177.27 0.01 OUTLIER Glycine 0 N--CA 1.465 0.608 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -99.33 140.49 33.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.626 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 49.4 m-85 -130.91 143.5 50.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.164 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -142.83 119.73 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.025 0.44 . . . . 0.0 109.949 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.5 5.23 11.34 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.406 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.3 m -87.32 179.27 6.63 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 38' ' ' THR . . . -61.37 -54.27 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.69 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -60.89 8.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -108.97 -38.67 5.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.26 -15.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.35 -18.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 t -70.8 -11.93 61.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.482 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -28.39 65.05 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.8 mt-10 -75.85 -9.58 58.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.752 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 3.7 tt0 -74.18 -1.11 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -84.65 8.11 18.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.288 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -103.51 -123.9 0.2 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.356 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 132.31 13.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 120.749 0.309 . . . . 0.0 110.824 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HG3' HG23 ' A' ' 9' ' ' THR . 93.0 Cg_exo -49.12 -179.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.209 2.606 . . . . 0.0 113.351 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.637 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -144.79 178.22 1.52 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.811 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 62.6 Cg_endo -90.67 79.05 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.745 2.297 . . . . 0.0 111.675 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' CYS . 31.8 p -162.09 59.97 0.24 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.283 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 1.0 ' HB2' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -122.12 178.75 4.79 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.242 -178.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 81.58 112.03 0.06 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -177.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.635 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . 166.57 -45.01 0.26 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.5 ' HG3' HH21 ' A' ' 20' ' ' ARG . 2.2 mt-30 -95.66 88.96 5.17 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.635 ' HE3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -67.89 121.29 79.07 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.314 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.703 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 34.7 Cg_exo -38.6 176.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.829 3.02 . . . . 0.0 114.077 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.27 154.77 19.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.72 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.8 6.26 5.18 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.142 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.555 ' HB3' ' SG ' ' A' ' 73' ' ' CYS . 18.3 t -92.15 51.0 1.72 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.006 0.431 . . . . 0.0 111.081 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.33 25.79 63.16 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.072 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 74' ' ' CYS . . . 164.63 -152.37 22.0 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.733 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 5.6 mmt-85 -115.31 157.17 24.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.179 -0.51 . . . . 0.0 111.444 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.718 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 30.6 t -58.28 143.54 44.28 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.933 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.646 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -137.46 -95.23 0.21 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.323 0.583 . . . . 0.0 112.085 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.919 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.98 -172.54 2.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.419 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.941 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.92 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.029 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.3 71.11 0.76 Allowed Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 118.93 -1.605 . . . . 0.0 110.188 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.919 HG13 ' HB3' ' A' ' 69' ' ' ALA . 3.9 mm -138.53 146.25 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 23.4 t -135.14 104.19 5.83 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.751 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.6 t -91.33 152.87 20.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.544 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.7 m -119.6 -179.25 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.606 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.9 Cg_exo -72.18 -10.66 26.14 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.393 2.062 . . . . 0.0 112.154 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.92 -33.0 7.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.453 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.81 168.22 37.07 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -98.28 165.36 11.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 111.853 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.624 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.3 141.57 21.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.399 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.605 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.78 114.72 2.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.5 p30 -95.98 106.42 27.99 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 121.303 0.573 . . . . 0.0 111.296 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.817 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.84 -9.88 3.43 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 124.142 3.228 . . . . 0.0 110.495 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.18 -29.13 57.55 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.651 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -109.72 -27.77 9.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 118.122 2.638 . . . . 0.0 118.122 -176.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 175.6 -31.19 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.334 1 N-CA-C 122.179 4.14 . . . . 0.0 122.179 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.029 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.8 Cg_endo -105.46 -70.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.717 2.278 . . . . 0.0 112.097 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 65.0 tt0 -69.97 -6.65 34.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.735 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.25 -157.48 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.237 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.45 -178.82 0.72 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.48 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.36 62.36 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.204 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.791 0.329 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.73 162.37 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.201 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.53 166.66 23.16 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.583 0.706 . . . . 0.0 112.564 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.763 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 50.1 t0 -78.78 -79.0 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.348 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -84.07 -150.78 0.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.815 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -82.47 -51.84 7.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 7' ' ' VAL . 32.5 m -119.44 84.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG3' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -81.87 158.99 23.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.89 65.25 0.3 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -57.37 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.553 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.2 mp -110.58 136.08 20.66 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 111.943 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.665 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.7 Cg_exo -66.01 -166.73 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.455 2.103 . . . . 0.0 112.239 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.2 t -157.87 -176.38 5.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.898 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.37 -138.17 47.36 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.748 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 14.3 Cg_endo -89.6 98.15 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 124.456 3.437 . . . . 0.0 112.551 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.31 -69.04 2.84 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.129 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.69 32.86 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 121.54 0.522 . . . . 0.0 112.478 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.69 -35.49 72.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.043 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.91 -171.87 22.59 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.984 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.66 179.98 7.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 120.799 0.333 . . . . 0.0 110.135 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -80.44 145.12 32.1 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.7 m-85 -118.51 -60.3 1.79 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.871 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -142.12 -100.16 0.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.268 -0.967 . . . . 0.0 114.02 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.8 Cg_endo -100.85 105.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.344 2.696 . . . . 0.0 113.387 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.46 25.42 1.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 110.464 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 23' ' ' GLY . 3.0 tt -112.9 164.75 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.949 0.881 . . . . 0.0 112.922 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.44 141.28 22.81 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.033 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -145.38 108.76 4.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.708 -177.013 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -97.59 117.13 5.71 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.744 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 36.9 t0 -57.92 -56.56 20.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.553 1.177 . . . . 0.0 108.33 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.635 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -83.85 15.27 3.39 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -145.36 32.92 1.07 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.94 173.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.085 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t -112.98 136.84 52.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.67 125.28 29.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.822 177.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.8 t -95.18 97.7 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.53 14.19 56.95 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.854 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 4.7 m -78.54 -177.4 5.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 38' ' ' THR . . . -53.58 -55.55 24.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.267 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -72.66 4.21 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -114.25 -21.42 10.45 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.696 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.84 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.63 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.29 -25.84 4.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 118.305 0.502 . . . . 0.0 110.865 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.91 2.26 15.21 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.697 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -57.82 -25.66 60.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.84 -17.44 55.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.819 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -2.63 31.02 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 1.4 t30 -78.23 -5.02 50.64 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.101 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' HD1' ' O ' ' A' ' 48' ' ' ASN . 2.9 m-30 -136.02 30.45 3.04 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' HD2' ' A' ' 51' ' ' PRO . 3.2 tp -141.0 142.31 27.21 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.778 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 56.5 Cg_exo -44.53 174.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.4 . . . . 0.0 113.084 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.566 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 22.2 m -65.87 -50.95 50.81 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.633 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 52' ' ' SER . 92.0 Cg_endo -86.2 153.98 9.53 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.364 2.043 . . . . 0.0 112.389 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.473 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 43.9 t -177.63 80.16 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.605 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 55' ' ' GLN . 48.4 tt0 55.2 12.72 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.686 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -50.59 150.59 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.017 -0.427 . . . . 0.0 110.922 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.7 97.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.731 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.743 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 5.0 mm-40 -117.02 88.89 2.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.583 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -66.85 102.68 0.39 Allowed Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.623 0.769 . . . . 0.0 111.376 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 25.8 Cg_exo -40.82 157.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.577 3.518 . . . . 0.0 118.563 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -164.62 153.99 13.37 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.869 176.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.7 7.01 1.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.54 -0.754 . . . . 0.0 114.122 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 24.2 t -92.85 52.08 1.79 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.397 0.598 . . . . 0.0 111.265 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.06 34.89 58.67 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.752 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.731 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.05 -151.44 21.13 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.604 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.743 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 2.9 mmt180 -117.99 154.17 32.42 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.922 0.391 . . . . 0.0 111.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -61.86 155.32 23.59 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.71 -99.16 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.384 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.03 -170.78 1.48 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.924 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.942 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.51 86.61 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.011 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.94 70.76 0.88 Allowed Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.967 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 68' ' ' ALA . 3.3 mm -142.64 116.25 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 121.643 0.735 . . . . 0.0 109.028 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.2 t -104.88 106.3 16.73 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.608 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 1.8 t -92.72 161.58 14.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -128.04 -179.92 1.09 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.176 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -73.47 -10.12 23.53 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.38 2.054 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -32.52 7.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.423 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 167.1 35.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.912 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.638 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 29.2 m -97.08 167.21 11.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.0 111.935 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.587 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.54 142.22 20.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.996 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.514 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -60.98 113.07 2.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.077 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 35.4 p30 -95.05 108.63 39.58 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-O 121.667 0.746 . . . . 0.0 111.769 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 48.5 Cg_exo -58.51 -12.09 13.03 Favored 'Trans proline' 0 CA--C 1.504 -0.985 0 C-N-CA 123.99 3.126 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.58 59.93 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.32 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.724 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.6 -24.09 10.73 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -175.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 6.9 t70 173.77 -29.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.391 1 N-CA-C 122.262 4.171 . . . . 0.0 122.262 -178.085 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.011 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.8 Cg_endo -107.56 -71.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.481 2.121 . . . . 0.0 112.465 -171.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.733 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.1 tt0 -69.56 -6.68 32.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.692 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.31 -155.53 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.073 -2.331 . . . . 0.0 111.613 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.24 -178.85 0.69 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.445 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -74.48 62.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 8.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.745 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 54' ' ' CYS . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.849 0.356 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.13 163.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.818 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -67.86 168.72 11.08 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.465 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 12.0 t0 -74.87 -134.44 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.779 HD13 ' HE ' ' A' ' 66' ' ' ARG . 1.1 pp -91.1 -125.64 0.08 Allowed 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 122.029 -0.419 . . . . 0.0 111.103 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 5' ' ' LEU . 1.1 t70 -73.12 -52.68 13.31 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.697 ' H ' HD12 ' A' ' 5' ' ' LEU . 6.4 m -85.85 85.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.43 176.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.818 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 33.1 mtt85 -76.13 123.86 26.5 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.749 HG22 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -75.36 -151.26 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.966 178.166 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 54' ' ' CYS . 0.6 OUTLIER 73.59 -15.94 0.53 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.365 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.6 mp -110.19 91.79 12.08 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.24 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.697 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 51.6 Cg_exo -49.08 168.55 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.157 1.904 . . . . 0.0 112.778 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.644 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 5.2 t -158.3 -171.86 3.65 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.88 -149.78 33.2 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.013 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.37 85.49 1.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.669 2.913 . . . . 0.0 112.836 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -71.52 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.697 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.7 31.9 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 121.416 0.453 . . . . 0.0 112.578 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -75.01 -37.38 61.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.884 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -105.54 -163.54 23.46 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.526 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.749 ' HD3' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.92 153.69 45.77 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.187 0.994 . . . . 0.0 112.881 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' CA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.06 127.13 36.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.209 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.834 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -102.07 -102.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -113.13 -87.71 1.64 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 26' ' ' ILE . 30.7 Cg_endo -101.91 113.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.171 2.58 . . . . 0.0 114.451 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.42 23.27 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.725 0.298 . . . . 0.0 110.622 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.834 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 6.6 tt -112.8 161.85 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.556 1.169 . . . . 0.0 114.036 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.795 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 49.2 t -159.4 159.54 33.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.763 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.1 106.15 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.892 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -96.76 122.54 7.43 Favored Glycine 0 N--CA 1.414 -2.814 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 25.8 t70 -58.78 -59.15 5.89 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.61 1.205 . . . . 0.0 107.942 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.2 pt-20 -81.82 11.62 4.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.892 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.49 41.66 1.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.197 -175.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 27.89 -164.39 0.0 OUTLIER Glycine 0 N--CA 1.472 1.066 0 N-CA-C 115.398 0.919 . . . . 0.0 115.398 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -114.81 144.34 43.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.701 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.6 m-85 -131.46 98.23 4.46 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.818 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 26' ' ' ILE . 3.2 t -94.69 131.46 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.037 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 53.18 31.76 42.04 Favored Glycine 0 C--N 1.319 -0.406 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.809 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.28 -177.69 3.23 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -69.55 -49.15 57.01 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -68.99 8.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -106.3 -27.19 11.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.706 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.78 -11.2 2.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.86 -19.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.425 ' CA ' ' HB2' ' A' ' 21' ' ' CYS . 1.2 t -69.47 -21.96 63.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.927 0.394 . . . . 0.0 110.086 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.4 mp0 -60.16 -24.19 64.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.11 -7.68 57.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.031 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -69.86 -6.26 31.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.896 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.82 -34.65 69.88 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 110.318 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 3.6 m-30 -80.32 174.43 11.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.653 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -121.49 95.21 48.35 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.92 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 50' ' ' LEU . 99.2 Cg_exo -50.79 -165.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.202 2.601 . . . . 0.0 113.253 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.529 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -141.68 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.73 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD2' ' H ' ' A' ' 52' ' ' SER . 71.7 Cg_endo -77.57 83.02 2.25 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.439 2.093 . . . . 0.0 112.702 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -64.48 -171.86 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.687 -179.372 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 54' ' ' CYS . 0.4 OUTLIER 172.12 158.77 0.1 Allowed 'General case' 0 C--N 1.346 0.456 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.705 -178.115 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 9' ' ' THR . 2.0 p -73.91 -172.78 1.39 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 9' ' ' THR . . . 165.81 -79.88 0.12 Allowed Glycine 0 CA--C 1.489 -1.536 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.789 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.513 ' NE2' ' HB ' ' A' ' 7' ' ' VAL . 19.7 mt-30 -69.22 88.66 0.44 Allowed 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -69.78 113.5 17.82 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.676 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.746 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 68.6 Cg_exo -40.3 155.17 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.221 2.614 . . . . 0.0 115.576 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -161.46 153.9 20.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.19 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.46 4.18 5.33 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.174 -0.921 . . . . 0.0 114.06 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.9 t -90.51 57.02 3.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.434 0.617 . . . . 0.0 111.5 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.63 29.07 57.39 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.879 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.741 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.61 -149.05 16.6 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.443 -0.885 . . . . 0.0 115.307 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.779 ' HE ' HD13 ' A' ' 5' ' ' LEU . 6.7 mmt180 -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.22 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 34.8 t -60.38 154.25 20.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.3 -92.7 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.2 -171.24 1.98 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.939 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.64 89.18 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.953 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.21 68.46 1.69 Allowed Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.787 -1.673 . . . . 0.0 110.202 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.734 HG21 ' SG ' ' A' ' 28' ' ' CYS . 1.4 mm -138.52 141.2 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.3 t -128.89 104.96 7.9 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.3 t -90.21 153.13 20.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -119.76 -179.61 0.73 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.403 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -72.87 -11.58 25.77 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.189 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -29.97 9.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.078 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.19 171.06 36.77 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -97.54 164.34 12.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.267 0.556 . . . . 0.0 111.925 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.642 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -151.38 139.51 20.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.664 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.539 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.13 118.84 5.88 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.911 0.386 . . . . 0.0 110.503 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.69 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 45.7 p30 -98.97 108.31 48.57 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.732 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.9 Cg_exo -55.91 -16.57 16.35 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 123.868 3.045 . . . . 0.0 109.941 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -28.23 63.93 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -111.38 -27.39 8.66 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -176.218 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.5 t70 174.58 -28.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 1 N-CA-C 122.432 4.234 . . . . 0.0 122.432 -177.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.8 Cg_endo -106.39 -71.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.559 2.173 . . . . 0.0 112.542 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.5 tt0 -69.75 -6.18 30.25 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.732 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.23 -158.1 0.06 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.958 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.03 -178.11 0.57 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.541 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -73.0 62.11 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.0 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 1' ' ' ALA . 35.3 m 44.56 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.413 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -78.13 171.22 15.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.681 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 4.8 t0 -81.65 -87.88 0.09 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -81.4 -74.1 0.35 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.175 0.988 . . . . 0.0 109.294 177.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.639 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -152.75 -59.51 0.14 Allowed 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.827 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.688 ' H ' HD12 ' A' ' 5' ' ' LEU . 31.4 m -106.49 86.49 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.012 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.681 ' NE ' ' HB2' ' A' ' 4' ' ' ASP . 4.9 mtt-85 -73.44 -178.32 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.578 0.704 . . . . 0.0 112.678 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.81 41.65 0.06 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.741 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -75.92 -77.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.716 -178.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD11 ' HG2' ' A' ' 46' ' ' GLU . 5.2 tp -125.05 91.39 49.41 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 121.316 0.579 . . . . 0.0 112.177 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.714 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo -69.74 -167.77 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.517 2.145 . . . . 0.0 111.736 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -158.8 -177.16 6.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.775 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 62.67 -136.67 44.34 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.555 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.9 Cg_endo -91.8 101.04 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.519 3.48 . . . . 0.0 112.599 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.59 -71.65 2.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.75 33.64 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.578 0.543 . . . . 0.0 112.267 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.94 -35.63 69.67 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.48 -0.86 . . . . 0.0 110.228 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -104.37 -172.22 24.95 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.151 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.29 178.82 8.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' HD23 ' A' ' 11' ' ' LEU . 1.3 m -75.98 154.6 35.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 15.1 m-85 -135.01 -28.02 1.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -170.72 -110.24 0.23 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.593 -1.289 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 42.1 Cg_endo -98.51 103.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.293 2.662 . . . . 0.0 112.793 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.79 22.95 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.036 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.614 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -111.63 163.16 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 122.0 0.905 . . . . 0.0 113.016 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.31 143.23 23.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.608 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.82 103.11 3.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.066 -177.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.01 116.04 4.59 Favored Glycine 0 N--CA 1.402 -3.603 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.822 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 27.0 t70 -58.42 -55.27 37.25 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.525 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.9 pt-20 -83.63 11.78 6.74 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.05 37.75 1.16 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.51 -175.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -118.13 138.52 52.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 1.055 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -132.19 129.82 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.419 178.034 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.614 HG22 HD11 ' A' ' 26' ' ' ILE . 6.3 t -103.79 97.61 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.183 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.54 17.52 62.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.005 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 10.0 p -74.15 -170.92 1.03 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.022 0.411 . . . . 0.0 109.933 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.25 -45.75 83.36 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.15 -14.27 61.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.331 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.055 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.21 -9.84 20.11 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -17.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.214 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.689 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.36 -28.81 8.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.484 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -2.76 38.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.927 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 7.9 mt-30 -57.32 -26.56 61.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HG2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.18 -22.65 41.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.807 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -0.44 38.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.711 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.32 -13.43 55.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.973 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -84.83 -106.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tp -103.19 102.26 27.36 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 120.632 0.254 . . . . 0.0 110.996 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -43.28 127.65 5.54 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.856 2.371 . . . . 0.0 112.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.2 t -123.67 124.07 26.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.73 55.77 3.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.343 2.028 . . . . 0.0 112.161 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.2 t -119.01 122.01 41.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.331 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.6 ' CA ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 51.13 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.024 0.44 . . . . 0.0 111.54 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.9 p 178.56 125.65 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.958 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 146.27 11.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.174 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.584 ' HA ' ' HZ2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -130.29 89.63 2.82 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.584 ' HZ2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.61 103.86 0.39 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.088 0.555 . . . . 0.0 110.783 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.711 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 77.8 Cg_exo -44.29 155.76 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.018 3.146 . . . . 0.0 117.018 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.21 168.59 20.48 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.734 1.254 . . . . 0.0 112.591 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.55 -2.18 33.94 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 112.465 -2.152 . . . . 0.0 116.317 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.598 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 41.5 t -94.21 56.52 2.21 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 117.745 0.772 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.43 38.89 35.45 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.29 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.585 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.96 -153.72 24.38 Favored Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.329 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 mmt180 -111.68 147.89 34.58 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.194 0.521 . . . . 0.0 111.816 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 t -62.23 156.04 23.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.708 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -157.69 -94.05 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.99 -171.16 1.05 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.746 0.819 . . . . 0.0 112.747 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.944 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.45 89.66 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.929 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.4 63.29 5.41 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.505 -1.807 . . . . 0.0 110.289 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.743 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -130.19 146.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.775 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 1.9 t -135.97 104.4 5.7 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.4 t -89.49 159.16 17.39 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -173.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.527 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.5 m -127.49 -179.27 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.2 Cg_exo -71.92 -10.13 25.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.336 2.024 . . . . 0.0 112.697 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -33.2 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 111.304 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.8 169.95 37.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.466 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 8.0 m -96.38 165.8 12.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.4 0.619 . . . . 0.0 112.111 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.637 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.79 140.81 21.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.694 178.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.85 117.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.0 110.006 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 55.7 p30 -99.01 109.7 54.98 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.907 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.756 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -57.24 -14.78 16.37 Favored 'Trans proline' 0 CA--C 1.504 -1.0 0 C-N-CA 123.682 2.921 . . . . 0.0 109.887 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.24 -29.36 62.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.251 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.8 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.32 -26.6 9.49 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.28 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.7 t70 174.52 -29.22 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.245 1 N-CA-C 122.481 4.252 . . . . 0.0 122.481 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.944 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.31 -70.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -171.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 30.6 tt0 -69.47 -6.55 31.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.756 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.99 -154.83 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.059 -2.337 . . . . 0.0 112.549 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.96 -178.7 1.29 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.817 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -74.62 62.04 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.252 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 3' ' ' LEU . 13.4 t -56.86 173.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.779 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.18 173.17 5.89 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.884 0.85 . . . . 0.0 112.923 -178.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.843 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 43.5 t0 -81.45 -144.87 0.05 Allowed 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.895 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 58' ' ' GLN . 0.4 OUTLIER -88.96 -116.98 0.06 Allowed 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.684 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -74.69 -47.88 29.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 7' ' ' VAL . 11.1 m -87.68 84.19 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.365 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.843 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 45.5 mtt180 -80.09 167.33 20.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.853 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 21.4 m 69.98 97.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.666 -1.152 . . . . 0.0 113.19 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' N ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -38.12 105.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 178.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -108.76 91.75 9.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 121.254 0.55 . . . . 0.0 110.179 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 94.4 Cg_exo -41.57 164.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.041 2.494 . . . . 0.0 114.869 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.645 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.6 t -157.42 -172.02 3.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.103 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.44 -142.59 45.06 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.664 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 26.3 Cg_endo -85.63 95.84 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.148 3.232 . . . . 0.0 112.796 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.46 -66.68 3.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.025 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' PRO . . . 178.29 32.02 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 121.591 0.551 . . . . 0.0 112.438 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.47 -34.85 72.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -0.827 . . . . 0.0 109.866 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.24 -169.11 15.77 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.721 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.55 -178.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 34.3 m -76.03 159.87 30.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.809 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 63.2 m-85 -148.24 16.94 1.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 142.73 -113.56 0.8 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.263 -1.446 . . . . 0.0 114.879 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.5 Cg_endo -105.75 111.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.878 3.052 . . . . 0.0 112.986 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.79 22.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.388 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.722 HG13 HG13 ' A' ' 36' ' ' VAL . 1.5 tt -115.76 154.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 122.177 0.989 . . . . 0.0 112.486 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -158.63 134.04 8.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.76 -1.563 . . . . 0.0 107.324 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.977 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 33.2 m -150.38 108.95 3.81 Favored 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.187 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.11 123.08 5.96 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.185 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.652 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 22.9 t70 -58.21 -57.62 12.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.32 18.04 1.21 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -152.2 39.36 0.59 Allowed 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.766 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.4 178.67 0.01 OUTLIER Glycine 0 N--CA 1.464 0.561 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -105.32 129.08 53.74 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.7 m-85 -132.1 105.63 7.5 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.68 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.722 HG13 HG13 ' A' ' 26' ' ' ILE . 8.1 t -95.25 110.28 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.232 0.539 . . . . 0.0 109.599 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.46 21.08 53.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.919 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -94.38 178.26 5.68 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.29 -53.85 31.72 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 111.589 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -71.09 8.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -108.25 -24.95 11.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -16.91 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 1.2 mpp_? -55.15 -18.14 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -72.13 -8.15 53.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -26.68 65.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -12.96 60.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.908 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.1 tm-20 -66.69 -4.27 8.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.763 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.61 -44.16 65.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.796 0.332 . . . . 0.0 110.253 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -97.26 165.83 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.16 74.58 15.85 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-O 120.814 0.34 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.42 -168.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.178 2.585 . . . . 0.0 113.299 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.652 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 72.0 m -59.99 173.26 0.58 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.707 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.679 ' HA ' HD11 ' A' ' 3' ' ' LEU . 87.1 Cg_exo -48.63 -179.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.628 2.219 . . . . 0.0 113.103 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.853 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 44.2 t -161.38 -60.48 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.576 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.679 ' HG2' ' H ' ' A' ' 56' ' ' SER . 3.9 tt0 173.88 -175.62 0.07 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.94 0.336 . . . . 0.0 111.203 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.679 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -60.62 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.514 ' HA2' ' NH2' ' A' ' 20' ' ' ARG . . . 179.39 -100.63 0.14 Allowed Glycine 0 CA--C 1.489 -1.556 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.839 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 1.032 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -74.33 90.4 2.13 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.003 -0.599 . . . . 0.0 109.456 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -64.52 107.48 1.4 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.22 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 90.9 Cg_exo -40.7 158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.199 2.6 . . . . 0.0 116.386 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.09 154.17 14.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.539 177.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.35 3.87 7.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.747 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 11.0 t -91.08 54.07 2.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 117.222 0.511 . . . . 0.0 111.311 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.07 33.18 60.5 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.133 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.88 -151.35 21.08 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.816 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.0 mmt85 -118.35 156.01 29.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.992 -0.604 . . . . 0.0 111.26 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 24.6 t -61.25 151.73 30.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.853 ' HB2' ' NE2' ' A' ' 58' ' ' GLN . . . -149.07 -94.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.977 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . . . -76.7 -171.68 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.651 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.975 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.05 91.76 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.982 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.95 68.21 1.8 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.006 -1.569 . . . . 0.0 110.206 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -136.12 142.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.6 t -128.93 104.47 7.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -88.5 154.42 20.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.555 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.8 m -123.16 -179.24 0.77 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -72.04 -9.68 24.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.334 2.023 . . . . 0.0 112.927 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -34.07 7.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.691 0.282 . . . . 0.0 110.984 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.83 170.17 38.31 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.282 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.622 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 11.6 m -94.03 165.95 12.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.482 0.658 . . . . 0.0 112.666 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.645 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -150.82 140.0 21.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.597 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -60.41 117.93 5.84 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.985 0.422 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.703 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.7 p30 -99.19 108.53 50.33 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.281 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.23 -12.74 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.014 3.142 . . . . 0.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.64 60.36 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.35 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.939 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -108.88 -27.56 9.65 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -176.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.33 -29.36 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.362 1 N-CA-C 122.321 4.193 . . . . 0.0 122.321 -178.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.7 Cg_endo -106.2 -70.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.495 0 C-N-CA 122.345 2.03 . . . . 0.0 112.29 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 62.1 tt0 -69.49 -6.83 33.18 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.76 -158.04 0.08 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 111.79 -2.459 . . . . 0.0 112.11 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.67 -177.97 0.85 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.613 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.92 61.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.455 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.8 t -65.71 167.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.827 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.15 173.97 6.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.0 112.641 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.567 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.9 t0 -80.14 -78.49 0.17 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.584 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.046 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.65 -127.64 0.06 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.826 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.046 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.01 -41.85 73.78 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.015 HG22 HD11 ' A' ' 5' ' ' LEU . 34.3 m -91.62 109.22 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.783 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.827 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 86.2 mtt180 -71.4 126.66 30.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.667 ' HB ' ' HA ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -104.09 -162.85 0.93 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.922 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.665 ' H ' ' HA ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER 65.88 62.72 0.61 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.632 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.8 tp -89.66 132.25 37.4 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.493 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 26.8 Cg_exo -55.76 -173.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.081 1.854 . . . . 0.0 112.677 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 3.9 t -157.86 -175.02 5.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.53 -137.47 49.88 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.85 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.3 Cg_endo -89.76 94.94 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.437 3.425 . . . . 0.0 112.667 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.05 -68.61 2.48 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.418 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.56 32.41 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.504 0.502 . . . . 0.0 112.32 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.562 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -69.8 -35.5 74.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.573 -0.813 . . . . 0.0 110.109 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -114.94 -165.38 14.85 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.809 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.613 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.59 177.0 10.41 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.67 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -79.43 153.71 29.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.684 ' HB2' HG23 ' A' ' 26' ' ' ILE . 15.6 m-85 -125.71 -94.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.695 -0.402 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.691 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -98.86 -106.84 2.67 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.575 -0.822 . . . . 0.0 114.565 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -101.95 113.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.798 2.999 . . . . 0.0 113.559 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 50.9 21.02 0.87 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.691 ' CG2' ' H ' ' A' ' 23' ' ' GLY . 4.2 tt -111.74 166.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 122.134 0.968 . . . . 0.0 113.316 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.77 143.08 18.2 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.751 -1.568 . . . . 0.0 107.886 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.848 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -147.5 104.88 3.67 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.908 -177.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.14 119.58 5.96 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.646 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 36.3 t0 -58.22 -58.63 7.6 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.607 1.203 . . . . 0.0 108.009 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.562 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.3 pt-20 -81.18 20.39 0.83 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -152.08 35.21 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.218 -175.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.681 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.3 -164.81 0.01 OUTLIER Glycine 0 C--N 1.33 0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 114.164 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.75 140.29 53.07 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.756 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -131.91 114.88 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.582 178.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -97.17 113.8 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.409 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 58.92 19.86 46.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.738 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.2 m -94.47 163.76 13.27 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.411 0.284 . . . . 0.0 110.384 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.83 -53.62 7.28 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.282 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.3 mp0 -69.06 7.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.858 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -116.03 -26.69 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -43.37 -19.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.601 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.23 -21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.572 0.624 . . . . 0.0 111.702 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 13.7 t -77.68 -4.69 47.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.013 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -59.12 -25.08 63.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.632 ' HG2' HD22 ' A' ' 11' ' ' LEU . 2.1 pp20? -76.49 -14.05 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.518 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 1.6 tt0 -68.6 0.6 3.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.278 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.64 -19.35 15.82 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 12.4 m-30 -61.57 -168.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.639 ' H ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -107.56 84.71 1.98 Allowed Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 120.879 0.371 . . . . 0.0 111.903 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 44.2 Cg_exo -43.57 147.85 0.95 Allowed 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.834 2.356 . . . . 0.0 113.374 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.554 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -172.66 -64.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.69 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 52' ' ' SER . 63.9 Cg_endo -82.15 -86.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.132 1.888 . . . . 0.0 112.928 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.432 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 t -100.3 -84.02 0.43 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.576 0.226 . . . . 0.0 111.339 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.683 ' HG2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER 37.39 29.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.612 ' HB3' ' O ' ' A' ' 55' ' ' GLN . 64.6 p 165.67 -177.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.027 0.441 . . . . 0.0 110.663 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.486 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -162.93 87.08 0.1 Allowed Glycine 0 CA--C 1.5 -0.898 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.658 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mt-30 -113.6 89.54 3.11 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -63.65 103.2 0.38 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.238 178.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 57.9 Cg_exo -42.83 160.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.134 3.223 . . . . 0.0 117.662 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -164.75 154.06 13.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.155 177.259 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.93 3.37 3.07 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.044 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.03 54.74 2.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.562 0.681 . . . . 0.0 111.339 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.99 35.85 49.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.947 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.701 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.8 -154.84 25.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.973 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 5.6 mmt180 -115.43 155.46 27.4 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.207 -0.497 . . . . 0.0 111.587 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 25.1 t -60.98 153.03 26.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.043 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -151.39 -92.62 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.23 -173.86 2.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.6 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.981 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.78 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.944 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.68 66.02 3.14 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 118.601 -1.761 . . . . 0.0 110.215 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.871 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.9 mm -134.25 144.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.6 t -132.38 105.96 7.6 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.606 ' HB3' HE22 ' A' ' 58' ' ' GLN . 1.7 t -92.0 153.59 19.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -173.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.531 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.3 m -119.03 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.66 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -71.94 -10.22 25.86 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.313 2.008 . . . . 0.0 112.562 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 -32.24 7.62 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.656 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.92 168.49 36.92 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.703 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.591 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 8.6 m -96.44 165.89 11.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.482 0.658 . . . . 0.0 112.442 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.705 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -152.18 142.46 22.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.555 178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.591 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -61.11 117.88 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.58 -178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.723 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 45.1 p30 -98.32 108.08 45.37 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-O 121.549 0.69 . . . . 0.0 111.285 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.766 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -56.24 -11.02 5.31 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 124.099 3.199 . . . . 0.0 110.147 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -77.02 -28.86 55.07 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.165 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -109.44 -27.37 9.49 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -175.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.4 t70 174.36 -29.35 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.246 1 N-CA-C 122.428 4.233 . . . . 0.0 122.428 -178.123 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.981 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.42 -70.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.746 2.297 . . . . 0.0 112.306 -172.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -70.96 -5.88 34.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 175.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.766 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.72 -160.3 0.15 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 111.767 -2.469 . . . . 0.0 112.371 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.11 -177.58 0.38 Allowed 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.675 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -74.23 61.77 0.89 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.248 0.993 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.235 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.868 0.366 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -83.41 143.52 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.2 0.524 . . . . 0.0 111.98 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.633 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -75.07 175.64 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.781 0.801 . . . . 0.0 112.975 -178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 20.0 t0 -77.95 -140.77 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.944 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -91.12 -123.8 0.07 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.652 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -68.93 -47.98 64.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 7' ' ' VAL . 15.9 m -85.92 90.43 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.947 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.633 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 58.6 mtt85 -69.26 -168.33 0.15 Allowed 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.67 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.4 m 67.22 111.61 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.791 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -48.17 -178.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.28 -178.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 11.0 mp -68.8 118.6 62.49 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.737 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 20.0 Cg_exo -58.84 -174.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.264 1.976 . . . . 0.0 112.241 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -156.67 -176.74 6.14 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.102 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.09 -133.08 49.01 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.876 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 8.2 Cg_endo -92.71 100.31 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.905 3.737 . . . . 0.0 112.446 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 -68.27 3.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.919 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.68 31.63 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 121.416 0.453 . . . . 0.0 112.792 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.92 -37.85 69.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.764 0.792 . . . . 0.0 109.797 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -101.11 -176.58 29.1 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.783 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -162.14 -179.38 7.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.83 0.348 . . . . 0.0 110.655 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 m -80.91 144.88 31.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.676 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.6 m-85 -119.68 -43.47 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -165.01 -95.27 0.1 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.277 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.9 Cg_endo -101.91 103.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.567 2.844 . . . . 0.0 113.554 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.69 25.53 1.01 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 110.62 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -113.86 160.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.85 0.833 . . . . 0.0 112.852 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -153.42 136.94 15.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.169 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 2.2 m -148.39 117.29 6.72 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.513 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.893 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -104.93 119.36 6.18 Favored Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.162 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.6 t70 -57.79 -57.02 14.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.552 1.176 . . . . 0.0 108.21 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -83.06 26.53 0.61 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.893 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -159.77 33.01 0.19 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.536 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.965 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 40.58 176.14 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' HG21 ' A' ' 72' ' ' ILE . 1.2 m -106.03 132.25 52.34 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.838 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -131.92 117.08 17.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.19 98.28 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.021 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.83 10.72 40.12 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.984 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -76.41 174.5 10.18 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.079 0.552 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.55 -56.14 4.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.344 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -73.7 6.98 2.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -112.87 -23.25 10.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.99 -18.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.37 -23.99 1.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.55 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.79 -5.2 49.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.281 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -59.97 -23.18 63.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.155 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 29.3 mt-10 -76.8 -13.83 59.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.192 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.5 mt-10 -75.49 2.02 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.75 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.58 -7.0 59.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.727 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -56.74 -163.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.224 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HG ' ' HD2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -92.67 155.87 41.54 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.782 -179.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.591 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 21.9 Cg_exo -39.0 122.17 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.093 2.529 . . . . 0.0 113.38 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -143.38 160.26 52.19 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -93.03 72.89 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.083 2.522 . . . . 0.0 112.725 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -175.54 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.256 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -137.8 171.09 14.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.172 0.511 . . . . 0.0 111.476 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.495 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 1.2 m -154.75 -170.82 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.92 102.29 0.21 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.356 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.679 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -124.65 88.95 2.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 120.902 0.382 . . . . 0.0 111.411 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' H ' ' CD ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -63.7 102.0 0.3 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.261 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 71.9 Cg_exo -44.01 160.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.873 3.049 . . . . 0.0 117.306 -176.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -165.17 155.02 13.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.805 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.12 7.14 3.46 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.4 t -93.38 51.94 1.68 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.124 0.462 . . . . 0.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.16 34.6 58.8 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.982 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.744 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.61 -151.85 21.53 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.744 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.6 mmt180 -118.82 155.41 31.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.758 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 27.0 t -62.89 155.59 26.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.04 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.58 -89.85 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.369 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.965 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -73.34 -169.59 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 114.829 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . -28.44 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.36 1.03 0 CA-C-O 122.253 1.025 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.79 ' C ' ' OD1' ' A' ' 82' ' ' ASP . . . -177.01 78.53 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.847 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.751 HG21 ' SG ' ' A' ' 34' ' ' CYS . 2.0 mm -132.41 149.83 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 114.202 -0.999 . . . . 0.0 108.888 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 29.8 t -132.95 102.88 5.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -85.35 146.57 26.95 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.49 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -113.58 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.443 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.49 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 7.9 Cg_exo -74.67 -11.83 22.18 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.467 2.111 . . . . 0.0 112.271 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -28.14 11.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.015 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.04 168.2 33.2 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.642 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.1 m -94.17 165.93 12.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.276 0.56 . . . . 0.0 112.264 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.62 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.64 141.64 20.27 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.96 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.629 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 122.1 12.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.79 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 54.0 p30 -101.55 106.65 47.39 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.438 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.695 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 52.8 Cg_exo -57.1 -17.64 25.83 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.786 2.991 . . . . 0.0 109.61 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.3 69.28 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.26 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.744 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 m -103.52 -33.76 8.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 9.2 t70 167.84 -24.84 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.457 0 N-CA-C 121.703 3.964 . . . . 0.0 121.703 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.705 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_endo -101.67 -69.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.263 1.975 . . . . 0.0 112.347 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.1 tt0 -71.85 -5.7 36.35 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -74.16 -155.3 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.207 -2.27 . . . . 0.0 111.44 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.24 -178.72 1.11 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -74.93 62.53 1.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.473 ' OG ' ' OD2' ' A' ' 86' ' ' ASP . 3.4 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.568 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.482 0.182 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m 36.51 -163.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.01 174.73 6.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.641 0.734 . . . . 0.0 112.706 -178.154 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.642 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . 66.9 t0 -78.27 -89.89 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.238 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 6' ' ' ASP . 1.3 pp -152.52 -42.37 0.1 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.53 -48.73 0.14 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.416 176.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 7' ' ' VAL . 4.4 m -82.68 92.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.232 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.5 mtt85 -67.26 171.04 6.24 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.576 ' H ' ' HB3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER 23.2 90.19 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.327 0.584 . . . . 0.0 111.06 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 13.9 p -145.15 17.33 1.56 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.939 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD22 ' HB2' ' A' ' 53' ' ' PRO . 4.6 tp -109.23 90.2 7.89 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.016 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 11.0 Cg_exo -63.63 179.11 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.901 1.734 . . . . 0.0 113.296 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.5 t -157.35 -169.77 3.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.673 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.6 -144.05 44.06 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.469 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 17.5 Cg_endo -87.92 90.91 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 124.206 3.271 . . . . 0.0 112.462 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.54 -70.69 0.61 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.101 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.87 32.2 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.868 0 CA-C-O 121.449 0.472 . . . . 0.0 112.447 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.43 -38.03 74.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.87 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.04 -164.54 18.47 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.569 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.717 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.71 179.07 9.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.59 151.96 37.76 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.717 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 24.2 m-85 -132.98 -1.13 3.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 166.18 -114.55 0.59 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.324 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -101.07 105.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.701 2.934 . . . . 0.0 112.571 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.48 23.78 3.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.948 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.583 HG13 HG13 ' A' ' 36' ' ' VAL . 2.9 tt -111.66 162.83 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.363 1.078 . . . . 0.0 113.584 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.475 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 49.3 t -147.83 149.92 33.22 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.227 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.45 96.08 1.87 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.589 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.48 119.08 5.27 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 119.445 -1.359 . . . . 0.0 110.005 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.583 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 15.2 t70 -58.77 -55.7 31.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.595 1.198 . . . . 0.0 107.809 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.8 pt-20 -81.15 1.3 32.52 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.893 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.939 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -134.18 39.19 3.11 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.614 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.687 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.72 -172.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.768 0 N-CA-C 114.769 0.668 . . . . 0.0 114.769 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -120.87 133.68 55.3 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.862 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.43 126.68 33.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.844 178.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.583 HG13 HG13 ' A' ' 26' ' ' ILE . 3.4 t -99.77 106.43 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.18 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.86 24.16 62.21 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.0 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.4 m -94.74 172.01 8.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.58 0.352 . . . . 0.0 110.535 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -44.11 -54.99 5.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.55 -10.99 60.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.751 0.31 . . . . 0.0 111.642 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.48 -14.55 16.78 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -18.37 0.15 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -51.7 -26.98 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.627 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -4.13 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.442 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 5.2 mt-30 -58.48 -24.42 60.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -23.33 52.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.209 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -1.94 44.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.594 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.26 -7.1 59.65 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.314 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.421 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.8 m-85 -95.53 -99.97 0.16 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.572 0.225 . . . . 0.0 111.431 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -106.62 96.85 15.08 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.946 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 78.0 Cg_exo -47.88 86.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.992 2.461 . . . . 0.0 113.286 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 179.95 59.3 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 52' ' ' SER . 44.2 Cg_endo -93.32 -72.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.958 2.439 . . . . 0.0 112.51 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 4' ' ' ASP . 38.1 t -146.26 -107.99 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.006 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.576 ' HB3' ' H ' ' A' ' 9' ' ' THR . 5.2 tp60 -157.52 163.6 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.011 0.434 . . . . 0.0 111.832 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.507 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 3.4 p -110.44 -168.5 1.32 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.02 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -155.33 89.16 0.12 Allowed Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.74 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 3.1 mt-30 -113.57 89.37 3.07 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -65.65 105.61 0.82 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.084 0.553 . . . . 0.0 110.526 178.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -41.88 158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.122 3.215 . . . . 0.0 117.649 -176.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.41 154.13 13.99 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.371 177.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.87 4.39 4.38 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.452 -0.794 . . . . 0.0 114.143 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.0 t -91.42 53.28 2.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.485 0.642 . . . . 0.0 111.223 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.58 57.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.912 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.75 -154.5 25.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.964 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.74 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.9 mmt-85 -115.9 153.98 30.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -62.87 153.21 34.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.984 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.69 -91.91 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -74.81 -171.67 1.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.968 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.6 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.941 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.46 64.74 4.1 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 118.879 -1.629 . . . . 0.0 110.165 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.865 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -131.28 146.11 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 20.1 t -133.62 101.22 5.04 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -83.05 146.93 28.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.7 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.2 m -111.32 -179.47 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.561 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 34.7 Cg_endo -74.01 -22.51 17.1 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.552 1.501 . . . . 0.0 112.238 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.9 -27.2 15.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.266 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.22 168.87 33.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.425 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.1 m -94.28 165.71 12.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.442 0.639 . . . . 0.0 112.434 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.628 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.98 140.89 21.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.497 178.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.563 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.94 119.31 7.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.961 0.41 . . . . 0.0 110.616 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.732 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.3 p30 -98.93 109.21 52.98 Favored Pre-proline 0 N--CA 1.438 -1.067 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.722 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -56.98 -12.24 9.07 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 124.061 3.174 . . . . 0.0 110.146 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.69 -28.11 58.51 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.268 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.846 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.68 -25.88 9.71 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -175.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.7 t70 174.2 -30.44 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.42 1 N-CA-C 122.194 4.146 . . . . 0.0 122.194 -177.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.968 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -106.66 -71.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.391 0 C-N-CA 122.636 2.224 . . . . 0.0 112.74 -171.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.712 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.7 tt0 -69.5 -6.11 28.43 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.722 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.88 -157.5 0.06 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.86 -2.427 . . . . 0.0 112.443 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.69 -178.19 0.53 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.2 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.84 62.27 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.929 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.707 0.289 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.12 143.24 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.802 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.85 169.06 18.69 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.282 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 54' ' ' CYS . 37.1 t0 -79.8 -137.81 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.814 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -92.37 -120.58 0.08 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.679 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.73 -48.45 31.84 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.272 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 5' ' ' LEU . 11.7 m -86.75 83.7 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.053 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 39.3 mtt180 -82.29 147.44 28.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.754 ' CG2' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m 59.47 115.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.203 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.637 ' SG ' ' HB3' ' A' ' 52' ' ' SER . 81.3 m -85.2 -84.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 7.3 mp -121.4 91.49 48.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.981 0.419 . . . . 0.0 110.318 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HG3' ' CG2' ' A' ' 9' ' ' THR . 7.6 Cg_exo -68.95 -177.82 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.386 2.057 . . . . 0.0 114.857 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.0 t -155.56 -170.88 3.58 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.113 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 58.36 -137.62 49.86 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.063 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.5 Cg_endo -90.19 93.19 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.598 3.532 . . . . 0.0 113.13 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.54 -68.3 2.12 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.324 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.87 34.34 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.775 0.653 . . . . 0.0 112.267 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.949 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.8 -35.08 69.86 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.916 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.682 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -117.12 -163.49 13.06 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.197 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.577 ' HE ' HE21 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -158.2 176.87 11.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -86.68 158.33 19.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.078 178.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.1 m-85 -131.11 -90.76 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.723 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -120.51 -93.43 1.36 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -99.53 104.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.545 2.83 . . . . 0.0 114.177 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 51.65 19.97 1.0 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.363 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.7 tt -109.24 163.09 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.146 0.974 . . . . 0.0 113.327 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.41 145.01 20.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.229 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -149.05 115.37 5.82 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.995 -177.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.949 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.76 122.0 7.39 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.966 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 3.4 t70 -58.62 -56.91 16.08 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -84.98 24.09 1.12 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.223 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.949 ' HB2' ' HB3' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -157.11 36.35 0.29 Allowed 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.762 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 38.31 -170.81 0.01 OUTLIER Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 139.7 49.9 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.728 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 1.7 m-85 -131.19 104.38 7.03 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.09 177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.553 HG13 HG13 ' A' ' 26' ' ' ILE . 5.0 t -95.03 115.17 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.495 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 62.89 8.28 21.18 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.422 -0.895 . . . . 0.0 112.038 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.5 m -82.86 172.69 12.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.362 0.265 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -56.09 -54.33 46.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -65.39 8.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.879 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -109.0 -33.37 6.92 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.89 -17.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.396 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.01 -20.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 52.9 t -72.25 -13.22 61.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -58.96 -26.52 64.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -9.0 58.46 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -70.41 0.67 6.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.164 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -67.37 -4.77 11.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.575 0.226 . . . . 0.0 111.082 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.5 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 10.3 m-30 -88.58 -143.37 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.455 0.302 . . . . 0.0 110.6 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.455 ' H ' ' HB3' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -102.27 98.07 9.81 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-O 120.566 0.222 . . . . 0.0 110.542 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 83.9 Cg_exo -48.63 175.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.653 2.235 . . . . 0.0 112.828 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.637 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.9 t -174.06 132.74 0.55 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.66 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 52.8 Cg_endo -94.84 83.87 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.354 2.703 . . . . 0.0 113.385 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.471 ' HB2' ' CG ' ' A' ' 4' ' ' ASP . 26.3 p -125.74 -161.4 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.317 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.577 HE21 ' HE ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 56.64 161.04 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.624 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.579 ' OG ' ' HE3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER 60.24 -164.65 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.627 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.65 -127.82 2.84 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.483 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 mt-30 -75.33 88.15 2.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.807 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -75.7 -34.36 1.52 Allowed Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.8 -177.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 33.8 Cg_exo -41.32 155.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 125.258 3.972 . . . . 0.0 115.932 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.08 156.69 19.84 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.191 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.61 6.34 3.59 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.846 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.22 51.65 1.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 117.267 0.534 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.16 30.68 61.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.878 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.55 -152.72 22.83 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.3 mmt-85 -118.17 165.38 13.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.977 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 5.8 t -59.43 149.11 30.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.49 -25.6 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.966 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -161.32 -170.84 2.78 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 122.727 0.411 . . . . 0.0 111.786 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -41.0 86.58 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.96 67.71 2.07 Favored Glycine 0 N--CA 1.419 -2.485 0 C-N-CA 118.627 -1.749 . . . . 0.0 111.124 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 68' ' ' ALA . 3.4 mm -137.62 135.3 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -124.18 108.92 12.8 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.698 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.8 t -95.23 154.62 17.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.503 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -122.26 -179.37 0.76 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.837 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -71.78 -9.66 25.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.38 2.053 . . . . 0.0 112.147 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.7 -34.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.32 169.77 38.86 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.812 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.645 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.3 m -99.13 164.95 11.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.369 0.604 . . . . 0.0 111.668 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.592 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.7 144.02 22.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.467 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.55 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pt-20 -61.7 116.63 4.94 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.778 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 41.0 p30 -97.34 107.01 36.12 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.001 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 57.7 Cg_exo -55.03 -13.84 7.25 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.569 2.846 . . . . 0.0 110.445 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -72.71 -29.25 63.22 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.169 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.975 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -106.55 -30.11 9.24 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 -176.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.648 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 7.2 t70 174.66 -28.62 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.325 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -177.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.2 Cg_endo -106.11 -70.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.525 0 C-N-CA 122.376 2.051 . . . . 0.0 112.276 -172.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.695 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.7 tt0 -70.27 -6.23 33.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.006 -1.906 . . . . 0.0 106.029 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.7 -155.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.695 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.48 -178.48 0.52 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.877 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.71 62.67 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 4.5 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.476 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -68.07 149.59 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.676 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.91 170.02 14.62 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.677 0.751 . . . . 0.0 112.937 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 54' ' ' CYS . 40.9 t0 -82.43 -77.03 0.24 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.986 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.008 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -148.95 -133.96 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.048 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 1.008 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -73.13 -38.52 66.26 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.626 ' CG2' HD11 ' A' ' 5' ' ' LEU . 27.2 m -97.69 104.44 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.676 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.2 mtt85 -71.74 178.65 3.5 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.2 m 67.09 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.546 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -45.86 177.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 112.245 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.018 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 tp -71.23 139.9 84.97 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.368 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 26.4 Cg_exo -55.82 -171.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.923 1.749 . . . . 0.0 111.934 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.5 t -157.69 -176.67 6.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.687 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.515 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 64.93 -139.4 40.65 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.833 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.8 Cg_endo -91.78 95.23 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.667 3.578 . . . . 0.0 112.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 -72.08 0.78 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.85 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 175.51 35.58 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.69 0.606 . . . . 0.0 111.985 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.89 -36.05 69.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.353 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.18 -167.3 18.74 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.829 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.79 -179.89 6.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 151.53 34.81 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.903 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -127.0 -24.53 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -174.91 -105.75 0.19 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.466 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 38.8 Cg_endo -99.52 103.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.263 2.642 . . . . 0.0 112.789 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.39 24.68 2.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.775 0.321 . . . . 0.0 110.139 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.605 HD11 HG22 ' A' ' 36' ' ' VAL . 1.2 tt -112.18 162.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.976 0.893 . . . . 0.0 113.324 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 140.4 20.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.744 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.28 101.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.793 -177.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.58 120.0 5.54 Favored Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 32.3 t0 -58.4 -58.19 9.62 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.633 1.217 . . . . 0.0 108.211 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.4 pt-20 -81.34 6.33 14.68 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -136.65 37.34 2.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.338 -174.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.632 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.21 -172.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.01 136.4 54.99 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.17 115.26 15.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.133 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.605 HG22 HD11 ' A' ' 26' ' ' ILE . 5.7 t -93.71 107.91 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.984 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.96 24.82 55.27 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.808 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.793 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.1 m -94.38 175.24 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 122.568 0.347 . . . . 0.0 110.661 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.35 -59.12 2.55 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.998 0.428 . . . . 0.0 111.509 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -72.9 7.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -110.71 -22.74 11.43 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.69 -12.27 0.73 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.77 -24.7 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.22 0.463 . . . . 0.0 111.811 -179.464 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -75.56 -3.05 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.187 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.1 mt-30 -56.38 -28.99 60.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.018 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -77.82 -15.23 59.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.19 179.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -77.38 0.39 22.63 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 23.1 p30 -117.71 -13.22 10.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.373 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -90.96 -5.65 55.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 0.0 111.278 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -143.2 85.85 9.45 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.115 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.25 95.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.975 2.45 . . . . 0.0 112.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p -152.44 145.68 17.66 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -92.89 78.17 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 111.762 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 4' ' ' ASP . 15.2 p -65.65 -163.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.828 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.3 tp60 -143.02 148.29 36.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 12.5 m -115.08 -163.99 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.258 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.92 93.7 0.15 Allowed Glycine 0 CA--C 1.503 -0.711 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.629 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -114.4 89.56 3.12 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -63.66 104.73 0.54 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.326 0.65 . . . . 0.0 110.315 177.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 74.6 Cg_exo -43.08 160.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.084 3.189 . . . . 0.0 117.779 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.54 153.41 10.99 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.329 -1.759 . . . . 0.0 110.33 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.9 4.65 5.37 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.736 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -90.91 52.48 2.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 117.183 0.491 . . . . 0.0 111.554 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.97 31.2 61.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.029 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.617 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.42 -154.42 25.25 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.889 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.709 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -115.79 153.09 32.07 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.078 0.466 . . . . 0.0 111.153 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 40.1 t -61.89 156.31 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.385 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -152.39 -92.67 0.05 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -78.48 -170.5 2.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.82 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.96 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.43 65.43 3.57 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.537 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' C ' ' A' ' 80' ' ' GLU . 1.8 mm -134.44 143.26 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.5 t -131.46 104.7 7.13 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -91.85 158.6 16.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.506 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.6 m -127.1 -179.22 0.89 Allowed Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.248 -1.796 . . . . 0.0 109.287 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.85 -9.97 24.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.278 1.985 . . . . 0.0 112.459 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.4 -33.04 8.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.458 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.4 168.91 35.84 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.517 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.594 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 15.1 m -96.12 166.59 11.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.457 0.646 . . . . 0.0 112.343 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.716 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -152.21 141.92 21.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.621 178.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.604 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -61.26 117.36 5.51 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.729 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.8 p30 -100.16 108.19 51.04 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-O 121.626 0.727 . . . . 0.0 111.18 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 66.0 Cg_exo -55.49 -16.09 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.07 3.18 . . . . 0.0 110.095 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.26 64.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.09 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.866 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -108.75 -27.55 9.71 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -176.403 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' ' OG ' ' A' ' 92' ' ' SER . 3.3 t70 173.67 -26.0 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.354 1 N-CA-C 122.853 4.39 . . . . 0.0 122.853 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.96 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -109.64 -72.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 -171.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.4 tt0 -70.62 -3.97 21.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.505 -1.679 . . . . 0.0 106.766 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.686 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -70.95 -160.82 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 112.448 -2.16 . . . . 0.0 114.892 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.31 -175.18 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.335 -2.212 . . . . 0.0 108.308 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.84 66.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 90' ' ' ALA . 1.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.371 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.73 ' HA ' ' HA ' ' A' ' 52' ' ' SER . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -157.07 -169.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.96 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HG ' ' NE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.17 170.17 12.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.519 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.82 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 56.3 t0 -79.11 -127.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -93.61 -126.59 0.11 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.041 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.563 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -74.45 -54.91 6.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.633 ' H ' HD12 ' A' ' 5' ' ' LEU . 16.5 m -90.32 112.5 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.157 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 27.3 mtt85 -69.15 121.32 16.52 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.792 0.806 . . . . 0.0 113.067 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.557 ' H ' ' CB ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -173.96 56.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.829 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.513 ' HB3' ' CG ' ' A' ' 4' ' ' ASP . 5.3 p -109.88 34.5 3.81 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.797 HD13 ' HB2' ' A' ' 54' ' ' CYS . 4.1 tp -129.77 90.18 44.05 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 118.361 0.528 . . . . 0.0 110.966 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -73.55 177.25 8.23 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.619 2.213 . . . . 0.0 113.907 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.9 t -155.16 -177.45 6.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.58 -134.48 47.46 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.509 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 14.0 Cg_endo -89.56 101.3 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.603 3.536 . . . . 0.0 112.677 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.68 -66.04 3.79 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.015 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.06 32.66 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 121.529 0.516 . . . . 0.0 112.324 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.41 -36.11 73.84 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.972 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -108.36 -171.27 21.38 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.226 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.742 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 177.87 10.03 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.538 ' SG ' HD23 ' A' ' 11' ' ' LEU . 11.4 m -79.01 163.81 24.88 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 35.1 m-85 -141.55 -30.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -170.78 -103.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.886 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -101.32 102.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.485 2.79 . . . . 0.0 112.971 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.36 23.54 2.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.4 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -111.57 159.28 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.0 0.905 . . . . 0.0 112.882 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.84 140.38 21.56 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.859 -1.518 . . . . 0.0 108.504 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.708 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.99 99.23 3.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.759 -176.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.956 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.43 117.55 4.51 Favored Glycine 0 N--CA 1.406 -3.307 0 C-N-CA 118.973 -1.584 . . . . 0.0 110.058 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.6 t0 -59.03 -57.42 13.17 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.6 pt-20 -82.02 11.98 4.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.956 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.17 37.89 1.15 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.172 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.35 -178.15 0.01 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.5 t -114.84 136.76 52.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.804 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -133.12 119.34 19.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.278 177.475 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 26' ' ' ILE . 5.6 t -91.84 103.21 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.106 178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.66 47.98 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.829 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -86.27 -176.94 6.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.217 0.607 . . . . 0.0 110.025 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.13 -58.8 4.77 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -72.02 -2.32 17.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.65 -21.14 14.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.29 -14.65 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -51.19 -23.63 3.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.433 0.56 . . . . 0.0 111.3 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -13.95 60.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.159 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.608 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -60.55 -22.74 63.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -74.6 -24.05 58.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 19.9 tp10 -83.0 22.77 0.9 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.105 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -158.57 0.25 0.09 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.259 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -132.41 -9.84 3.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.598 0.237 . . . . 0.0 110.936 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 102.47 5.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -42.27 101.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.789 2.326 . . . . 0.0 112.801 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.73 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 5.3 t -163.74 93.6 1.07 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.031 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.69 69.76 5.03 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.486 2.124 . . . . 0.0 113.02 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.797 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.27 -162.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.731 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -131.19 176.89 7.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -135.37 -153.27 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.3 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.61 118.77 0.82 Allowed Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.018 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -130.15 89.41 2.79 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -61.53 104.32 0.46 Allowed Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.568 178.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 47.2 Cg_exo -43.32 158.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.287 3.325 . . . . 0.0 117.406 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -163.93 153.38 14.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.3 177.156 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.52 3.69 4.55 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.331 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 t -91.42 57.08 3.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 117.656 0.728 . . . . 0.0 111.268 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.65 34.46 50.14 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 114.03 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.0 -154.38 25.37 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.8 mmt180 -115.62 154.6 29.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.3 -0.45 . . . . 0.0 111.21 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -62.0 158.19 16.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.171 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -155.3 -95.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.43 -171.23 1.74 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.994 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.48 86.51 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.774 0.671 . . . . 0.0 109.341 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 56.72 67.38 2.25 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.4 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -132.8 145.98 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -132.09 104.27 6.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -87.46 141.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -173.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.519 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.1 m -105.23 -179.76 0.8 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.817 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.519 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -73.08 -11.39 25.26 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.584 2.19 . . . . 0.0 112.523 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 -31.85 7.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.58 170.04 39.39 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.224 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 6.3 m -93.83 166.14 12.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.533 0.682 . . . . 0.0 112.326 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.605 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.16 141.45 21.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.654 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.26 117.67 5.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.063 0.458 . . . . 0.0 110.568 -179.202 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.724 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 50.6 p30 -99.56 110.02 57.23 Favored Pre-proline 0 N--CA 1.44 -0.974 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.3 Cg_exo -56.93 -14.85 15.21 Favored 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 124.099 3.199 . . . . 0.0 109.764 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.63 -27.5 62.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.255 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -111.07 -27.56 8.69 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -175.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.0 t70 173.05 -29.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.413 1 N-CA-C 122.311 4.189 . . . . 0.0 122.311 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.4 Cg_endo -106.22 -71.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 112.576 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -69.35 -5.77 25.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.36 -157.94 0.09 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.941 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.2 -178.9 0.69 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.682 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.17 62.4 0.92 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.787 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -93.82 -170.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.598 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.82 162.9 28.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.658 0.742 . . . . 0.0 112.971 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -83.18 -76.57 0.27 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.404 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.35 -136.56 0.09 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.81 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.94 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.9 -40.57 68.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' CG2' HD11 ' A' ' 5' ' ' LEU . 19.4 m -94.58 101.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 87.0 mtt180 -67.65 -164.76 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.904 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER 46.75 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.213 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.041 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 19.6 Cg_exo . . . . . 0 N--CA 1.459 -0.54 0 CA-C-O 121.322 0.468 . . . . 0.0 112.233 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.6 t -158.06 -176.54 5.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.268 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.79 -136.06 50.42 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.36 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 12.7 Cg_endo -89.79 108.53 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 112.847 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.17 -67.39 2.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.068 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.27 32.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.439 0.466 . . . . 0.0 112.686 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.69 -36.88 73.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.063 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -103.01 -174.56 26.55 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.786 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.23 179.5 7.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -84.03 146.99 27.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 13.0 m-85 -120.96 -101.98 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.938 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.68 -98.56 0.35 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.669 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 26' ' ' ILE . 26.3 Cg_endo -99.7 -119.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.617 2.878 . . . . 0.0 111.627 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.98 51.38 0.4 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -128.07 157.12 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 122.251 1.024 . . . . 0.0 113.35 -176.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -154.97 134.16 12.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.607 178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 32.2 m -152.1 119.38 5.94 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.783 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.96 122.55 7.35 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.369 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 44.1 t0 -58.08 -56.32 23.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.73 1.265 . . . . 0.0 107.824 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.02 24.82 0.74 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.87 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -157.84 33.17 0.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.764 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 51.08 172.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -104.17 129.77 51.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.53 116.66 17.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.55 177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -97.95 106.89 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.065 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.39 26.41 56.56 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.895 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.6 m -95.95 173.46 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.611 0.364 . . . . 0.0 110.62 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.72 -56.57 4.33 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.327 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.4 mp0 -73.07 6.16 2.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -113.27 -21.62 10.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.87 -19.15 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.585 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.6 -23.67 6.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.886 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.401 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.658 0.266 . . . . 0.0 110.486 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.5 Cg_exo -40.01 159.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.237 3.291 . . . . 0.0 116.982 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.19 152.64 10.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.767 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.94 3.25 6.97 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.955 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -90.27 57.29 3.67 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 117.33 0.565 . . . . 0.0 111.135 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.8 34.31 36.83 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.85 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.535 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.74 -156.57 28.6 Favored Glycine 0 CA--C 1.502 -0.739 0 C-N-CA 120.449 -0.882 . . . . 0.0 115.128 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.7 mmt-85 -116.32 152.94 32.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.189 0.519 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -63.61 160.54 16.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.579 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -159.97 -96.1 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.782 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -75.9 -169.81 1.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.876 0.87 . . . . 0.0 112.558 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.793 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -38.16 97.46 0.01 OUTLIER 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.508 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.947 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 50.81 30.47 21.75 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.099 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.05 HG13 ' HB3' ' A' ' 69' ' ' ALA . 5.1 mm -90.34 155.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 122.097 0.951 . . . . 0.0 111.628 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.728 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 19.0 t -141.81 106.52 4.88 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -91.61 160.56 15.33 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.505 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -127.11 -179.83 1.04 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 113.996 -1.457 . . . . 0.0 110.052 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.2 Cg_exo -72.67 -10.83 25.58 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.453 2.102 . . . . 0.0 112.352 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.91 -29.5 9.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.87 31.27 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.437 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.597 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.2 m -97.81 167.94 10.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.097 0.475 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.708 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -151.87 144.61 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.391 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -61.92 94.29 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.1 m-20 -91.85 126.78 52.43 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.881 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 34.0 Cg_exo -59.83 -3.25 2.01 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 123.658 2.905 . . . . 0.0 109.716 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.39 -25.76 59.68 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.309 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.947 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.3 m -127.46 -20.14 4.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.8 t70 171.18 -26.15 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.068 1 N-CA-C 121.909 4.04 . . . . 0.0 121.909 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.814 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.1 Cg_endo -103.1 -70.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.656 0 C-N-CA 122.335 2.024 . . . . 0.0 112.135 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.628 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -72.52 -6.97 47.56 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.051 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.881 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.67 -157.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 112.436 -2.166 . . . . 0.0 112.546 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.79 -178.32 1.49 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.122 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -74.37 62.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.257 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.912 HG22 ' H ' ' A' ' 3' ' ' LEU . 3.6 p -144.69 -162.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.383 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.912 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -70.47 157.3 38.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.84 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.33 -122.69 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.185 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.855 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -94.97 -139.44 0.24 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.855 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.97 -36.15 49.36 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.817 HG22 HD21 ' A' ' 5' ' ' LEU . 28.0 m -100.98 85.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.33 0.586 . . . . 0.0 111.495 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.6 ' HE ' ' HG ' ' A' ' 3' ' ' LEU . 9.2 mtt180 -73.09 123.97 24.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.048 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -173.35 74.38 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.667 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 6.6 Cg_exo . . . . . 0 N--CA 1.458 -0.613 0 N-CA-C 114.121 0.777 . . . . 0.0 114.121 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 8.2 t -153.75 -171.21 3.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.05 -136.93 49.97 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.555 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.8 Cg_endo -89.06 98.71 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.641 3.561 . . . . 0.0 112.965 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.07 -67.18 3.71 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.558 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.9 34.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-O 121.744 0.636 . . . . 0.0 112.282 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.83 -34.41 69.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.371 -0.915 . . . . 0.0 110.264 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.74 -168.34 15.32 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.821 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.52 -179.54 7.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.726 0.263 . . . . 0.0 110.612 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.443 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 1.7 m -78.59 158.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 37.6 m-85 -138.99 -69.52 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.919 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -132.5 -105.05 0.95 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.177 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -100.28 105.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.444 2.763 . . . . 0.0 113.037 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 52.5 21.98 1.98 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.756 0.313 . . . . 0.0 110.264 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.919 HG22 ' H ' ' A' ' 23' ' ' GLY . 4.8 tt -110.84 160.93 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.22 1.009 . . . . 0.0 112.763 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 145.62 27.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.736 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.43 103.84 3.72 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.897 -177.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.86 118.84 5.71 Favored Glycine 0 N--CA 1.409 -3.133 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.804 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 26.0 t0 -58.25 -57.72 11.65 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -83.09 21.78 1.04 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.24 35.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.71 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.23 -169.97 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.289 0.476 . . . . 0.0 114.289 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.3 t -125.17 138.24 54.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.764 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.03 119.32 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.493 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.4 t -95.2 105.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.804 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.25 22.15 55.17 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.855 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -89.09 178.64 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.553 0.341 . . . . 0.0 110.163 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -50.21 -56.42 11.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.827 0.346 . . . . 0.0 111.171 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.85 5.12 3.44 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.05 -23.91 12.15 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.732 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.98 -17.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.86 -23.18 1.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 111.482 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.71 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.01 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.77 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 31.5 Cg_exo -37.23 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.979 3.12 . . . . 0.0 117.362 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -161.66 152.99 18.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.43 177.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.27 4.73 7.93 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.881 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -90.34 54.55 2.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 117.395 0.597 . . . . 0.0 111.099 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.15 32.86 50.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.33 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.699 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 165.16 -158.7 31.64 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.307 -0.949 . . . . 0.0 114.921 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.77 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.0 mmt180 -117.33 154.08 31.87 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.017 0.437 . . . . 0.0 110.922 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 1.01 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 38.2 t -60.17 167.0 2.57 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.815 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -165.76 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.824 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.023 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.46 -169.7 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.827 0.851 . . . . 0.0 112.884 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.822 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.07 96.21 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 51.87 29.15 26.11 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.162 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.023 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -91.46 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 121.872 0.844 . . . . 0.0 111.397 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.714 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 44.6 t -139.6 108.4 5.96 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.648 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.9 t -91.04 155.9 18.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.52 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -128.97 -179.6 1.04 Allowed Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 114.062 -1.427 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.8 Cg_exo -72.22 -11.05 26.59 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.427 2.084 . . . . 0.0 112.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.97 -27.1 13.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.59 170.19 24.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.135 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.614 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.9 m -94.98 163.26 13.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 111.039 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.76 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.21 148.73 29.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.068 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.89 93.14 0.18 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.714 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.0 m-20 -91.4 128.57 46.4 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.89 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 31.4 Cg_exo -60.58 -2.45 2.0 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.445 2.763 . . . . 0.0 109.721 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.94 -24.99 58.57 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.034 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.914 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.4 m -128.98 -21.01 3.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.1 t70 171.67 -26.33 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.406 1 N-CA-C 122.163 4.134 . . . . 0.0 122.163 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.836 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 5.4 Cg_endo -102.18 -70.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.635 0 CA-C-N 122.693 1.997 . . . . 0.0 111.788 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.598 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.3 tt0 -72.89 -6.66 46.64 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.153 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.89 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.19 -157.81 0.08 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.646 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -70.33 -178.32 1.68 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.15 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -74.92 61.99 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.312 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.774 0.321 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.97 152.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.83 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.599 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.59 166.05 24.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.04 -136.27 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.32 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -94.87 -124.5 0.11 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.703 ' H ' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -73.06 -47.72 42.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.588 HG22 HD11 ' A' ' 5' ' ' LEU . 18.7 m -87.36 85.87 2.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.599 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 57.4 mtt180 -74.8 -162.98 0.18 Allowed 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.451 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 41.38 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.767 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.769 -179.521 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.586 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo . . . . . 0 N--CA 1.462 -0.371 0 CA-C-O 121.338 0.474 . . . . 0.0 113.207 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.5 t -156.89 -172.39 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.752 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.79 -139.49 47.12 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.637 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.9 Cg_endo -88.92 98.16 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.371 3.381 . . . . 0.0 112.721 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -73.66 1.39 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.59 34.36 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 121.637 0.576 . . . . 0.0 111.878 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.68 -37.9 67.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.284 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.02 -168.14 22.28 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.758 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.698 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.41 -179.22 6.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.26 148.58 33.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.857 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -128.1 -19.71 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 169.67 -104.21 0.2 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 118.999 -1.572 . . . . 0.0 114.81 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 28.8 Cg_endo -101.74 107.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.717 2.945 . . . . 0.0 113.12 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.52 22.6 1.58 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.182 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.857 HG23 ' HB2' ' A' ' 22' ' ' PHE . 3.3 tt -115.13 157.1 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 122.258 1.028 . . . . 0.0 113.029 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.557 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -160.43 138.45 9.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.356 -1.747 . . . . 0.0 107.35 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 20.4 m -150.1 128.35 12.06 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.097 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -107.02 126.63 8.51 Favored Glycine 0 N--CA 1.407 -3.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 37.3 t0 -59.16 -59.57 5.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.998 1.399 . . . . 0.0 108.722 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -81.09 15.15 1.98 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -144.16 31.49 1.24 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.083 -175.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.651 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.33 175.61 0.01 OUTLIER Glycine 0 CA--C 1.521 0.445 0 N-CA-C 114.899 0.719 . . . . 0.0 114.899 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -100.11 134.45 43.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.857 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 30.2 m-85 -131.04 101.66 5.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.404 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.752 HG13 HG13 ' A' ' 26' ' ' ILE . 4.5 t -97.16 107.36 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.253 0.549 . . . . 0.0 110.23 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.47 -0.0 44.5 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.394 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.9 p -70.13 -168.24 0.21 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 117.338 0.569 . . . . 0.0 110.245 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -76.61 -39.08 53.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.323 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -74.7 7.27 3.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.295 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -112.91 -21.12 11.3 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.745 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -51.15 -15.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.02 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.742 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.69 -21.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.254 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 44.4 Cg_exo -38.81 154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.761 2.307 . . . . 0.0 115.648 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -162.11 154.58 19.62 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.881 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 7.11 7.72 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.287 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 t -91.53 51.72 1.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.42 32.91 61.25 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.624 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.728 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.42 -153.96 24.67 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.533 -0.842 . . . . 0.0 115.202 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.785 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.0 mmt-85 -120.89 159.24 25.92 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.594 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.6 t -55.86 155.8 5.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -150.89 -26.82 0.21 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -157.67 -171.35 3.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.397 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.33 86.31 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 57.27 65.54 3.49 Favored Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.939 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.759 HG21 ' SG ' ' A' ' 34' ' ' CYS . 3.3 mm -136.77 136.6 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.1 t -122.98 109.58 14.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -96.23 158.59 15.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -173.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.542 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.2 m -128.26 -179.92 1.1 Allowed Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.315 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -72.14 -9.42 24.44 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.376 2.051 . . . . 0.0 112.687 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.88 -32.42 8.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.255 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.25 170.21 36.58 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.684 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 27.0 m -96.88 167.4 11.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.394 0.616 . . . . 0.0 111.87 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.556 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.98 142.92 21.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.596 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -62.87 117.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.024 0.44 . . . . 0.0 110.947 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 47.5 p30 -101.04 108.25 53.66 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.681 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.1 Cg_exo -56.37 -15.69 15.78 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.855 3.037 . . . . 0.0 110.084 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.04 64.13 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.66 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.986 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -109.54 -27.42 9.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -176.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.3 t70 172.56 -29.44 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.633 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.051 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.3 Cg_endo -108.97 -71.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 123.099 2.533 . . . . 0.0 112.767 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -67.74 -5.85 18.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.681 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -73.49 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 112.047 -2.342 . . . . 0.0 111.057 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -63.71 -178.82 0.32 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -74.42 62.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.41 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.798 0.332 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.0 t 64.05 168.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.536 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.552 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -69.66 156.85 38.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.668 0.747 . . . . 0.0 112.73 -178.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.54 -77.0 0.23 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.882 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -139.86 -139.59 0.13 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.474 -178.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.882 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -76.24 -38.43 56.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.73 0.3 . . . . 0.0 110.923 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -93.33 85.0 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 121.367 0.603 . . . . 0.0 110.677 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 56.4 mtt85 -74.33 -178.73 3.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.183 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m 57.38 101.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.572 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.524 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 23.8 Cg_exo . . . . . 0 N--CA 1.461 -0.386 0 CA-C-O 121.042 0.351 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.4 t -157.5 -179.98 8.69 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.903 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.89 -134.79 49.28 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.637 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 7.7 Cg_endo -91.89 99.5 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.562 3.508 . . . . 0.0 112.951 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.87 -69.13 3.13 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.56 32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 CA-C-O 121.533 0.518 . . . . 0.0 112.332 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -33.8 71.66 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.848 0.832 . . . . 0.0 109.862 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.8 -174.84 20.93 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.807 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.94 -178.95 5.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.6 m -77.57 141.21 39.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-85 -119.11 -23.67 6.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.567 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.56 -110.54 0.24 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.586 -1.293 . . . . 0.0 114.317 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.91 101.37 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 112.643 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 21.45 3.64 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.752 -0.379 . . . . 0.0 109.991 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 23' ' ' GLY . 2.3 tt -107.76 166.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.832 0.825 . . . . 0.0 112.742 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -153.76 140.45 18.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.37 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -144.88 100.91 3.57 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.876 -177.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.969 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.13 117.82 5.01 Favored Glycine 0 N--CA 1.405 -3.407 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.295 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.688 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 21.0 t0 -58.75 -57.27 13.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -83.87 20.14 1.56 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.969 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.61 33.22 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.691 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.53 176.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 t -115.83 134.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.65 125.88 31.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.568 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -93.81 101.71 12.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.131 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.84 19.51 50.08 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.12 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.706 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 2.0 m -83.27 174.73 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.893 0.477 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -43.75 -55.8 4.21 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.15 -7.61 50.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.99 -16.96 15.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.731 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -19.0 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.638 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.47 -24.01 2.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.126 0.421 . . . . 0.0 111.26 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -38.74 155.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.133 3.222 . . . . 0.0 117.619 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -165.04 153.31 11.83 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.824 177.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 5.53 3.01 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.97 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.7 t -90.66 54.03 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 117.425 0.612 . . . . 0.0 111.164 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.98 33.21 56.92 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.861 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.662 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.0 -154.09 24.96 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.642 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.726 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 7.3 mmt180 -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.153 0.502 . . . . 0.0 110.986 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 46.2 t -62.32 157.94 18.56 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.039 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -155.39 -91.65 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 33' ' ' GLY . . . -77.66 -171.18 2.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.959 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.37 90.68 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.004 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.88 62.4 6.36 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 119.062 -1.542 . . . . 0.0 110.89 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -129.99 149.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.4 t -136.63 102.99 5.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -91.37 160.11 15.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.524 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -127.85 -179.49 0.98 Allowed Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.261 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.51 -10.08 24.89 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.364 2.042 . . . . 0.0 112.634 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -31.2 8.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.482 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.1 167.73 34.05 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.465 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 16.3 m -96.0 167.11 11.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.383 0.611 . . . . 0.0 112.4 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.641 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -151.57 140.77 21.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.977 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -62.18 116.68 5.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.894 0.378 . . . . 0.0 110.534 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.777 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 52.2 p30 -99.06 109.32 53.72 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-O 121.573 0.701 . . . . 0.0 111.702 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.82 -14.61 14.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.064 3.176 . . . . 0.0 110.06 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.96 -27.84 62.06 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.123 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -109.89 -28.45 8.75 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -176.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 173.6 -29.18 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.253 1 N-CA-C 122.371 4.211 . . . . 0.0 122.371 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.004 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -106.01 -70.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.459 0 C-N-CA 122.628 2.219 . . . . 0.0 112.568 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.709 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.3 tt0 -69.04 -7.07 32.19 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.733 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.5 -157.76 0.07 Allowed 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.635 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.01 -179.3 1.18 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -74.76 62.36 1.07 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.57 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.06 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.853 0.359 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -67.8 156.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.126 0.488 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.747 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.64 169.69 17.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.449 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 18.9 t0 -78.59 -137.55 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 113.952 -1.476 . . . . 0.0 108.192 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.676 HD11 HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -91.28 -123.62 0.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -72.23 -45.6 59.58 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.676 HG22 HD11 ' A' ' 5' ' ' LEU . 11.1 m -88.13 85.19 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.662 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.747 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 51.5 mtt85 -75.56 -177.12 3.51 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 27.62 104.54 0.0 OUTLIER 'General case' 0 C--N 1.34 0.17 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.972 179.661 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 22.7 Cg_exo . . . . . 0 N--CA 1.445 -1.366 0 CA-C-O 121.061 0.359 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 43' ' ' ARG . 4.0 t -158.85 -172.39 3.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 65.02 -141.34 43.28 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.14 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.95 89.6 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.018 3.145 . . . . 0.0 112.881 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.48 -68.28 0.94 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.301 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.99 34.12 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-O 121.632 0.573 . . . . 0.0 112.022 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -73.0 -35.82 66.92 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.339 -0.93 . . . . 0.0 110.61 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.74 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -111.1 -162.04 17.57 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.293 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.86 174.28 13.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -89.18 170.34 10.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.823 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 67.5 m-85 -144.02 -12.05 0.65 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.42 -95.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 118.691 -1.718 . . . . 0.0 115.055 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -101.07 99.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.378 2.718 . . . . 0.0 113.481 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.59 21.84 1.98 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.316 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.667 HG13 HG13 ' A' ' 36' ' ' VAL . 3.8 tt -108.95 160.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -157.32 145.47 19.23 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 113.745 -1.57 . . . . 0.0 108.653 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.836 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.95 106.25 3.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.553 -178.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.883 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.23 128.22 8.96 Favored Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.63 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.909 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 35.9 t70 -58.5 -65.84 0.59 Allowed 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 pt-20 -81.36 26.87 0.44 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.883 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.58 31.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 36.49 -166.7 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.5 142.88 38.25 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.724 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 10.3 m-85 -131.93 98.0 4.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.391 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.667 HG13 HG13 ' A' ' 26' ' ' ILE . 3.5 t -95.75 130.71 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.211 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.76 28.53 5.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.811 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -109.23 170.25 8.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.46 0.304 . . . . 0.0 110.66 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -54.95 -55.12 34.21 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.56 8.89 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -107.05 -37.3 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -56.83 -11.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.676 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.8 -13.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 18.0 t . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 120.874 0.369 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 27.3 Cg_exo -61.72 179.56 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.277 2.651 . . . . 0.0 115.615 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.74 154.32 9.51 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.256 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.07 -0.03 6.77 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.277 -0.874 . . . . 0.0 114.141 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.7 t -92.08 50.79 1.7 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 117.478 0.639 . . . . 0.0 111.369 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.69 40.91 49.36 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.083 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.644 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.68 -159.44 32.44 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.4 mmt180 -114.68 155.99 25.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.094 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 23.9 t -61.11 144.89 52.71 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.523 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ASP . . . -139.85 -97.82 0.16 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.271 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.909 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.51 -170.21 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -43.73 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.958 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 54.8 71.61 0.69 Allowed Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.179 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.836 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.2 mm -137.01 145.47 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 33.8 t -132.08 103.67 6.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -91.44 152.36 20.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.493 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -125.07 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.892 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.493 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -71.72 -9.71 25.35 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -33.0 8.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.021 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.09 169.92 34.65 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.562 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 3.3 m -98.68 164.43 12.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.102 0.477 . . . . 0.0 111.132 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.63 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.67 141.81 21.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.03 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -58.81 111.3 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.853 0.358 . . . . 0.0 110.102 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.675 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.1 p30 -92.03 110.5 44.46 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.751 . . . . 0.0 111.683 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.734 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -57.49 -13.02 12.3 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.188 3.258 . . . . 0.0 110.086 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.33 -30.0 57.51 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.561 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.958 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -108.93 -27.27 9.78 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 5.4 t70 175.37 -29.97 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 1 N-CA-C 122.28 4.178 . . . . 0.0 122.28 -177.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.94 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.2 Cg_endo -104.28 -70.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.46 0 C-N-CA 122.45 2.1 . . . . 0.0 112.242 -172.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 28.9 tt0 -70.36 -8.48 50.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.717 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.85 -157.64 0.08 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.89 -2.414 . . . . 0.0 112.741 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.46 -178.7 1.46 Allowed 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.929 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -74.42 62.39 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.6 t . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.027 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.342 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.94 -172.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.556 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.09 159.92 33.83 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.709 0.766 . . . . 0.0 112.723 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.29 -124.98 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.721 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.833 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -95.16 -136.79 0.22 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.833 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -73.99 -39.85 63.37 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.77 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -95.04 85.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.556 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 20.4 mtt180 -73.92 -163.2 0.16 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.272 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.461 ' O ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER 41.69 85.74 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.529 0.165 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.303 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.511 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.5 Cg_exo . . . . . 0 N--CA 1.462 -0.367 0 CA-C-O 121.567 0.57 . . . . 0.0 113.189 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' GLY . 2.0 t -156.84 -175.81 5.63 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.242 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.01 -138.68 48.7 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.657 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.7 Cg_endo -90.32 100.23 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.371 3.381 . . . . 0.0 112.808 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.14 -69.08 3.09 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.152 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.57 31.4 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 121.386 0.437 . . . . 0.0 112.489 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.09 -36.69 72.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.646 0.736 . . . . 0.0 109.946 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.07 -174.44 23.56 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.155 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.3 -178.79 5.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.63 151.53 37.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 11.3 m-85 -133.51 -17.72 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -179.0 -112.07 0.33 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.937 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -101.15 107.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.572 2.848 . . . . 0.0 112.744 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.48 24.12 2.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 36' ' ' VAL . 1.9 tt -114.6 161.79 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.922 0.868 . . . . 0.0 113.118 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 141.4 22.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.371 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.646 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -144.13 102.66 3.9 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.839 -177.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.906 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.43 118.72 5.28 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.023 -1.561 . . . . 0.0 109.42 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.706 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -57.93 -61.67 2.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -81.31 19.9 0.91 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.437 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.906 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -150.48 32.77 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.657 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.34 175.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.448 0.539 . . . . 0.0 114.448 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -111.39 136.54 50.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.23 119.74 21.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.327 178.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -93.98 102.08 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.725 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.46 50.89 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.843 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 m -86.29 179.42 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.304 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.61 -61.07 1.7 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.67 5.76 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.01 -24.28 12.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.85 -15.42 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -51.58 -23.21 3.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.77 0.319 . . . . 0.0 111.334 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.439 179.558 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 49.6 Cg_exo -39.76 154.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.242 3.294 . . . . 0.0 117.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.58 152.89 12.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.478 177.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.02 5.8 4.45 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.735 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -90.97 53.71 2.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 117.252 0.526 . . . . 0.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.13 61.04 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.923 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.596 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.82 -151.23 20.93 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.629 -0.796 . . . . 0.0 114.87 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.712 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -118.11 152.87 34.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.7 t -63.91 149.64 46.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.583 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -146.92 -93.32 0.09 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.901 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.31 -170.74 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.919 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.95 91.04 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.988 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.73 60.51 8.73 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.798 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -128.96 146.55 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 17.0 t -134.48 101.78 5.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -90.08 160.19 16.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.468 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.2 m -129.59 -179.46 1.02 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.92 -10.94 25.29 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.326 2.017 . . . . 0.0 112.144 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.81 -30.55 9.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.312 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.68 169.96 34.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.551 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.4 m -96.75 166.71 11.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.436 0.636 . . . . 0.0 112.147 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.27 138.06 17.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.715 178.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.3 pt-20 -59.52 116.53 4.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.961 0.41 . . . . 0.0 110.42 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.796 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.5 p30 -98.8 109.74 54.69 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-O 121.578 0.704 . . . . 0.0 111.552 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 51.1 Cg_exo -56.67 -16.08 18.18 Favored 'Trans proline' 0 CA--C 1.503 -1.038 0 C-N-CA 123.92 3.08 . . . . 0.0 110.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.68 -29.37 64.52 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.161 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.85 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.94 -27.88 9.44 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -176.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.9 t70 173.88 -27.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.158 1 N-CA-C 122.38 4.215 . . . . 0.0 122.38 -178.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.988 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.4 Cg_endo -107.18 -71.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.5 0 C-N-CA 122.476 2.117 . . . . 0.0 112.734 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 29.5 tt0 -68.87 -6.74 28.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.2 -155.83 0.05 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.093 -2.321 . . . . 0.0 111.924 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.78 -178.51 0.96 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.809 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -73.81 62.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.241 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.761 0.315 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.31 156.13 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.212 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.734 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.78 171.19 10.96 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.991 0.9 . . . . 0.0 113.228 -178.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 13.0 t0 -80.11 -139.54 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.46 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -91.88 -119.98 0.08 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 122.393 -0.192 . . . . 0.0 110.773 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.659 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.57 -47.09 43.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 7' ' ' VAL . 14.5 m -88.61 84.01 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.914 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.734 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 62.3 mtt180 -82.18 160.99 22.93 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.518 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' CYS . 5.9 m 60.98 129.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.959 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 20.9 Cg_exo . . . . . 0 N--CA 1.461 -0.425 0 N-CA-C 114.127 0.78 . . . . 0.0 114.127 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' GLY . 3.4 t -153.74 -174.24 4.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.456 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.61 51.69 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.073 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -82.52 87.56 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.772 2.981 . . . . 0.0 112.564 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 100.32 -67.5 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.042 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.585 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.8 34.1 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 121.645 0.581 . . . . 0.0 111.955 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.82 -36.71 70.31 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.84 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.57 -167.92 18.42 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.502 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -165.52 179.5 6.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.62 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 32.4 m -77.08 149.45 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.741 ' HE2' ' HB3' ' A' ' 28' ' ' CYS . 15.9 m-30 -139.09 26.43 2.43 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 139.53 -106.2 0.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.272 -1.442 . . . . 0.0 114.643 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 24.1 Cg_endo -104.81 100.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.46 2.773 . . . . 0.0 113.466 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.88 26.24 4.49 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.369 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.621 HG23 ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -111.52 160.13 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -156.09 138.96 15.28 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.52 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -146.48 105.61 3.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.477 -178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.29 129.87 9.36 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.337 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.907 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 12.7 t70 -58.83 -63.34 1.33 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -82.03 13.9 3.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -142.56 38.55 1.52 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.799 -174.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.863 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 29.22 -163.34 0.0 OUTLIER Glycine 0 CA--C 1.531 1.091 0 N-CA-C 115.995 1.158 . . . . 0.0 115.995 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.11 137.16 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.808 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 6.8 m-85 -132.89 106.73 7.88 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.583 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 26' ' ' ILE . 6.6 t -94.62 103.73 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.783 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.45 16.81 55.61 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.937 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.723 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -85.44 173.11 10.5 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -43.22 -55.57 3.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.802 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.9 -3.0 13.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -104.25 -21.8 13.47 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.747 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.78 -20.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.66 -19.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 36.2 Cg_exo -40.09 155.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.826 3.017 . . . . 0.0 116.659 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.6 154.52 20.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.505 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.45 4.0 5.49 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 114.051 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.2 t -90.58 54.67 2.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 117.382 0.591 . . . . 0.0 111.424 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.95 61.86 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.121 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.63 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 160.87 -152.17 22.76 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.994 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.5 mmt-85 -116.91 157.47 25.63 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.593 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.869 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 17.0 t -63.26 160.9 14.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.109 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -153.07 -97.26 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.34 -169.83 1.54 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.4 88.48 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.006 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 55.86 72.06 0.63 Allowed Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 118.854 -1.641 . . . . 0.0 110.439 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.7 mm -138.37 145.97 27.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.9 t -133.25 104.72 6.61 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -91.07 147.91 22.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -174.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -116.42 -179.47 0.64 Allowed Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.996 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.1 Cg_exo -72.62 -11.18 25.98 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.503 2.136 . . . . 0.0 112.223 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.71 -31.19 9.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.018 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 26' ' ' ILE . . . 174.05 170.45 37.4 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.855 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.5 m -98.24 163.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.191 0.519 . . . . 0.0 110.956 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.576 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.95 140.11 19.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.917 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.12 114.14 2.24 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.968 0.413 . . . . 0.0 110.001 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 85' ' ' CYS . 50.4 p30 -95.21 110.16 48.82 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-O 121.712 0.767 . . . . 0.0 111.423 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.8 Cg_exo -57.59 -13.8 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 124.109 3.206 . . . . 0.0 109.973 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.23 -26.35 60.19 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.281 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.006 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -110.85 -29.82 7.8 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -175.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.42 -29.75 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.33 1 N-CA-C 122.31 4.189 . . . . 0.0 122.31 -176.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.902 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -105.21 -71.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 122.61 2.207 . . . . 0.0 112.423 -172.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.63 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -70.71 -5.7 31.82 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.09 -158.23 0.09 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 111.861 -2.427 . . . . 0.0 112.769 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.13 -178.8 1.1 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.73 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.01 61.78 0.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.956 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.836 HG22 ' H ' ' A' ' 3' ' ' LEU . 2.6 p -84.05 -159.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.0 111.52 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.836 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -72.44 168.3 18.76 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.869 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.568 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 2.2 t70 -76.87 -90.99 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.65 -75.68 0.32 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.71 0.767 . . . . 0.0 110.138 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.968 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.67 -44.86 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.26 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.733 HG22 HD21 ' A' ' 5' ' ' LEU . 34.3 m -115.96 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.524 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.639 ' HD2' HD12 ' A' ' 3' ' ' LEU . 5.3 mtt-85 -75.42 175.35 8.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.277 0.56 . . . . 0.0 112.224 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.6 40.83 0.17 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.224 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.87 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.2 Cg_exo . . . . . 0 N--CA 1.459 -0.521 0 CA-C-O 121.108 0.378 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -157.36 -178.17 7.15 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.64 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.71 -134.54 47.1 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.556 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.5 Cg_endo -92.31 100.15 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.607 3.538 . . . . 0.0 112.763 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 -68.71 3.38 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.965 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.72 31.58 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.369 0.427 . . . . 0.0 112.739 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.11 -36.02 74.55 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.641 0.734 . . . . 0.0 109.792 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.12 -172.59 22.48 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.077 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.462 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -163.75 179.28 7.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.15 154.9 35.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' HG23 ' A' ' 26' ' ' ILE . 9.4 m-85 -131.08 -43.18 1.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.749 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -158.73 -103.44 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.189 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -98.16 104.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.069 2.513 . . . . 0.0 112.844 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.61 26.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.801 0.334 . . . . 0.0 110.401 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.749 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.7 tt -114.17 164.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.064 0.935 . . . . 0.0 113.361 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.54 140.94 21.51 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.316 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -146.5 102.06 3.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.908 -177.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -87.71 113.56 4.02 Favored Glycine 0 N--CA 1.402 -3.597 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.055 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.3 t0 -57.97 -54.3 48.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.7 pt-20 -83.65 15.97 2.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.93 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.6 41.81 0.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.712 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.96 -167.67 0.01 OUTLIER Glycine 0 N--CA 1.463 0.445 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -129.92 134.15 47.3 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.835 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.35 124.5 28.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.466 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.516 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.11 101.59 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.096 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.35 24.95 47.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.775 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.781 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 5.2 m -87.39 173.41 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.895 0.478 . . . . 0.0 109.757 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -42.75 -53.58 4.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 111.254 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -72.98 -7.96 53.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.73 -14.86 15.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.701 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.66 -16.47 0.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.97 -26.47 4.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.093 0.473 . . . . 0.0 111.041 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.497 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.662 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 61.8 Cg_exo -41.52 157.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.915 3.077 . . . . 0.0 117.585 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.628 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.63 153.21 12.6 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.358 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.51 2.85 4.02 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.288 -0.869 . . . . 0.0 114.038 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.8 t -89.24 54.59 3.0 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.556 0.678 . . . . 0.0 111.557 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.66 32.3 58.39 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.235 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.612 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.15 -150.86 20.17 Favored Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 120.659 -0.782 . . . . 0.0 114.763 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 7.6 mmt180 -116.94 154.16 31.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.066 0.46 . . . . 0.0 110.971 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -63.49 161.04 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.509 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -160.64 -92.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.8 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.94 -170.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.47 90.95 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.923 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.22 62.94 5.63 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 118.57 -1.776 . . . . 0.0 109.893 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.8 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm -129.99 146.26 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.4 t -134.24 103.92 5.96 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.525 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -117.31 -179.36 0.63 Allowed Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.525 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -72.35 -11.46 26.69 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.331 2.021 . . . . 0.0 112.732 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -30.47 8.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 111.329 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.65 170.15 36.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.302 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.6 m -95.76 165.98 12.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.182 0.515 . . . . 0.0 112.184 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.616 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -151.69 141.26 21.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.445 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -56.91 113.13 1.54 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.838 0.351 . . . . 0.0 110.296 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.804 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.6 p30 -97.91 110.86 57.42 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 121.878 0.847 . . . . 0.0 112.307 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.769 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.0 Cg_exo -56.75 -17.36 22.85 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 124.174 3.25 . . . . 0.0 110.025 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.48 63.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.628 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.898 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -110.88 -27.83 8.65 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 -175.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.6 t70 174.32 -28.95 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.213 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.923 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.5 Cg_endo -105.66 -71.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.54 2.16 . . . . 0.0 112.518 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.8 tp10 -69.37 -7.39 36.98 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.769 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.01 -155.21 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.113 -2.312 . . . . 0.0 112.493 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.45 -178.55 1.13 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.868 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -75.04 62.02 1.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' LEU . 2.7 t 61.55 167.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.633 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.53 168.4 17.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 122.117 0.961 . . . . 0.0 113.591 -178.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 10.8 t70 -80.52 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.25 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.748 HD11 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.0 -123.87 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.591 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -73.16 -44.13 60.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 HD11 ' A' ' 5' ' ' LEU . 9.4 m -88.71 86.69 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.095 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.635 ' HB3' HD12 ' A' ' 3' ' ' LEU . 41.4 mtt180 -70.88 -167.3 0.19 Allowed 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.977 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 43.87 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.968 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.235 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 39.4 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 CA-C-O 121.22 0.425 . . . . 0.0 112.775 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.8 t -157.31 -172.93 4.19 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.305 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.98 -139.31 47.94 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.445 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.0 Cg_endo -90.21 97.02 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.304 3.336 . . . . 0.0 112.771 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.2 -70.32 1.75 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.031 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.74 33.18 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.578 0.543 . . . . 0.0 112.133 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.96 -34.8 69.26 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.568 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -110.57 -167.73 19.32 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.732 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.566 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.31 177.25 9.13 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.86 156.09 30.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.643 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -130.55 -83.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.122 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -114.46 -103.74 2.53 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.816 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.8 118.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.65 2.9 . . . . 0.0 113.214 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.6 27.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 23' ' ' GLY . 2.6 tt -118.8 163.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.242 1.02 . . . . 0.0 113.453 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.62 140.99 21.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.529 -1.669 . . . . 0.0 108.284 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.9 106.65 4.27 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.718 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.65 116.41 5.09 Favored Glycine 0 N--CA 1.401 -3.65 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 22.8 t0 -57.94 -56.94 15.53 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.46 19.64 1.22 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -151.68 34.15 0.55 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.24 -169.55 0.01 OUTLIER Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.316 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 140.24 52.5 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.685 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 19.1 m-85 -131.16 115.18 16.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.141 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.0 t -94.14 101.72 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.436 0.636 . . . . 0.0 110.27 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.54 20.25 55.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.067 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.685 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.6 p -77.73 -173.15 2.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.07 -42.19 99.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -75.82 -10.83 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.456 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -100.93 -12.93 18.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.707 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -53.48 -14.28 0.77 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.24 -25.31 3.55 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.062 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.726 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 64.0 Cg_exo -41.36 157.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.278 3.319 . . . . 0.0 117.668 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -165.85 153.27 10.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.784 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.19 5.5 3.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.035 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -90.79 55.88 3.08 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 117.415 0.607 . . . . 0.0 111.25 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.26 31.96 56.95 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.953 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.34 -149.78 18.29 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.864 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.705 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.4 mmt180 -119.03 155.35 31.58 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.871 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 49.1 t -63.24 162.75 11.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.4 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -162.56 -91.59 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.78 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.83 -171.5 1.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.711 0.804 . . . . 0.0 112.929 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -47.49 91.14 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.936 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.44 60.74 8.32 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 118.605 -1.76 . . . . 0.0 110.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.78 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -128.58 147.49 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 24.3 t -136.18 103.59 5.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -87.31 152.19 22.49 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -173.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -121.24 -179.27 0.71 Allowed Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.963 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_exo -73.73 -13.22 24.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.501 2.134 . . . . 0.0 112.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.81 -26.96 12.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.967 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.88 171.21 32.73 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.89 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.3 m -93.42 166.21 12.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.398 0.618 . . . . 0.0 112.059 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.625 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -151.76 141.29 21.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.662 178.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -60.9 118.14 6.32 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.914 0.388 . . . . 0.0 110.89 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.0 p30 -99.75 109.39 55.43 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 121.577 0.703 . . . . 0.0 111.556 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.3 Cg_exo -56.55 -15.67 16.43 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 124.036 3.157 . . . . 0.0 110.192 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.49 63.51 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.141 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.882 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.91 -28.69 9.0 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -176.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.53 -29.16 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.164 1 N-CA-C 122.17 4.137 . . . . 0.0 122.17 -177.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.936 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -107.38 -71.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.409 0 C-N-CA 122.684 2.256 . . . . 0.0 112.926 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.696 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.75 -6.71 28.08 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -72.8 -152.95 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.731 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.81 -178.54 0.43 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.617 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -74.05 62.15 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.5 t . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.047 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.96 0.409 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 m -82.75 129.81 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.529 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.882 ' HG ' ' H ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.94 170.67 15.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.308 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 1.005 ' HB3' ' HD2' ' A' ' 8' ' ' ARG . 22.4 t70 -79.22 -74.13 0.3 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.039 HD22 ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -77.6 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.954 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 1.035 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -84.48 -77.12 0.28 Allowed 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 7' ' ' VAL . 18.7 m -121.72 82.16 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 1.039 ' HG3' HD22 ' A' ' 5' ' ' LEU . 34.9 mtt85 -84.68 -167.91 1.99 Allowed 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.247 -0.908 . . . . 0.0 111.214 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.35 80.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.965 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.152 179.714 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.656 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 53.4 Cg_exo . . . . . 0 C--O 1.233 0.263 0 N-CA-C 114.491 0.919 . . . . 0.0 114.491 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 7.3 t -160.18 -169.47 2.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.9 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 56.5 -142.83 39.67 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.491 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -86.24 93.43 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.972 3.115 . . . . 0.0 112.545 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.97 -69.7 1.13 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.689 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.26 32.22 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.43 0.461 . . . . 0.0 112.095 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.07 -36.4 69.55 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.753 0.787 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.53 -167.4 20.19 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.023 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.953 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.04 -179.51 6.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 41.8 t -83.87 155.76 22.75 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.497 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.953 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 45.6 m-85 -142.5 8.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 149.27 -103.09 0.25 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.016 -1.564 . . . . 0.0 115.351 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.4 Cg_endo -105.53 105.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.914 3.076 . . . . 0.0 113.31 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 52.46 18.92 1.03 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.558 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.716 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.8 tt -108.01 153.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.225 1.012 . . . . 0.0 113.533 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.902 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -160.36 138.03 9.65 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.48 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 21.4 m -147.9 110.03 4.56 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.524 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -90.62 131.16 10.62 Favored Glycine 0 N--CA 1.415 -2.702 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.482 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 17.2 t70 -59.51 -62.59 1.76 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.329 1.064 . . . . 0.0 109.462 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.654 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -75.57 -0.84 21.8 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -125.61 31.44 5.52 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.601 -176.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.9 -177.27 0.01 OUTLIER Glycine 0 N--CA 1.465 0.608 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -99.33 140.49 33.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.626 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 49.4 m-85 -130.91 143.5 50.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.164 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -142.83 119.73 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.025 0.44 . . . . 0.0 109.949 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.5 5.23 11.34 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.406 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.3 m -87.32 179.27 6.63 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 38' ' ' THR . . . -61.37 -54.27 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.69 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -60.89 8.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -108.97 -38.67 5.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.26 -15.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.35 -18.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.482 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.703 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 34.7 Cg_exo -38.6 176.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.829 3.02 . . . . 0.0 114.077 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.27 154.77 19.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.72 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.8 6.26 5.18 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.142 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.555 ' HB3' ' SG ' ' A' ' 73' ' ' CYS . 18.3 t -92.15 51.0 1.72 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.006 0.431 . . . . 0.0 111.081 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.33 25.79 63.16 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.072 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 74' ' ' CYS . . . 164.63 -152.37 22.0 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.733 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 5.6 mmt-85 -115.31 157.17 24.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.179 -0.51 . . . . 0.0 111.444 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.718 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 30.6 t -58.28 143.54 44.28 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.933 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.646 ' HB3' HG22 ' A' ' 72' ' ' ILE . . . -137.46 -95.23 0.21 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.323 0.583 . . . . 0.0 112.085 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.919 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.98 -172.54 2.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.419 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.941 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.92 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.029 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.3 71.11 0.76 Allowed Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 118.93 -1.605 . . . . 0.0 110.188 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.919 HG13 ' HB3' ' A' ' 69' ' ' ALA . 3.9 mm -138.53 146.25 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 23.4 t -135.14 104.19 5.83 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.751 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.6 t -91.33 152.87 20.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.544 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.7 m -119.6 -179.25 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.606 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.9 Cg_exo -72.18 -10.66 26.14 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.393 2.062 . . . . 0.0 112.154 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.92 -33.0 7.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.453 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.81 168.22 37.07 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -98.28 165.36 11.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 111.853 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.624 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.3 141.57 21.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.399 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.605 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.78 114.72 2.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.5 p30 -95.98 106.42 27.99 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 121.303 0.573 . . . . 0.0 111.296 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.817 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.84 -9.88 3.43 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 124.142 3.228 . . . . 0.0 110.495 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.18 -29.13 57.55 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.651 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -109.72 -27.77 9.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 118.122 2.638 . . . . 0.0 118.122 -176.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 175.6 -31.19 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.334 1 N-CA-C 122.179 4.14 . . . . 0.0 122.179 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.029 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.8 Cg_endo -105.46 -70.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.717 2.278 . . . . 0.0 112.097 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 65.0 tt0 -69.97 -6.65 34.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.735 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.25 -157.48 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.237 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.45 -178.82 0.72 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.48 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.36 62.36 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.204 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.791 0.329 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.73 162.37 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.201 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.568 ' HG ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.53 166.66 23.16 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.583 0.706 . . . . 0.0 112.564 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.763 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 50.1 t0 -78.78 -79.0 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.348 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -84.07 -150.78 0.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.815 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -82.47 -51.84 7.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.655 ' O ' HG23 ' A' ' 7' ' ' VAL . 32.5 m -119.44 84.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG3' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -81.87 158.99 23.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.89 65.25 0.3 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.553 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.665 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.7 Cg_exo . . . . . 0 N--CA 1.46 -0.448 0 CA-C-O 121.243 0.434 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.2 t -157.87 -176.38 5.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.898 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.37 -138.17 47.36 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.748 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 14.3 Cg_endo -89.6 98.15 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 124.456 3.437 . . . . 0.0 112.551 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.31 -69.04 2.84 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.129 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.69 32.86 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 121.54 0.522 . . . . 0.0 112.478 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.69 -35.49 72.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.043 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.91 -171.87 22.59 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.984 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.66 179.98 7.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 120.799 0.333 . . . . 0.0 110.135 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -80.44 145.12 32.1 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.7 m-85 -118.51 -60.3 1.79 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.871 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -142.12 -100.16 0.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.268 -0.967 . . . . 0.0 114.02 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.8 Cg_endo -100.85 105.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.344 2.696 . . . . 0.0 113.387 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.46 25.42 1.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 110.464 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 23' ' ' GLY . 3.0 tt -112.9 164.75 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.949 0.881 . . . . 0.0 112.922 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.44 141.28 22.81 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.033 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -145.38 108.76 4.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.708 -177.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -97.59 117.13 5.71 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.744 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 36.9 t0 -57.92 -56.56 20.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.553 1.177 . . . . 0.0 108.33 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.635 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -83.85 15.27 3.39 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -145.36 32.92 1.07 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.94 173.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.085 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t -112.98 136.84 52.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.67 125.28 29.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.822 177.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.8 t -95.18 97.7 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.53 14.19 56.95 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.854 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 4.7 m -78.54 -177.4 5.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 38' ' ' THR . . . -53.58 -55.55 24.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.267 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -72.66 4.21 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -114.25 -21.42 10.45 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.84 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.63 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.29 -25.84 4.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 118.305 0.502 . . . . 0.0 110.865 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.697 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.583 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 120.648 0.261 . . . . 0.0 111.376 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 25.8 Cg_exo -40.82 157.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.577 3.518 . . . . 0.0 118.563 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -164.62 153.99 13.37 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.869 176.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.7 7.01 1.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.54 -0.754 . . . . 0.0 114.122 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 24.2 t -92.85 52.08 1.79 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.397 0.598 . . . . 0.0 111.265 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.06 34.89 58.67 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.752 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.731 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.05 -151.44 21.13 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.604 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.731 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 2.9 mmt180 -117.99 154.17 32.42 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.922 0.391 . . . . 0.0 111.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -61.86 155.32 23.59 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.71 -99.16 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.384 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.03 -170.78 1.48 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.924 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.942 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.51 86.61 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.011 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.94 70.76 0.88 Allowed Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.967 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 68' ' ' ALA . 3.3 mm -142.64 116.25 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 121.643 0.735 . . . . 0.0 109.028 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.2 t -104.88 106.3 16.73 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -92.72 161.58 14.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -128.04 -179.92 1.09 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.176 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -73.47 -10.12 23.53 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.38 2.054 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -32.52 7.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.423 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 167.1 35.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.912 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.638 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 29.2 m -97.08 167.21 11.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.0 111.935 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.587 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.54 142.22 20.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.996 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.514 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -60.98 113.07 2.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.077 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 35.4 p30 -95.05 108.63 39.58 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-O 121.667 0.746 . . . . 0.0 111.769 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 48.5 Cg_exo -58.51 -12.09 13.03 Favored 'Trans proline' 0 CA--C 1.504 -0.985 0 C-N-CA 123.99 3.126 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.58 59.93 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.32 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.724 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.6 -24.09 10.73 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -175.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 6.9 t70 173.77 -29.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.391 1 N-CA-C 122.262 4.171 . . . . 0.0 122.262 -178.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.011 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.8 Cg_endo -107.56 -71.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.481 2.121 . . . . 0.0 112.465 -171.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.733 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.1 tt0 -69.56 -6.68 32.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.692 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.31 -155.53 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.073 -2.331 . . . . 0.0 111.613 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.24 -178.85 0.69 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.445 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -74.48 62.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 8.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.745 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.849 0.356 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.13 163.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.818 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -67.86 168.72 11.08 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.465 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 12.0 t0 -74.87 -134.44 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.779 HD13 ' HE ' ' A' ' 66' ' ' ARG . 1.1 pp -91.1 -125.64 0.08 Allowed 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 122.029 -0.419 . . . . 0.0 111.103 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 5' ' ' LEU . 1.1 t70 -73.12 -52.68 13.31 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.697 ' H ' HD12 ' A' ' 5' ' ' LEU . 6.4 m -85.85 85.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.43 176.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.818 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 33.1 mtt85 -76.13 123.86 26.5 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.749 HG22 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -75.36 -151.26 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.966 178.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' SG ' ' C ' ' A' ' 9' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.365 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.697 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 51.6 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 CA-C-O 121.371 0.488 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.644 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 5.2 t -158.3 -171.86 3.65 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.88 -149.78 33.2 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.013 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.37 85.49 1.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.669 2.913 . . . . 0.0 112.836 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -71.52 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.697 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.7 31.9 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 121.416 0.453 . . . . 0.0 112.578 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -75.01 -37.38 61.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.884 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -105.54 -163.54 23.46 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.526 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.749 ' HD3' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.92 153.69 45.77 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.187 0.994 . . . . 0.0 112.881 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' CA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.06 127.13 36.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.209 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.834 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -102.07 -102.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -113.13 -87.71 1.64 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 26' ' ' ILE . 30.7 Cg_endo -101.91 113.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.171 2.58 . . . . 0.0 114.451 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.42 23.27 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.725 0.298 . . . . 0.0 110.622 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.834 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 6.6 tt -112.8 161.85 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.556 1.169 . . . . 0.0 114.036 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.795 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 49.2 t -159.4 159.54 33.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.763 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.1 106.15 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.892 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -96.76 122.54 7.43 Favored Glycine 0 N--CA 1.414 -2.814 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 25.8 t70 -58.78 -59.15 5.89 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.61 1.205 . . . . 0.0 107.942 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.2 pt-20 -81.82 11.62 4.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.892 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.49 41.66 1.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.197 -175.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 27.89 -164.39 0.0 OUTLIER Glycine 0 N--CA 1.472 1.066 0 N-CA-C 115.398 0.919 . . . . 0.0 115.398 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -114.81 144.34 43.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.701 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.6 m-85 -131.46 98.23 4.46 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.818 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 26' ' ' ILE . 3.2 t -94.69 131.46 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.037 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 53.18 31.76 42.04 Favored Glycine 0 C--N 1.319 -0.406 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.809 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.28 -177.69 3.23 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -69.55 -49.15 57.01 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -68.99 8.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -106.3 -27.19 11.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.706 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.78 -11.2 2.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.86 -19.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' CA ' ' HB2' ' A' ' 21' ' ' CYS . 1.2 t . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 120.927 0.394 . . . . 0.0 110.086 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt . . . . . 0 N--CA 1.433 -1.32 0 CA-C-O 120.488 0.185 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.746 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 68.6 Cg_exo -40.3 155.17 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.221 2.614 . . . . 0.0 115.576 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -161.46 153.9 20.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.19 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.46 4.18 5.33 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.174 -0.921 . . . . 0.0 114.06 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.9 t -90.51 57.02 3.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.434 0.617 . . . . 0.0 111.5 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.63 29.07 57.39 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.879 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.741 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.61 -149.05 16.6 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.443 -0.885 . . . . 0.0 115.307 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.779 ' HE ' HD13 ' A' ' 5' ' ' LEU . 6.7 mmt180 -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.22 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 34.8 t -60.38 154.25 20.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.3 -92.7 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.2 -171.24 1.98 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.939 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.64 89.18 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.953 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.21 68.46 1.69 Allowed Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.787 -1.673 . . . . 0.0 110.202 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.734 HG21 ' SG ' ' A' ' 28' ' ' CYS . 1.4 mm -138.52 141.2 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.3 t -128.89 104.96 7.9 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.3 t -90.21 153.13 20.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -119.76 -179.61 0.73 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.403 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -72.87 -11.58 25.77 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.189 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -29.97 9.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.078 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.19 171.06 36.77 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -97.54 164.34 12.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.267 0.556 . . . . 0.0 111.925 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.642 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -151.38 139.51 20.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.664 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.539 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.13 118.84 5.88 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.911 0.386 . . . . 0.0 110.503 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.69 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 45.7 p30 -98.97 108.31 48.57 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.732 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.9 Cg_exo -55.91 -16.57 16.35 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 123.868 3.045 . . . . 0.0 109.941 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -28.23 63.93 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -111.38 -27.39 8.66 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -176.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.5 t70 174.58 -28.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 1 N-CA-C 122.432 4.234 . . . . 0.0 122.432 -177.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.8 Cg_endo -106.39 -71.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.559 2.173 . . . . 0.0 112.542 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.5 tt0 -69.75 -6.18 30.25 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.732 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.23 -158.1 0.06 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.958 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.03 -178.11 0.57 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.541 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -73.0 62.11 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.0 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 1' ' ' ALA . 35.3 m 44.56 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.413 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -78.13 171.22 15.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.681 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 4.8 t0 -81.65 -87.88 0.09 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -81.4 -74.1 0.35 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.175 0.988 . . . . 0.0 109.294 177.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.639 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -152.75 -59.51 0.14 Allowed 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.827 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.688 ' H ' HD12 ' A' ' 5' ' ' LEU . 31.4 m -106.49 86.49 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.012 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.681 ' NE ' ' HB2' ' A' ' 4' ' ' ASP . 4.9 mtt-85 -73.44 -178.32 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.578 0.704 . . . . 0.0 112.678 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.81 41.65 0.06 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.741 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.716 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.714 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo . . . . . 0 N--CA 1.455 -0.766 0 CA-C-O 121.164 0.402 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -158.8 -177.16 6.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.775 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 62.67 -136.67 44.34 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.555 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.9 Cg_endo -91.8 101.04 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.519 3.48 . . . . 0.0 112.599 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.59 -71.65 2.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.75 33.64 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.578 0.543 . . . . 0.0 112.267 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.94 -35.63 69.67 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.48 -0.86 . . . . 0.0 110.228 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -104.37 -172.22 24.95 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.151 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.29 178.82 8.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.98 154.6 35.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 15.1 m-85 -135.01 -28.02 1.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -170.72 -110.24 0.23 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.593 -1.289 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 42.1 Cg_endo -98.51 103.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.293 2.662 . . . . 0.0 112.793 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.79 22.95 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.036 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.614 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -111.63 163.16 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 122.0 0.905 . . . . 0.0 113.016 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.31 143.23 23.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.608 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.82 103.11 3.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.066 -177.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.01 116.04 4.59 Favored Glycine 0 N--CA 1.402 -3.603 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.822 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 27.0 t70 -58.42 -55.27 37.25 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.525 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.9 pt-20 -83.63 11.78 6.74 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.05 37.75 1.16 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.51 -175.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -118.13 138.52 52.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 1.055 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -132.19 129.82 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.419 178.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.614 HG22 HD11 ' A' ' 26' ' ' ILE . 6.3 t -103.79 97.61 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.183 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.54 17.52 62.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.005 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 10.0 p -74.15 -170.92 1.03 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.022 0.411 . . . . 0.0 109.933 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.25 -45.75 83.36 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.15 -14.27 61.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.331 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 1.055 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.21 -9.84 20.11 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -17.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.689 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.36 -28.81 8.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.484 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.927 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.711 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 77.8 Cg_exo -44.29 155.76 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.018 3.146 . . . . 0.0 117.018 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.21 168.59 20.48 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.734 1.254 . . . . 0.0 112.591 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.55 -2.18 33.94 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 112.465 -2.152 . . . . 0.0 116.317 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.598 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 41.5 t -94.21 56.52 2.21 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 117.745 0.772 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.43 38.89 35.45 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.29 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.585 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.96 -153.72 24.38 Favored Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.329 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 mmt180 -111.68 147.89 34.58 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.194 0.521 . . . . 0.0 111.816 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 t -62.23 156.04 23.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.708 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -157.69 -94.05 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.99 -171.16 1.05 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.746 0.819 . . . . 0.0 112.747 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.944 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.45 89.66 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.929 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.4 63.29 5.41 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.505 -1.807 . . . . 0.0 110.289 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.743 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -130.19 146.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.775 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 1.9 t -135.97 104.4 5.7 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.4 t -89.49 159.16 17.39 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -173.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.527 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.5 m -127.49 -179.27 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.527 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.2 Cg_exo -71.92 -10.13 25.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.336 2.024 . . . . 0.0 112.697 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -33.2 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 111.304 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.8 169.95 37.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.466 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 8.0 m -96.38 165.8 12.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.4 0.619 . . . . 0.0 112.111 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.637 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.79 140.81 21.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.694 178.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.85 117.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.0 110.006 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 55.7 p30 -99.01 109.7 54.98 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.907 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.756 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -57.24 -14.78 16.37 Favored 'Trans proline' 0 CA--C 1.504 -1.0 0 C-N-CA 123.682 2.921 . . . . 0.0 109.887 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.24 -29.36 62.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.251 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.8 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.32 -26.6 9.49 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.7 t70 174.52 -29.22 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.245 1 N-CA-C 122.481 4.252 . . . . 0.0 122.481 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.944 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.31 -70.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -171.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 30.6 tt0 -69.47 -6.55 31.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.756 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.99 -154.83 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.059 -2.337 . . . . 0.0 112.549 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.96 -178.7 1.29 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.817 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -74.62 62.04 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.252 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 3' ' ' LEU . 13.4 t -56.86 173.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.779 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.18 173.17 5.89 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.884 0.85 . . . . 0.0 112.923 -178.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.843 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 43.5 t0 -81.45 -144.87 0.05 Allowed 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.895 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.684 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.4 OUTLIER -88.96 -116.98 0.06 Allowed 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.684 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -74.69 -47.88 29.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 7' ' ' VAL . 11.1 m -87.68 84.19 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.365 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.843 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 45.5 mtt180 -80.09 167.33 20.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 21.4 m 69.98 97.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.666 -1.152 . . . . 0.0 113.19 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 94.4 Cg_exo . . . . . 0 N--CA 1.46 -0.5 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.645 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.6 t -157.42 -172.02 3.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.103 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.44 -142.59 45.06 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.664 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 26.3 Cg_endo -85.63 95.84 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.148 3.232 . . . . 0.0 112.796 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.46 -66.68 3.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.025 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' PRO . . . 178.29 32.02 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 121.591 0.551 . . . . 0.0 112.438 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.47 -34.85 72.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -0.827 . . . . 0.0 109.866 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.24 -169.11 15.77 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.721 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.55 -178.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 34.3 m -76.03 159.87 30.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.809 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 63.2 m-85 -148.24 16.94 1.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 142.73 -113.56 0.8 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.263 -1.446 . . . . 0.0 114.879 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.5 Cg_endo -105.75 111.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.878 3.052 . . . . 0.0 112.986 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.79 22.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.388 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.722 HG13 HG13 ' A' ' 36' ' ' VAL . 1.5 tt -115.76 154.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 122.177 0.989 . . . . 0.0 112.486 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -158.63 134.04 8.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.76 -1.563 . . . . 0.0 107.324 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.977 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 33.2 m -150.38 108.95 3.81 Favored 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.187 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.11 123.08 5.96 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.185 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.652 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 22.9 t70 -58.21 -57.62 12.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.32 18.04 1.21 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -152.2 39.36 0.59 Allowed 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.766 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.4 178.67 0.01 OUTLIER Glycine 0 N--CA 1.464 0.561 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -105.32 129.08 53.74 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.7 m-85 -132.1 105.63 7.5 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.68 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.722 HG13 HG13 ' A' ' 26' ' ' ILE . 8.1 t -95.25 110.28 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.232 0.539 . . . . 0.0 109.599 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.46 21.08 53.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.919 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -94.38 178.26 5.68 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.29 -53.85 31.72 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 111.589 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -71.09 8.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -108.25 -24.95 11.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -16.91 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 1.2 mpp_? -55.15 -18.14 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 90.9 Cg_exo -40.7 158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.199 2.6 . . . . 0.0 116.386 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.09 154.17 14.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.539 177.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.35 3.87 7.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.747 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 11.0 t -91.08 54.07 2.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 117.222 0.511 . . . . 0.0 111.311 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.07 33.18 60.5 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.133 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.553 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.88 -151.35 21.08 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.646 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 4.0 mmt85 -118.35 156.01 29.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.992 -0.604 . . . . 0.0 111.26 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 24.6 t -61.25 151.73 30.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -149.07 -94.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.977 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . . . -76.7 -171.68 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.651 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.975 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.05 91.76 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.982 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.95 68.21 1.8 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.006 -1.569 . . . . 0.0 110.206 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -136.12 142.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.6 t -128.93 104.47 7.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -88.5 154.42 20.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.555 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.8 m -123.16 -179.24 0.77 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.555 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -72.04 -9.68 24.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.334 2.023 . . . . 0.0 112.927 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -34.07 7.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.691 0.282 . . . . 0.0 110.984 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.83 170.17 38.31 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.282 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.622 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 11.6 m -94.03 165.95 12.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.482 0.658 . . . . 0.0 112.666 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.645 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -150.82 140.0 21.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.597 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -60.41 117.93 5.84 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.985 0.422 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.703 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.7 p30 -99.19 108.53 50.33 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.281 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.23 -12.74 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.014 3.142 . . . . 0.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.64 60.36 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.35 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.939 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -108.88 -27.56 9.65 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -176.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.33 -29.36 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.362 1 N-CA-C 122.321 4.193 . . . . 0.0 122.321 -178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.7 Cg_endo -106.2 -70.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.495 0 C-N-CA 122.345 2.03 . . . . 0.0 112.29 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 62.1 tt0 -69.49 -6.83 33.18 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.76 -158.04 0.08 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 111.79 -2.459 . . . . 0.0 112.11 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.67 -177.97 0.85 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.613 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.92 61.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.455 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.8 t -65.71 167.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.827 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.15 173.97 6.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.0 112.641 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.567 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.9 t0 -80.14 -78.49 0.17 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.584 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.046 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.65 -127.64 0.06 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.826 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 1.046 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.01 -41.85 73.78 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.015 HG22 HD11 ' A' ' 5' ' ' LEU . 34.3 m -91.62 109.22 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.783 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.827 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 86.2 mtt180 -71.4 126.66 30.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 4' ' ' ASP . 0.1 OUTLIER -104.09 -162.85 0.93 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.922 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.458 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 26.8 Cg_exo . . . . . 0 N--CA 1.462 -0.365 0 CA-C-O 120.964 0.318 . . . . 0.0 112.677 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 3.9 t -157.86 -175.02 5.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.53 -137.47 49.88 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.85 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.3 Cg_endo -89.76 94.94 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.437 3.425 . . . . 0.0 112.667 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.05 -68.61 2.48 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.418 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.56 32.41 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.504 0.502 . . . . 0.0 112.32 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.562 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -69.8 -35.5 74.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.573 -0.813 . . . . 0.0 110.109 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -114.94 -165.38 14.85 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.809 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.613 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.59 177.0 10.41 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.67 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -79.43 153.71 29.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.684 ' HB2' HG23 ' A' ' 26' ' ' ILE . 15.6 m-85 -125.71 -94.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.695 -0.402 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.691 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -98.86 -106.84 2.67 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.575 -0.822 . . . . 0.0 114.565 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -101.95 113.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.798 2.999 . . . . 0.0 113.559 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 50.9 21.02 0.87 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.691 ' CG2' ' H ' ' A' ' 23' ' ' GLY . 4.2 tt -111.74 166.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 122.134 0.968 . . . . 0.0 113.316 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.77 143.08 18.2 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.751 -1.568 . . . . 0.0 107.886 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.848 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -147.5 104.88 3.67 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.908 -177.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.14 119.58 5.96 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.646 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 36.3 t0 -58.22 -58.63 7.6 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.607 1.203 . . . . 0.0 108.009 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.562 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.3 pt-20 -81.18 20.39 0.83 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -152.08 35.21 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.218 -175.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.681 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.3 -164.81 0.01 OUTLIER Glycine 0 C--N 1.33 0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 114.164 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.75 140.29 53.07 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.756 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -131.91 114.88 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.582 178.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -97.17 113.8 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.409 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 58.92 19.86 46.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.738 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.2 m -94.47 163.76 13.27 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.411 0.284 . . . . 0.0 110.384 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.83 -53.62 7.28 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.282 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.3 mp0 -69.06 7.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.858 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -116.03 -26.69 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -43.37 -19.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.601 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.23 -21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.572 0.624 . . . . 0.0 111.702 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 13.7 t . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.013 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.516 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 57.9 Cg_exo -42.83 160.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.134 3.223 . . . . 0.0 117.662 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -164.75 154.06 13.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.155 177.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.93 3.37 3.07 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.044 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.03 54.74 2.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.562 0.681 . . . . 0.0 111.339 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.99 35.85 49.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.947 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.701 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.8 -154.84 25.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.973 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 5.6 mmt180 -115.43 155.46 27.4 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.207 -0.497 . . . . 0.0 111.587 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 25.1 t -60.98 153.03 26.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.043 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -151.39 -92.62 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.23 -173.86 2.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.6 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.981 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.78 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.944 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.68 66.02 3.14 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 118.601 -1.761 . . . . 0.0 110.215 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.871 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.9 mm -134.25 144.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.6 t -132.38 105.96 7.6 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -92.0 153.59 19.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -173.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.531 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.3 m -119.03 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.66 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -71.94 -10.22 25.86 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.313 2.008 . . . . 0.0 112.562 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 -32.24 7.62 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.656 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.92 168.49 36.92 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.703 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.591 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 8.6 m -96.44 165.89 11.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.482 0.658 . . . . 0.0 112.442 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.705 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -152.18 142.46 22.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.555 178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.591 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -61.11 117.88 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.58 -178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.723 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 45.1 p30 -98.32 108.08 45.37 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-O 121.549 0.69 . . . . 0.0 111.285 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.766 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -56.24 -11.02 5.31 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 124.099 3.199 . . . . 0.0 110.147 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -77.02 -28.86 55.07 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.165 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -109.44 -27.37 9.49 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -175.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.4 t70 174.36 -29.35 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.246 1 N-CA-C 122.428 4.233 . . . . 0.0 122.428 -178.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.981 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.42 -70.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.746 2.297 . . . . 0.0 112.306 -172.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -70.96 -5.88 34.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 175.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.766 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.72 -160.3 0.15 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 111.767 -2.469 . . . . 0.0 112.371 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.11 -177.58 0.38 Allowed 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.675 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -74.23 61.77 0.89 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.248 0.993 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.235 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.868 0.366 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -83.41 143.52 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.2 0.524 . . . . 0.0 111.98 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.633 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -75.07 175.64 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.781 0.801 . . . . 0.0 112.975 -178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 20.0 t0 -77.95 -140.77 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.944 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -91.12 -123.8 0.07 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.652 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -68.93 -47.98 64.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 7' ' ' VAL . 15.9 m -85.92 90.43 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.947 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.633 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 58.6 mtt85 -69.26 -168.33 0.15 Allowed 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.67 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.4 m 67.22 111.61 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.791 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.28 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 20.0 Cg_exo . . . . . 0 N--CA 1.459 -0.518 0 CA-C-O 121.34 0.475 . . . . 0.0 112.241 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -156.67 -176.74 6.14 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.102 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.602 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.09 -133.08 49.01 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.876 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 8.2 Cg_endo -92.71 100.31 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.905 3.737 . . . . 0.0 112.446 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 -68.27 3.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.919 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.68 31.63 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 121.416 0.453 . . . . 0.0 112.792 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.92 -37.85 69.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.764 0.792 . . . . 0.0 109.797 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -101.11 -176.58 29.1 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.783 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -162.14 -179.38 7.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.83 0.348 . . . . 0.0 110.655 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 m -80.91 144.88 31.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.676 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.6 m-85 -119.68 -43.47 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -165.01 -95.27 0.1 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.277 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.9 Cg_endo -101.91 103.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.567 2.844 . . . . 0.0 113.554 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.69 25.53 1.01 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 110.62 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -113.86 160.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.85 0.833 . . . . 0.0 112.852 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -153.42 136.94 15.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.169 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 2.2 m -148.39 117.29 6.72 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.513 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.893 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -104.93 119.36 6.18 Favored Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.162 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.6 t70 -57.79 -57.02 14.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.552 1.176 . . . . 0.0 108.21 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -83.06 26.53 0.61 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.893 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -159.77 33.01 0.19 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.536 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.965 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 40.58 176.14 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' HG21 ' A' ' 72' ' ' ILE . 1.2 m -106.03 132.25 52.34 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.838 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -131.92 117.08 17.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.19 98.28 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.021 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.83 10.72 40.12 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.984 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -76.41 174.5 10.18 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.079 0.552 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.55 -56.14 4.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.344 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -73.7 6.98 2.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -112.87 -23.25 10.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.703 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.99 -18.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.37 -23.99 1.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.55 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.281 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.463 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 120.814 0.34 . . . . 0.0 111.261 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 71.9 Cg_exo -44.01 160.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.873 3.049 . . . . 0.0 117.306 -176.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -165.17 155.02 13.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.805 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.12 7.14 3.46 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.4 t -93.38 51.94 1.68 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.124 0.462 . . . . 0.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.16 34.6 58.8 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.982 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.744 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.61 -151.85 21.53 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.744 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.6 mmt180 -118.82 155.41 31.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.758 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 27.0 t -62.89 155.59 26.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.04 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.58 -89.85 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.369 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.965 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -73.34 -169.59 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 114.829 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . -28.44 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.36 1.03 0 CA-C-O 122.253 1.025 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.79 ' C ' ' OD1' ' A' ' 82' ' ' ASP . . . -177.01 78.53 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.847 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.751 HG21 ' SG ' ' A' ' 34' ' ' CYS . 2.0 mm -132.41 149.83 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 114.202 -0.999 . . . . 0.0 108.888 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 29.8 t -132.95 102.88 5.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -85.35 146.57 26.95 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.49 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -113.58 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.443 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.49 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 7.9 Cg_exo -74.67 -11.83 22.18 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.467 2.111 . . . . 0.0 112.271 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -28.14 11.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.015 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.04 168.2 33.2 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.642 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.1 m -94.17 165.93 12.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.276 0.56 . . . . 0.0 112.264 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.62 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.64 141.64 20.27 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.96 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.629 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 122.1 12.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.79 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 54.0 p30 -101.55 106.65 47.39 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.438 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.695 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 52.8 Cg_exo -57.1 -17.64 25.83 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.786 2.991 . . . . 0.0 109.61 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.3 69.28 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.26 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.744 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 m -103.52 -33.76 8.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 9.2 t70 167.84 -24.84 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.457 0 N-CA-C 121.703 3.964 . . . . 0.0 121.703 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.705 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_endo -101.67 -69.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.263 1.975 . . . . 0.0 112.347 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.1 tt0 -71.85 -5.7 36.35 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -74.16 -155.3 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.207 -2.27 . . . . 0.0 111.44 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.24 -178.72 1.11 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -74.93 62.53 1.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.473 ' OG ' ' OD2' ' A' ' 86' ' ' ASP . 3.4 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.568 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.482 0.182 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m 36.51 -163.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.01 174.73 6.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.641 0.734 . . . . 0.0 112.706 -178.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -78.27 -89.89 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.238 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 6' ' ' ASP . 1.3 pp -152.52 -42.37 0.1 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.53 -48.73 0.14 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.416 176.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 7' ' ' VAL . 4.4 m -82.68 92.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.232 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.5 mtt85 -67.26 171.04 6.24 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 23.2 90.19 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.327 0.584 . . . . 0.0 111.06 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 13.9 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.939 -177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 11.0 Cg_exo . . . . . 0 N--CA 1.453 -0.88 0 CA-C-O 121.708 0.628 . . . . 0.0 113.296 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.5 t -157.35 -169.77 3.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.673 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.6 -144.05 44.06 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.469 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 17.5 Cg_endo -87.92 90.91 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 124.206 3.271 . . . . 0.0 112.462 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.54 -70.69 0.61 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.101 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.87 32.2 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.868 0 CA-C-O 121.449 0.472 . . . . 0.0 112.447 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.43 -38.03 74.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.87 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.04 -164.54 18.47 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.569 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.717 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.71 179.07 9.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.59 151.96 37.76 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.717 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 24.2 m-85 -132.98 -1.13 3.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 166.18 -114.55 0.59 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.324 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -101.07 105.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.701 2.934 . . . . 0.0 112.571 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.48 23.78 3.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.948 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.583 HG13 HG13 ' A' ' 36' ' ' VAL . 2.9 tt -111.66 162.83 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.363 1.078 . . . . 0.0 113.584 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.475 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 49.3 t -147.83 149.92 33.22 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.227 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.45 96.08 1.87 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.589 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.48 119.08 5.27 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 119.445 -1.359 . . . . 0.0 110.005 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.583 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 15.2 t70 -58.77 -55.7 31.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.595 1.198 . . . . 0.0 107.809 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.8 pt-20 -81.15 1.3 32.52 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.893 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.939 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -134.18 39.19 3.11 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.614 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.687 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.72 -172.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.768 0 N-CA-C 114.769 0.668 . . . . 0.0 114.769 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -120.87 133.68 55.3 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.862 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.43 126.68 33.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.844 178.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.583 HG13 HG13 ' A' ' 26' ' ' ILE . 3.4 t -99.77 106.43 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.18 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.86 24.16 62.21 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.0 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.4 m -94.74 172.01 8.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.58 0.352 . . . . 0.0 110.535 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -44.11 -54.99 5.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.55 -10.99 60.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.751 0.31 . . . . 0.0 111.642 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.48 -14.55 16.78 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.701 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -18.37 0.15 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -51.7 -26.98 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.627 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.442 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.576 0.227 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -41.88 158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.122 3.215 . . . . 0.0 117.649 -176.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.41 154.13 13.99 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.371 177.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.87 4.39 4.38 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.452 -0.794 . . . . 0.0 114.143 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.0 t -91.42 53.28 2.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.485 0.642 . . . . 0.0 111.223 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.58 57.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.912 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.574 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.75 -154.5 25.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.964 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 7.9 mmt-85 -115.9 153.98 30.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -62.87 153.21 34.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.984 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.69 -91.91 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -74.81 -171.67 1.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.968 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.6 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.941 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.46 64.74 4.1 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 118.879 -1.629 . . . . 0.0 110.165 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.865 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -131.28 146.11 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 20.1 t -133.62 101.22 5.04 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -83.05 146.93 28.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.7 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.2 m -111.32 -179.47 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.561 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 34.7 Cg_endo -74.01 -22.51 17.1 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.552 1.501 . . . . 0.0 112.238 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.9 -27.2 15.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.266 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.22 168.87 33.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.425 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.1 m -94.28 165.71 12.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.442 0.639 . . . . 0.0 112.434 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.628 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.98 140.89 21.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.497 178.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.563 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.94 119.31 7.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.961 0.41 . . . . 0.0 110.616 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.732 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.3 p30 -98.93 109.21 52.98 Favored Pre-proline 0 N--CA 1.438 -1.067 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.722 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -56.98 -12.24 9.07 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 124.061 3.174 . . . . 0.0 110.146 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.69 -28.11 58.51 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.268 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.846 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.68 -25.88 9.71 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -175.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.7 t70 174.2 -30.44 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.42 1 N-CA-C 122.194 4.146 . . . . 0.0 122.194 -177.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.968 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -106.66 -71.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.391 0 C-N-CA 122.636 2.224 . . . . 0.0 112.74 -171.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.712 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.7 tt0 -69.5 -6.11 28.43 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.722 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.88 -157.5 0.06 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.86 -2.427 . . . . 0.0 112.443 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.69 -178.19 0.53 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.2 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.84 62.27 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.929 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.707 0.289 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.12 143.24 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.802 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.85 169.06 18.69 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 37.1 t0 -79.8 -137.81 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.814 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -92.37 -120.58 0.08 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.679 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.73 -48.45 31.84 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 5' ' ' LEU . 11.7 m -86.75 83.7 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.053 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 39.3 mtt180 -82.29 147.44 28.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.754 ' CG2' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m 59.47 115.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.203 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 81.3 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.251 -179.747 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HG3' ' CG2' ' A' ' 9' ' ' THR . 7.6 Cg_exo . . . . . 0 N--CA 1.46 -0.472 0 N-CA-C 114.857 1.061 . . . . 0.0 114.857 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.0 t -155.56 -170.88 3.58 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.113 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 58.36 -137.62 49.86 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.063 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.5 Cg_endo -90.19 93.19 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.598 3.532 . . . . 0.0 113.13 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.54 -68.3 2.12 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.324 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.87 34.34 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.775 0.653 . . . . 0.0 112.267 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.949 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.8 -35.08 69.86 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.916 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.682 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -117.12 -163.49 13.06 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.197 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -158.2 176.87 11.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -86.68 158.33 19.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.078 178.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.1 m-85 -131.11 -90.76 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.723 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -120.51 -93.43 1.36 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -99.53 104.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.545 2.83 . . . . 0.0 114.177 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 51.65 19.97 1.0 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.363 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.7 tt -109.24 163.09 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.146 0.974 . . . . 0.0 113.327 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.41 145.01 20.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.229 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -149.05 115.37 5.82 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.995 -177.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.949 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.76 122.0 7.39 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.966 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 3.4 t70 -58.62 -56.91 16.08 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -84.98 24.09 1.12 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.223 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.949 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.11 36.35 0.29 Allowed 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.762 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 38.31 -170.81 0.01 OUTLIER Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 139.7 49.9 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.728 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 1.7 m-85 -131.19 104.38 7.03 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.09 177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.553 HG13 HG13 ' A' ' 26' ' ' ILE . 5.0 t -95.03 115.17 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.495 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 62.89 8.28 21.18 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.422 -0.895 . . . . 0.0 112.038 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.5 m -82.86 172.69 12.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.362 0.265 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -56.09 -54.33 46.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -65.39 8.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.879 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -109.0 -33.37 6.92 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.89 -17.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.01 -20.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.451 -0.403 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.807 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 33.8 Cg_exo -41.32 155.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 125.258 3.972 . . . . 0.0 115.932 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.08 156.69 19.84 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.191 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.61 6.34 3.59 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.846 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.22 51.65 1.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 117.267 0.534 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.16 30.68 61.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.878 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.55 -152.72 22.83 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.3 mmt-85 -118.17 165.38 13.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.977 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 5.8 t -59.43 149.11 30.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.49 -25.6 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.966 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -161.32 -170.84 2.78 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 122.727 0.411 . . . . 0.0 111.786 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -41.0 86.58 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.96 67.71 2.07 Favored Glycine 0 N--CA 1.419 -2.485 0 C-N-CA 118.627 -1.749 . . . . 0.0 111.124 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 68' ' ' ALA . 3.4 mm -137.62 135.3 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -124.18 108.92 12.8 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.698 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.8 t -95.23 154.62 17.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.503 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -122.26 -179.37 0.76 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.837 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -71.78 -9.66 25.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.38 2.053 . . . . 0.0 112.147 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.7 -34.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.32 169.77 38.86 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.812 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.645 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.3 m -99.13 164.95 11.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.369 0.604 . . . . 0.0 111.668 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.592 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.7 144.02 22.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.467 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.55 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pt-20 -61.7 116.63 4.94 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.778 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 41.0 p30 -97.34 107.01 36.12 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.001 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 57.7 Cg_exo -55.03 -13.84 7.25 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.569 2.846 . . . . 0.0 110.445 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -72.71 -29.25 63.22 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.169 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.975 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -106.55 -30.11 9.24 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 -176.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.648 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 7.2 t70 174.66 -28.62 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.325 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -177.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.2 Cg_endo -106.11 -70.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.525 0 C-N-CA 122.376 2.051 . . . . 0.0 112.276 -172.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.695 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.7 tt0 -70.27 -6.23 33.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.006 -1.906 . . . . 0.0 106.029 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.7 -155.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.695 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.48 -178.48 0.52 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.877 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.71 62.67 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 4.5 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.476 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -68.07 149.59 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.676 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.91 170.02 14.62 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.677 0.751 . . . . 0.0 112.937 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 5' ' ' LEU . 40.9 t0 -82.43 -77.03 0.24 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.986 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.008 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -148.95 -133.96 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.048 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 1.008 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -73.13 -38.52 66.26 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.626 ' CG2' HD11 ' A' ' 5' ' ' LEU . 27.2 m -97.69 104.44 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.676 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.2 mtt85 -71.74 178.65 3.5 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.2 m 67.09 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.546 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 9' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 112.245 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 26.4 Cg_exo . . . . . 0 N--CA 1.454 -0.812 0 CA-C-O 121.13 0.387 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.5 t -157.69 -176.67 6.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.687 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.515 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 64.93 -139.4 40.65 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.833 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.8 Cg_endo -91.78 95.23 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.667 3.578 . . . . 0.0 112.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 -72.08 0.78 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.85 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 175.51 35.58 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.69 0.606 . . . . 0.0 111.985 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.89 -36.05 69.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.353 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.18 -167.3 18.74 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.829 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.79 -179.89 6.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 151.53 34.81 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.903 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -127.0 -24.53 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -174.91 -105.75 0.19 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.466 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 38.8 Cg_endo -99.52 103.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.263 2.642 . . . . 0.0 112.789 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.39 24.68 2.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.775 0.321 . . . . 0.0 110.139 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.605 HD11 HG22 ' A' ' 36' ' ' VAL . 1.2 tt -112.18 162.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.976 0.893 . . . . 0.0 113.324 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 140.4 20.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.744 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.28 101.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.793 -177.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.58 120.0 5.54 Favored Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 32.3 t0 -58.4 -58.19 9.62 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.633 1.217 . . . . 0.0 108.211 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.4 pt-20 -81.34 6.33 14.68 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -136.65 37.34 2.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.338 -174.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.632 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.21 -172.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.01 136.4 54.99 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.17 115.26 15.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.133 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.605 HG22 HD11 ' A' ' 26' ' ' ILE . 5.7 t -93.71 107.91 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.984 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.96 24.82 55.27 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.808 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.793 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.1 m -94.38 175.24 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 122.568 0.347 . . . . 0.0 110.661 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.35 -59.12 2.55 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.998 0.428 . . . . 0.0 111.509 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -72.9 7.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -110.71 -22.74 11.43 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.69 -12.27 0.73 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.77 -24.7 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.22 0.463 . . . . 0.0 111.811 -179.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.187 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 74.6 Cg_exo -43.08 160.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.084 3.189 . . . . 0.0 117.779 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.54 153.41 10.99 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.329 -1.759 . . . . 0.0 110.33 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.9 4.65 5.37 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.736 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -90.91 52.48 2.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 117.183 0.491 . . . . 0.0 111.554 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.97 31.2 61.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.029 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.617 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.42 -154.42 25.25 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.889 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.709 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -115.79 153.09 32.07 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.078 0.466 . . . . 0.0 111.153 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 40.1 t -61.89 156.31 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.385 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -152.39 -92.67 0.05 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -78.48 -170.5 2.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.82 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.96 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.43 65.43 3.57 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.537 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' C ' ' A' ' 80' ' ' GLU . 1.8 mm -134.44 143.26 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.5 t -131.46 104.7 7.13 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -91.85 158.6 16.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.506 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.6 m -127.1 -179.22 0.89 Allowed Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.248 -1.796 . . . . 0.0 109.287 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.506 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.85 -9.97 24.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.278 1.985 . . . . 0.0 112.459 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.4 -33.04 8.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.458 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.4 168.91 35.84 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.517 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.594 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 15.1 m -96.12 166.59 11.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.457 0.646 . . . . 0.0 112.343 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.716 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -152.21 141.92 21.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.621 178.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.604 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -61.26 117.36 5.51 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.729 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.8 p30 -100.16 108.19 51.04 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-O 121.626 0.727 . . . . 0.0 111.18 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 66.0 Cg_exo -55.49 -16.09 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.07 3.18 . . . . 0.0 110.095 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.26 64.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.09 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.866 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -108.75 -27.55 9.71 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -176.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' ' OG ' ' A' ' 92' ' ' SER . 3.3 t70 173.67 -26.0 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.354 1 N-CA-C 122.853 4.39 . . . . 0.0 122.853 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.96 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -109.64 -72.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 -171.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.4 tt0 -70.62 -3.97 21.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.505 -1.679 . . . . 0.0 106.766 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.686 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -70.95 -160.82 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 112.448 -2.16 . . . . 0.0 114.892 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.31 -175.18 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.335 -2.212 . . . . 0.0 108.308 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.84 66.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 90' ' ' ALA . 1.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.371 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -157.07 -169.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.96 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HG ' ' NE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.17 170.17 12.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.519 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.82 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 56.3 t0 -79.11 -127.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -93.61 -126.59 0.11 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.563 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -74.45 -54.91 6.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.633 ' H ' HD12 ' A' ' 5' ' ' LEU . 16.5 m -90.32 112.5 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.157 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 27.3 mtt85 -69.15 121.32 16.52 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.792 0.806 . . . . 0.0 113.067 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.557 ' H ' ' CB ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -173.96 56.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.829 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.513 ' HB3' ' CG ' ' A' ' 4' ' ' ASP . 5.3 p . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 2.8 Cg_exo . . . . . 0 N--CA 1.462 -0.369 0 N-CA-C 113.907 0.695 . . . . 0.0 113.907 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.9 t -155.16 -177.45 6.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.58 -134.48 47.46 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.509 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 14.0 Cg_endo -89.56 101.3 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.603 3.536 . . . . 0.0 112.677 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.68 -66.04 3.79 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.015 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.06 32.66 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 121.529 0.516 . . . . 0.0 112.324 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.41 -36.11 73.84 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.972 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -108.36 -171.27 21.38 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.226 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.742 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 177.87 10.03 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 11.4 m -79.01 163.81 24.88 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 35.1 m-85 -141.55 -30.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -170.78 -103.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.886 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -101.32 102.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.485 2.79 . . . . 0.0 112.971 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.36 23.54 2.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.4 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -111.57 159.28 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.0 0.905 . . . . 0.0 112.882 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.84 140.38 21.56 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.859 -1.518 . . . . 0.0 108.504 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.708 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.99 99.23 3.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.759 -176.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.956 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.43 117.55 4.51 Favored Glycine 0 N--CA 1.406 -3.307 0 C-N-CA 118.973 -1.584 . . . . 0.0 110.058 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.6 t0 -59.03 -57.42 13.17 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.6 pt-20 -82.02 11.98 4.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.956 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.17 37.89 1.15 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.35 -178.15 0.01 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.5 t -114.84 136.76 52.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.804 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -133.12 119.34 19.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.278 177.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 26' ' ' ILE . 5.6 t -91.84 103.21 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.106 178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.66 47.98 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.829 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -86.27 -176.94 6.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.217 0.607 . . . . 0.0 110.025 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.13 -58.8 4.77 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -72.02 -2.32 17.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.65 -21.14 14.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.29 -14.65 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -51.19 -23.63 3.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.433 0.56 . . . . 0.0 111.3 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.159 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.584 0.23 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 47.2 Cg_exo -43.32 158.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.287 3.325 . . . . 0.0 117.406 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -163.93 153.38 14.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.3 177.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.52 3.69 4.55 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.331 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 t -91.42 57.08 3.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 117.656 0.728 . . . . 0.0 111.268 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.65 34.46 50.14 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 114.03 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.0 -154.38 25.37 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.8 mmt180 -115.62 154.6 29.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.3 -0.45 . . . . 0.0 111.21 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -62.0 158.19 16.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.171 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -155.3 -95.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.43 -171.23 1.74 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.994 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.48 86.51 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.774 0.671 . . . . 0.0 109.341 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 56.72 67.38 2.25 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.4 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -132.8 145.98 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -132.09 104.27 6.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -87.46 141.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -173.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.519 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.1 m -105.23 -179.76 0.8 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.817 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.519 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -73.08 -11.39 25.26 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.584 2.19 . . . . 0.0 112.523 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 -31.85 7.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.58 170.04 39.39 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.224 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 6.3 m -93.83 166.14 12.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.533 0.682 . . . . 0.0 112.326 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.605 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.16 141.45 21.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.654 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.26 117.67 5.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.063 0.458 . . . . 0.0 110.568 -179.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.724 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 50.6 p30 -99.56 110.02 57.23 Favored Pre-proline 0 N--CA 1.44 -0.974 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.3 Cg_exo -56.93 -14.85 15.21 Favored 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 124.099 3.199 . . . . 0.0 109.764 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.63 -27.5 62.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.255 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -111.07 -27.56 8.69 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -175.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.0 t70 173.05 -29.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.413 1 N-CA-C 122.311 4.189 . . . . 0.0 122.311 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.4 Cg_endo -106.22 -71.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 112.576 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -69.35 -5.77 25.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.36 -157.94 0.09 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.941 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.2 -178.9 0.69 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.682 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.17 62.4 0.92 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.787 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -93.82 -170.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.598 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.82 162.9 28.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.658 0.742 . . . . 0.0 112.971 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -83.18 -76.57 0.27 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.404 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.35 -136.56 0.09 Allowed 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.81 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.94 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -71.9 -40.57 68.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' CG2' HD11 ' A' ' 5' ' ' LEU . 19.4 m -94.58 101.04 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 87.0 mtt180 -67.65 -164.76 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.904 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER 46.75 98.3 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.213 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -50.56 -169.89 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.041 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 HD22 ' HG2' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -69.08 137.95 89.68 Favored Pre-proline 0 C--O 1.237 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.925 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 19.6 Cg_exo -62.55 -169.75 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.241 1.96 . . . . 0.0 112.233 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.559 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.6 t -158.06 -176.54 5.98 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.268 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.79 -136.06 50.42 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.36 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 12.7 Cg_endo -89.79 108.53 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 112.847 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.17 -67.39 2.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.068 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.27 32.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.439 0.466 . . . . 0.0 112.686 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.69 -36.88 73.5 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.735 -0.733 . . . . 0.0 110.063 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -103.01 -174.56 26.55 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.786 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.23 179.5 7.85 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 m -84.03 146.99 27.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 13.0 m-85 -120.96 -101.98 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.938 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.68 -98.56 0.35 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.669 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 26' ' ' ILE . 26.3 Cg_endo -99.7 -119.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.617 2.878 . . . . 0.0 111.627 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.98 51.38 0.4 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.619 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 0.8 OUTLIER -128.07 157.12 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 122.251 1.024 . . . . 0.0 113.35 -176.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -154.97 134.16 12.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.607 178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.994 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 32.2 m -152.1 119.38 5.94 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.783 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -95.96 122.55 7.35 Favored Glycine 0 N--CA 1.408 -3.203 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.369 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 44.1 t0 -58.08 -56.32 23.57 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 118.73 1.265 . . . . 0.0 107.824 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.02 24.82 0.74 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.87 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -157.84 33.17 0.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -175.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.764 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 51.08 172.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -104.17 129.77 51.92 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.53 116.66 17.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.55 177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG22 HD11 ' A' ' 26' ' ' ILE . 3.4 t -97.95 106.89 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.065 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.39 26.41 56.56 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.895 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.6 m -95.95 173.46 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.611 0.364 . . . . 0.0 110.62 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.72 -56.57 4.33 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 111.327 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.4 mp0 -73.07 6.16 2.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -113.27 -21.62 10.87 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.87 -19.15 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.585 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.6 -23.67 6.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.903 0.382 . . . . 0.0 110.886 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -2.45 39.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.401 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -58.72 -25.41 62.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG2' HD22 ' A' ' 11' ' ' LEU . 1.7 pp20? -78.88 -15.77 57.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.859 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -78.55 2.52 18.91 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.151 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -141.14 20.35 2.27 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.674 0.273 . . . . 0.0 110.84 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -111.99 -17.01 12.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.184 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.44 95.18 6.0 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.201 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -45.69 100.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.804 2.336 . . . . 0.0 112.664 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.3 p -156.41 171.52 7.27 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -71.48 177.27 6.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.658 2.239 . . . . 0.0 111.923 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 43.2 t -176.66 158.26 1.69 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 5.1 tp60 -138.02 159.71 41.29 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.798 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 62.3 m -131.67 -174.58 3.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.513 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -138.56 82.68 0.25 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.811 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -107.01 89.25 2.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -64.41 107.17 1.21 Allowed Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 178.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.633 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 88.5 Cg_exo -40.01 159.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.237 3.291 . . . . 0.0 116.982 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.19 152.64 10.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.767 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.94 3.25 6.97 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.955 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.2 t -90.27 57.29 3.67 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 117.33 0.565 . . . . 0.0 111.135 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.8 34.31 36.83 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.85 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.535 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.74 -156.57 28.6 Favored Glycine 0 CA--C 1.502 -0.739 0 C-N-CA 120.449 -0.882 . . . . 0.0 115.128 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.811 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.7 mmt-85 -116.32 152.94 32.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.189 0.519 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -63.61 160.54 16.56 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.579 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -159.97 -96.1 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.782 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -75.9 -169.81 1.2 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.876 0.87 . . . . 0.0 112.558 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.793 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -38.16 97.46 0.01 OUTLIER 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.508 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.947 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 50.81 30.47 21.75 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 119.733 -1.222 . . . . 0.0 112.099 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.05 HG13 ' HB3' ' A' ' 69' ' ' ALA . 5.1 mm -90.34 155.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-O 122.097 0.951 . . . . 0.0 111.628 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.728 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 19.0 t -141.81 106.52 4.88 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -91.61 160.56 15.33 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.505 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -127.11 -179.83 1.04 Allowed Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 113.996 -1.457 . . . . 0.0 110.052 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.2 Cg_exo -72.67 -10.83 25.58 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.453 2.102 . . . . 0.0 112.352 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.91 -29.5 9.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.57 168.87 31.27 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.437 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.597 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.2 m -97.81 167.94 10.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.097 0.475 . . . . 0.0 111.834 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.708 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 2.2 pt-20 -151.87 144.61 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.391 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -61.92 94.29 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.728 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.1 m-20 -91.85 126.78 52.43 Favored Pre-proline 0 N--CA 1.425 -1.722 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.881 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 34.0 Cg_exo -59.83 -3.25 2.01 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 123.658 2.905 . . . . 0.0 109.716 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.39 -25.76 59.68 Favored 'General case' 0 N--CA 1.41 -2.455 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.309 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.947 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.3 m -127.46 -20.14 4.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.687 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.8 t70 171.18 -26.15 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.068 1 N-CA-C 121.909 4.04 . . . . 0.0 121.909 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.814 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 6.1 Cg_endo -103.1 -70.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.656 0 C-N-CA 122.335 2.024 . . . . 0.0 112.135 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.628 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -72.52 -6.97 47.56 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.051 176.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.881 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.67 -157.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 112.436 -2.166 . . . . 0.0 112.546 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.79 -178.32 1.49 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.122 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -74.37 62.04 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.4 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.257 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.912 HG22 ' H ' ' A' ' 3' ' ' LEU . 3.6 p -144.69 -162.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.149 0.499 . . . . 0.0 111.383 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.912 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -70.47 157.3 38.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.84 -178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.33 -122.69 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.185 178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.855 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -94.97 -139.44 0.24 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.855 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.97 -36.15 49.36 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.817 HG22 HD21 ' A' ' 5' ' ' LEU . 28.0 m -100.98 85.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.33 0.586 . . . . 0.0 111.495 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.835 ' HB3' ' HB2' ' A' ' 55' ' ' GLN . 9.2 mtt180 -73.09 123.97 24.63 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.048 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.47 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -173.35 74.38 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.667 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -75.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.721 HD11 HD22 ' A' ' 50' ' ' LEU . 1.8 tp -115.0 90.83 24.45 Favored Pre-proline 0 N--CA 1.462 0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.744 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 6.6 Cg_exo -68.79 176.88 5.46 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.448 2.098 . . . . 0.0 114.121 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 8.2 t -153.75 -171.21 3.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.506 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 57.05 -136.93 49.97 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.555 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.8 Cg_endo -89.06 98.71 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.641 3.561 . . . . 0.0 112.965 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.07 -67.18 3.71 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.558 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.9 34.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 CA-C-O 121.744 0.636 . . . . 0.0 112.282 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.83 -34.41 69.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.371 -0.915 . . . . 0.0 110.264 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.64 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.74 -168.34 15.32 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.821 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.52 -179.54 7.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.726 0.263 . . . . 0.0 110.612 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.443 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 1.7 m -78.59 158.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 37.6 m-85 -138.99 -69.52 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.919 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -132.5 -105.05 0.95 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.177 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -100.28 105.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.444 2.763 . . . . 0.0 113.037 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER 52.5 21.98 1.98 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.756 0.313 . . . . 0.0 110.264 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.919 HG22 ' H ' ' A' ' 23' ' ' GLY . 4.8 tt -110.84 160.93 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.22 1.009 . . . . 0.0 112.763 -177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.31 145.62 27.13 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.604 -1.635 . . . . 0.0 107.736 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.43 103.84 3.72 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.897 -177.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.86 118.84 5.71 Favored Glycine 0 N--CA 1.409 -3.133 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.804 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 26.0 t0 -58.25 -57.72 11.65 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -83.09 21.78 1.04 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.24 35.72 0.43 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.71 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.23 -169.97 0.01 OUTLIER Glycine 0 CA--C 1.52 0.345 0 N-CA-C 114.289 0.476 . . . . 0.0 114.289 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.3 t -125.17 138.24 54.14 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.764 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.03 119.32 20.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.493 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HA ' HG13 ' A' ' 26' ' ' ILE . 2.4 t -95.2 105.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.804 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 59.25 22.15 55.17 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.855 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -89.09 178.64 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 122.553 0.341 . . . . 0.0 110.163 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -50.21 -56.42 11.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.827 0.346 . . . . 0.0 111.171 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.85 5.12 3.44 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.712 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.05 -23.91 12.15 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.732 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.98 -17.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.86 -23.18 1.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 111.482 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.76 -6.94 54.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.71 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -26.27 62.43 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.785 ' O ' HD23 ' A' ' 50' ' ' LEU . 42.9 mt-10 -75.36 -17.03 60.33 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.237 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -74.71 4.21 6.65 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.336 179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.491 ' O ' ' CD1' ' A' ' 49' ' ' TYR . 50.5 p-10 -82.73 -4.45 57.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -160.3 44.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 111.367 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 46' ' ' GLU . 4.3 pp -143.99 129.88 9.93 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-O 120.682 0.277 . . . . 0.0 110.783 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.614 ' O ' HD12 ' A' ' 50' ' ' LEU . 80.0 Cg_exo -48.43 179.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.085 2.523 . . . . 0.0 113.2 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.77 160.91 9.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.699 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -86.95 161.93 8.88 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.524 2.149 . . . . 0.0 111.885 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.33 -164.54 1.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.835 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 53.03 175.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.377 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.437 ' H ' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.52 174.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.524 ' HA2' HH21 ' A' ' 20' ' ' ARG . . . -175.03 -98.77 0.11 Allowed Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 119.579 -1.296 . . . . 0.0 111.366 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.857 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 3.6 mt-30 -83.86 87.36 7.09 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.01 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -70.3 108.72 3.77 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.77 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 31.5 Cg_exo -37.23 155.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.979 3.12 . . . . 0.0 117.362 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.607 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -161.66 152.99 18.55 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.43 177.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.27 4.73 7.93 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.881 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 t -90.34 54.55 2.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 117.395 0.597 . . . . 0.0 111.099 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.15 32.86 50.92 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.33 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.699 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 165.16 -158.7 31.64 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.307 -0.949 . . . . 0.0 114.921 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.857 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.0 mmt180 -117.33 154.08 31.87 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.017 0.437 . . . . 0.0 110.922 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 1.01 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 38.2 t -60.17 167.0 2.57 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.815 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -165.76 -94.57 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.824 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.023 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.46 -169.7 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.827 0.851 . . . . 0.0 112.884 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.822 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.07 96.21 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.914 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 51.87 29.15 26.11 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.162 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.023 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -91.46 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 121.872 0.844 . . . . 0.0 111.397 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.714 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 44.6 t -139.6 108.4 5.96 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.648 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 2.9 t -91.04 155.9 18.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -173.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.52 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -128.97 -179.6 1.04 Allowed Pre-proline 0 N--CA 1.447 -0.575 0 CA-C-N 114.062 -1.427 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.8 Cg_exo -72.22 -11.05 26.59 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.427 2.084 . . . . 0.0 112.382 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.97 -27.1 13.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.489 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.59 170.19 24.87 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.135 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.614 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 3.9 m -94.98 163.26 13.39 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 111.039 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.76 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.21 148.73 29.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.068 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -65.89 93.14 0.18 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.714 ' OD2' ' N ' ' A' ' 73' ' ' CYS . 10.0 m-20 -91.4 128.57 46.4 Favored Pre-proline 0 N--CA 1.429 -1.521 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.89 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 31.4 Cg_exo -60.58 -2.45 2.0 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.445 2.763 . . . . 0.0 109.721 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -74.94 -24.99 58.57 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.034 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.914 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 1.4 m -128.98 -21.01 3.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.1 t70 171.67 -26.33 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.406 1 N-CA-C 122.163 4.134 . . . . 0.0 122.163 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.836 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 5.4 Cg_endo -102.18 -70.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.491 -1.635 0 CA-C-N 122.693 1.997 . . . . 0.0 111.788 -172.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.598 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 20.3 tt0 -72.89 -6.66 46.64 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 112.885 -1.961 . . . . 0.0 106.153 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.89 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.19 -157.81 0.08 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.646 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -70.33 -178.32 1.68 Allowed 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 113.774 -1.557 . . . . 0.0 108.15 176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -74.92 61.99 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.312 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.774 0.321 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 55' ' ' GLN . 7.0 m -70.97 152.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.83 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.604 ' CD1' ' HB2' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -74.59 166.05 24.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -82.04 -136.27 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.32 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.703 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -94.87 -124.5 0.11 Allowed 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.703 ' H ' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -73.06 -47.72 42.29 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.588 HG22 HD11 ' A' ' 5' ' ' LEU . 18.7 m -87.36 85.87 2.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.882 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.599 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 57.4 mtt180 -74.8 -162.98 0.18 Allowed 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.451 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.659 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER 41.38 103.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.767 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.6 m -63.66 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.769 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 6.0 mp -114.12 90.53 20.16 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 120.836 0.35 . . . . 0.0 111.646 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.586 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo -68.69 -175.75 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.362 2.041 . . . . 0.0 113.207 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 4.5 t -156.89 -172.39 4.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.752 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.79 -139.49 47.12 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.637 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 15.9 Cg_endo -88.92 98.16 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.371 3.381 . . . . 0.0 112.721 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.64 -73.66 1.39 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.149 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.59 34.36 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 121.637 0.576 . . . . 0.0 111.878 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.68 -37.9 67.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.318 -0.941 . . . . 0.0 110.284 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.02 -168.14 22.28 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.758 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.698 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.41 -179.22 6.8 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.7 m -78.26 148.58 33.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.857 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -128.1 -19.71 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 169.67 -104.21 0.2 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 118.999 -1.572 . . . . 0.0 114.81 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 28.8 Cg_endo -101.74 107.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.717 2.945 . . . . 0.0 113.12 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.52 22.6 1.58 Allowed 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.182 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.857 HG23 ' HB2' ' A' ' 22' ' ' PHE . 3.3 tt -115.13 157.1 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-O 122.258 1.028 . . . . 0.0 113.029 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -160.43 138.45 9.86 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.356 -1.747 . . . . 0.0 107.35 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 22' ' ' PHE . 20.4 m -150.1 128.35 12.06 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 120.063 -0.655 . . . . 0.0 112.097 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -107.02 126.63 8.51 Favored Glycine 0 N--CA 1.407 -3.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 37.3 t0 -59.16 -59.57 5.26 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.998 1.399 . . . . 0.0 108.722 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -81.09 15.15 1.98 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -144.16 31.49 1.24 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.083 -175.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.651 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.33 175.61 0.01 OUTLIER Glycine 0 CA--C 1.521 0.445 0 N-CA-C 114.899 0.719 . . . . 0.0 114.899 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.759 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -100.11 134.45 43.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.857 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 30.2 m-85 -131.04 101.66 5.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.404 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG13 HG13 ' A' ' 26' ' ' ILE . 4.5 t -97.16 107.36 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.253 0.549 . . . . 0.0 110.23 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.47 -0.0 44.5 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.394 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.9 p -70.13 -168.24 0.21 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 117.338 0.569 . . . . 0.0 110.245 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -76.61 -39.08 53.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.323 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -74.7 7.27 3.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.295 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -112.91 -21.12 11.3 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.745 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -51.15 -15.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -179.02 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.742 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.69 -21.18 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -74.55 -3.42 30.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.254 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.658 HE22 HD22 ' A' ' 42' ' ' LEU . 5.7 pt20 -54.19 -36.51 63.5 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.057 0.932 . . . . 0.0 108.489 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' HD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -74.55 -7.41 53.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.74 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 3.3 tt0 -71.64 1.8 6.16 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.57 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -66.79 -6.94 17.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.082 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 99.8 m-85 -92.6 -105.22 0.12 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.528 0.204 . . . . 0.0 110.814 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.7 107.15 6.44 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-O 120.621 0.248 . . . . 0.0 110.65 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -44.61 159.25 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.024 2.482 . . . . 0.0 113.546 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.5 t -172.28 90.52 0.41 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.245 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -91.89 72.46 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.128 2.552 . . . . 0.0 113.299 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 55' ' ' GLN . 19.5 p -93.4 -178.16 4.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.928 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER 60.0 160.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.432 178.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 1.2 p -56.22 148.73 17.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.71 -79.17 0.05 OUTLIER Glycine 0 CA--C 1.49 -1.474 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.301 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.834 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -89.43 88.82 7.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -68.12 105.72 1.06 Allowed Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.935 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.785 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 44.4 Cg_exo -38.81 154.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.761 2.307 . . . . 0.0 115.648 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -162.11 154.58 19.62 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.881 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 7.11 7.72 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.287 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.5 t -91.53 51.72 1.93 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.42 32.91 61.25 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.624 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.728 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.42 -153.96 24.67 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.533 -0.842 . . . . 0.0 115.202 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.834 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.0 mmt-85 -120.89 159.24 25.92 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.594 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.6 t -55.86 155.8 5.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -150.89 -26.82 0.21 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -157.67 -171.35 3.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.397 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.33 86.31 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.051 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 57.27 65.54 3.49 Favored Glycine 0 N--CA 1.423 -2.221 0 C-N-CA 118.877 -1.63 . . . . 0.0 110.939 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.759 HG21 ' SG ' ' A' ' 34' ' ' CYS . 3.3 mm -136.77 136.6 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.1 t -122.98 109.58 14.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.645 -1.984 . . . . 0.0 105.645 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -96.23 158.59 15.37 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -173.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.542 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.2 m -128.26 -179.92 1.1 Allowed Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.315 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -72.14 -9.42 24.44 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.376 2.051 . . . . 0.0 112.687 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.88 -32.42 8.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.255 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.25 170.21 36.58 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.467 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.684 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 27.0 m -96.88 167.4 11.11 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.394 0.616 . . . . 0.0 111.87 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.556 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.98 142.92 21.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.596 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -62.87 117.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.024 0.44 . . . . 0.0 110.947 -178.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.682 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 47.5 p30 -101.04 108.25 53.66 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.987 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.681 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.1 Cg_exo -56.37 -15.69 15.78 Favored 'Trans proline' 0 CA--C 1.503 -1.063 0 C-N-CA 123.855 3.037 . . . . 0.0 110.084 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.04 64.13 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.66 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.986 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -109.54 -27.42 9.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -176.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 8.3 t70 172.56 -29.44 0.0 OUTLIER Pre-proline 0 N--CA 1.512 2.633 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 -178.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.051 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.3 Cg_endo -108.97 -71.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 123.099 2.533 . . . . 0.0 112.767 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.622 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.9 tt0 -67.74 -5.85 18.15 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.681 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -73.49 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 112.047 -2.342 . . . . 0.0 111.057 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -63.71 -178.82 0.32 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -74.42 62.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.41 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.798 0.332 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.0 t 64.05 168.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.536 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.552 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -69.66 156.85 38.33 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.668 0.747 . . . . 0.0 112.73 -178.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -81.54 -77.0 0.23 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.635 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.882 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -139.86 -139.59 0.13 Allowed 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.474 -178.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.882 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -76.24 -38.43 56.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.73 0.3 . . . . 0.0 110.923 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -93.33 85.0 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 121.367 0.603 . . . . 0.0 110.677 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 56.4 mtt85 -74.33 -178.73 3.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.183 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m 57.38 101.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.33 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' CA ' ' HB2' ' A' ' 54' ' ' CYS . 0.1 OUTLIER -82.71 -161.43 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.572 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.831 HD22 ' HG2' ' A' ' 46' ' ' GLU . 4.5 tp -97.81 137.07 20.94 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 111.216 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HD2' ' HG ' ' A' ' 11' ' ' LEU . 23.8 Cg_exo -57.71 -171.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.176 1.917 . . . . 0.0 112.347 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.613 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.4 t -157.5 -179.98 8.69 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.903 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.89 -134.79 49.28 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.637 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 7.7 Cg_endo -91.89 99.5 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 124.562 3.508 . . . . 0.0 112.951 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.87 -69.13 3.13 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.088 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.56 32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 CA-C-O 121.533 0.518 . . . . 0.0 112.332 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -33.8 71.66 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.848 0.832 . . . . 0.0 109.862 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.613 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.8 -174.84 20.93 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.807 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.94 -178.95 5.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.6 m -77.57 141.21 39.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 68' ' ' ALA . 8.8 m-85 -119.11 -23.67 6.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.567 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -171.56 -110.54 0.24 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.586 -1.293 . . . . 0.0 114.317 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.91 101.37 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.322 2.681 . . . . 0.0 112.643 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 21.45 3.64 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.752 -0.379 . . . . 0.0 109.991 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 23' ' ' GLY . 2.3 tt -107.76 166.16 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 121.832 0.825 . . . . 0.0 112.742 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -153.76 140.45 18.97 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.37 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -144.88 100.91 3.57 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.876 -177.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.969 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.13 117.82 5.01 Favored Glycine 0 N--CA 1.405 -3.407 0 C-N-CA 118.92 -1.609 . . . . 0.0 109.295 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.688 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 21.0 t0 -58.75 -57.27 13.74 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -83.87 20.14 1.56 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.969 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.61 33.22 0.56 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.691 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.53 176.77 0.01 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.416 0.526 . . . . 0.0 114.416 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.6 t -115.83 134.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.65 125.88 31.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.568 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.0 t -93.81 101.71 12.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.131 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.84 19.51 50.08 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.12 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.706 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 2.0 m -83.27 174.73 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.893 0.477 . . . . 0.0 110.497 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -43.75 -55.8 4.21 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -72.15 -7.61 50.06 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.851 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.99 -16.96 15.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.731 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -19.0 0.18 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.638 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.47 -24.01 2.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.126 0.421 . . . . 0.0 111.26 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 1.58 14.15 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -56.54 -26.02 53.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.831 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.5 -19.61 49.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.51 178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.55 -1.04 35.97 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.029 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -9.45 59.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.07 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 10.9 m-30 -111.91 -6.7 14.22 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.305 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.62 85.71 9.18 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 120.807 0.337 . . . . 0.0 111.175 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -44.79 161.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.855 2.37 . . . . 0.0 112.748 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m 64.61 153.21 0.12 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.857 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.58 -164.18 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.566 2.177 . . . . 0.0 112.143 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.459 ' HB2' ' CA ' ' A' ' 10' ' ' CYS . 3.0 m -133.61 -7.96 2.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.499 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' HG3' HD13 ' A' ' 3' ' ' LEU . 15.2 tt0 177.82 -57.24 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.115 0.483 . . . . 0.0 109.723 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.563 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 3.8 m 57.49 166.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.08 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.592 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -141.38 75.95 0.32 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.869 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 mt-30 -107.11 88.77 2.81 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -68.07 105.78 1.07 Allowed Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 122.961 0.504 . . . . 0.0 110.366 177.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.726 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 35.8 Cg_exo -38.74 155.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.133 3.222 . . . . 0.0 117.619 -177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -165.04 153.31 11.83 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 113.891 -1.504 . . . . 0.0 110.824 177.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 5.53 3.01 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.97 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.7 t -90.66 54.03 2.59 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 117.425 0.612 . . . . 0.0 111.164 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.98 33.21 56.92 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.707 -0.679 . . . . 0.0 113.861 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.662 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.0 -154.09 24.96 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.642 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.869 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.3 mmt180 -115.76 152.73 32.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.153 0.502 . . . . 0.0 110.986 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 46.2 t -62.32 157.94 18.56 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.039 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -155.39 -91.65 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 33' ' ' GLY . . . -77.66 -171.18 2.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.959 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.37 90.68 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.004 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.88 62.4 6.36 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 119.062 -1.542 . . . . 0.0 110.89 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.762 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -129.99 149.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.4 t -136.63 102.99 5.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -91.37 160.11 15.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.524 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -127.85 -179.49 0.98 Allowed Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.261 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.51 -10.08 24.89 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.364 2.042 . . . . 0.0 112.634 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -31.2 8.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.482 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.1 167.73 34.05 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.465 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 16.3 m -96.0 167.11 11.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.383 0.611 . . . . 0.0 112.4 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.641 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -151.57 140.77 21.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.977 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -62.18 116.68 5.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.894 0.378 . . . . 0.0 110.534 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.777 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 52.2 p30 -99.06 109.32 53.72 Favored Pre-proline 0 N--CA 1.439 -1.006 0 CA-C-O 121.573 0.701 . . . . 0.0 111.702 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.82 -14.61 14.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.064 3.176 . . . . 0.0 110.06 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.96 -27.84 62.06 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.123 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -109.89 -28.45 8.75 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -176.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.642 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 173.6 -29.18 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.253 1 N-CA-C 122.371 4.211 . . . . 0.0 122.371 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.004 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -106.01 -70.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.459 0 C-N-CA 122.628 2.219 . . . . 0.0 112.568 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.709 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.3 tt0 -69.04 -7.07 32.19 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.733 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.5 -157.76 0.07 Allowed 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.635 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.01 -179.3 1.18 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -74.76 62.36 1.07 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.57 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.06 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.853 0.359 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -67.8 156.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.126 0.488 . . . . 0.0 111.152 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.747 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -74.64 169.69 17.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.465 ' OD1' ' HG3' ' A' ' 58' ' ' GLN . 18.9 t0 -78.59 -137.55 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 113.952 -1.476 . . . . 0.0 108.192 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.676 HD11 HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -91.28 -123.62 0.07 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.607 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -72.23 -45.6 59.58 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.676 HG22 HD11 ' A' ' 5' ' ' LEU . 11.1 m -88.13 85.19 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.662 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.747 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 51.5 mtt85 -75.56 -177.12 3.51 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.63 ' HA ' ' HB2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 27.62 104.54 0.0 OUTLIER 'General case' 0 C--N 1.34 0.17 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.63 ' HA ' ' HG3' ' A' ' 47' ' ' GLU . 4.2 m -130.06 134.48 47.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.972 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -98.99 168.15 10.16 Favored Pre-proline 0 C--O 1.238 0.472 0 CA-C-O 121.731 0.777 . . . . 0.0 112.516 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.736 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 22.7 Cg_exo -50.28 179.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.008 1.806 . . . . 0.0 111.767 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HB3' ' A' ' 43' ' ' ARG . 4.0 t -158.85 -172.39 3.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.049 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 65.02 -141.34 43.28 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.14 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -84.95 89.6 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.018 3.145 . . . . 0.0 112.881 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.48 -68.28 0.94 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.301 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.99 34.12 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.904 0 CA-C-O 121.632 0.573 . . . . 0.0 112.022 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -73.0 -35.82 66.92 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.339 -0.93 . . . . 0.0 110.61 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.74 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -111.1 -162.04 17.57 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.293 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.771 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.86 174.28 13.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 0.5 OUTLIER -89.18 170.34 10.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.823 177.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.771 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 67.5 m-85 -144.02 -12.05 0.65 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 167.42 -95.44 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 118.691 -1.718 . . . . 0.0 115.055 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -101.07 99.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.378 2.718 . . . . 0.0 113.481 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 52.59 21.84 1.98 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.316 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.667 HG13 HG13 ' A' ' 36' ' ' VAL . 3.8 tt -108.95 160.4 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -157.32 145.47 19.23 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 113.745 -1.57 . . . . 0.0 108.653 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.836 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -146.95 106.25 3.9 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.553 -178.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.883 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.23 128.22 8.96 Favored Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.63 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.909 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 35.9 t70 -58.5 -65.84 0.59 Allowed 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.4 pt-20 -81.36 26.87 0.44 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.883 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -154.58 31.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.713 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 36.49 -166.7 0.01 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 115.172 0.829 . . . . 0.0 115.172 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.5 142.88 38.25 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -177.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.724 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 10.3 m-85 -131.93 98.0 4.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.391 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.667 HG13 HG13 ' A' ' 26' ' ' ILE . 3.5 t -95.75 130.71 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.211 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 47.76 28.53 5.4 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.811 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -109.23 170.25 8.17 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.46 0.304 . . . . 0.0 110.66 -179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -54.95 -55.12 34.21 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -62.56 8.89 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -107.05 -37.3 6.35 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -56.83 -11.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.749 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -49.8 -13.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 47' ' ' GLU . 18.0 t -69.27 -5.4 22.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.527 ' H ' ' HG2' ' A' ' 45' ' ' GLN . 0.4 OUTLIER -56.48 -32.88 65.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 122.466 1.127 . . . . 0.0 107.979 177.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.904 ' O ' HD22 ' A' ' 11' ' ' LEU . 2.1 pt-20 -70.84 -8.36 52.1 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.431 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -57.39 -2.95 0.13 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' GLU . 1.7 m-80 -50.37 -20.73 1.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.3 -0.25 . . . . 0.0 111.451 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.914 ' HB2' HD11 ' A' ' 11' ' ' LEU . 12.0 m-30 -101.91 -161.16 0.83 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.638 0.375 . . . . 0.0 111.594 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.734 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.6 pp -144.4 83.52 9.86 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.942 ' HG2' ' HA ' ' A' ' 11' ' ' LEU . 49.8 Cg_exo -65.34 -159.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.703 2.935 . . . . 0.0 113.638 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.816 ' O ' ' HB2' ' A' ' 56' ' ' SER . 10.7 t -85.85 -58.21 0.33 Allowed Pre-proline 0 C--O 1.226 -0.156 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.419 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 52' ' ' SER . 41.5 Cg_exo -55.5 167.25 2.1 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 120.944 1.096 . . . . 0.0 111.454 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.67 ' HA ' ' HG3' ' A' ' 58' ' ' GLN . 0.1 OUTLIER 63.51 -79.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.138 -179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.708 ' HG3' ' CD1' ' A' ' 3' ' ' LEU . 2.0 tt0 -83.53 51.45 2.0 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.323 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.816 ' HB2' ' O ' ' A' ' 52' ' ' SER . 0.4 OUTLIER 172.08 -77.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.34 98.89 0.87 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.43 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.675 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -120.69 89.77 3.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.982 0.42 . . . . 0.0 110.962 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.568 ' CD ' ' H ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -59.39 100.3 0.21 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.99 -179.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.686 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 27.3 Cg_exo -61.72 179.56 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.277 2.651 . . . . 0.0 115.615 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.74 154.32 9.51 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.256 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.07 -0.03 6.77 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.277 -0.874 . . . . 0.0 114.141 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.7 t -92.08 50.79 1.7 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 117.478 0.639 . . . . 0.0 111.369 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.69 40.91 49.36 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.083 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.644 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.68 -159.44 32.44 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 4.4 mmt180 -114.68 155.99 25.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.094 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 23.9 t -61.11 144.89 52.71 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.523 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ASP . . . -139.85 -97.82 0.16 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.271 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.909 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.51 -170.21 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -43.73 89.88 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.958 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 54.8 71.61 0.69 Allowed Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.179 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.836 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.2 mm -137.01 145.47 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 63' ' ' SER . 33.8 t -132.08 103.67 6.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -91.44 152.36 20.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.493 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -125.07 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.892 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.493 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -71.72 -9.71 25.35 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.371 2.047 . . . . 0.0 112.098 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.69 -33.0 8.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.021 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.09 169.92 34.65 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.562 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 3.3 m -98.68 164.43 12.24 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.102 0.477 . . . . 0.0 111.132 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.63 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.67 141.81 21.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.03 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -58.81 111.3 1.23 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.853 0.358 . . . . 0.0 110.102 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.675 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.1 p30 -92.03 110.5 44.46 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.751 . . . . 0.0 111.683 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.734 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 52.9 Cg_exo -57.49 -13.02 12.3 Favored 'Trans proline' 0 CA--C 1.504 -0.981 0 C-N-CA 124.188 3.258 . . . . 0.0 110.086 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.33 -30.0 57.51 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.561 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.958 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -108.93 -27.27 9.78 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -175.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 5.4 t70 175.37 -29.97 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.278 1 N-CA-C 122.28 4.178 . . . . 0.0 122.28 -177.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.94 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.2 Cg_endo -104.28 -70.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.46 0 C-N-CA 122.45 2.1 . . . . 0.0 112.242 -172.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 28.9 tt0 -70.36 -8.48 50.97 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.717 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.85 -157.64 0.08 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.89 -2.414 . . . . 0.0 112.741 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -69.46 -178.7 1.46 Allowed 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.929 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -74.42 62.39 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.628 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 1.6 t . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.027 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 56' ' ' SER . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.817 0.342 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.94 -172.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.556 ' HG ' ' CD ' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.09 159.92 33.83 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 121.709 0.766 . . . . 0.0 112.723 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.29 -124.98 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.721 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.833 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -95.16 -136.79 0.22 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.833 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -73.99 -39.85 63.37 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.77 HG22 HD21 ' A' ' 5' ' ' LEU . 19.3 m -95.04 85.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.556 ' CD ' ' HG ' ' A' ' 3' ' ' LEU . 20.4 mtt180 -73.92 -163.2 0.16 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.272 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.711 ' HA ' ' HB3' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 41.69 85.74 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.87 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 54' ' ' CYS . 8.1 m -77.99 -43.72 28.8 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.493 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 1.3 mp -118.22 91.82 41.38 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-O 121.353 0.597 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.511 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.5 Cg_exo -62.84 -173.4 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.496 2.131 . . . . 0.0 113.189 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.6 ' N ' ' O ' ' A' ' 19' ' ' GLY . 2.0 t -156.84 -175.81 5.63 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.242 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.01 -138.68 48.7 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.657 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.7 Cg_endo -90.32 100.23 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.371 3.381 . . . . 0.0 112.808 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.14 -69.08 3.09 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.152 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.57 31.4 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 121.386 0.437 . . . . 0.0 112.489 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.09 -36.69 72.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.646 0.736 . . . . 0.0 109.946 179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.07 -174.44 23.56 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.155 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.3 -178.79 5.21 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.437 ' H ' HE22 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -75.63 151.53 37.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 11.3 m-85 -133.51 -17.72 2.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -179.0 -112.07 0.33 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.937 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.0 Cg_endo -101.15 107.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.572 2.848 . . . . 0.0 112.744 -178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.48 24.12 2.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 36' ' ' VAL . 1.9 tt -114.6 161.79 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.922 0.868 . . . . 0.0 113.118 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.45 141.4 22.92 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.371 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.646 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -144.13 102.66 3.9 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.839 -177.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.906 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.43 118.72 5.28 Favored Glycine 0 N--CA 1.4 -3.709 0 C-N-CA 119.023 -1.561 . . . . 0.0 109.42 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.706 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -57.93 -61.67 2.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.0 pt-20 -81.31 19.9 0.91 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.437 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.906 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -150.48 32.77 0.64 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.657 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.34 175.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.448 0.539 . . . . 0.0 114.448 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.5 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -111.39 136.54 50.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.23 119.74 21.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.327 178.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -93.98 102.08 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.725 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.35 20.46 50.89 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.843 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.8 m -86.29 179.42 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.304 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.61 -61.07 1.7 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.67 5.76 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.76 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -107.01 -24.28 12.04 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.85 -15.42 1.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -51.58 -23.21 3.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.77 0.319 . . . . 0.0 111.334 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 47' ' ' GLU . 55.0 m -75.43 -4.51 39.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.439 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -26.51 34.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -74.92 -27.71 60.32 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.049 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 44' ' ' CYS . 0.7 OUTLIER -80.76 7.62 9.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.265 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.82 -17.15 15.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.463 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -100.77 -19.19 16.11 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.727 0.299 . . . . 0.0 111.776 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.23 78.81 13.34 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.33 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.99 106.7 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.792 2.328 . . . . 0.0 112.611 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -127.26 124.64 23.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.851 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 1.0 OUTLIER -82.87 32.88 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.966 2.444 . . . . 0.0 112.765 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 2.1 t -81.34 -165.81 1.03 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.711 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 0.6 OUTLIER 35.84 -147.53 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.489 ' H ' ' CD ' ' A' ' 20' ' ' ARG . 5.4 m 76.33 115.22 0.06 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.64 0.376 . . . . 0.0 110.284 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.15 100.43 0.24 Allowed Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.7 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -117.14 88.18 2.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -177.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -68.02 106.58 1.36 Allowed Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 122.972 0.509 . . . . 0.0 110.093 177.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 49.6 Cg_exo -39.76 154.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.242 3.294 . . . . 0.0 117.83 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.641 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.58 152.89 12.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.489 -1.687 . . . . 0.0 110.478 177.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.02 5.8 4.45 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.735 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 5.2 t -90.97 53.71 2.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 117.252 0.526 . . . . 0.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.13 61.04 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.923 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.596 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.82 -151.23 20.93 Favored Glycine 0 CA--C 1.499 -0.927 0 C-N-CA 120.629 -0.796 . . . . 0.0 114.87 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.712 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.9 mmt180 -118.11 152.87 34.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.095 0.474 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 49.7 t -63.91 149.64 46.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.583 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -146.92 -93.32 0.09 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.901 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.31 -170.74 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.919 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.95 91.04 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.988 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.73 60.51 8.73 Favored Glycine 0 N--CA 1.426 -2.009 0 C-N-CA 118.781 -1.676 . . . . 0.0 110.798 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 67' ' ' CYS . 2.1 mm -128.96 146.55 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 17.0 t -134.48 101.78 5.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -90.08 160.19 16.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.468 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.2 m -129.59 -179.46 1.02 Allowed Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.92 -10.94 25.29 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.326 2.017 . . . . 0.0 112.144 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.81 -30.55 9.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.312 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.68 169.96 34.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.551 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.4 m -96.75 166.71 11.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.436 0.636 . . . . 0.0 112.147 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.626 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -152.27 138.06 17.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.715 178.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.564 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.3 pt-20 -59.52 116.53 4.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.961 0.41 . . . . 0.0 110.42 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.796 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 49.5 p30 -98.8 109.74 54.69 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-O 121.578 0.704 . . . . 0.0 111.552 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 51.1 Cg_exo -56.67 -16.08 18.18 Favored 'Trans proline' 0 CA--C 1.503 -1.038 0 C-N-CA 123.92 3.08 . . . . 0.0 110.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.68 -29.37 64.52 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.161 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.85 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.94 -27.88 9.44 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -176.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.9 t70 173.88 -27.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.158 1 N-CA-C 122.38 4.215 . . . . 0.0 122.38 -178.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.988 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.4 Cg_endo -107.18 -71.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.5 0 C-N-CA 122.476 2.117 . . . . 0.0 112.734 -171.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 29.5 tt0 -68.87 -6.74 28.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.2 -155.83 0.05 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 112.093 -2.321 . . . . 0.0 111.924 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.78 -178.51 0.96 Allowed 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.809 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -73.81 62.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.034 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.241 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.761 0.315 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 35.8 m -62.31 156.13 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.212 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.734 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.78 171.19 10.96 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.991 0.9 . . . . 0.0 113.228 -178.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 13.0 t0 -80.11 -139.54 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.46 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -91.88 -119.98 0.08 Allowed 'General case' 0 N--CA 1.435 -1.191 0 O-C-N 122.393 -0.192 . . . . 0.0 110.773 179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.659 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.57 -47.09 43.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 7' ' ' VAL . 14.5 m -88.61 84.01 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.914 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.734 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 62.3 mtt180 -82.18 160.99 22.93 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.518 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' CYS . 5.9 m 60.98 129.53 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.7 -160.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.959 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD21 ' CB ' ' A' ' 46' ' ' GLU . 6.8 tp -91.56 103.22 7.23 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 120.786 0.327 . . . . 0.0 110.549 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 20.9 Cg_exo -59.04 173.23 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.111 1.874 . . . . 0.0 114.127 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.634 ' N ' ' O ' ' A' ' 19' ' ' GLY . 3.4 t -153.74 -174.24 4.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.456 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 -149.61 51.69 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.073 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -82.52 87.56 1.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 123.772 2.981 . . . . 0.0 112.564 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' H ' HH21 ' A' ' 43' ' ' ARG . . . 100.32 -67.5 0.53 Allowed Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.042 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.585 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.8 34.1 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.956 0 CA-C-O 121.645 0.581 . . . . 0.0 111.955 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.82 -36.71 70.31 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.84 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.57 -167.92 18.42 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.502 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -165.52 179.5 6.06 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.62 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 32.4 m -77.08 149.45 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.741 ' HE2' ' HB3' ' A' ' 28' ' ' CYS . 15.9 m-30 -139.09 26.43 2.43 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 139.53 -106.2 0.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.272 -1.442 . . . . 0.0 114.643 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 24.1 Cg_endo -104.81 100.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.46 2.773 . . . . 0.0 113.466 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.88 26.24 4.49 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.369 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.621 HG23 ' HB2' ' A' ' 22' ' ' PHE . 2.3 tt -111.52 160.13 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -156.09 138.96 15.28 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.52 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -146.48 105.61 3.89 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.477 -178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.29 129.87 9.36 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.337 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.907 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 12.7 t70 -58.83 -63.34 1.33 Allowed 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -82.03 13.9 3.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -142.56 38.55 1.52 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.799 -174.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.863 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 29.22 -163.34 0.0 OUTLIER Glycine 0 CA--C 1.531 1.091 0 N-CA-C 115.995 1.158 . . . . 0.0 115.995 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -108.11 137.16 46.58 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.808 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 6.8 m-85 -132.89 106.73 7.88 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.583 175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 26' ' ' ILE . 6.6 t -94.62 103.73 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.783 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.45 16.81 55.61 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.937 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.723 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -85.44 173.11 10.5 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -43.22 -55.57 3.91 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.802 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.9 -3.0 13.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -104.25 -21.8 13.47 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.747 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.78 -20.58 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.66 -19.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -0.19 13.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 42' ' ' LEU . 4.3 pt20 -54.2 -35.14 62.05 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' CB ' HD21 ' A' ' 11' ' ' LEU . 21.7 mt-10 -74.71 -11.58 60.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.538 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -69.54 -4.13 17.7 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.792 0.33 . . . . 0.0 110.796 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.474 ' OD1' ' CD1' ' A' ' 49' ' ' TYR . 6.1 p30 -52.12 -24.92 7.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.827 0.346 . . . . 0.0 110.813 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.474 ' CD1' ' OD1' ' A' ' 48' ' ' ASN . 13.2 m-30 -75.77 -171.26 1.54 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -102.28 122.73 45.65 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.201 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HD2' HD13 ' A' ' 50' ' ' LEU . 68.5 Cg_exo -46.37 149.33 2.74 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.77 2.313 . . . . 0.0 112.897 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.43 154.46 66.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.926 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.82 93.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.697 2.265 . . . . 0.0 112.067 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 7.1 p -96.18 -171.94 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.096 0.474 . . . . 0.0 111.659 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -72.85 172.9 9.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.828 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.424 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 59.8 p -59.33 171.7 0.74 Allowed 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.705 0.288 . . . . 0.0 110.638 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.41 -59.31 0.23 Allowed Glycine 0 CA--C 1.492 -1.375 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.895 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.4 OUTLIER -95.23 88.7 5.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -67.57 110.05 4.74 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.739 -178.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 36.2 Cg_exo -40.09 155.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.826 3.017 . . . . 0.0 116.659 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.6 154.52 20.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.505 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.45 4.0 5.49 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 114.051 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.2 t -90.58 54.67 2.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 117.382 0.591 . . . . 0.0 111.424 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.6 32.95 61.86 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.745 -0.661 . . . . 0.0 114.121 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.63 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 160.87 -152.17 22.76 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.511 -0.852 . . . . 0.0 114.994 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.895 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 5.5 mmt-85 -116.91 157.47 25.63 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.593 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.869 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 17.0 t -63.26 160.9 14.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.109 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -153.07 -97.26 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.279 -178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -77.34 -169.83 1.54 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.4 88.48 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.006 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 55.86 72.06 0.63 Allowed Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 118.854 -1.641 . . . . 0.0 110.439 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 28' ' ' CYS . 2.7 mm -138.37 145.97 27.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.9 t -133.25 104.72 6.61 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -91.07 147.91 22.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -174.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -116.42 -179.47 0.64 Allowed Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.996 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.1 Cg_exo -72.62 -11.18 25.98 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.503 2.136 . . . . 0.0 112.223 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.71 -31.19 9.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.018 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA2' ' CD1' ' A' ' 26' ' ' ILE . . . 174.05 170.45 37.4 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.855 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.5 m -98.24 163.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.191 0.519 . . . . 0.0 110.956 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.576 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.95 140.11 19.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.917 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.12 114.14 2.24 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.968 0.413 . . . . 0.0 110.001 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.691 ' CG ' ' HB2' ' A' ' 85' ' ' CYS . 50.4 p30 -95.21 110.16 48.82 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-O 121.712 0.767 . . . . 0.0 111.423 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.8 Cg_exo -57.59 -13.8 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 124.109 3.206 . . . . 0.0 109.973 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.23 -26.35 60.19 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.281 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.006 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -110.85 -29.82 7.8 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -175.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.42 -29.75 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.33 1 N-CA-C 122.31 4.189 . . . . 0.0 122.31 -176.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.902 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -105.21 -71.12 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 122.61 2.207 . . . . 0.0 112.423 -172.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.63 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.8 OUTLIER -70.71 -5.7 31.82 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.09 -158.23 0.09 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 111.861 -2.427 . . . . 0.0 112.769 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.13 -178.8 1.1 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.73 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -74.01 61.78 0.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.0 t . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.956 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.836 HG22 ' H ' ' A' ' 3' ' ' LEU . 2.6 p -84.05 -159.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.0 111.52 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.836 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -72.44 168.3 18.76 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.869 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.568 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 2.2 t70 -76.87 -90.99 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -83.65 -75.68 0.32 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.71 0.767 . . . . 0.0 110.138 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.968 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.67 -44.86 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.26 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.733 HG22 HD21 ' A' ' 5' ' ' LEU . 34.3 m -115.96 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.524 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.639 ' HD2' HD12 ' A' ' 3' ' ' LEU . 5.3 mtt-85 -75.42 175.35 8.52 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.277 0.56 . . . . 0.0 112.224 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.6 40.83 0.17 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.224 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 1.0 OUTLIER -67.81 -85.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.87 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HG ' ' CG ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -129.61 95.53 29.35 Favored Pre-proline 0 C--O 1.24 0.588 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 16.2 Cg_exo -62.57 -171.37 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.985 1.79 . . . . 0.0 111.803 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.574 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -157.36 -178.17 7.15 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.64 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.71 -134.54 47.1 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.556 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.5 Cg_endo -92.31 100.15 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.607 3.538 . . . . 0.0 112.763 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.48 -68.71 3.38 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.965 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.72 31.58 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.369 0.427 . . . . 0.0 112.739 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.11 -36.02 74.55 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.641 0.734 . . . . 0.0 109.792 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -107.12 -172.59 22.48 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.077 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.462 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -163.75 179.28 7.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.6 m -76.15 154.9 35.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HB2' HG23 ' A' ' 26' ' ' ILE . 9.4 m-85 -131.08 -43.18 1.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.749 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -158.73 -103.44 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.189 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -98.16 104.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.069 2.513 . . . . 0.0 112.844 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.61 26.89 1.32 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.801 0.334 . . . . 0.0 110.401 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.749 HG22 ' H ' ' A' ' 23' ' ' GLY . 1.7 tt -114.17 164.86 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.064 0.935 . . . . 0.0 113.361 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.43 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.54 140.94 21.51 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.316 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -146.5 102.06 3.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.908 -177.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.93 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -87.71 113.56 4.02 Favored Glycine 0 N--CA 1.402 -3.597 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.055 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 20.3 t0 -57.97 -54.3 48.46 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.7 pt-20 -83.65 15.97 2.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.93 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -151.6 41.81 0.7 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.712 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 39.96 -167.67 0.01 OUTLIER Glycine 0 N--CA 1.463 0.445 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -129.92 134.15 47.3 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.835 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.35 124.5 28.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.466 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.516 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.11 101.59 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.096 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 56.35 24.95 47.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.775 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.781 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 5.2 m -87.39 173.41 9.16 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.895 0.478 . . . . 0.0 109.757 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -42.75 -53.58 4.48 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 111.254 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -72.98 -7.96 53.5 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -103.73 -14.86 15.93 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.701 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.66 -16.47 0.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -177.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.68 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -49.97 -26.47 4.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.093 0.473 . . . . 0.0 111.041 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 1.85 12.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.497 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.526 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.64 -29.68 53.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' CG ' ' HG ' ' A' ' 11' ' ' LEU . 1.3 pp20? -80.28 -18.26 49.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.312 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.66 1.33 23.22 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.636 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 -23.46 15.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.767 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.7 m-30 -90.38 -74.32 0.49 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.281 0.562 . . . . 0.0 111.51 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.16 94.17 6.42 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.356 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 53' ' ' PRO . 68.6 Cg_exo -46.04 109.62 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.514 2.143 . . . . 0.0 112.219 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 97.2 5.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.896 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 51' ' ' PRO . 90.7 Cg_endo -80.65 72.97 6.24 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.416 2.077 . . . . 0.0 111.39 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.758 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 26.5 p -153.49 -177.46 6.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.429 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.758 ' HG2' ' O ' ' A' ' 54' ' ' CYS . 5.1 pt20 48.47 -152.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.491 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 5.4 m 73.46 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.25 105.75 0.3 Allowed Glycine 0 CA--C 1.499 -0.935 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.359 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.721 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -117.55 89.11 3.05 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -66.52 107.3 1.52 Allowed Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.995 177.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.662 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 61.8 Cg_exo -41.52 157.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.915 3.077 . . . . 0.0 117.585 -176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.628 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.63 153.21 12.6 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.358 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.51 2.85 4.02 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.288 -0.869 . . . . 0.0 114.038 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.8 t -89.24 54.59 3.0 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 117.556 0.678 . . . . 0.0 111.557 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.66 32.3 58.39 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.235 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.612 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.15 -150.86 20.17 Favored Glycine 0 CA--C 1.497 -1.055 0 C-N-CA 120.659 -0.782 . . . . 0.0 114.763 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.6 mmt180 -116.94 154.16 31.34 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.066 0.46 . . . . 0.0 110.971 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -63.49 161.04 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.509 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -160.64 -92.2 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.8 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.94 -170.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.902 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.47 90.95 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.923 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.22 62.94 5.63 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 118.57 -1.776 . . . . 0.0 109.893 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.8 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.5 mm -129.99 146.26 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.4 t -134.24 103.92 5.96 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -89.14 150.32 22.76 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.525 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.9 m -117.31 -179.36 0.63 Allowed Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.805 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.525 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -72.35 -11.46 26.69 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.331 2.021 . . . . 0.0 112.732 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.72 -30.47 8.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 111.329 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.65 170.15 36.78 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.302 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.6 m -95.76 165.98 12.03 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.182 0.515 . . . . 0.0 112.184 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.616 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -151.69 141.26 21.69 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.445 179.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.522 ' CD ' ' HB2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -56.91 113.13 1.54 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.838 0.351 . . . . 0.0 110.296 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.804 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 55.6 p30 -97.91 110.86 57.42 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-O 121.878 0.847 . . . . 0.0 112.307 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.769 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.0 Cg_exo -56.75 -17.36 22.85 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 124.174 3.25 . . . . 0.0 110.025 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.48 63.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.628 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.898 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -110.88 -27.83 8.65 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 -175.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.6 t70 174.32 -28.95 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.213 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.923 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.5 Cg_endo -105.66 -71.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.54 2.16 . . . . 0.0 112.518 -172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.8 tp10 -69.37 -7.39 36.98 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 176.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.769 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.01 -155.21 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.113 -2.312 . . . . 0.0 112.493 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.45 -178.55 1.13 Allowed 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.868 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -75.04 62.02 1.12 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.26 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 3' ' ' LEU . 2.7 t 61.55 167.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.633 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.53 168.4 17.65 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 122.117 0.961 . . . . 0.0 113.591 -178.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 53' ' ' PRO . 10.8 t70 -80.52 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.25 177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.748 HD11 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -91.0 -123.87 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.591 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -73.16 -44.13 60.45 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.748 HG22 HD11 ' A' ' 5' ' ' LEU . 9.4 m -88.71 86.69 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.095 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.635 ' HB3' HD12 ' A' ' 3' ' ' LEU . 41.4 mtt180 -70.88 -167.3 0.19 Allowed 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.977 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER 43.87 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.968 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -46.28 177.19 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.235 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -94.68 159.89 32.54 Favored Pre-proline 0 C--O 1.239 0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 112.068 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 39.4 Cg_exo -53.51 -173.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.725 2.283 . . . . 0.0 112.775 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.8 t -157.31 -172.93 4.19 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.305 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 60.98 -139.31 47.94 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.445 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.0 Cg_endo -90.21 97.02 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.304 3.336 . . . . 0.0 112.771 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.2 -70.32 1.75 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.031 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.74 33.18 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.578 0.543 . . . . 0.0 112.133 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.96 -34.8 69.26 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.568 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -110.57 -167.73 19.32 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.732 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.566 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -163.31 177.25 9.13 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -77.86 156.09 30.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.643 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.6 m-85 -130.55 -83.55 0.53 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.122 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -114.46 -103.74 2.53 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.816 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -103.8 118.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.65 2.9 . . . . 0.0 113.214 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.6 27.7 0.27 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 23' ' ' GLY . 2.6 tt -118.8 163.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.242 1.02 . . . . 0.0 113.453 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.62 140.99 21.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.529 -1.669 . . . . 0.0 108.284 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -144.9 106.65 4.27 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.718 -177.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.927 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -92.65 116.41 5.09 Favored Glycine 0 N--CA 1.401 -3.65 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 22.8 t0 -57.94 -56.94 15.53 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.46 19.64 1.22 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.927 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -151.68 34.15 0.55 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 43.24 -169.55 0.01 OUTLIER Glycine 0 CA--C 1.517 0.182 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.316 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 140.24 52.5 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.685 ' HB3' ' OG1' ' A' ' 38' ' ' THR . 19.1 m-85 -131.16 115.18 16.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.141 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.0 t -94.14 101.72 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.436 0.636 . . . . 0.0 110.27 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.54 20.25 55.54 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.067 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.685 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 2.6 p -77.73 -173.15 2.9 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.07 -42.19 99.6 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 35' ' ' PHE . 1.6 mp0 -75.82 -10.83 59.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.456 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -100.93 -12.93 18.55 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.707 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -53.48 -14.28 0.77 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -178.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.686 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.24 -25.31 3.55 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.062 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.29 -7.67 57.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.726 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.56 -24.32 60.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -17.74 56.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.499 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' OE2' ' HA ' ' A' ' 53' ' ' PRO . 38.0 tp10 -81.21 -1.15 43.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.709 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.47 -6.64 25.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.575 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -141.78 46.28 1.68 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.724 0.297 . . . . 0.0 111.776 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -138.37 145.15 45.76 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 120.967 0.413 . . . . 0.0 110.756 178.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.38 114.84 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.646 2.231 . . . . 0.0 112.804 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.47 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 57.22 178.6 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.941 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 98.5 Cg_endo -90.65 168.21 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.84 2.36 . . . . 0.0 112.095 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.403 ' N ' ' OE2' ' A' ' 47' ' ' GLU . 26.4 p -105.93 -158.85 0.68 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.251 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 3.5 tt0 -140.01 153.33 46.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.038 0.447 . . . . 0.0 111.312 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 20' ' ' ARG . 98.9 p -121.27 -159.35 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.937 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -139.32 89.14 0.2 Allowed Glycine 0 CA--C 1.5 -0.863 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.819 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -110.99 89.68 3.11 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.684 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -63.64 107.25 1.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.155 178.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 64.0 Cg_exo -41.36 157.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.278 3.319 . . . . 0.0 117.668 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -165.85 153.27 10.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.784 177.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.19 5.5 3.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.035 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -90.79 55.88 3.08 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 117.415 0.607 . . . . 0.0 111.25 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.26 31.96 56.95 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.953 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.34 -149.78 18.29 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.0 114.864 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.819 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 mmt180 -119.03 155.35 31.58 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.871 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.684 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 49.1 t -63.24 162.75 11.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.4 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.613 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . . . -162.56 -91.59 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.78 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.83 -171.5 1.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.711 0.804 . . . . 0.0 112.929 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.935 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -47.49 91.14 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.936 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.44 60.74 8.32 Favored Glycine 0 N--CA 1.424 -2.13 0 C-N-CA 118.605 -1.76 . . . . 0.0 110.317 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.78 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -128.58 147.49 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 24.3 t -136.18 103.59 5.37 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.6 t -87.31 152.19 22.49 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -173.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.5 m -121.24 -179.27 0.71 Allowed Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.963 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 10.7 Cg_exo -73.73 -13.22 24.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.501 2.134 . . . . 0.0 112.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.81 -26.96 12.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.967 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.88 171.21 32.73 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.89 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 13.3 m -93.42 166.21 12.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.398 0.618 . . . . 0.0 112.059 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.625 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -151.76 141.29 21.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.662 178.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -60.9 118.14 6.32 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.914 0.388 . . . . 0.0 110.89 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.754 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.0 p30 -99.75 109.39 55.43 Favored Pre-proline 0 N--CA 1.44 -0.926 0 CA-C-O 121.577 0.703 . . . . 0.0 111.556 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.73 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.3 Cg_exo -56.55 -15.67 16.43 Favored 'Trans proline' 0 CA--C 1.505 -0.952 0 C-N-CA 124.036 3.157 . . . . 0.0 110.192 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.49 63.51 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 113.605 -1.634 . . . . 0.0 110.141 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.882 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -108.91 -28.69 9.0 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.667 2.469 . . . . 0.0 117.667 -176.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.53 -29.16 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.164 1 N-CA-C 122.17 4.137 . . . . 0.0 122.17 -177.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.936 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.4 Cg_endo -107.38 -71.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.409 0 C-N-CA 122.684 2.256 . . . . 0.0 112.926 -171.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.696 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -68.75 -6.71 28.08 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 176.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.73 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -72.8 -152.95 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.731 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -64.81 -178.54 0.43 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.617 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -74.05 62.15 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 90' ' ' ALA . 3.5 t . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.047 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.545 ' HA ' ' CG ' ' A' ' 53' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.96 0.409 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.579 ' N ' ' HB3' ' A' ' 53' ' ' PRO . 12.1 m -82.75 129.81 36.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.529 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.882 ' HG ' ' H ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.94 170.67 15.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.308 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 1.005 ' HB3' ' HD2' ' A' ' 8' ' ' ARG . 22.4 t70 -79.22 -74.13 0.3 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.039 HD22 ' HG3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -77.6 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.954 177.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.035 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -84.48 -77.12 0.28 Allowed 'General case' 0 N--CA 1.414 -2.272 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 7' ' ' VAL . 18.7 m -121.72 82.16 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 1.039 ' HG3' HD22 ' A' ' 5' ' ' LEU . 34.9 mtt85 -84.68 -167.91 1.99 Allowed 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 121.247 -0.908 . . . . 0.0 111.214 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -163.35 80.14 0.45 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.965 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 54' ' ' CYS . 32.0 p -83.63 101.7 11.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.818 0.342 . . . . 0.0 111.152 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.64 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 6.4 mp -127.06 96.27 34.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.458 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.656 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 53.4 Cg_exo -48.69 172.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.835 2.357 . . . . 0.0 114.491 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 20' ' ' ARG . 7.3 t -160.18 -169.47 2.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.9 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 40' ' ' GLU . . . 56.5 -142.83 39.67 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.491 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -86.24 93.43 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.972 3.115 . . . . 0.0 112.545 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.97 -69.7 1.13 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.689 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.656 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.26 32.22 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.43 0.461 . . . . 0.0 112.095 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.654 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -72.07 -36.4 69.55 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.753 0.787 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -109.53 -167.4 20.19 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.023 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.953 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -164.04 -179.51 6.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 41.8 t -83.87 155.76 22.75 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.497 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.953 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 45.6 m-85 -142.5 8.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 149.27 -103.09 0.25 Allowed Glycine 0 CA--C 1.522 0.489 0 C-N-CA 119.016 -1.564 . . . . 0.0 115.351 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.4 Cg_endo -105.53 105.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.914 3.076 . . . . 0.0 113.31 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 52.46 18.92 1.03 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.558 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.716 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 1.8 tt -108.01 153.82 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.225 1.012 . . . . 0.0 113.533 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.902 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -160.36 138.03 9.65 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.48 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 21.4 m -147.9 110.03 4.56 Favored 'General case' 0 N--CA 1.415 -2.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.524 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.905 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -90.62 131.16 10.62 Favored Glycine 0 N--CA 1.415 -2.702 0 C-N-CA 119.942 -1.123 . . . . 0.0 110.482 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.563 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 17.2 t70 -59.51 -62.59 1.76 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.329 1.064 . . . . 0.0 109.462 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.654 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -75.57 -0.84 21.8 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -125.61 31.44 5.52 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.601 -176.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.9 -177.27 0.01 OUTLIER Glycine 0 N--CA 1.465 0.608 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -99.33 140.49 33.43 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.626 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 49.4 m-85 -130.91 143.5 50.78 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.164 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 26' ' ' ILE . 2.6 t -142.83 119.73 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.025 0.44 . . . . 0.0 109.949 176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.5 5.23 11.34 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.406 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.594 HG22 ' H ' ' A' ' 39' ' ' ALA . 3.3 m -87.32 179.27 6.63 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' H ' HG22 ' A' ' 38' ' ' THR . . . -61.37 -54.27 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.69 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 0.4 OUTLIER -60.89 8.17 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -108.97 -38.67 5.52 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -46.26 -15.17 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.35 -18.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.3 t -70.8 -11.93 61.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.482 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -28.39 65.05 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 30.8 mt-10 -75.85 -9.58 58.72 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.752 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 3.7 tt0 -74.18 -1.11 19.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -84.65 8.11 18.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.288 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 -103.51 -123.9 0.2 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.356 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 132.31 13.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 120.749 0.309 . . . . 0.0 110.824 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HG3' HG23 ' A' ' 9' ' ' THR . 93.0 Cg_exo -49.12 -179.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.209 2.606 . . . . 0.0 113.351 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.637 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -144.79 178.22 1.52 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.811 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 62.6 Cg_endo -90.67 79.05 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.745 2.297 . . . . 0.0 111.675 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.58 ' O ' ' CB ' ' A' ' 10' ' ' CYS . 31.8 p -162.09 59.97 0.24 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.283 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 1.0 ' HB2' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -122.12 178.75 4.79 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 120.451 -0.5 . . . . 0.0 112.242 -178.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 81.58 112.03 0.06 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 -177.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.635 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . 166.57 -45.01 0.26 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.865 HE22 ' HA ' ' A' ' 68' ' ' ALA . 1.7 mt-30 -95.66 88.96 5.17 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.635 ' HE3' ' O ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -67.89 121.29 79.07 Favored Pre-proline 0 N--CA 1.436 -1.164 0 CA-C-N 114.401 -1.272 . . . . 0.0 113.314 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.703 ' CB ' ' HD2' ' A' ' 66' ' ' ARG . 34.7 Cg_exo -38.6 176.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.829 3.02 . . . . 0.0 114.077 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.27 154.77 19.48 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.72 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.8 6.26 5.18 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.142 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.555 ' HB3' ' SG ' ' A' ' 73' ' ' CYS . 18.3 t -92.15 51.0 1.72 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.006 0.431 . . . . 0.0 111.081 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.33 25.79 63.16 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.65 . . . . 0.0 114.072 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 74' ' ' CYS . . . 164.63 -152.37 22.0 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.733 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 5.6 mmt-85 -115.31 157.17 24.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.179 -0.51 . . . . 0.0 111.444 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.718 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 30.6 t -58.28 143.54 44.28 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.933 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.865 ' HA ' HE22 ' A' ' 58' ' ' GLN . . . -137.46 -95.23 0.21 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.323 0.583 . . . . 0.0 112.085 -178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.919 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.98 -172.54 2.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.419 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.941 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.92 94.98 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.029 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.3 71.11 0.76 Allowed Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 118.93 -1.605 . . . . 0.0 110.188 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.919 HG13 ' HB3' ' A' ' 69' ' ' ALA . 3.9 mm -138.53 146.25 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 23.4 t -135.14 104.19 5.83 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.751 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.6 t -91.33 152.87 20.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -173.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.544 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.7 m -119.6 -179.25 0.66 Allowed Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 113.245 -1.798 . . . . 0.0 109.606 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.9 Cg_exo -72.18 -10.66 26.14 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.393 2.062 . . . . 0.0 112.154 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.92 -33.0 7.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.453 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.81 168.22 37.07 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -98.28 165.36 11.91 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.331 0.586 . . . . 0.0 111.853 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.624 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.3 141.57 21.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.399 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.605 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -59.78 114.72 2.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.5 p30 -95.98 106.42 27.99 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-O 121.303 0.573 . . . . 0.0 111.296 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.817 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 54.1 Cg_exo -55.84 -9.88 3.43 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 124.142 3.228 . . . . 0.0 110.495 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -76.18 -29.13 57.55 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-N 113.442 -1.708 . . . . 0.0 109.651 177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -109.72 -27.77 9.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 118.122 2.638 . . . . 0.0 118.122 -176.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.2 t70 175.6 -31.19 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.334 1 N-CA-C 122.179 4.14 . . . . 0.0 122.179 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.029 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 8.8 Cg_endo -105.46 -70.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.717 2.278 . . . . 0.0 112.097 -172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.817 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 65.0 tt0 -69.97 -6.65 34.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.735 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.25 -157.48 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.237 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.45 -178.82 0.72 Allowed 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.211 -1.359 . . . . 0.0 107.48 176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.36 62.36 0.97 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 3.0 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.204 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.791 0.329 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.73 162.37 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.201 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.53 166.66 23.16 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.583 0.706 . . . . 0.0 112.564 -179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.763 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 50.1 t0 -78.78 -79.0 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.348 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -84.07 -150.78 0.11 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.815 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -82.47 -51.84 7.44 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.655 ' O ' HG23 ' A' ' 7' ' ' VAL . 32.5 m -119.44 84.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG3' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -81.87 158.99 23.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.89 65.25 0.3 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.669 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -57.37 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.553 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.2 mp -110.58 136.08 20.66 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 111.943 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.665 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.7 Cg_exo -66.01 -166.73 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.455 2.103 . . . . 0.0 112.239 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.2 t -157.87 -176.38 5.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.898 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.37 -138.17 47.36 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.748 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 14.3 Cg_endo -89.6 98.15 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 124.456 3.437 . . . . 0.0 112.551 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.31 -69.04 2.84 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.129 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 178.69 32.86 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 121.54 0.522 . . . . 0.0 112.478 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.69 -35.49 72.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.043 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -106.91 -171.87 22.59 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.984 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.66 179.98 7.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 120.799 0.333 . . . . 0.0 110.135 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -80.44 145.12 32.1 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.624 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.7 m-85 -118.51 -60.3 1.79 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.871 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -142.12 -100.16 0.37 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.268 -0.967 . . . . 0.0 114.02 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 31.8 Cg_endo -100.85 105.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.344 2.696 . . . . 0.0 113.387 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.46 25.42 1.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 110.464 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 23' ' ' GLY . 3.0 tt -112.9 164.75 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.949 0.881 . . . . 0.0 112.922 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.44 141.28 22.81 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.033 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -145.38 108.76 4.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.708 -177.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.924 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -97.59 117.13 5.71 Favored Glycine 0 N--CA 1.403 -3.508 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.744 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 36.9 t0 -57.92 -56.56 20.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.553 1.177 . . . . 0.0 108.33 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.635 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -83.85 15.27 3.39 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.924 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -145.36 32.92 1.07 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -174.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 42.94 173.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.085 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 69' ' ' ALA . 1.8 t -112.98 136.84 52.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.67 125.28 29.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.822 177.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.626 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.8 t -95.18 97.7 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.53 14.19 56.95 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.854 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 4.7 m -78.54 -177.4 5.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' H ' HG22 ' A' ' 38' ' ' THR . . . -53.58 -55.55 24.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.267 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.525 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -72.66 4.21 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -114.25 -21.42 10.45 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -44.84 -18.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.63 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -50.29 -25.84 4.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 118.305 0.502 . . . . 0.0 110.865 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.91 2.26 15.21 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.697 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -57.82 -25.66 60.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -78.84 -17.44 55.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.819 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 -2.63 31.02 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.101 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 1.4 t30 -78.23 -5.02 50.64 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.101 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' HD1' ' O ' ' A' ' 48' ' ' ASN . 2.9 m-30 -136.02 30.45 3.04 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.109 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HG ' ' HD2' ' A' ' 51' ' ' PRO . 3.2 tp -141.0 142.31 27.21 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.778 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 56.5 Cg_exo -44.53 174.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.899 2.4 . . . . 0.0 113.084 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.566 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 22.2 m -65.87 -50.95 50.81 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.633 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 52' ' ' SER . 92.0 Cg_endo -86.2 153.98 9.53 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.364 2.043 . . . . 0.0 112.389 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.473 ' HA ' ' HE ' ' A' ' 8' ' ' ARG . 43.9 t -177.63 80.16 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.605 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.68 ' HG2' ' O ' ' A' ' 55' ' ' GLN . 48.4 tt0 55.2 12.72 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.766 0.317 . . . . 0.0 111.686 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -50.59 150.59 2.67 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 122.017 -0.427 . . . . 0.0 110.922 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.7 97.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.731 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.743 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 5.0 mm-40 -117.02 88.89 2.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.583 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -66.85 102.68 0.39 Allowed Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.623 0.769 . . . . 0.0 111.376 178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.708 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 25.8 Cg_exo -40.82 157.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.577 3.518 . . . . 0.0 118.563 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -164.62 153.99 13.37 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.869 176.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.7 7.01 1.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.54 -0.754 . . . . 0.0 114.122 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 24.2 t -92.85 52.08 1.79 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 117.397 0.598 . . . . 0.0 111.265 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.06 34.89 58.67 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.752 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.731 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.05 -151.44 21.13 Favored Glycine 0 CA--C 1.498 -1.004 0 C-N-CA 120.756 -0.735 . . . . 0.0 114.604 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.743 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 2.9 mmt180 -117.99 154.17 32.42 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 120.922 0.391 . . . . 0.0 111.52 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -61.86 155.32 23.59 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.698 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.71 -99.16 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.384 -176.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -76.03 -170.78 1.48 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.924 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.942 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.51 86.61 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.011 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.94 70.76 0.88 Allowed Glycine 0 N--CA 1.42 -2.392 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.967 -176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 68' ' ' ALA . 3.3 mm -142.64 116.25 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 121.643 0.735 . . . . 0.0 109.028 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.2 t -104.88 106.3 16.73 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.608 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 1.8 t -92.72 161.58 14.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.477 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -128.04 -179.92 1.09 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 CA-C-N 113.538 -1.665 . . . . 0.0 109.176 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -73.47 -10.12 23.53 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.38 2.054 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.68 -32.52 7.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.423 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.24 167.1 35.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.912 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.638 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 29.2 m -97.08 167.21 11.19 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.0 111.935 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.587 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -153.54 142.22 20.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.996 178.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.514 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -60.98 113.07 2.33 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.077 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 35.4 p30 -95.05 108.63 39.58 Favored Pre-proline 0 N--CA 1.439 -0.975 0 CA-C-O 121.667 0.746 . . . . 0.0 111.769 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.733 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 48.5 Cg_exo -58.51 -12.09 13.03 Favored 'Trans proline' 0 CA--C 1.504 -0.985 0 C-N-CA 123.99 3.126 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.37 -29.58 59.93 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.32 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.724 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.6 -24.09 10.73 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -175.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.666 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 6.9 t70 173.77 -29.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.391 1 N-CA-C 122.262 4.171 . . . . 0.0 122.262 -178.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.011 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 10.8 Cg_endo -107.56 -71.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.396 0 C-N-CA 122.481 2.121 . . . . 0.0 112.465 -171.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.733 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 2.1 tt0 -69.56 -6.68 32.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.692 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.31 -155.53 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.073 -2.331 . . . . 0.0 111.613 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.24 -178.85 0.69 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.445 176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -74.48 62.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 8.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.745 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 54' ' ' CYS . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.849 0.356 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.13 163.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.818 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -67.86 168.72 11.08 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.465 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 12.0 t0 -74.87 -134.44 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.779 HD13 ' HE ' ' A' ' 66' ' ' ARG . 1.1 pp -91.1 -125.64 0.08 Allowed 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 122.029 -0.419 . . . . 0.0 111.103 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.723 ' N ' HD12 ' A' ' 5' ' ' LEU . 1.1 t70 -73.12 -52.68 13.31 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.697 ' H ' HD12 ' A' ' 5' ' ' LEU . 6.4 m -85.85 85.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.43 176.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.818 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 33.1 mtt85 -76.13 123.86 26.5 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.749 HG22 ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -75.36 -151.26 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.966 178.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 54' ' ' CYS . 0.6 OUTLIER 73.59 -15.94 0.53 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.365 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.6 mp -110.19 91.79 12.08 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 120.783 0.325 . . . . 0.0 111.24 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.697 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 51.6 Cg_exo -49.08 168.55 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.157 1.904 . . . . 0.0 112.778 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.644 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 5.2 t -158.3 -171.86 3.65 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.88 -149.78 33.2 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.013 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.37 85.49 1.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.669 2.913 . . . . 0.0 112.836 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -71.52 0.21 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.118 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.697 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.7 31.9 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 121.416 0.453 . . . . 0.0 112.578 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -75.01 -37.38 61.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.756 -0.722 . . . . 0.0 110.884 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' C ' ' HB3' ' A' ' 13' ' ' CYS . . . -105.54 -163.54 23.46 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.526 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.749 ' HD3' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.92 153.69 45.77 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-O 122.187 0.994 . . . . 0.0 112.881 -178.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HB2' ' CA ' ' A' ' 44' ' ' CYS . 0.1 OUTLIER -91.06 127.13 36.36 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.209 178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.834 ' HB2' ' CG2' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -102.07 -102.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -113.13 -87.71 1.64 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 26' ' ' ILE . 30.7 Cg_endo -101.91 113.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.171 2.58 . . . . 0.0 114.451 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 43.42 23.27 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.725 0.298 . . . . 0.0 110.622 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.834 ' CG2' ' HB2' ' A' ' 22' ' ' PHE . 6.6 tt -112.8 161.85 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-O 122.556 1.169 . . . . 0.0 114.036 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.795 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 49.2 t -159.4 159.54 33.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.763 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.1 106.15 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.892 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -96.76 122.54 7.43 Favored Glycine 0 N--CA 1.414 -2.814 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 25.8 t70 -58.78 -59.15 5.89 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.61 1.205 . . . . 0.0 107.942 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.2 pt-20 -81.82 11.62 4.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.892 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.49 41.66 1.24 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.197 -175.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 27.89 -164.39 0.0 OUTLIER Glycine 0 N--CA 1.472 1.066 0 N-CA-C 115.398 0.919 . . . . 0.0 115.398 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -114.81 144.34 43.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.701 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.6 m-85 -131.46 98.23 4.46 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.818 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 26' ' ' ILE . 3.2 t -94.69 131.46 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.037 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 53.18 31.76 42.04 Favored Glycine 0 C--N 1.319 -0.406 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.809 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.28 -177.69 3.23 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -69.55 -49.15 57.01 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.537 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -68.99 8.5 0.53 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . . . -106.3 -27.19 11.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.706 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.78 -11.2 2.95 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.644 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -48.86 -19.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.425 ' CA ' ' HB2' ' A' ' 21' ' ' CYS . 1.2 t -69.47 -21.96 63.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.927 0.394 . . . . 0.0 110.086 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -60.16 -24.19 64.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.11 -7.68 57.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.031 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -69.86 -6.26 31.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.896 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.82 -34.65 69.88 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 110.318 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 3.6 m-30 -80.32 174.43 11.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.653 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -121.49 95.21 48.35 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.92 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 50' ' ' LEU . 99.2 Cg_exo -50.79 -165.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.202 2.601 . . . . 0.0 113.253 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.529 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.6 OUTLIER -141.68 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.73 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD2' ' H ' ' A' ' 52' ' ' SER . 71.7 Cg_endo -77.57 83.02 2.25 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.439 2.093 . . . . 0.0 112.702 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -64.48 -171.86 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.687 -179.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.575 ' HB2' ' O ' ' A' ' 54' ' ' CYS . 8.5 tt0 172.12 158.77 0.1 Allowed 'General case' 0 C--N 1.346 0.456 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.705 -178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' HG21 ' A' ' 9' ' ' THR . 2.0 p -73.91 -172.78 1.39 Allowed 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 9' ' ' THR . . . 165.81 -79.88 0.12 Allowed Glycine 0 CA--C 1.489 -1.536 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.789 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.513 ' NE2' ' HB ' ' A' ' 7' ' ' VAL . 19.7 mt-30 -69.22 88.66 0.44 Allowed 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -69.78 113.5 17.82 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.676 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.746 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 68.6 Cg_exo -40.3 155.17 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 123.221 2.614 . . . . 0.0 115.576 -178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' O ' ' O ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -161.46 153.9 20.13 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.19 178.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.46 4.18 5.33 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.174 -0.921 . . . . 0.0 114.06 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.9 t -90.51 57.02 3.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.434 0.617 . . . . 0.0 111.5 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.63 29.07 57.39 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.879 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.741 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.61 -149.05 16.6 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.443 -0.885 . . . . 0.0 115.307 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.779 ' HE ' HD13 ' A' ' 5' ' ' LEU . 6.7 mmt180 -121.05 158.88 26.85 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.22 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 34.8 t -60.38 154.25 20.84 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.649 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.3 -92.7 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.2 -171.24 1.98 Allowed 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.939 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.64 89.18 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.953 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.21 68.46 1.69 Allowed Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.787 -1.673 . . . . 0.0 110.202 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.734 HG21 ' SG ' ' A' ' 28' ' ' CYS . 1.4 mm -138.52 141.2 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.72 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.3 t -128.89 104.96 7.9 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.3 t -90.21 153.13 20.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -173.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.498 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.3 m -119.76 -179.61 0.73 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.403 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -72.87 -11.58 25.77 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.482 2.121 . . . . 0.0 112.189 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -29.97 9.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 111.078 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.19 171.06 36.77 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 5.2 m -97.54 164.34 12.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.267 0.556 . . . . 0.0 111.925 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.642 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -151.38 139.51 20.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.664 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.539 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -58.13 118.84 5.88 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.911 0.386 . . . . 0.0 110.503 -179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.69 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 45.7 p30 -98.97 108.31 48.57 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-O 121.596 0.712 . . . . 0.0 111.319 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.732 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 53.9 Cg_exo -55.91 -16.57 16.35 Favored 'Trans proline' 0 CA--C 1.506 -0.904 0 C-N-CA 123.868 3.045 . . . . 0.0 109.941 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.34 -28.23 63.93 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.904 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -111.38 -27.39 8.66 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -176.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.5 t70 174.58 -28.99 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.172 1 N-CA-C 122.432 4.234 . . . . 0.0 122.432 -177.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.953 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.8 Cg_endo -106.39 -71.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.504 0 C-N-CA 122.559 2.173 . . . . 0.0 112.542 -172.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.645 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 25.5 tt0 -69.75 -6.18 30.25 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.732 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.23 -158.1 0.06 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.958 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.03 -178.11 0.57 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.541 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -73.0 62.11 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 90' ' ' ALA . 2.6 t . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.0 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.694 0.283 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 1' ' ' ALA . 35.3 m 44.56 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.413 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -78.13 171.22 15.35 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.681 ' HB2' ' NE ' ' A' ' 8' ' ' ARG . 4.8 t0 -81.65 -87.88 0.09 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.688 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -81.4 -74.1 0.35 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.175 0.988 . . . . 0.0 109.294 177.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.639 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -152.75 -59.51 0.14 Allowed 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.827 179.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.688 ' H ' HD12 ' A' ' 5' ' ' LEU . 31.4 m -106.49 86.49 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.012 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.681 ' NE ' ' HB2' ' A' ' 4' ' ' ASP . 4.9 mtt-85 -73.44 -178.32 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.578 0.704 . . . . 0.0 112.678 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.81 41.65 0.06 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.741 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -75.92 -77.13 0.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.716 -178.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD11 ' HG2' ' A' ' 46' ' ' GLU . 5.2 tp -125.05 91.39 49.41 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 121.316 0.579 . . . . 0.0 112.177 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.714 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.4 Cg_exo -69.74 -167.77 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.517 2.145 . . . . 0.0 111.736 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -158.8 -177.16 6.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.775 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 62.67 -136.67 44.34 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.555 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.9 Cg_endo -91.8 101.04 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.519 3.48 . . . . 0.0 112.599 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.59 -71.65 2.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.714 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 177.75 33.64 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.578 0.543 . . . . 0.0 112.267 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.94 -35.63 69.67 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.48 -0.86 . . . . 0.0 110.228 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -104.37 -172.22 24.95 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.151 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.622 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.29 178.82 8.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' HD23 ' A' ' 11' ' ' LEU . 1.3 m -75.98 154.6 35.71 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 15.1 m-85 -135.01 -28.02 1.21 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -170.72 -110.24 0.23 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.593 -1.289 . . . . 0.0 114.203 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 42.1 Cg_endo -98.51 103.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.293 2.662 . . . . 0.0 112.793 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.79 22.95 2.52 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.036 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.614 HD11 HG22 ' A' ' 36' ' ' VAL . 2.5 tt -111.63 163.16 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 122.0 0.905 . . . . 0.0 113.016 -177.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.31 143.23 23.87 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.608 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.82 103.11 3.74 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.066 -177.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -89.01 116.04 4.59 Favored Glycine 0 N--CA 1.402 -3.603 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.822 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 27.0 t70 -58.42 -55.27 37.25 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.525 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.9 pt-20 -83.63 11.78 6.74 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.05 37.75 1.16 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.706 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 40.51 -175.61 0.01 OUTLIER Glycine 0 CA--C 1.523 0.558 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HB2' HG13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -118.13 138.52 52.22 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 1.055 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -132.19 129.82 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.419 178.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.614 HG22 HD11 ' A' ' 26' ' ' ILE . 6.3 t -103.79 97.61 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.183 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 64.54 17.52 62.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.005 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 35' ' ' PHE . 10.0 p -74.15 -170.92 1.03 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 117.022 0.411 . . . . 0.0 109.933 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.25 -45.75 83.36 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.15 -14.27 61.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.331 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.055 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.21 -9.84 20.11 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -17.41 1.31 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -178.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.689 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.36 -28.81 8.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.484 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -2.76 38.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.927 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.5 mt-30 -57.32 -26.56 61.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.592 ' HG2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.18 -22.65 41.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.807 179.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -0.44 38.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.711 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -83.32 -13.43 55.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.973 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -84.83 -106.6 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tp -103.19 102.26 27.36 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 120.632 0.254 . . . . 0.0 110.996 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -43.28 127.65 5.54 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.856 2.371 . . . . 0.0 112.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.2 t -123.67 124.07 26.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.73 55.77 3.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.343 2.028 . . . . 0.0 112.161 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.2 t -119.01 122.01 41.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.331 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.6 ' CA ' ' HD3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER 51.13 97.23 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.024 0.44 . . . . 0.0 111.54 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.9 p 178.56 125.65 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.958 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 146.27 11.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.174 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.662 ' NE2' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -130.29 89.63 2.82 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.584 ' HZ2' ' HA ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.61 103.86 0.39 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.088 0.555 . . . . 0.0 110.783 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.711 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 77.8 Cg_exo -44.29 155.76 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.018 3.146 . . . . 0.0 117.018 -176.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.21 168.59 20.48 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.734 1.254 . . . . 0.0 112.591 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.55 -2.18 33.94 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 112.465 -2.152 . . . . 0.0 116.317 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.598 ' HB3' ' CB ' ' A' ' 73' ' ' CYS . 41.5 t -94.21 56.52 2.21 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 117.745 0.772 . . . . 0.0 111.501 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 50.43 38.89 35.45 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.29 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.585 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.96 -153.72 24.38 Favored Glycine 0 CA--C 1.496 -1.098 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.329 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.775 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 mmt180 -111.68 147.89 34.58 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.194 0.521 . . . . 0.0 111.816 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 t -62.23 156.04 23.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.708 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.662 ' HB2' ' NE2' ' A' ' 58' ' ' GLN . . . -157.69 -94.05 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.743 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -73.99 -171.16 1.05 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.746 0.819 . . . . 0.0 112.747 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.944 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.45 89.66 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.929 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.4 63.29 5.41 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 118.505 -1.807 . . . . 0.0 110.289 -177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.743 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -130.19 146.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.775 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 1.9 t -135.97 104.4 5.7 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.4 t -89.49 159.16 17.39 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -173.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.527 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.5 m -127.49 -179.27 0.92 Allowed Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.645 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.2 Cg_exo -71.92 -10.13 25.75 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.336 2.024 . . . . 0.0 112.697 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -33.2 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 111.304 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.8 169.95 37.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.466 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 8.0 m -96.38 165.8 12.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.4 0.619 . . . . 0.0 112.111 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.637 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -151.79 140.81 21.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.694 178.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.85 117.31 4.48 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.125 0.488 . . . . 0.0 110.006 -179.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 55.7 p30 -99.01 109.7 54.98 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.907 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.756 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -57.24 -14.78 16.37 Favored 'Trans proline' 0 CA--C 1.504 -1.0 0 C-N-CA 123.682 2.921 . . . . 0.0 109.887 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.24 -29.36 62.71 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.251 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.8 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.32 -26.6 9.49 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 4.7 t70 174.52 -29.22 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.245 1 N-CA-C 122.481 4.252 . . . . 0.0 122.481 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.944 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.31 -70.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.535 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -171.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 30.6 tt0 -69.47 -6.55 31.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.756 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.99 -154.83 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 112.059 -2.337 . . . . 0.0 112.549 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.96 -178.7 1.29 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.817 176.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -74.62 62.04 1.01 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.493 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.3 t . . . . . 0 C--O 1.248 1.017 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.252 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.099 0.476 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.671 HG12 ' H ' ' A' ' 3' ' ' LEU . 13.4 t -56.86 173.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.779 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -69.18 173.17 5.89 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.884 0.85 . . . . 0.0 112.923 -178.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.843 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 43.5 t0 -81.45 -144.87 0.05 Allowed 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.895 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 58' ' ' GLN . 0.4 OUTLIER -88.96 -116.98 0.06 Allowed 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.684 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -74.69 -47.88 29.09 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 7' ' ' VAL . 11.1 m -87.68 84.19 2.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.365 176.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.843 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 45.5 mtt180 -80.09 167.33 20.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -177.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.853 ' HA ' ' HB3' ' A' ' 54' ' ' CYS . 21.4 m 69.98 97.96 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.666 -1.152 . . . . 0.0 113.19 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' N ' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -38.12 105.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 178.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -108.76 91.75 9.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 121.254 0.55 . . . . 0.0 110.179 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 94.4 Cg_exo -41.57 164.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.041 2.494 . . . . 0.0 114.869 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.645 ' N ' ' O ' ' A' ' 19' ' ' GLY . 5.6 t -157.42 -172.02 3.82 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.103 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.44 -142.59 45.06 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.664 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 26.3 Cg_endo -85.63 95.84 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.148 3.232 . . . . 0.0 112.796 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.46 -66.68 3.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.025 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' PRO . . . 178.29 32.02 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 CA-C-O 121.591 0.551 . . . . 0.0 112.438 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.764 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.47 -34.85 72.87 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -0.827 . . . . 0.0 109.866 179.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -115.24 -169.11 15.77 Favored Glycine 0 N--CA 1.433 -1.502 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.721 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -162.55 -178.34 6.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 34.3 m -76.03 159.87 30.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.809 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 63.2 m-85 -148.24 16.94 1.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 24' ' ' PRO . . . 142.73 -113.56 0.8 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.263 -1.446 . . . . 0.0 114.879 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 18.5 Cg_endo -105.75 111.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.878 3.052 . . . . 0.0 112.986 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.79 22.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.388 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.722 HG13 HG13 ' A' ' 36' ' ' VAL . 1.5 tt -115.76 154.22 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 122.177 0.989 . . . . 0.0 112.486 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -158.63 134.04 8.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.76 -1.563 . . . . 0.0 107.324 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.977 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . 33.2 m -150.38 108.95 3.81 Favored 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.187 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.917 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -83.11 123.08 5.96 Favored Glycine 0 N--CA 1.413 -2.86 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.185 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.652 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 22.9 t70 -58.21 -57.62 12.05 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.32 18.04 1.21 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.917 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -152.2 39.36 0.59 Allowed 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.766 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.4 178.67 0.01 OUTLIER Glycine 0 N--CA 1.464 0.561 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -105.32 129.08 53.74 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -177.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HE1' ' O ' ' A' ' 32' ' ' LEU . 1.7 m-85 -132.1 105.63 7.5 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.68 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.722 HG13 HG13 ' A' ' 26' ' ' ILE . 8.1 t -95.25 110.28 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.232 0.539 . . . . 0.0 109.599 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.46 21.08 53.51 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.919 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -94.38 178.26 5.68 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -51.29 -53.85 31.72 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 111.589 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.662 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -71.09 8.01 1.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -108.25 -24.95 11.28 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -52.71 -16.91 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 1.2 mpp_? -55.15 -18.14 5.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -72.13 -8.15 53.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.199 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -26.68 65.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -12.96 60.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.908 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 2.1 tm-20 -66.69 -4.27 8.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.763 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -52.61 -44.16 65.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.796 0.332 . . . . 0.0 110.253 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -97.26 165.83 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.492 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.16 74.58 15.85 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-O 120.814 0.34 . . . . 0.0 111.092 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -53.42 -168.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.178 2.585 . . . . 0.0 113.299 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.652 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 72.0 m -59.99 173.26 0.58 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.707 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.679 ' HA ' HD11 ' A' ' 3' ' ' LEU . 87.1 Cg_exo -48.63 -179.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.628 2.219 . . . . 0.0 113.103 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.853 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 44.2 t -161.38 -60.48 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.576 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.679 ' HG2' ' H ' ' A' ' 56' ' ' SER . 3.9 tt0 173.88 -175.62 0.07 Allowed 'General case' 0 C--N 1.344 0.336 0 CA-C-N 117.94 0.336 . . . . 0.0 111.203 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.679 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -60.62 -152.14 0.0 OUTLIER 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.514 ' HA2' ' NH2' ' A' ' 20' ' ' ARG . . . 179.39 -100.63 0.14 Allowed Glycine 0 CA--C 1.489 -1.556 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.839 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 1.032 ' HB2' HD21 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -74.33 90.4 2.13 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.003 -0.599 . . . . 0.0 109.456 179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -64.52 107.48 1.4 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.22 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 90.9 Cg_exo -40.7 158.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.199 2.6 . . . . 0.0 116.386 -177.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.09 154.17 14.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.539 177.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.35 3.87 7.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.747 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 11.0 t -91.08 54.07 2.52 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 117.222 0.511 . . . . 0.0 111.311 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.07 33.18 60.5 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.133 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.88 -151.35 21.08 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.816 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 4.0 mmt85 -118.35 156.01 29.67 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.992 -0.604 . . . . 0.0 111.26 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 24.6 t -61.25 151.73 30.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.065 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . . . -149.07 -94.27 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.977 ' HB2' ' HB3' ' A' ' 28' ' ' CYS . . . -76.7 -171.68 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.651 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.975 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -45.05 91.76 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.982 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 54.95 68.21 1.8 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 119.006 -1.569 . . . . 0.0 110.206 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.86 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.0 mm -136.12 142.83 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 16.6 t -128.93 104.47 7.61 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -88.5 154.42 20.37 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.555 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 3.8 m -123.16 -179.24 0.77 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.894 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 14.5 Cg_exo -72.04 -9.68 24.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.334 2.023 . . . . 0.0 112.927 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -34.07 7.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.691 0.282 . . . . 0.0 110.984 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.83 170.17 38.31 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.282 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.622 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 11.6 m -94.03 165.95 12.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.482 0.658 . . . . 0.0 112.666 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.645 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -150.82 140.0 21.2 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.597 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -60.41 117.93 5.84 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.985 0.422 . . . . 0.0 110.049 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.703 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.7 p30 -99.19 108.53 50.33 Favored Pre-proline 0 N--CA 1.439 -1.009 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.281 -178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 52.1 Cg_exo -56.23 -12.74 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.014 3.142 . . . . 0.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.64 60.36 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.35 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.939 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -108.88 -27.56 9.65 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 117.865 2.543 . . . . 0.0 117.865 -176.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.2 t70 174.33 -29.36 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.362 1 N-CA-C 122.321 4.193 . . . . 0.0 122.321 -178.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.982 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.7 Cg_endo -106.2 -70.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.495 0 C-N-CA 122.345 2.03 . . . . 0.0 112.29 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 62.1 tt0 -69.49 -6.83 33.18 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -75.76 -158.04 0.08 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 111.79 -2.459 . . . . 0.0 112.11 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.67 -177.97 0.85 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.613 176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.92 61.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.455 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 3' ' ' LEU . 4.8 t -65.71 167.86 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.631 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.827 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -70.15 173.97 6.03 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.46 0.648 . . . . 0.0 112.641 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.567 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.9 t0 -80.14 -78.49 0.17 Allowed 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.584 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.046 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -146.65 -127.64 0.06 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.826 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.046 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -70.01 -41.85 73.78 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.015 HG22 HD11 ' A' ' 5' ' ' LEU . 34.3 m -91.62 109.22 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.783 176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.827 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 86.2 mtt180 -71.4 126.66 30.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.667 ' HB ' ' HA ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -104.09 -162.85 0.93 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.922 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.665 ' H ' ' HA ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER 65.88 62.72 0.61 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.632 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.8 tp -89.66 132.25 37.4 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.493 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 26.8 Cg_exo -55.76 -173.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.081 1.854 . . . . 0.0 112.677 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 3.9 t -157.86 -175.02 5.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.256 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 59.53 -137.47 49.88 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 120.409 -0.9 . . . . 0.0 113.85 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 11.3 Cg_endo -89.76 94.94 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.437 3.425 . . . . 0.0 112.667 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.05 -68.61 2.48 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.418 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.56 32.41 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.504 0.502 . . . . 0.0 112.32 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.562 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -69.8 -35.5 74.89 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.573 -0.813 . . . . 0.0 110.109 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -114.94 -165.38 14.85 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.809 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.613 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -161.59 177.0 10.41 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.67 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -79.43 153.71 29.47 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.684 ' HB2' HG23 ' A' ' 26' ' ' ILE . 15.6 m-85 -125.71 -94.15 0.48 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.695 -0.402 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.691 ' H ' ' CG2' ' A' ' 26' ' ' ILE . . . -98.86 -106.84 2.67 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.575 -0.822 . . . . 0.0 114.565 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -101.95 113.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.798 2.999 . . . . 0.0 113.559 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER 50.9 21.02 0.87 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.225 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.691 ' CG2' ' H ' ' A' ' 23' ' ' GLY . 4.2 tt -111.74 166.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 122.134 0.968 . . . . 0.0 113.316 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.77 143.08 18.2 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.751 -1.568 . . . . 0.0 107.886 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.848 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -147.5 104.88 3.67 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.908 -177.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.931 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -93.14 119.58 5.96 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.646 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 36.3 t0 -58.22 -58.63 7.6 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.607 1.203 . . . . 0.0 108.009 -178.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.562 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.3 pt-20 -81.18 20.39 0.83 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -152.08 35.21 0.53 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.218 -175.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.681 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.3 -164.81 0.01 OUTLIER Glycine 0 C--N 1.33 0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 114.164 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.75 140.29 53.07 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.756 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -131.91 114.88 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.582 178.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' HG13 ' A' ' 26' ' ' ILE . 3.2 t -97.17 113.8 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.409 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 58.92 19.86 46.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.738 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 3.2 m -94.47 163.76 13.27 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.411 0.284 . . . . 0.0 110.384 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.83 -53.62 7.28 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.927 0.394 . . . . 0.0 111.282 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.3 mp0 -69.06 7.57 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.858 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -116.03 -26.69 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -43.37 -19.77 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.601 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -52.23 -21.81 3.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.572 0.624 . . . . 0.0 111.702 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.67 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 13.7 t -77.68 -4.69 47.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.013 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -59.12 -25.08 63.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.632 ' HG2' HD22 ' A' ' 11' ' ' LEU . 2.1 pp20? -76.49 -14.05 60.06 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.518 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 1.6 tt0 -68.6 0.6 3.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.278 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -56.64 -19.35 15.82 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 12.4 m-30 -61.57 -168.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.639 ' H ' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -107.56 84.71 1.98 Allowed Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-O 120.879 0.371 . . . . 0.0 111.903 -179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HA ' ' HG2' ' A' ' 55' ' ' GLN . 44.2 Cg_exo -43.57 147.85 0.95 Allowed 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.834 2.356 . . . . 0.0 113.374 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.554 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -172.66 -64.86 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.69 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 52' ' ' SER . 63.9 Cg_endo -82.15 -86.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.132 1.888 . . . . 0.0 112.928 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.432 ' C ' ' HG3' ' A' ' 55' ' ' GLN . 2.7 t -100.3 -84.02 0.43 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.576 0.226 . . . . 0.0 111.339 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.683 ' HG2' ' HA ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER 37.39 29.6 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.612 ' HB3' ' O ' ' A' ' 55' ' ' GLN . 64.6 p 165.67 -177.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.027 0.441 . . . . 0.0 110.663 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.486 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -162.93 87.08 0.1 Allowed Glycine 0 CA--C 1.5 -0.898 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.658 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mt-30 -113.6 89.54 3.11 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' C ' ' HB3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -63.65 103.2 0.38 Allowed Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.238 178.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 57.9 Cg_exo -42.83 160.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.134 3.223 . . . . 0.0 117.662 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -164.75 154.06 13.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.155 177.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.93 3.37 3.07 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.044 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.03 54.74 2.46 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 117.562 0.681 . . . . 0.0 111.339 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.99 35.85 49.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.947 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.701 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.8 -154.84 25.93 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.694 -0.765 . . . . 0.0 114.973 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 5.6 mmt180 -115.43 155.46 27.4 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.207 -0.497 . . . . 0.0 111.587 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 25.1 t -60.98 153.03 26.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.043 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -151.39 -92.62 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.871 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -77.23 -173.86 2.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.6 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.981 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -44.78 92.19 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.944 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.68 66.02 3.14 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 118.601 -1.761 . . . . 0.0 110.215 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.871 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.9 mm -134.25 144.97 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.6 t -132.38 105.96 7.6 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.606 ' HB3' HE22 ' A' ' 58' ' ' GLN . 1.7 t -92.0 153.59 19.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -173.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.531 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.3 m -119.03 -179.41 0.67 Allowed Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.66 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.6 Cg_exo -71.94 -10.22 25.86 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.313 2.008 . . . . 0.0 112.562 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 -32.24 7.62 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.656 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.92 168.49 36.92 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.703 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.591 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 8.6 m -96.44 165.89 11.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.482 0.658 . . . . 0.0 112.442 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.705 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -152.18 142.46 22.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.555 178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.591 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -61.11 117.88 6.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.58 -178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.723 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 45.1 p30 -98.32 108.08 45.37 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-O 121.549 0.69 . . . . 0.0 111.285 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.766 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 54.1 Cg_exo -56.24 -11.02 5.31 Favored 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 124.099 3.199 . . . . 0.0 110.147 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . -77.02 -28.86 55.07 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.397 -1.728 . . . . 0.0 110.165 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.903 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -109.44 -27.37 9.49 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -175.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.4 t70 174.36 -29.35 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.246 1 N-CA-C 122.428 4.233 . . . . 0.0 122.428 -178.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.981 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.0 Cg_endo -106.42 -70.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.746 2.297 . . . . 0.0 112.306 -172.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -70.96 -5.88 34.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 175.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.766 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.72 -160.3 0.15 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 111.767 -2.469 . . . . 0.0 112.371 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.11 -177.58 0.38 Allowed 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.114 -1.403 . . . . 0.0 107.675 176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -74.23 61.77 0.89 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.2 t . . . . . 0 C--O 1.248 0.993 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.235 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.868 0.366 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 m -83.41 143.52 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.2 0.524 . . . . 0.0 111.98 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.633 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -75.07 175.64 8.0 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.781 0.801 . . . . 0.0 112.975 -178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.623 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 20.0 t0 -77.95 -140.77 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.944 177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -91.12 -123.8 0.07 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.652 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -68.93 -47.98 64.39 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 7' ' ' VAL . 15.9 m -85.92 90.43 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.947 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.633 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 58.6 mtt85 -69.26 -168.33 0.15 Allowed 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.67 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.4 m 67.22 111.61 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.791 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -48.17 -178.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.28 -178.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' GLU . 11.0 mp -68.8 118.6 62.49 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.737 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' CB ' ' HA2' ' A' ' 17' ' ' GLY . 20.0 Cg_exo -58.84 -174.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.264 1.976 . . . . 0.0 112.241 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.629 ' N ' ' O ' ' A' ' 19' ' ' GLY . 1.8 t -156.67 -176.74 6.14 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.102 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.602 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.09 -133.08 49.01 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.876 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' CD ' ' HG ' ' A' ' 32' ' ' LEU . 8.2 Cg_endo -92.71 100.31 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 124.905 3.737 . . . . 0.0 112.446 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 -68.27 3.54 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.919 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 178.68 31.63 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 121.416 0.453 . . . . 0.0 112.792 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.92 -37.85 69.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.764 0.792 . . . . 0.0 109.797 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -101.11 -176.58 29.1 Favored Glycine 0 N--CA 1.435 -1.38 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.783 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' CA ' ' HB2' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -162.14 -179.38 7.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.83 0.348 . . . . 0.0 110.655 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.9 m -80.91 144.88 31.6 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.676 ' HB2' HG23 ' A' ' 26' ' ' ILE . 6.6 m-85 -119.68 -43.47 2.58 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.653 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -165.01 -95.27 0.1 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.277 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.9 Cg_endo -101.91 103.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.567 2.844 . . . . 0.0 113.554 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.69 25.53 1.01 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.922 0.391 . . . . 0.0 110.62 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.7 tt -113.86 160.47 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.85 0.833 . . . . 0.0 112.852 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -153.42 136.94 15.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.169 179.232 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 2.2 m -148.39 117.29 6.72 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.513 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.893 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -104.93 119.36 6.18 Favored Glycine 0 N--CA 1.405 -3.373 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.162 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 8.6 t70 -57.79 -57.02 14.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 118.552 1.176 . . . . 0.0 108.21 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.1 pt-20 -83.06 26.53 0.61 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.893 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -159.77 33.01 0.19 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.536 -175.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.965 ' HA2' ' HB1' ' A' ' 69' ' ' ALA . . . 40.58 176.14 0.01 OUTLIER Glycine 0 CA--C 1.534 1.264 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.751 ' SG ' HG21 ' A' ' 72' ' ' ILE . 1.2 m -106.03 132.25 52.34 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.838 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -131.92 117.08 17.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.586 177.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.567 ' HA ' HG13 ' A' ' 26' ' ' ILE . 4.9 t -94.19 98.28 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.021 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.83 10.72 40.12 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.984 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.8 m -76.41 174.5 10.18 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 123.079 0.552 . . . . 0.0 109.744 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.55 -56.14 4.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.8 0.333 . . . . 0.0 111.344 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -73.7 6.98 2.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -112.87 -23.25 10.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.703 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -46.99 -18.25 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -49.37 -23.99 1.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.55 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -77.79 -5.2 49.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.281 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -59.97 -23.18 63.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 29.3 mt-10 -76.8 -13.83 59.98 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.192 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 1.5 mt-10 -75.49 2.02 12.65 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.75 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.58 -7.0 59.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.727 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -56.74 -163.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.224 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HG ' ' HD2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -92.67 155.87 41.54 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.782 -179.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.591 ' HD2' ' HG ' ' A' ' 50' ' ' LEU . 21.9 Cg_exo -39.0 122.17 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.093 2.529 . . . . 0.0 113.38 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -143.38 160.26 52.19 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -93.03 72.89 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.083 2.522 . . . . 0.0 112.725 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -175.54 5.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.256 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -137.8 171.09 14.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.172 0.511 . . . . 0.0 111.476 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.495 ' H ' ' HG2' ' A' ' 55' ' ' GLN . 1.2 m -154.75 -170.82 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.92 102.29 0.21 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.356 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.679 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -124.65 88.95 2.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 120.902 0.382 . . . . 0.0 111.411 -179.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' CD ' ' H ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -63.7 102.0 0.3 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.261 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 71.9 Cg_exo -44.01 160.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.873 3.049 . . . . 0.0 117.306 -176.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -165.17 155.02 13.15 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.106 -1.861 . . . . 0.0 109.805 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.12 7.14 3.46 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 3.4 t -93.38 51.94 1.68 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.124 0.462 . . . . 0.0 111.007 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.16 34.6 58.8 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.982 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.744 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.61 -151.85 21.53 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 115.112 0.805 . . . . 0.0 115.112 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.744 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.6 mmt180 -118.82 155.41 31.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.758 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 27.0 t -62.89 155.59 26.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.04 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.58 -89.85 0.12 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.369 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.965 ' HB1' ' HA2' ' A' ' 33' ' ' GLY . . . -73.34 -169.59 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 114.829 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 86' ' ' ASP . . . -28.44 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.36 1.03 0 CA-C-O 122.253 1.025 . . . . 0.0 110.309 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.79 ' C ' ' OD1' ' A' ' 82' ' ' ASP . . . -177.01 78.53 0.07 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.847 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.751 HG21 ' SG ' ' A' ' 34' ' ' CYS . 2.0 mm -132.41 149.83 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 114.202 -0.999 . . . . 0.0 108.888 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 29.8 t -132.95 102.88 5.79 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.8 t -85.35 146.57 26.95 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.49 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -113.58 -179.64 0.65 Allowed Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.443 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.49 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 7.9 Cg_exo -74.67 -11.83 22.18 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.467 2.111 . . . . 0.0 112.271 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.48 -28.14 11.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.015 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.04 168.2 33.2 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.642 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.1 m -94.17 165.93 12.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.276 0.56 . . . . 0.0 112.264 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.62 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.64 141.64 20.27 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.96 178.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.629 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.64 122.1 12.63 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.79 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 54.0 p30 -101.55 106.65 47.39 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.438 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.695 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 52.8 Cg_exo -57.1 -17.64 25.83 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 123.786 2.991 . . . . 0.0 109.61 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.3 69.28 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.26 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.744 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 1.2 m -103.52 -33.76 8.92 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 -177.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 9.2 t70 167.84 -24.84 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.457 0 N-CA-C 121.703 3.964 . . . . 0.0 121.703 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.705 ' HG2' ' O ' ' A' ' 71' ' ' GLY . 5.8 Cg_endo -101.67 -69.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.508 0 C-N-CA 122.263 1.975 . . . . 0.0 112.347 -172.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.551 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.1 tt0 -71.85 -5.7 36.35 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 175.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . . . -74.16 -155.3 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.207 -2.27 . . . . 0.0 111.44 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -68.24 -178.72 1.11 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -74.93 62.53 1.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.473 ' OG ' ' OD2' ' A' ' 86' ' ' ASP . 3.4 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.568 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.482 0.182 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.1 m 36.51 -163.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -72.01 174.73 6.65 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.641 0.734 . . . . 0.0 112.706 -178.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.642 ' HB2' ' SG ' ' A' ' 54' ' ' CYS . 66.9 t0 -78.27 -89.89 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.238 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 6' ' ' ASP . 1.3 pp -152.52 -42.37 0.1 Allowed 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.807 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -149.53 -48.73 0.14 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.416 176.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 7' ' ' VAL . 4.4 m -82.68 92.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.232 178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.5 mtt85 -67.26 171.04 6.24 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.98 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.576 ' H ' ' HB3' ' A' ' 55' ' ' GLN . 0.1 OUTLIER 23.2 90.19 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.327 0.584 . . . . 0.0 111.06 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 13.9 p -145.15 17.33 1.56 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.939 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD22 ' HB2' ' A' ' 53' ' ' PRO . 4.6 tp -109.23 90.2 7.89 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.016 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 10' ' ' CYS . 11.0 Cg_exo -63.63 179.11 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.901 1.734 . . . . 0.0 113.296 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.676 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 7.5 t -157.35 -169.77 3.02 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.673 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.6 -144.05 44.06 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.469 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 17.5 Cg_endo -87.92 90.91 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 124.206 3.271 . . . . 0.0 112.462 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.54 -70.69 0.61 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.101 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.87 32.2 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.868 0 CA-C-O 121.449 0.472 . . . . 0.0 112.447 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.43 -38.03 74.49 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.87 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.04 -164.54 18.47 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.569 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.717 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -159.71 179.07 9.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.59 151.96 37.76 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.717 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 24.2 m-85 -132.98 -1.13 3.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 26' ' ' ILE . . . 166.18 -114.55 0.59 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 119.212 -1.47 . . . . 0.0 114.324 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -101.07 105.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.701 2.934 . . . . 0.0 112.571 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.48 23.78 3.64 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.948 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.583 HG13 HG13 ' A' ' 36' ' ' VAL . 2.9 tt -111.66 162.83 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 122.363 1.078 . . . . 0.0 113.584 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.475 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 49.3 t -147.83 149.92 33.22 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.227 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -154.45 96.08 1.87 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.589 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.939 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.48 119.08 5.27 Favored Glycine 0 N--CA 1.412 -2.91 0 C-N-CA 119.445 -1.359 . . . . 0.0 110.005 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.583 ' HA ' ' C ' ' A' ' 69' ' ' ALA . 15.2 t70 -58.77 -55.7 31.72 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.595 1.198 . . . . 0.0 107.809 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 2.8 pt-20 -81.15 1.3 32.52 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.893 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.939 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -134.18 39.19 3.11 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.614 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.687 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.72 -172.24 0.01 OUTLIER Glycine 0 N--CA 1.468 0.768 0 N-CA-C 114.769 0.668 . . . . 0.0 114.769 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.4 t -120.87 133.68 55.3 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.862 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.43 126.68 33.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.844 178.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.583 HG13 HG13 ' A' ' 26' ' ' ILE . 3.4 t -99.77 106.43 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.18 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 60.86 24.16 62.21 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.0 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.4 m -94.74 172.01 8.43 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.58 0.352 . . . . 0.0 110.535 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.61 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -44.11 -54.99 5.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.55 -10.99 60.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.751 0.31 . . . . 0.0 111.642 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.48 -14.55 16.78 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.701 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -47.73 -18.37 0.15 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -51.7 -26.98 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.627 179.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -4.13 50.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.442 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.595 HE21 ' HB2' ' A' ' 42' ' ' LEU . 4.0 mt-30 -58.48 -24.42 60.33 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -23.33 52.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.209 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -1.94 44.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.594 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.26 -7.1 59.65 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.314 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.421 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.8 m-85 -95.53 -99.97 0.16 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.572 0.225 . . . . 0.0 111.431 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -106.62 96.85 15.08 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.946 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 78.0 Cg_exo -47.88 86.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.992 2.461 . . . . 0.0 113.286 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.519 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 179.95 59.3 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 52' ' ' SER . 44.2 Cg_endo -93.32 -72.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.958 2.439 . . . . 0.0 112.51 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 4' ' ' ASP . 38.1 t -146.26 -107.99 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.006 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.576 ' HB3' ' H ' ' A' ' 9' ' ' THR . 5.2 tp60 -157.52 163.6 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.011 0.434 . . . . 0.0 111.832 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.507 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 3.4 p -110.44 -168.5 1.32 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.02 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -155.33 89.16 0.12 Allowed Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.74 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -113.57 89.37 3.07 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -65.65 105.61 0.82 Allowed Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.084 0.553 . . . . 0.0 110.526 178.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 56.0 Cg_exo -41.88 158.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.122 3.215 . . . . 0.0 117.649 -176.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -164.41 154.13 13.99 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.371 177.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.87 4.39 4.38 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.452 -0.794 . . . . 0.0 114.143 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.0 t -91.42 53.28 2.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.485 0.642 . . . . 0.0 111.223 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.58 57.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.912 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.574 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 162.75 -154.5 25.47 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.669 -0.777 . . . . 0.0 114.964 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.74 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 7.9 mmt-85 -115.9 153.98 30.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.415 -0.392 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.6 t -62.87 153.21 34.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.984 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -153.69 -91.91 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.865 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -74.81 -171.67 1.37 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.968 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.6 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.941 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.46 64.74 4.1 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 118.879 -1.629 . . . . 0.0 110.165 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.865 HG13 ' HB3' ' A' ' 69' ' ' ALA . 1.8 mm -131.28 146.11 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 20.1 t -133.62 101.22 5.04 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.9 t -83.05 146.93 28.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.7 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 1.2 m -111.32 -179.47 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.806 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.561 179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.7 ' HD2' ' HB3' ' A' ' 75' ' ' SER . 34.7 Cg_endo -74.01 -22.51 17.1 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 121.552 1.501 . . . . 0.0 112.238 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.9 -27.2 15.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.266 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.22 168.87 33.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.425 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 4.1 m -94.28 165.71 12.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.442 0.639 . . . . 0.0 112.434 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.628 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -150.98 140.89 21.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.497 178.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.563 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.94 119.31 7.5 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.961 0.41 . . . . 0.0 110.616 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.732 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 48.3 p30 -98.93 109.21 52.98 Favored Pre-proline 0 N--CA 1.438 -1.067 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.533 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.722 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.6 Cg_exo -56.98 -12.24 9.07 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 124.061 3.174 . . . . 0.0 110.146 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.69 -28.11 58.51 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.268 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.846 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -110.68 -25.88 9.71 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 118.178 2.659 . . . . 0.0 118.178 -175.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.7 t70 174.2 -30.44 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.42 1 N-CA-C 122.194 4.146 . . . . 0.0 122.194 -177.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.968 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.9 Cg_endo -106.66 -71.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.391 0 C-N-CA 122.636 2.224 . . . . 0.0 112.74 -171.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.712 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 3.7 tt0 -69.5 -6.11 28.43 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.722 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -74.88 -157.5 0.06 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 111.86 -2.427 . . . . 0.0 112.443 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.69 -178.19 0.53 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.2 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.84 62.27 0.58 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 90' ' ' ALA . 12.0 t . . . . . 0 C--O 1.249 1.072 0 CA-C-N 114.264 -1.334 . . . . 0.0 110.929 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.707 0.289 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.12 143.24 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.802 ' HB3' ' HG2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -74.85 169.06 18.69 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.471 ' CG ' ' HB2' ' A' ' 54' ' ' CYS . 37.1 t0 -79.8 -137.81 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.814 178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.679 HD12 ' H ' ' A' ' 6' ' ' ASP . 0.7 OUTLIER -92.37 -120.58 0.08 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.679 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -73.73 -48.45 31.84 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 5' ' ' LEU . 11.7 m -86.75 83.7 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.053 177.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.802 ' HG2' ' HB3' ' A' ' 3' ' ' LEU . 39.3 mtt180 -82.29 147.44 28.9 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.37 -178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.754 ' CG2' ' HG3' ' A' ' 12' ' ' PRO . 3.1 m 59.47 115.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.203 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.637 ' SG ' ' HB3' ' A' ' 52' ' ' SER . 81.3 m -85.2 -84.41 0.15 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.251 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 7.3 mp -121.4 91.49 48.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.981 0.419 . . . . 0.0 110.318 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.754 ' HG3' ' CG2' ' A' ' 9' ' ' THR . 7.6 Cg_exo -68.95 -177.82 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.386 2.057 . . . . 0.0 114.857 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 6.0 t -155.56 -170.88 3.58 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.113 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 58.36 -137.62 49.86 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.513 -0.851 . . . . 0.0 114.063 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 12.5 Cg_endo -90.19 93.19 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.598 3.532 . . . . 0.0 113.13 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.54 -68.3 2.12 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.324 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA2' ' CB ' ' A' ' 12' ' ' PRO . . . 177.87 34.34 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.775 0.653 . . . . 0.0 112.267 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.949 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.8 -35.08 69.86 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.166 -1.017 . . . . 0.0 109.916 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.682 ' HA2' ' HA2' ' A' ' 29' ' ' GLY . . . -117.12 -163.49 13.06 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.475 -1.238 . . . . 0.0 112.197 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.577 ' HE ' HE21 ' A' ' 55' ' ' GLN . 0.0 OUTLIER -158.2 176.87 11.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 110.475 -179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -86.68 158.33 19.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.078 178.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.758 ' HB2' HG23 ' A' ' 26' ' ' ILE . 11.1 m-85 -131.11 -90.76 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.723 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -120.51 -93.43 1.36 Allowed Glycine 0 CA--C 1.528 0.882 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -99.53 104.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.545 2.83 . . . . 0.0 114.177 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLY . 0.3 OUTLIER 51.65 19.97 1.0 Allowed 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.363 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 22' ' ' PHE . 5.7 tt -109.24 163.09 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.146 0.974 . . . . 0.0 113.327 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' CB ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -156.41 145.01 20.01 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.701 -1.591 . . . . 0.0 108.229 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.722 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.5 OUTLIER -149.05 115.37 5.82 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.995 -177.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.949 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -98.76 122.0 7.39 Favored Glycine 0 N--CA 1.406 -3.342 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.966 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 3.4 t70 -58.62 -56.91 16.08 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -84.98 24.09 1.12 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.223 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.949 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.11 36.35 0.29 Allowed 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.762 ' CA ' ' HB1' ' A' ' 69' ' ' ALA . . . 38.31 -170.81 0.01 OUTLIER Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 139.7 49.9 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.728 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 1.7 m-85 -131.19 104.38 7.03 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.09 177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.553 HG13 HG13 ' A' ' 26' ' ' ILE . 5.0 t -95.03 115.17 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.495 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 25' ' ' SER . . . 62.89 8.28 21.18 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.422 -0.895 . . . . 0.0 112.038 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.5 m -82.86 172.69 12.56 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.362 0.265 . . . . 0.0 110.32 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -56.09 -54.33 46.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.063 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -65.39 8.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.879 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . -109.0 -33.37 6.92 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.1 OUTLIER -47.89 -17.28 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -50.01 -20.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 52.9 t -72.25 -13.22 61.46 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.74 -0.209 . . . . 0.0 111.106 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -26.52 64.52 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -9.0 58.46 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.941 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -70.41 0.67 6.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -67.37 -4.77 11.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.575 0.226 . . . . 0.0 111.082 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.5 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 10.3 m-30 -88.58 -143.37 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.455 0.302 . . . . 0.0 110.6 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.455 ' H ' ' HB3' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -102.27 98.07 9.81 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-O 120.566 0.222 . . . . 0.0 110.542 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 49' ' ' TYR . 83.9 Cg_exo -48.63 175.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.653 2.235 . . . . 0.0 112.828 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.637 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.9 t -174.06 132.74 0.55 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.66 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 52.8 Cg_endo -94.84 83.87 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.354 2.703 . . . . 0.0 113.385 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.471 ' HB2' ' CG ' ' A' ' 4' ' ' ASP . 26.3 p -125.74 -161.4 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.317 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.577 HE21 ' HE ' ' A' ' 20' ' ' ARG . 0.8 OUTLIER 56.64 161.04 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.624 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.579 ' OG ' ' HE3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER 60.24 -164.65 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.627 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.65 -127.82 2.84 Favored Glycine 0 CA--C 1.499 -0.962 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.483 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 mt-30 -75.33 88.15 2.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.807 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.2 OUTLIER -75.7 -34.36 1.52 Allowed Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.8 -177.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.807 ' CD ' ' N ' ' A' ' 59' ' ' LYS . 33.8 Cg_exo -41.32 155.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 125.258 3.972 . . . . 0.0 115.932 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -163.08 156.69 19.84 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.191 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.61 6.34 3.59 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.861 . . . . 0.0 113.846 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 73' ' ' CYS . 8.8 t -92.22 51.65 1.82 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 117.267 0.534 . . . . 0.0 111.142 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.16 30.68 61.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.878 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 163.55 -152.72 22.83 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 115.627 1.011 . . . . 0.0 115.627 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.3 mmt-85 -118.17 165.38 13.86 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.077 -0.562 . . . . 0.0 110.977 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 5.8 t -59.43 149.11 30.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -143.49 -25.6 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.966 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -161.32 -170.84 2.78 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 122.727 0.411 . . . . 0.0 111.786 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -41.0 86.58 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.058 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 55.96 67.71 2.07 Favored Glycine 0 N--CA 1.419 -2.485 0 C-N-CA 118.627 -1.749 . . . . 0.0 111.124 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 68' ' ' ALA . 3.4 mm -137.62 135.3 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 14.2 t -124.18 108.92 12.8 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.698 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 1.8 t -95.23 154.62 17.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.503 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.4 m -122.26 -179.37 0.76 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.837 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.5 Cg_exo -71.78 -9.66 25.2 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.38 2.053 . . . . 0.0 112.147 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.7 -34.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.568 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.32 169.77 38.86 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.812 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.645 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 9.3 m -99.13 164.95 11.95 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.369 0.604 . . . . 0.0 111.668 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.592 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -153.7 144.02 22.29 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.467 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.55 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pt-20 -61.7 116.63 4.94 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.778 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 41.0 p30 -97.34 107.01 36.12 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.001 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.724 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 57.7 Cg_exo -55.03 -13.84 7.25 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.569 2.846 . . . . 0.0 110.445 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 82' ' ' ASP . . . -72.71 -29.25 63.22 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.169 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.975 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -106.55 -30.11 9.24 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 -176.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.648 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 7.2 t70 174.66 -28.62 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.325 1 N-CA-C 122.27 4.174 . . . . 0.0 122.27 -177.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 1.058 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 9.2 Cg_endo -106.11 -70.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.525 0 C-N-CA 122.376 2.051 . . . . 0.0 112.276 -172.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.695 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 27.7 tt0 -70.27 -6.23 33.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.006 -1.906 . . . . 0.0 106.029 175.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.7 -155.54 0.06 Allowed 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 112.16 -2.291 . . . . 0.0 112.695 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.48 -178.48 0.52 Allowed 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.877 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.71 62.67 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 4.5 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.476 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.839 0.352 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -68.07 149.59 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.676 ' HG ' ' HG2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -71.91 170.02 14.62 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.677 0.751 . . . . 0.0 112.937 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 54' ' ' CYS . 40.9 t0 -82.43 -77.03 0.24 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.986 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.008 HD22 ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -148.95 -133.96 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.048 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 1.008 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -73.13 -38.52 66.26 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.626 ' CG2' HD11 ' A' ' 5' ' ' LEU . 27.2 m -97.69 104.44 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.051 0.453 . . . . 0.0 110.875 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.676 ' HG2' ' HG ' ' A' ' 3' ' ' LEU . 61.2 mtt85 -71.74 178.65 3.5 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 8' ' ' ARG . 1.2 m 67.09 108.2 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.546 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -45.86 177.37 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 112.245 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.018 HD22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 tp -71.23 139.9 84.97 Favored Pre-proline 0 C--O 1.24 0.565 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.368 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 26.4 Cg_exo -55.82 -171.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.923 1.749 . . . . 0.0 111.934 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.5 t -157.69 -176.67 6.07 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.687 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.515 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 64.93 -139.4 40.65 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.833 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.574 ' HD2' ' HG ' ' A' ' 32' ' ' LEU . 6.8 Cg_endo -91.78 95.23 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.667 3.578 . . . . 0.0 112.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.64 -72.08 0.78 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.85 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 12' ' ' PRO . . . 175.51 35.58 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.69 0.606 . . . . 0.0 111.985 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HG3' ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -71.89 -36.05 69.93 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.353 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -111.18 -167.3 18.74 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.829 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -164.79 -179.89 6.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.38 151.53 34.81 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.903 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 26' ' ' ILE . 12.7 m-85 -127.0 -24.53 3.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 26' ' ' ILE . . . -174.91 -105.75 0.19 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.292 -1.433 . . . . 0.0 114.466 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 38.8 Cg_endo -99.52 103.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.263 2.642 . . . . 0.0 112.789 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.39 24.68 2.25 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.775 0.321 . . . . 0.0 110.139 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.605 HD11 HG22 ' A' ' 36' ' ' VAL . 1.2 tt -112.18 162.28 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.976 0.893 . . . . 0.0 113.324 -177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -152.11 140.4 20.44 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.744 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -145.28 101.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.793 -177.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -88.58 120.0 5.54 Favored Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 32.3 t0 -58.4 -58.19 9.62 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.633 1.217 . . . . 0.0 108.211 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.526 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 3.4 pt-20 -81.34 6.33 14.68 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -136.65 37.34 2.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.338 -174.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.632 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 37.21 -172.08 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -121.01 136.4 54.99 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -177.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.793 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.1 OUTLIER -132.17 115.26 15.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.133 178.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.605 HG22 HD11 ' A' ' 26' ' ' ILE . 5.7 t -93.71 107.91 19.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.984 178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.96 24.82 55.27 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.808 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.793 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 2.1 m -94.38 175.24 6.76 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 122.568 0.347 . . . . 0.0 110.661 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -44.35 -59.12 2.55 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.998 0.428 . . . . 0.0 111.509 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -72.9 7.84 1.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -110.71 -22.74 11.43 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -54.69 -12.27 0.73 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -48.77 -24.7 1.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.22 0.463 . . . . 0.0 111.811 -179.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -75.56 -3.05 32.06 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.187 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.478 ' NE2' ' HB2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.38 -28.99 60.89 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.018 ' HG2' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -77.82 -15.23 59.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.19 179.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -77.38 0.39 22.63 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 23.1 p30 -117.71 -13.22 10.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.373 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -90.96 -5.65 55.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.691 0.282 . . . . 0.0 111.278 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -143.2 85.85 9.45 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.115 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -45.25 95.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.975 2.45 . . . . 0.0 112.77 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p -152.44 145.68 17.66 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -92.89 78.17 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.257 2.638 . . . . 0.0 111.762 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.66 ' HA ' ' HB2' ' A' ' 4' ' ' ASP . 15.2 p -65.65 -163.6 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.828 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.3 tp60 -143.02 148.29 36.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.268 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' A' ' 55' ' ' GLN . 12.5 m -115.08 -163.99 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.258 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.92 93.7 0.15 Allowed Glycine 0 CA--C 1.503 -0.711 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.019 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.679 ' NE2' ' HB2' ' A' ' 68' ' ' ALA . 1.4 mm-40 -114.4 89.56 3.12 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -63.66 104.73 0.54 Allowed Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.326 0.65 . . . . 0.0 110.315 177.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 74.6 Cg_exo -43.08 160.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.084 3.189 . . . . 0.0 117.779 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -165.54 153.41 10.99 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 113.329 -1.759 . . . . 0.0 110.33 177.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.9 4.65 5.37 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.736 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -90.91 52.48 2.17 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 117.183 0.491 . . . . 0.0 111.554 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.97 31.2 61.15 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.029 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.617 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 164.42 -154.42 25.25 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.889 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.709 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 6.9 mmt180 -115.79 153.09 32.07 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.078 0.466 . . . . 0.0 111.153 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 40.1 t -61.89 156.31 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.385 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.679 ' HB2' ' NE2' ' A' ' 58' ' ' GLN . . . -152.39 -92.67 0.05 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 30' ' ' ASP . . . -78.48 -170.5 2.08 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.924 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -46.82 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.96 ' HA3' ' HD3' ' A' ' 87' ' ' PRO . . . 56.43 65.43 3.57 Favored Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.537 -177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.716 HD13 ' C ' ' A' ' 80' ' ' GLU . 1.8 mm -134.44 143.26 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.5 t -131.46 104.7 7.13 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.5 t -91.85 158.6 16.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.397 1.628 . . . . 0.0 115.397 -173.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.506 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 1.6 m -127.1 -179.22 0.89 Allowed Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 113.248 -1.796 . . . . 0.0 109.287 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.506 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 13.3 Cg_exo -72.85 -9.97 24.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.278 1.985 . . . . 0.0 112.459 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.4 -33.04 8.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.458 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.4 168.91 35.84 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.517 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.594 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 15.1 m -96.12 166.59 11.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.457 0.646 . . . . 0.0 112.343 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.716 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -152.21 141.92 21.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.621 178.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.604 ' N ' HD13 ' A' ' 72' ' ' ILE . 1.4 pm0 -61.26 117.36 5.51 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 120.793 0.33 . . . . 0.0 110.411 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.729 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 50.8 p30 -100.16 108.19 51.04 Favored Pre-proline 0 N--CA 1.438 -1.062 0 CA-C-O 121.626 0.727 . . . . 0.0 111.18 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.698 ' HG3' ' HB3' ' A' ' 88' ' ' GLU . 66.0 Cg_exo -55.49 -16.09 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.07 3.18 . . . . 0.0 110.095 178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.26 64.95 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.09 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.866 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -108.75 -27.55 9.71 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 117.87 2.544 . . . . 0.0 117.87 -176.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.622 ' O ' ' OG ' ' A' ' 92' ' ' SER . 3.3 t70 173.67 -26.0 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.354 1 N-CA-C 122.853 4.39 . . . . 0.0 122.853 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.96 ' HD3' ' HA3' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -109.64 -72.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 -171.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.698 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 1.4 tt0 -70.62 -3.97 21.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.505 -1.679 . . . . 0.0 106.766 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.686 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -70.95 -160.82 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 112.448 -2.16 . . . . 0.0 114.892 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.679 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -65.31 -175.18 0.21 Allowed 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.335 -2.212 . . . . 0.0 108.308 176.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -65.84 66.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 90' ' ' ALA . 1.7 p . . . . . 0 C--O 1.251 1.147 0 CA-C-N 112.907 -1.951 . . . . 0.0 111.371 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.73 ' HA ' ' HA ' ' A' ' 52' ' ' SER . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.726 0.298 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 1' ' ' ALA . 3.4 m -157.07 -169.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.96 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HG ' ' NE ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -70.17 170.17 12.11 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.519 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.82 ' HB3' ' HA ' ' A' ' 8' ' ' ARG . 56.3 t0 -79.11 -127.77 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -93.61 -126.59 0.11 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.563 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -74.45 -54.91 6.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.633 ' H ' HD12 ' A' ' 5' ' ' LEU . 16.5 m -90.32 112.5 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.157 175.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 27.3 mtt85 -69.15 121.32 16.52 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.792 0.806 . . . . 0.0 113.067 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.557 ' H ' ' CB ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -173.96 56.68 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.829 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.513 ' HB3' ' CG ' ' A' ' 4' ' ' ASP . 5.3 p -109.88 34.5 3.81 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.797 HD13 ' HB2' ' A' ' 54' ' ' CYS . 4.1 tp -129.77 90.18 44.05 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 118.361 0.528 . . . . 0.0 110.966 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' CA ' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -73.55 177.25 8.23 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.619 2.213 . . . . 0.0 113.907 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 43' ' ' ARG . 2.9 t -155.16 -177.45 6.54 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.015 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.58 -134.48 47.46 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.509 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 18' ' ' LYS . 14.0 Cg_endo -89.56 101.3 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.603 3.536 . . . . 0.0 112.677 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.68 -66.04 3.79 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.015 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 178.06 32.66 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 121.529 0.516 . . . . 0.0 112.324 178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.41 -36.11 73.84 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.972 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' A' ' 13' ' ' CYS . . . -108.36 -171.27 21.38 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.226 178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.742 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -160.73 177.87 10.03 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.538 ' SG ' HD23 ' A' ' 11' ' ' LEU . 11.4 m -79.01 163.81 24.88 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CE1' ' HG3' ' A' ' 20' ' ' ARG . 35.1 m-85 -141.55 -30.79 0.59 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.529 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -170.78 -103.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.459 -1.353 . . . . 0.0 113.886 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 29.5 Cg_endo -101.32 102.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.485 2.79 . . . . 0.0 112.971 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.36 23.54 2.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.4 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 22' ' ' PHE . 1.5 tt -111.57 159.28 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 122.0 0.905 . . . . 0.0 112.882 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -150.84 140.38 21.56 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.859 -1.518 . . . . 0.0 108.504 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.708 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.99 99.23 3.3 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.759 -176.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.956 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.43 117.55 4.51 Favored Glycine 0 N--CA 1.406 -3.307 0 C-N-CA 118.973 -1.584 . . . . 0.0 110.058 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 16.6 t0 -59.03 -57.42 13.17 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CD ' ' HG3' ' A' ' 18' ' ' LYS . 1.6 pt-20 -82.02 11.98 4.61 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.956 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -145.17 37.89 1.15 Allowed 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -175.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 36.35 -178.15 0.01 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.719 0.648 . . . . 0.0 114.719 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 1.5 t -114.84 136.76 52.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -177.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.804 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -133.12 119.34 19.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.278 177.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 26' ' ' ILE . 5.6 t -91.84 103.21 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.106 178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.66 47.98 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.829 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.779 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m -86.27 -176.94 6.11 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.217 0.607 . . . . 0.0 110.025 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -50.13 -58.8 4.77 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.861 0.362 . . . . 0.0 111.321 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -72.02 -2.32 17.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.804 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -102.65 -21.14 14.18 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -50.29 -14.65 0.18 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -51.19 -23.63 3.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.433 0.56 . . . . 0.0 111.3 179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -13.95 60.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.159 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.608 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -60.55 -22.74 63.99 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -74.6 -24.05 58.82 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 19.9 tp10 -83.0 22.77 0.9 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.105 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -158.57 0.25 0.09 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.259 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.2 m-30 -132.41 -9.84 3.26 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.598 0.237 . . . . 0.0 110.936 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 102.47 5.67 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.439 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -42.27 101.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.789 2.326 . . . . 0.0 112.801 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.73 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 5.3 t -163.74 93.6 1.07 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.031 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.69 69.76 5.03 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.486 2.124 . . . . 0.0 113.02 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.797 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.27 -162.99 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.731 ' HB2' ' HB3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -131.19 176.89 7.89 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -135.37 -153.27 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.3 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.61 118.77 0.82 Allowed Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.018 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -130.15 89.41 2.79 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -61.53 104.32 0.46 Allowed Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.568 178.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 47.2 Cg_exo -43.32 158.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.287 3.325 . . . . 0.0 117.406 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -163.93 153.38 14.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.91 -1.495 . . . . 0.0 110.3 177.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.52 3.69 4.55 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.331 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.3 t -91.42 57.08 3.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 117.656 0.728 . . . . 0.0 111.268 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.65 34.46 50.14 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 114.03 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.749 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 161.0 -154.38 25.37 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD3' ' C ' ' A' ' 65' ' ' GLY . 4.8 mmt180 -115.62 154.6 29.16 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.3 -0.45 . . . . 0.0 111.21 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 38.0 t -62.0 158.19 16.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.171 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HB1' ' HB3' ' A' ' 28' ' ' CYS . . . -155.3 -95.31 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HB3' HG13 ' A' ' 72' ' ' ILE . . . -76.43 -171.23 1.74 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.994 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -42.48 86.51 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.774 0.671 . . . . 0.0 109.341 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.924 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 56.72 67.38 2.25 Favored Glycine 0 N--CA 1.425 -2.073 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.4 -177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' A' ' 69' ' ' ALA . 2.2 mm -132.8 145.98 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 21.2 t -132.09 104.27 6.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 1.7 t -87.46 141.56 28.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -173.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.519 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 2.1 m -105.23 -179.76 0.8 Allowed Pre-proline 0 N--CA 1.446 -0.641 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.817 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.519 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 12.0 Cg_exo -73.08 -11.39 25.26 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.584 2.19 . . . . 0.0 112.523 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 -31.85 7.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.58 170.04 39.39 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.224 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 74' ' ' CYS . 6.3 m -93.83 166.14 12.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.533 0.682 . . . . 0.0 112.326 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.605 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.16 141.45 21.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.654 179.068 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.554 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.26 117.67 5.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.063 0.458 . . . . 0.0 110.568 -179.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.724 ' OD1' ' HB2' ' A' ' 85' ' ' CYS . 50.6 p30 -99.56 110.02 57.23 Favored Pre-proline 0 N--CA 1.44 -0.974 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.91 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.746 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 50.3 Cg_exo -56.93 -14.85 15.21 Favored 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 124.099 3.199 . . . . 0.0 109.764 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.63 -27.5 62.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.255 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.924 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -111.07 -27.56 8.69 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -175.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 5.0 t70 173.05 -29.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.413 1 N-CA-C 122.311 4.189 . . . . 0.0 122.311 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 9.4 Cg_endo -106.22 -71.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 112.576 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.601 ' HB3' ' HG3' ' A' ' 83' ' ' PRO . 0.5 OUTLIER -69.35 -5.77 25.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' CA ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.36 -157.94 0.09 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 111.741 -2.481 . . . . 0.0 111.941 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -66.2 -178.9 0.69 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.066 -1.424 . . . . 0.0 107.682 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -74.17 62.4 0.92 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 86' ' ' ASP . 2.8 t . . . . . 0 C--O 1.249 1.043 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.787 -178.742 . . . . . . . . 1 1 . 1 stop_ save_